data_1t6w_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1t6w _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.718 HG13 ' HA ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.486 0 CA-C-O 120.657 0.265 . . . . 0.0 110.432 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -117.68 131.46 56.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.895 0.378 . . . . 0.0 110.92 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.96 -178.04 19.36 Favored Glycine 0 C--O 1.229 -0.163 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.562 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.429 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.23 134.09 48.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.995 0.426 . . . . 0.0 111.178 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.62 130.88 47.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.837 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.89 -7.18 81.55 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.507 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.531 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.88 167.64 9.84 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.6 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.68 -172.69 12.23 Favored Glycine 0 C--O 1.226 -0.366 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.607 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER 163.29 136.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.432 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -120.83 122.13 39.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.545 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.471 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -79.07 103.47 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.788 179.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -87.74 122.25 31.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.226 0.536 . . . . 0.0 112.186 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.445 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.3 mt -79.9 119.91 78.2 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.158 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.11 131.04 36.95 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.272 1.982 . . . . 0.0 112.829 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.4 m120 43.56 65.28 1.02 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -142.71 149.4 38.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.766 0.317 . . . . 0.0 110.576 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -142.88 104.49 4.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.905 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.78 75.2 0.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.83 -173.53 2.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.76 -31.07 62.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.017 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -64.12 -26.64 68.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.966 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 mm -86.04 127.06 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.437 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.406 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -112.32 -42.72 3.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.081 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 36.0 tt0 -126.46 117.28 22.58 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.433 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.9 t -116.88 107.62 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.149 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -105.44 134.76 48.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.233 0.539 . . . . 0.0 112.034 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.471 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 69.0 m95 -112.39 88.1 2.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.209 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -102.11 146.35 28.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.253 0.549 . . . . 0.0 112.295 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.5 116.22 12.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.527 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.14 -116.34 8.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.745 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 p -116.5 43.4 2.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.768 0.318 . . . . 0.0 110.642 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.2 m -152.86 159.76 43.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.271 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.51 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.6 mt -102.43 148.56 25.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.808 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.7 t -119.57 -43.53 2.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.256 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -167.2 113.23 0.76 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.547 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -120.61 113.54 20.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.226 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.3 t80 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.742 179.764 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 0 N--CA 1.463 -0.288 0 CA-C-O 120.557 0.149 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.51 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 70.1 t80 -125.71 101.93 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.688 0.28 . . . . 0.0 111.51 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 mt -98.08 110.99 23.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.423 . . . . 0.0 109.879 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -43.83 -39.5 3.89 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.82 0.343 . . . . 0.0 111.365 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.05 165.97 0.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.943 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.84 -10.56 2.37 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.371 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.88 2.15 10.97 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 117.819 0.809 . . . . 0.0 112.343 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -134.05 156.93 47.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.153 0.502 . . . . 0.0 111.261 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -152.35 118.54 5.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.191 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.409 ' O ' ' CG2' ' A' ' 57' ' ' ILE . 6.6 tt -73.96 101.62 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.122 0.487 . . . . 0.0 111.388 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.6 169.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.177 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.8 -25.06 65.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.581 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -97.06 33.25 1.96 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.753 0.311 . . . . 0.0 111.122 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.55 30.51 65.39 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.672 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.99 170.47 9.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 111.096 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 tp -110.08 119.24 38.65 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.469 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.73 110.94 23.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.742 0.306 . . . . 0.0 110.746 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.43 ' CG1' HG21 ' A' ' 14' ' ' ILE . 2.6 mt -89.42 138.53 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.468 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -84.26 -49.17 9.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.009 0.433 . . . . 0.0 111.875 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.26 110.65 5.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.494 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.429 ' CD1' ' O ' ' A' ' 9' ' ' ALA . 5.1 mt -54.09 147.9 11.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.273 0.559 . . . . 0.0 111.779 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.0 p -152.3 169.41 22.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.485 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -51.33 -52.89 41.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.477 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -56.06 -21.65 23.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.597 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.12 -14.87 52.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.549 0.214 . . . . 0.0 111.498 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -82.82 117.84 22.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.678 0.275 . . . . 0.0 110.601 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.95 -166.26 33.43 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.17 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.44 126.39 39.68 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 122.507 0.323 . . . . 0.0 111.266 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -102.95 148.41 25.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.358 -0.383 . . . . 0.0 109.982 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -129.67 126.17 37.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 0.0 111.707 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.445 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -111.99 132.67 59.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.025 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.03 96.85 5.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.588 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.417 HG11 ' HB ' ' A' ' 88' ' ' ILE . 76.0 t -85.58 128.61 39.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.301 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.511 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.5 m-85 -119.25 153.02 35.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.068 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.25 175.42 7.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.355 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.406 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.1 p -62.69 -28.4 69.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.994 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -77.62 -4.49 46.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.427 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.6 27.91 45.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.6 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.33 165.5 11.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.867 0.365 . . . . 0.0 110.764 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.53 127.08 31.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.592 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.417 ' HB ' HG11 ' A' ' 80' ' ' VAL . 33.0 mm -104.12 -67.31 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.372 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tt -137.37 127.17 25.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.132 0.492 . . . . 0.0 111.799 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -115.75 106.69 14.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.199 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -117.19 161.96 18.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.372 0.606 . . . . 0.0 112.526 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.95 122.07 12.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.993 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.418 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -120.25 156.22 31.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.937 0.399 . . . . 0.0 111.679 -179.045 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.78 110.72 22.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.17 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.718 ' HA ' HG13 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -101.73 98.2 8.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.286 -179.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -92.78 121.83 34.56 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 110.743 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.439 ' CD1' HD23 ' A' ' 95' ' ' LEU . 2.9 mm -107.24 116.38 50.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.991 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.3 mt . . . . . 0 N--CA 1.439 -0.979 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.467 179.044 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.701 HG11 ' HA ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 120.8 0.333 . . . . 0.0 110.737 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.481 ' CD2' ' HD3' ' A' ' 96' ' ' ARG . 79.1 m95 -110.85 129.65 55.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.689 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.41 -179.9 26.58 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.062 -1.066 . . . . 0.0 112.969 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.426 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.15 134.55 49.1 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.95 0.405 . . . . 0.0 110.962 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 70' ' ' ARG . 1.4 tp -55.81 133.27 51.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.41 -5.72 84.4 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.47 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.523 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -110.61 168.71 9.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.596 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -72.3 -169.4 12.76 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.5 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER 160.36 136.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 122.647 0.379 . . . . 0.0 110.347 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -118.71 130.1 55.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.949 0.404 . . . . 0.0 111.299 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.94 106.45 18.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.765 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -88.85 123.86 33.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.165 0.507 . . . . 0.0 111.867 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.443 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.4 mt -79.89 119.86 78.05 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.284 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.93 131.3 38.75 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.325 2.017 . . . . 0.0 112.856 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 43.04 65.42 0.96 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -142.65 149.31 38.73 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.579 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -139.26 117.46 11.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -80.24 80.98 6.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.38 -174.23 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.843 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.23 -30.86 62.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.991 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -62.19 -27.86 69.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.962 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.1 mm -88.21 127.21 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.369 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.408 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -113.13 -42.27 3.57 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.053 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 45.9 tt0 -123.94 115.91 22.03 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.365 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.41 112.79 42.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.829 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -111.01 130.6 55.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.024 0.44 . . . . 0.0 112.149 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.401 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 69.4 m95 -112.03 84.06 1.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.934 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -100.73 153.77 19.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.338 0.59 . . . . 0.0 112.297 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.34 116.14 8.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.676 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.24 -117.76 11.43 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.207 -0.997 . . . . 0.0 111.88 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.07 42.61 2.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.818 0.342 . . . . 0.0 110.738 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.1 m -151.14 160.26 43.97 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.155 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.497 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 6.0 mt -104.97 146.08 29.53 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.424 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 52.8 t -117.1 -42.94 3.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.983 0.42 . . . . 0.0 110.227 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -165.76 111.86 0.89 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.519 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -120.77 117.02 26.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.203 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 23.8 t80 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.648 179.867 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 N--CA 1.463 -0.308 0 CA-C-O 120.878 0.283 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.497 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 58.9 t80 -131.39 103.47 6.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.202 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.3 mt -97.6 111.87 23.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.081 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 33.6 tttm -45.2 -42.64 9.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.745 0.307 . . . . 0.0 111.527 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.8 p -176.63 165.79 2.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.888 0.375 . . . . 0.0 111.154 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.14 -11.34 4.62 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.158 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.17 2.19 11.47 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 117.707 0.753 . . . . 0.0 112.098 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -133.15 157.16 46.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.074 0.464 . . . . 0.0 111.184 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -153.92 120.18 5.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.331 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.41 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 7.9 tt -74.93 99.94 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 0.0 111.282 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.68 163.39 0.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.209 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.88 -22.0 65.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.458 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -96.53 31.91 2.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.761 0.315 . . . . 0.0 111.096 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.66 35.65 68.18 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.901 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.06 157.19 21.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.836 0.35 . . . . 0.0 111.033 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.95 123.25 36.07 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.782 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -108.24 108.57 19.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.693 0.283 . . . . 0.0 110.919 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.407 ' CD1' ' CG2' ' A' ' 14' ' ' ILE . 3.2 mt -88.1 137.47 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.404 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -87.82 -45.98 9.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.974 0.416 . . . . 0.0 111.829 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.53 109.21 5.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.481 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.443 ' HB3' ' CG2' ' A' ' 97' ' ' ILE . 5.7 mt -57.37 152.5 14.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.178 0.514 . . . . 0.0 111.564 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.5 p -154.11 161.35 41.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.136 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.408 ' N ' HD12 ' A' ' 10' ' ' LEU . 26.2 mmm180 -50.62 -56.18 12.98 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.247 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -54.85 -22.19 13.79 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.465 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.39 -15.09 56.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.307 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.8 p -83.13 132.19 35.1 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.72 0.295 . . . . 0.0 110.733 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.45 -131.34 3.25 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.344 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -128.81 130.48 47.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.722 0.761 . . . . 0.0 110.627 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -105.08 148.51 26.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.219 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -130.73 122.35 27.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.767 0.318 . . . . 0.0 111.374 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.443 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -105.75 129.04 59.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.232 179.267 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.6 97.8 6.34 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.655 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.402 HG12 ' HB ' ' A' ' 88' ' ' ILE . 87.2 t -89.36 129.92 39.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.335 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.51 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 96.9 m-85 -123.87 154.01 40.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.403 0.62 . . . . 0.0 111.188 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.79 175.31 7.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.352 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 2.1 p -62.13 -21.69 65.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.115 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -96.27 25.6 4.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.161 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.95 27.72 51.51 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.69 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.15 156.84 16.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.319 . . . . 0.0 110.866 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -77.38 110.26 11.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.783 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.402 ' HB ' HG12 ' A' ' 80' ' ' VAL . 33.3 mm -91.46 -48.33 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.293 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 tt -154.57 149.85 27.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.277 0.56 . . . . 0.0 111.709 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -141.11 108.58 5.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.289 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.59 157.33 30.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.416 0.627 . . . . 0.0 112.598 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.0 124.59 18.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.126 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.41 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -122.34 164.82 17.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.036 0.446 . . . . 0.0 111.674 -179.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -111.94 124.21 51.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.239 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.701 ' HA ' HG11 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -108.84 113.61 26.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.419 -179.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.481 ' HD3' ' CD2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -113.21 117.13 31.02 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.193 0.52 . . . . 0.0 110.447 178.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.443 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 1.2 mt -108.61 110.28 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.924 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.5 mt . . . . . 0 N--CA 1.439 -0.979 0 CA-C-O 121.077 0.465 . . . . 0.0 110.219 178.906 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.653 HG11 ' HA ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 120.751 0.31 . . . . 0.0 110.724 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -120.27 130.16 54.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.56 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.9 -179.02 24.46 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.904 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.405 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -132.09 134.85 45.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.071 0.462 . . . . 0.0 111.226 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 70' ' ' ARG . 0.7 OUTLIER -52.84 136.22 34.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.031 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.2 -9.6 72.15 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.702 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.527 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.44 168.35 9.3 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.6 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -71.95 -170.94 14.65 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.424 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER 162.03 136.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.815 0.34 . . . . 0.0 110.43 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -123.72 130.43 52.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.402 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.425 HD12 ' HG ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -84.27 135.73 34.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.692 179.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -116.39 122.02 43.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.275 0.559 . . . . 0.0 111.813 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.445 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.2 mt -81.46 119.6 76.02 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.245 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.65 130.87 37.19 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.364 2.043 . . . . 0.0 112.999 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.0 m120 42.78 65.07 1.0 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -141.43 149.3 40.83 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.772 0.32 . . . . 0.0 110.559 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -137.91 117.43 12.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.939 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.7 tpt -79.57 75.39 6.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.972 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.7 p -107.44 -173.16 2.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.99 -32.34 70.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -59.24 -27.04 65.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.98 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 mm -78.81 128.1 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.492 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.3 -44.32 3.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 73.3 tt0 -130.31 116.32 18.18 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.172 -0.611 . . . . 0.0 112.537 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.42 111.24 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.743 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 6.5 mtp180 -108.18 130.31 55.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.178 0.513 . . . . 0.0 112.239 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -112.68 84.65 2.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.9 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.35 154.16 19.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.316 0.579 . . . . 0.0 112.247 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.403 ' HD3' ' CZ ' ' A' ' 76' ' ' TYR . 10.3 ttp-105 -143.96 118.32 9.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.602 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.01 -117.64 10.9 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.829 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.1 m -115.99 43.02 2.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.743 0.306 . . . . 0.0 110.739 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.7 m -151.14 160.06 44.09 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.171 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.504 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 6.0 mt -103.73 145.66 29.76 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.7 t -117.5 -43.42 3.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.153 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -166.06 111.31 0.84 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.752 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -117.66 112.42 20.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.042 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.1 t80 . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.85 179.928 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo . . . . . 0 N--CA 1.463 -0.29 0 CA-C-O 120.898 0.291 . . . . 0.0 112.607 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 71.1 t80 -137.49 105.46 5.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.352 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.1 mt -99.73 112.26 24.52 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -44.53 -45.87 9.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.725 0.298 . . . . 0.0 111.368 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.87 166.69 2.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.94 0.4 . . . . 0.0 111.112 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.77 -11.61 2.13 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.401 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.49 2.01 10.58 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 117.79 0.795 . . . . 0.0 112.296 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -135.46 157.16 47.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.084 0.468 . . . . 0.0 111.284 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -153.32 122.06 6.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.249 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.412 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 6.4 tt -76.0 101.52 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.152 0.501 . . . . 0.0 111.213 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.35 160.35 1.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.138 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.19 -21.97 66.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.404 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -96.13 32.81 1.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.052 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.71 34.37 56.25 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.778 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.26 155.3 22.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.866 0.365 . . . . 0.0 111.028 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 tp -92.95 122.71 35.59 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.821 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -108.04 110.06 21.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.71 0.29 . . . . 0.0 110.863 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.421 ' CD1' HG23 ' A' ' 14' ' ' ILE . 2.8 mt -89.18 138.79 18.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.408 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -86.69 -47.67 8.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.008 0.432 . . . . 0.0 111.91 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -142.73 110.73 5.96 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.335 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.46 ' CD2' HG12 ' A' ' 97' ' ' ILE . 7.2 mt -55.65 150.77 11.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.308 0.575 . . . . 0.0 111.795 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 p -153.36 161.42 42.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.813 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.43 ' N ' HD12 ' A' ' 10' ' ' LEU . 1.5 ptp180 -50.91 -54.84 20.64 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.429 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -57.43 -20.64 31.53 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.459 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.76 -15.53 51.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.389 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.8 t -82.78 130.69 35.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.582 0.23 . . . . 0.0 110.446 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.51 -166.25 29.63 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.172 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.7 126.4 36.77 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 122.522 0.329 . . . . 0.0 111.538 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.403 ' CZ ' ' HD3' ' A' ' 34' ' ' ARG . 18.9 m-85 -102.93 151.83 22.01 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -131.52 125.77 33.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.754 0.312 . . . . 0.0 111.492 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.445 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -110.1 130.8 62.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.211 179.155 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.02 98.46 6.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.512 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.5 t -91.46 125.73 44.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.748 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.431 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.5 m-85 -118.39 152.79 35.18 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.91 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.67 172.32 8.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.567 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 16.9 p -60.04 -19.46 52.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.377 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -93.97 25.27 3.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.233 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.59 20.95 40.63 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.787 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.62 166.08 11.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.703 0.287 . . . . 0.0 110.696 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -90.89 120.19 31.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.731 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.3 mt -90.71 -58.87 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.498 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.7 tt -147.83 133.68 19.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.117 0.484 . . . . 0.0 111.879 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.23 109.61 15.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.923 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -121.5 162.66 20.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.01 121.95 14.52 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.047 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.405 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -113.76 164.71 13.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.03 0.443 . . . . 0.0 111.737 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -114.73 111.82 21.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.271 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.653 ' HA ' HG11 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -99.22 99.38 10.34 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.245 -179.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.73 120.47 40.14 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.004 0.431 . . . . 0.0 110.455 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.46 HG12 ' CD2' ' A' ' 68' ' ' LEU . 1.7 mt -128.42 129.13 68.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.794 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 N--CA 1.436 -1.134 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.71 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.733 HG13 ' HA ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.521 0 CA-C-O 120.708 0.289 . . . . 0.0 110.717 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -115.89 127.91 55.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.525 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.75 -178.8 21.52 Favored Glycine 0 N--CA 1.459 0.171 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.705 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.429 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.96 134.68 48.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.069 0.461 . . . . 0.0 111.287 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.402 ' HA ' ' CB ' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -55.62 134.82 51.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.741 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.66 -8.58 77.02 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.456 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.53 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -106.95 167.16 10.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.615 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.41 -173.85 14.06 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.551 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.615 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER 161.24 136.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 122.579 0.352 . . . . 0.0 110.367 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -124.85 123.78 40.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.955 0.407 . . . . 0.0 111.525 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.432 HD11 ' HG ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -79.07 112.19 16.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.744 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -93.76 124.89 38.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.191 0.52 . . . . 0.0 111.884 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.442 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.3 mt -81.64 120.04 76.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.252 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.01 131.12 37.63 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.278 1.985 . . . . 0.0 112.901 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.9 m120 43.12 65.16 1.01 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -142.14 149.37 39.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.758 0.313 . . . . 0.0 110.607 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -138.83 117.41 12.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.1 tpt -81.17 76.22 8.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 46.8 p -111.43 -173.03 2.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -57.8 -30.52 65.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.966 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -62.1 -28.12 69.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.6 mm -87.74 126.8 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.383 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.73 -41.92 3.71 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 61.3 tt0 -125.84 118.32 25.24 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.28 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 30.9 t -121.32 117.69 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.019 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.449 ' NH1' ' CE2' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -115.81 136.94 52.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.266 0.555 . . . . 0.0 112.223 -178.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.478 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 74.8 m95 -112.12 87.38 2.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.702 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -101.05 149.91 23.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.355 0.598 . . . . 0.0 112.283 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.7 ttp85 -142.13 117.59 10.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.462 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.81 -115.65 7.13 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.737 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 t -118.59 44.35 2.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.786 0.327 . . . . 0.0 110.683 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.3 m -151.94 160.39 43.51 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.328 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.49 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.5 mt -103.25 146.89 27.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 56.1 t -119.01 -43.52 2.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.959 0.409 . . . . 0.0 110.476 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -174.73 114.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.045 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 1.1 pt-20 -128.35 156.04 43.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.009 0.433 . . . . 0.0 110.947 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 57.0 t80 . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.871 -179.723 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.923 0.301 . . . . 0.0 112.585 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.49 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 33.8 t80 -115.86 101.85 9.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.34 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mt -91.29 116.22 28.66 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 12.1 tptm -38.88 -90.33 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.729 0.641 . . . . 0.0 112.729 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 m -117.41 22.68 12.28 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.76 -0.03 52.77 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.089 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.32 5.33 27.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 117.53 0.665 . . . . 0.0 111.02 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -126.24 158.22 36.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.024 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -138.71 119.55 14.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.147 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.416 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 7.4 tt -78.13 99.67 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.182 0.515 . . . . 0.0 111.064 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.47 153.14 7.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.279 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.32 -19.79 56.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.475 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.24 31.94 2.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.861 0.363 . . . . 0.0 111.043 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.37 36.35 57.64 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.847 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -112.97 157.88 20.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.023 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 tp -95.2 122.49 37.93 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.125 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.26 104.71 13.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.715 0.293 . . . . 0.0 110.696 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.437 ' CG1' HG21 ' A' ' 14' ' ' ILE . 2.6 mt -81.02 134.59 26.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.774 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -78.28 -49.06 14.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.09 0.471 . . . . 0.0 111.513 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.53 112.99 5.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.134 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.429 ' CD1' ' O ' ' A' ' 9' ' ' ALA . 5.8 mt -52.73 148.37 7.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.261 0.553 . . . . 0.0 111.873 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 p -152.13 163.1 40.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.78 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -55.22 17.91 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.291 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -52.66 -22.95 5.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.614 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -82.99 -13.87 55.13 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.571 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.7 t -83.45 119.96 25.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.672 0.272 . . . . 0.0 110.582 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.46 -139.06 5.85 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.467 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 m -120.32 130.86 54.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 117.382 0.591 . . . . 0.0 110.648 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.428 ' CE1' HD12 ' A' ' 95' ' ' LEU . 23.0 m-85 -106.43 151.27 25.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.386 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -134.47 121.81 21.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.332 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.442 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -106.8 133.46 51.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.24 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.28 103.6 9.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.549 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 91.1 t -93.81 129.28 44.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.689 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.8 m-85 -121.44 153.64 37.61 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.998 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.99 176.45 7.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.336 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.0 p -64.63 -28.67 69.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.979 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -77.3 -4.53 45.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.421 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.62 27.33 43.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.536 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.6 165.68 11.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 110.783 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.98 134.13 38.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.568 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 37.8 mm -111.52 -66.64 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.397 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 tt -141.09 128.76 21.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.1 0.476 . . . . 0.0 111.845 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.47 107.22 14.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.177 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -118.1 158.57 24.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.389 0.614 . . . . 0.0 112.536 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.63 125.79 18.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.152 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.415 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -125.32 161.53 26.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.047 0.451 . . . . 0.0 111.65 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -110.32 116.85 32.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.228 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.733 ' HA ' HG13 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -104.8 103.76 13.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.308 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.46 115.26 28.88 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 110.692 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.1 mt -106.4 111.79 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.557 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 N--CA 1.437 -1.114 0 CA-C-O 121.246 0.546 . . . . 0.0 110.734 179.692 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.702 HG13 ' HA ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 120.64 0.257 . . . . 0.0 110.642 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -118.84 131.15 56.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.29 -178.53 19.19 Favored Glycine 0 N--CA 1.459 0.21 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.508 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.444 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -126.48 133.25 51.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.048 0.452 . . . . 0.0 111.313 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.408 ' CD1' ' HA ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -55.6 131.06 45.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.874 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.51 -6.42 83.22 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.452 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.524 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.05 167.66 9.84 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.594 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.4 -172.93 11.85 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.597 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.594 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER 163.31 136.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.773 0.32 . . . . 0.0 110.354 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -121.75 122.47 39.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.936 0.398 . . . . 0.0 111.476 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.448 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -77.96 108.82 11.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.773 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -93.3 123.11 36.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.176 0.513 . . . . 0.0 111.967 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.429 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.3 mt -79.37 119.47 77.12 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.262 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.54 131.21 36.94 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.393 2.062 . . . . 0.0 112.976 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 43.27 64.74 1.13 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -140.21 149.07 42.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.834 0.35 . . . . 0.0 110.497 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -132.9 116.72 16.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.1 90.01 7.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.8 p -125.84 -173.04 2.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.937 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.27 -30.53 64.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.941 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -62.07 -25.59 67.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.992 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 mm -79.34 128.47 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.509 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.2 -38.82 7.52 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.234 -0.291 . . . . 0.0 111.325 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 12.7 mt-10 -142.6 153.75 43.78 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-O 121.581 0.705 . . . . 0.0 112.355 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.8 t -148.26 116.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.162 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 4.5 mtm180 -112.24 134.1 53.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.071 0.462 . . . . 0.0 112.05 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.448 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 73.3 m95 -112.33 85.07 2.08 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -102.47 148.17 25.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.3 0.571 . . . . 0.0 112.22 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.04 118.75 13.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.557 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.91 -116.37 8.17 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.773 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.9 m -117.66 43.88 2.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.769 0.319 . . . . 0.0 110.71 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.7 m -152.88 160.0 43.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.265 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.505 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.8 mt -102.79 147.19 27.17 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.798 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.436 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 50.0 t -118.47 -42.92 2.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.285 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -167.47 112.17 0.7 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.597 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -118.51 119.32 34.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.969 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 49.1 t80 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.705 179.941 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo . . . . . 0 N--CA 1.463 -0.284 0 CA-C-O 120.897 0.29 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 68.7 t80 -136.82 104.24 5.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.284 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.1 mt -98.01 110.78 23.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.02 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 28.8 tttm -45.29 -40.58 7.8 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.77 0.319 . . . . 0.0 111.533 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 p -178.21 164.61 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 111.205 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.75 -11.73 4.42 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.166 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.83 1.6 12.21 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 117.593 0.697 . . . . 0.0 112.155 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -131.99 156.97 45.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.184 0.516 . . . . 0.0 111.262 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -151.82 117.24 5.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.196 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.404 ' O ' ' CG2' ' A' ' 57' ' ' ILE . 9.2 tt -73.83 99.48 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.321 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.12 166.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.163 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.9 -23.96 65.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.637 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -96.76 33.33 1.88 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.796 0.331 . . . . 0.0 111.16 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.75 33.9 69.12 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.621 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.08 165.79 10.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.868 0.366 . . . . 0.0 111.012 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 10.3 tp -107.0 119.71 40.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.518 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -105.75 111.25 23.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.309 . . . . 0.0 110.996 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.416 ' CG1' HG21 ' A' ' 14' ' ' ILE . 2.7 mt -90.93 138.22 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.449 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -84.16 -48.19 10.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.066 0.46 . . . . 0.0 111.896 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.11 111.35 5.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.312 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.444 ' CD1' ' O ' ' A' ' 9' ' ' ALA . 4.9 mt -53.61 147.22 11.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.22 0.533 . . . . 0.0 111.736 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.408 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 5.3 p -147.59 160.88 42.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.852 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.74 -56.43 12.04 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.093 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.6 -22.7 9.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.428 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.54 -15.24 57.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.627 0.251 . . . . 0.0 111.308 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.4 t -81.58 120.79 25.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.591 0.234 . . . . 0.0 110.578 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.98 -144.43 9.88 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.373 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.9 m -115.65 130.62 56.93 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.056 0.428 . . . . 0.0 110.663 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -108.26 133.23 52.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.24 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -114.98 124.37 51.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.458 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.429 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -107.02 133.52 51.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.192 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.36 96.37 5.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.695 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.9 t -86.74 126.9 40.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.234 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.488 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 2.6 m-30 -112.8 151.33 30.48 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.346 0.593 . . . . 0.0 110.612 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.42 178.99 5.53 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.199 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 73.5 p -68.51 -23.51 64.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.044 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -75.91 -5.22 45.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.592 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.29 24.57 47.08 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.666 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.64 -170.59 1.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.757 0.313 . . . . 0.0 110.683 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -105.31 115.62 30.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.971 0.415 . . . . 0.0 110.811 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 74.4 mt -78.89 -51.66 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.343 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.83 136.25 16.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.204 0.526 . . . . 0.0 111.9 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.4 106.98 13.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.884 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -116.48 156.97 25.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.14 122.45 18.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.132 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.409 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -117.98 159.41 23.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.896 0.379 . . . . 0.0 111.538 -179.239 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -109.16 110.76 22.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.381 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.702 ' HA ' HG13 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -102.27 100.2 10.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.071 -179.451 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -95.16 123.43 38.66 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.071 0.462 . . . . 0.0 110.89 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.429 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 2.9 mm -107.81 117.47 53.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.999 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 N--CA 1.439 -0.988 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.422 179.205 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.637 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 120.648 0.261 . . . . 0.0 110.855 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -121.89 136.39 54.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.033 0.444 . . . . 0.0 111.255 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.45 178.68 28.65 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.303 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.442 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.03 133.8 49.15 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.049 0.452 . . . . 0.0 111.221 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.41 ' HA ' ' CB ' ' A' ' 68' ' ' LEU . 1.2 tp -53.51 134.88 40.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.65 -10.94 71.81 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.632 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.524 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -106.66 168.0 9.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.594 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -72.02 -169.61 12.37 Favored Glycine 0 C--O 1.227 -0.315 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.491 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.594 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER 163.79 136.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.963 0.411 . . . . 0.0 110.632 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -117.97 130.1 56.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.043 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.5 102.99 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -88.68 123.5 33.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.174 0.511 . . . . 0.0 112.3 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.449 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.3 mt -79.2 119.96 78.95 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.022 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.03 131.04 37.15 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.262 1.975 . . . . 0.0 112.903 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 43.38 65.09 1.04 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -142.03 150.9 41.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.79 0.328 . . . . 0.0 110.595 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -139.44 117.75 12.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -82.78 78.37 9.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.7 p -112.51 -173.02 2.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -57.9 -30.66 66.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.967 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.49 -27.74 68.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.971 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.4 mm -84.38 127.62 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.447 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.5 OUTLIER -111.63 -44.08 3.55 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.247 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 45.8 tp10 -123.69 121.27 35.07 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.187 -0.605 . . . . 0.0 112.117 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.82 114.25 42.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.904 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -112.85 132.38 55.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.133 0.492 . . . . 0.0 112.289 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.416 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 71.7 m95 -113.3 87.77 2.68 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -101.7 148.13 25.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.313 0.578 . . . . 0.0 112.478 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -139.26 116.46 11.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.522 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.07 -116.52 8.46 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.729 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.5 t -117.39 43.87 2.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.866 0.365 . . . . 0.0 110.651 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.0 m -152.27 160.38 43.36 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.224 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.499 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.8 mt -101.7 146.5 27.65 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.443 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 52.9 t -118.52 -43.02 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.97 0.414 . . . . 0.0 110.199 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -166.6 110.17 0.75 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.579 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.44 121.76 40.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.79 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 39.3 t80 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.041 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 N--CA 1.465 -0.181 0 CA-C-O 120.937 0.307 . . . . 0.0 112.709 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.499 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 48.9 t80 -113.21 100.73 8.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.131 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.7 mt -94.08 111.15 22.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.069 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 36.3 tttt -45.99 -36.73 5.84 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.702 0.287 . . . . 0.0 111.452 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.0 p -178.74 164.29 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 111.222 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.74 -10.2 6.08 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.142 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.63 2.72 11.16 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.651 0.726 . . . . 0.0 112.188 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -132.08 156.89 45.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.107 0.48 . . . . 0.0 111.239 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -151.5 116.33 5.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.367 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.401 ' O ' ' CG2' ' A' ' 57' ' ' ILE . 9.7 tt -73.98 99.22 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.105 0.479 . . . . 0.0 111.295 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.19 165.75 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.154 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.46 -23.67 65.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.566 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -96.21 33.11 1.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.188 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.02 34.71 73.41 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.604 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.31 171.16 7.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.899 0.38 . . . . 0.0 110.874 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.6 tp -112.81 122.35 47.39 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -109.04 108.88 19.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.683 0.278 . . . . 0.0 110.947 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.421 ' CD1' ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -87.2 141.0 14.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.413 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -85.76 -50.86 6.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.025 0.441 . . . . 0.0 112.1 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.65 110.84 6.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.5 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.46 HD22 ' CD1' ' A' ' 97' ' ' ILE . 5.4 mt -53.83 147.58 11.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.643 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.1 p -152.7 161.3 42.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.786 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 mmm-85 -50.48 -56.12 12.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.331 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -57.6 -20.28 31.53 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.629 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.31 -15.75 45.47 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.533 0.206 . . . . 0.0 111.425 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 t -82.7 133.36 35.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.603 0.24 . . . . 0.0 110.483 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.07 -166.97 30.02 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.134 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.06 126.63 35.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.896 0.379 . . . . 0.0 111.435 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.418 ' CE1' HD21 ' A' ' 95' ' ' LEU . 24.5 m-85 -106.84 128.2 54.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.33 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -112.07 129.16 56.31 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.853 0.359 . . . . 0.0 111.657 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.449 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -112.08 130.59 65.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.98 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.65 98.9 6.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.8 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 82.0 t -92.02 128.71 43.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.462 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.499 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.3 m-85 -124.02 153.45 41.3 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.291 0.567 . . . . 0.0 111.108 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.93 174.81 7.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.408 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.4 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.1 p -61.07 -22.34 64.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.169 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.83 26.46 4.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.168 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.74 25.77 37.53 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.691 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.24 155.59 16.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.778 0.323 . . . . 0.0 110.889 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.53 116.35 18.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.649 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.2 mt -93.95 -69.3 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.339 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.402 ' CD2' ' CG ' ' A' ' 91' ' ' LYS . 2.6 tt -142.34 126.78 17.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.152 0.501 . . . . 0.0 111.903 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.3 106.95 14.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.402 ' CG ' ' CD2' ' A' ' 89' ' ' LEU . 5.7 mmpt? -118.15 162.49 18.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.464 0.65 . . . . 0.0 112.702 -178.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.6 119.96 10.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.067 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -114.45 157.83 22.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.836 0.351 . . . . 0.0 111.407 -179.235 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.09 115.23 29.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.361 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.637 ' HA ' HG12 ' A' ' 6' ' ' VAL . 38.3 tp -101.11 98.14 8.6 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.958 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -101.1 123.37 45.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.031 0.443 . . . . 0.0 110.599 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.46 ' CD1' HD22 ' A' ' 68' ' ' LEU . 1.9 mm -122.61 126.65 74.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.065 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 N--CA 1.435 -1.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.564 179.319 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.698 HG13 ' HA ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 120.735 0.303 . . . . 0.0 111.094 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -119.98 130.45 54.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.562 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.43 -178.07 18.92 Favored Glycine 0 N--CA 1.459 0.196 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.502 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.426 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -130.12 133.99 47.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.07 0.462 . . . . 0.0 111.551 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.416 ' CD1' ' HA ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -54.0 131.84 41.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.798 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.36 -10.65 74.3 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.58 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -107.07 168.97 8.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.599 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -73.52 -168.94 16.14 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.576 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.599 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER 161.7 137.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 122.675 0.39 . . . . 0.0 110.062 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.8 124.33 44.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.935 0.397 . . . . 0.0 111.812 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.42 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -82.02 105.98 13.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.482 178.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -90.83 123.07 34.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.287 0.565 . . . . 0.0 112.304 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.448 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.3 mt -80.38 120.35 79.13 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.176 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.27 130.71 37.27 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.32 2.013 . . . . 0.0 112.938 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 42.8 65.05 1.0 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -141.96 149.04 39.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.787 0.327 . . . . 0.0 110.501 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -141.7 117.15 10.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.941 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.38 80.44 3.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.01 -175.65 2.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.18 -33.09 68.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.912 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.79 -26.8 66.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.6 mm -79.41 128.32 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.405 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.9 OUTLIER -111.36 -44.44 3.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -179.089 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.416 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 42.6 tt0 -130.43 116.88 18.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.572 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -112.48 113.0 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.794 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -111.56 132.48 54.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.12 0.485 . . . . 0.0 112.206 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.42 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 70.3 m95 -113.31 86.53 2.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.954 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -102.62 148.1 25.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.316 0.579 . . . . 0.0 112.295 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.52 117.59 11.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.51 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.96 -116.62 8.53 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.768 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 t -117.28 43.76 2.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.76 0.315 . . . . 0.0 110.672 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.0 m -152.33 159.95 43.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.238 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.508 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.8 mt -103.11 146.83 27.8 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.441 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 51.3 t -118.45 -43.1 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.164 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -166.64 111.57 0.78 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.551 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -118.56 114.77 23.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.416 ' HA ' ' HB3' ' A' ' 48' ' ' PRO . 25.4 t80 . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.859 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.416 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 89.8 Cg_endo . . . . . 0 N--CA 1.461 -0.384 0 CA-C-O 120.865 0.277 . . . . 0.0 112.547 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.508 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 73.3 t80 -137.11 104.36 5.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.338 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.9 mt -98.57 111.18 23.63 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.441 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 12.8 tptm -44.38 -54.58 5.73 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.807 0.336 . . . . 0.0 111.484 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.0 165.07 22.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.146 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.16 -11.69 3.49 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.112 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.41 2.24 11.91 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 117.674 0.737 . . . . 0.0 112.163 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -131.99 156.48 46.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.124 0.488 . . . . 0.0 111.392 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -152.57 119.59 5.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.252 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.414 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 8.1 tt -75.0 100.26 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.112 0.482 . . . . 0.0 111.325 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.63 167.57 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.169 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.74 -24.54 65.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.651 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -96.57 33.12 1.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.736 0.303 . . . . 0.0 111.18 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.8 33.37 67.84 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.563 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.38 165.39 11.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 111.049 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 tp -105.14 121.46 43.86 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.47 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -107.91 110.18 21.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 111.13 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.426 HD13 HG23 ' A' ' 65' ' ' ILE . 2.6 mt -90.38 138.24 19.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.063 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -93.3 -41.64 9.76 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.2 106.93 5.36 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.582 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.426 ' CD1' ' O ' ' A' ' 9' ' ' ALA . 7.8 mt -57.35 143.73 38.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.13 0.491 . . . . 0.0 111.461 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.416 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 5.1 p -144.36 159.53 42.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.037 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.32 -56.46 12.93 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.022 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -54.25 -21.83 10.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.429 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.39 -14.44 58.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.3 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.4 t -80.57 129.11 34.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.65 0.262 . . . . 0.0 110.475 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.01 -165.06 30.18 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.12 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -93.98 126.65 39.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.702 0.287 . . . . 0.0 111.349 -179.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -104.44 130.86 52.31 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.129 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -112.84 125.8 54.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.881 0.372 . . . . 0.0 111.603 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.448 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.26 130.04 62.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.12 179.146 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.12 98.44 6.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.597 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 91.9 t -91.71 123.34 43.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.583 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.416 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 99.0 m-85 -116.33 152.68 33.39 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.172 0.511 . . . . 0.0 111.135 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.5 172.96 8.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.526 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 7.5 p -57.1 -22.63 41.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.234 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -96.02 26.42 4.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.147 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.87 25.52 30.53 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.718 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.4 156.65 16.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.832 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -79.01 107.52 11.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.695 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.435 HG21 HD13 ' A' ' 88' ' ' ILE . 38.6 mt -82.2 -70.71 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.347 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.5 tt -141.43 128.18 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.112 0.482 . . . . 0.0 111.892 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.85 106.57 14.33 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -117.36 162.45 17.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.446 0.641 . . . . 0.0 112.631 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.87 120.88 10.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.162 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.421 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -116.78 161.12 19.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.81 0.338 . . . . 0.0 111.403 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.81 112.22 24.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.201 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.698 ' HA ' HG13 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -102.26 101.84 12.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.279 -179.485 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.31 119.81 37.63 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.06 0.457 . . . . 0.0 110.67 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.423 HG12 ' CD2' ' A' ' 68' ' ' LEU . 3.8 mt -112.79 118.24 57.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.732 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.8 mt . . . . . 0 N--CA 1.443 -0.781 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.683 179.325 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.649 HG13 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.515 0 CA-C-O 120.798 0.332 . . . . 0.0 110.773 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -114.71 126.14 54.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.437 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.17 -179.62 22.49 Favored Glycine 0 N--CA 1.459 0.197 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.76 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.436 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -130.26 134.85 47.53 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.05 0.452 . . . . 0.0 111.353 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -53.07 136.3 35.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.006 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.33 -8.34 74.74 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.668 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.534 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.12 167.8 9.75 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.611 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -71.23 -173.86 17.23 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.565 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.611 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER 162.19 136.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 122.493 0.317 . . . . 0.0 110.401 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -122.86 128.18 50.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.964 0.412 . . . . 0.0 111.489 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.444 HD13 ' HG ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -85.14 106.6 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.858 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -89.22 124.45 34.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.152 0.501 . . . . 0.0 111.911 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.428 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.3 mt -79.97 119.62 77.23 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.138 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.16 131.38 38.69 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.367 2.045 . . . . 0.0 112.945 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m120 42.81 65.03 1.01 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -141.6 149.29 40.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.817 0.342 . . . . 0.0 110.56 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -143.87 116.43 8.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.02 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.0 ttt -80.68 77.69 7.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.15 -174.44 2.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.2 -30.73 62.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.08 -24.74 65.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.02 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.2 mm -85.52 126.54 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.457 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.413 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -111.59 -42.65 3.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 122.142 -0.349 . . . . 0.0 111.742 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.485 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 6.7 mp0 -117.57 158.75 24.05 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.001 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.6 t -154.28 108.7 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.884 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.457 ' NH1' ' CE2' ' A' ' 81' ' ' TYR . 0.6 OUTLIER -111.15 129.82 55.82 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -110.62 86.11 2.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.848 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -103.13 153.66 20.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.342 0.591 . . . . 0.0 112.303 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -145.48 116.24 7.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.503 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.08 -117.67 11.04 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.75 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 m -115.59 42.85 2.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.785 0.326 . . . . 0.0 110.659 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.4 m -150.59 160.62 43.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.145 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.519 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.7 mt -106.68 147.89 29.03 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.421 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 55.6 t -119.45 -44.16 2.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.255 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.34 112.55 1.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.43 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.48 114.62 22.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.081 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 26.0 t80 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.888 -179.989 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 N--CA 1.464 -0.221 0 CA-C-O 120.664 0.193 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 73.7 t80 -133.1 98.51 4.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.575 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.7 mt -95.24 112.78 24.44 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 19.3 tttm -34.82 -89.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.1 t -118.76 23.45 11.45 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.24 0.18 51.25 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.973 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.32 6.29 26.92 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 117.534 0.667 . . . . 0.0 111.012 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -126.57 158.37 36.41 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.975 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -140.27 118.66 12.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.203 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.4 tt -76.09 101.79 2.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.214 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.28 163.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.098 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.64 -21.79 64.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.72 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -97.88 33.31 2.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.779 0.323 . . . . 0.0 111.103 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.89 36.43 80.24 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.738 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.49 166.86 10.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 0.0 110.92 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.9 tp -107.71 121.41 44.65 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.893 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -109.15 103.87 12.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.735 0.302 . . . . 0.0 110.814 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.41 ' CD1' HG22 ' A' ' 14' ' ' ILE . 2.7 mt -79.91 134.54 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.533 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -79.47 -48.46 13.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.025 0.441 . . . . 0.0 111.675 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.31 113.29 5.79 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.243 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.439 HD21 ' CD1' ' A' ' 97' ' ' ILE . 5.7 mt -53.5 149.04 8.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 111.716 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.1 p -151.94 160.45 43.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.03 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.435 ' N ' HD12 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -51.28 -56.53 12.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.075 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -55.26 -20.82 12.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.346 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.33 -15.39 55.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.413 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.4 t -79.03 128.96 33.93 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.608 0.242 . . . . 0.0 110.576 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.46 -167.33 30.27 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.331 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.76 125.77 36.6 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.529 -0.336 . . . . 0.0 111.418 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -101.45 149.2 24.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.177 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -131.28 123.13 27.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.694 0.283 . . . . 0.0 111.567 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.428 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -108.65 128.81 64.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.036 179.159 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.13 97.9 6.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.64 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.427 HG11 ' HB ' ' A' ' 88' ' ' ILE . 82.0 t -86.25 137.97 19.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.139 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.466 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 84.2 m-85 -132.16 153.56 50.4 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.58 0.705 . . . . 0.0 111.602 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.64 -179.62 6.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.43 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.413 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 41.7 p -65.81 -35.5 80.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.942 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -77.91 -3.67 42.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.434 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.37 24.68 42.47 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.533 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.4 160.06 14.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.346 . . . . 0.0 110.699 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 106.71 11.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.682 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.427 ' HB ' HG11 ' A' ' 80' ' ' VAL . 40.2 mm -87.35 -43.67 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.304 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 tt -157.69 149.97 22.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.218 0.533 . . . . 0.0 111.822 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.92 109.9 5.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.003 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -121.63 162.24 21.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.482 0.658 . . . . 0.0 112.77 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.16 121.95 11.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.9 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.403 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -120.17 163.2 18.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 0.0 111.688 -179.189 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -111.13 114.27 27.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.369 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.649 ' HA ' HG13 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -100.94 103.71 14.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.396 -179.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.46 113.22 25.82 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.08 0.467 . . . . 0.0 110.551 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.439 ' CD1' HD21 ' A' ' 68' ' ' LEU . 3.7 mt -109.34 115.05 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.523 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 N--CA 1.438 -1.062 0 CA-C-O 121.24 0.543 . . . . 0.0 110.761 179.698 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.76 HG11 ' HA ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.447 -0.623 0 CA-C-O 120.717 0.294 . . . . 0.0 110.393 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -122.77 128.49 50.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.826 0.346 . . . . 0.0 111.005 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.7 178.51 24.31 Favored Glycine 0 N--CA 1.459 0.233 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.454 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.411 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -125.34 135.11 52.11 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.941 0.4 . . . . 0.0 111.106 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.7 132.41 36.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.792 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.66 -12.45 69.45 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.83 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.512 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -104.74 169.78 8.26 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.219 0.509 . . . . 0.0 110.016 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.512 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -79.68 168.78 52.87 Favored Glycine 0 C--O 1.224 -0.515 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.25 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.422 HG22 ' CD1' ' A' ' 65' ' ' ILE . 2.2 tp -179.09 140.26 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.696 0.284 . . . . 0.0 110.765 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -124.08 131.52 53.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.031 0.443 . . . . 0.0 111.647 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.405 HD11 ' HG ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -88.09 113.68 23.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.586 179.135 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -97.83 125.63 42.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.193 0.521 . . . . 0.0 111.931 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.451 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.2 mt -81.62 119.95 76.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.299 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.23 131.0 36.52 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.355 2.037 . . . . 0.0 112.865 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.6 m120 43.42 65.14 1.04 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -142.3 149.3 39.33 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.804 0.335 . . . . 0.0 110.531 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -138.65 117.46 12.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.931 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -80.87 82.41 6.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.78 -174.27 2.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.765 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -56.82 -30.94 64.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.954 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -60.98 -28.01 68.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.4 mm -81.57 127.75 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.444 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.55 -44.16 3.55 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 122.214 -0.304 . . . . 0.0 111.736 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.467 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 72.6 tt0 -127.43 116.23 20.13 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.217 -0.593 . . . . 0.0 112.31 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 t -113.2 114.28 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.974 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -113.08 132.12 55.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.084 0.469 . . . . 0.0 112.192 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.406 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 70.2 m95 -113.18 83.26 1.8 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -99.17 150.9 21.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.299 0.571 . . . . 0.0 112.274 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.47 116.01 9.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.62 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.29 -117.36 10.29 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.76 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.25 42.77 2.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.837 0.351 . . . . 0.0 110.759 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.2 m -152.0 160.03 43.58 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.215 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.502 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.8 mt -104.09 146.94 28.01 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.426 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 52.0 t -117.89 -42.83 2.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.293 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -166.21 113.11 0.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.455 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -120.53 116.32 25.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.094 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 32.1 t80 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.666 179.722 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo . . . . . 0 N--CA 1.463 -0.276 0 CA-C-O 120.862 0.276 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.502 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 69.4 t80 -135.03 104.64 6.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.343 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.1 mt -99.27 111.09 23.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.0 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 55.6 tttm -44.94 -42.46 8.16 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.579 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.0 p -176.66 164.96 2.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.966 0.412 . . . . 0.0 111.213 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.36 -12.37 4.36 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.732 -0.746 . . . . 0.0 113.118 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.44 1.06 12.69 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 117.75 0.775 . . . . 0.0 112.182 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -131.1 157.38 43.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.11 0.481 . . . . 0.0 111.214 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -153.95 125.24 7.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.513 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.436 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 6.9 tt -84.04 101.53 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.32 166.97 3.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.991 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.04 -45.58 80.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.205 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -56.32 -22.88 33.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.137 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.85 35.05 4.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.59 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -116.03 154.48 29.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.878 0.371 . . . . 0.0 110.924 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 12.7 tp -83.46 122.94 29.19 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.463 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -104.46 109.79 21.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.701 0.286 . . . . 0.0 111.38 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.422 ' CD1' HG22 ' A' ' 14' ' ' ILE . 2.8 mt -93.29 127.34 45.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.939 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 ttpp -85.63 -36.31 20.41 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -147.16 110.23 4.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.812 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.411 ' CD1' ' O ' ' A' ' 9' ' ' ALA . 4.9 mt -56.62 144.88 30.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.056 0.455 . . . . 0.0 111.469 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.5 p -149.25 163.79 36.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.843 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.84 -55.52 16.55 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.223 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -52.9 -23.01 6.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.539 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.53 -14.01 59.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.472 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.409 ' CB ' HG12 ' A' ' 97' ' ' ILE . 2.6 t -81.15 124.74 29.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.685 0.279 . . . . 0.0 110.707 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.1 -166.87 29.47 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.296 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.94 130.34 38.55 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.56 0.344 . . . . 0.0 111.139 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -106.21 148.65 27.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.063 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -132.42 127.2 34.85 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.834 0.35 . . . . 0.0 111.641 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.451 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -109.76 131.13 61.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.202 179.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.0 98.61 6.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.476 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.5 t -92.05 123.29 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.65 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.467 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 99.3 m-85 -117.17 152.11 35.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.271 0.558 . . . . 0.0 111.027 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.96 173.64 8.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.532 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.8 p -57.38 -24.31 54.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.191 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -96.01 27.5 3.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.169 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.78 25.13 28.59 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.686 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.04 144.26 25.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.799 0.333 . . . . 0.0 110.818 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.78 107.04 3.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.643 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.0 mt -80.97 -69.9 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.373 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 tt -141.68 129.76 22.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.192 0.52 . . . . 0.0 111.87 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.28 107.23 14.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.472 -0.786 . . . . 0.0 108.897 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -117.84 158.71 24.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.43 0.633 . . . . 0.0 112.676 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.19 122.33 18.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.146 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -120.63 162.98 18.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.984 0.421 . . . . 0.0 111.519 -179.286 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.92 136.85 48.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.335 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.76 ' HA ' HG11 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -131.78 100.8 5.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.273 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 1.1 mmm180 -92.81 124.04 36.52 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.038 0.446 . . . . 0.0 110.945 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.451 ' CD1' HD23 ' A' ' 95' ' ' LEU . 4.4 mm -106.46 103.73 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.841 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 mt . . . . . 0 N--CA 1.441 -0.902 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.598 179.353 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.666 HG13 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 120.729 0.299 . . . . 0.0 110.62 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -121.38 131.33 54.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.926 0.393 . . . . 0.0 110.697 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.69 -179.71 25.75 Favored Glycine 0 N--CA 1.459 0.226 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.812 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.49 135.34 51.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.938 0.399 . . . . 0.0 110.735 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.402 ' CD1' ' HA ' ' A' ' 69' ' ' THR . 1.2 tp -55.49 130.32 42.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.003 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.49 -6.96 77.97 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.656 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.534 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -106.28 169.18 8.66 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 117.122 0.461 . . . . 0.0 109.941 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.534 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -76.77 166.63 54.17 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.139 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.412 ' CG2' ' CD1' ' A' ' 65' ' ' ILE . 1.6 tp -177.56 138.34 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 0.0 110.986 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -120.6 120.48 35.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.44 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.474 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -77.44 105.08 8.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.767 179.299 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -88.93 124.84 34.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.228 0.537 . . . . 0.0 112.152 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.444 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.3 mt -81.8 119.96 76.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.118 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.93 131.8 39.02 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.221 1.947 . . . . 0.0 112.877 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 43.61 65.45 0.99 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -143.28 149.44 37.86 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.742 0.306 . . . . 0.0 110.549 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -141.08 117.14 10.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.958 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.82 79.91 6.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.31 -173.74 2.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.64 -30.46 61.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.0 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -62.56 -28.83 70.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.2 mm -86.05 127.16 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.476 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.406 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -112.82 -42.78 3.53 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.091 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 37.9 tt0 -127.67 118.22 23.44 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.155 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.81 118.52 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.21 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -117.43 135.83 53.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.271 0.558 . . . . 0.0 112.17 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.474 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 69.9 m95 -111.13 88.24 2.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.971 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -98.7 141.8 31.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.364 0.602 . . . . 0.0 112.267 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -132.12 114.92 15.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.396 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.26 -114.02 5.41 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.64 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.2 t -118.38 44.28 2.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.731 0.3 . . . . 0.0 110.652 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.1 m -154.95 159.56 40.49 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.906 0.384 . . . . 0.0 111.332 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.505 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 4.6 mt -99.18 148.17 24.37 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.804 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.454 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 48.4 t -119.32 -42.26 2.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.444 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -173.5 114.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.724 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -124.73 156.55 37.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.092 0.472 . . . . 0.0 110.907 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 47.7 t80 . . . . . 0 N--CA 1.45 -0.463 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.753 -179.76 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.909 0.295 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 43.6 t80 -112.7 103.09 11.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.158 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.9 mt -93.53 113.36 25.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.2 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 31.0 tttt -47.94 -45.39 30.99 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.745 0.307 . . . . 0.0 111.365 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.1 p -175.27 165.13 3.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.91 0.386 . . . . 0.0 111.191 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.92 -12.43 3.73 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.214 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.02 -1.48 17.35 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.727 0.763 . . . . 0.0 112.063 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -131.38 157.03 44.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.063 0.458 . . . . 0.0 111.206 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -151.3 119.18 6.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.134 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.413 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 4.2 tt -74.5 103.89 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.115 0.483 . . . . 0.0 111.223 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.77 173.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.313 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.5 -26.81 67.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.346 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -96.13 32.4 1.95 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.048 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.08 26.3 58.24 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.58 173.54 8.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 111.04 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.5 tp -109.93 118.35 36.21 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.633 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -106.63 108.71 20.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.83 0.347 . . . . 0.0 110.957 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.412 ' CD1' ' CG2' ' A' ' 14' ' ' ILE . 2.4 mt -87.65 135.77 24.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.435 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -82.62 -46.37 13.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.038 0.447 . . . . 0.0 111.831 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.72 112.04 5.78 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.132 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.484 ' CD2' HG12 ' A' ' 97' ' ' ILE . 6.1 mt -53.76 151.03 6.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.289 0.566 . . . . 0.0 111.865 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.402 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 7.1 p -154.3 162.42 41.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.815 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.78 -56.4 12.27 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.037 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -57.02 -20.86 26.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.327 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.06 -14.89 40.18 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.426 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.3 t -90.96 129.62 36.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.649 0.261 . . . . 0.0 110.609 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 154.08 -130.66 2.98 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.588 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 m -123.11 128.73 50.5 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 117.814 0.807 . . . . 0.0 110.931 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -109.06 149.09 29.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.235 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -131.26 125.57 33.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.849 0.356 . . . . 0.0 111.582 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.444 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.98 131.58 60.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.038 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.95 96.35 5.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.599 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 74.1 t -85.75 128.06 39.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.468 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.514 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 83.0 m-85 -117.61 151.56 36.93 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.062 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.73 174.26 8.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.494 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.406 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -61.76 -18.67 60.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.265 179.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -94.08 23.45 4.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.207 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.65 21.71 50.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.668 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.42 176.49 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.736 0.303 . . . . 0.0 110.617 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.09 116.46 30.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.708 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 31.9 mm -90.47 -46.93 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.362 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 tt -153.6 148.4 26.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 111.796 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -136.79 108.58 7.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.197 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -121.13 156.6 31.96 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.37 122.24 17.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.966 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -118.2 158.97 24.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.018 0.437 . . . . 0.0 111.728 -179.09 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -111.81 107.99 17.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.263 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.666 ' HA ' HG13 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -94.29 98.46 10.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.095 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.02 126.05 43.26 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.995 0.426 . . . . 0.0 110.498 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.484 HG12 ' CD2' ' A' ' 68' ' ' LEU . 2.3 mp -134.34 133.58 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.91 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 N--CA 1.436 -1.128 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.712 179.689 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 120.766 0.317 . . . . 0.0 110.812 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -120.89 128.87 53.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.669 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.24 -178.82 22.82 Favored Glycine 0 N--CA 1.46 0.254 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.748 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.448 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -130.11 133.63 46.79 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.146 0.498 . . . . 0.0 111.597 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.08 131.7 32.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.179 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.94 -7.96 80.72 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.74 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.528 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.01 168.33 9.36 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.6 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.91 -174.24 16.93 Favored Glycine 0 C--O 1.228 -0.249 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.502 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER 163.13 136.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.803 0.335 . . . . 0.0 110.386 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -126.25 125.22 42.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.919 0.39 . . . . 0.0 111.436 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.409 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -77.37 122.49 25.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.735 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -103.71 123.05 46.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.177 0.513 . . . . 0.0 111.963 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.452 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.3 mt -81.78 119.53 75.55 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.145 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.71 130.92 37.27 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.386 2.057 . . . . 0.0 112.98 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 42.79 65.13 0.99 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -141.72 149.13 40.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.79 0.329 . . . . 0.0 110.553 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -145.01 115.24 7.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.967 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.5 ttt -78.19 76.45 4.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.849 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.19 -173.74 2.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.822 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -56.86 -30.79 64.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.03 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -65.4 -26.74 68.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.009 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.6 mm -85.58 127.28 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.347 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.407 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -113.02 -42.05 3.62 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.182 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 6.6 tm-20 -128.26 138.78 52.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.881 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.2 t -145.27 124.37 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.295 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.446 ' NH1' ' CE2' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -118.84 139.16 52.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.136 0.493 . . . . 0.0 112.222 -179.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.482 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 69.2 m95 -111.49 83.28 1.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -96.54 151.59 19.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.408 0.623 . . . . 0.0 112.351 -178.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.422 ' HD2' ' CE1' ' A' ' 76' ' ' TYR . 6.0 ttp-105 -143.93 116.75 8.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.439 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.92 -114.82 6.09 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.18 -1.009 . . . . 0.0 111.671 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.2 m -118.47 44.25 2.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.754 0.311 . . . . 0.0 110.701 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.9 m -153.29 160.37 42.71 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.287 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.485 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.5 mt -104.4 147.86 27.07 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 46.9 t -119.14 -42.06 2.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.581 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -174.2 116.09 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.022 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.36 159.47 30.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.009 0.433 . . . . 0.0 110.792 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.1 t80 . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.884 -179.645 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.46 -0.456 0 CA-C-O 120.974 0.322 . . . . 0.0 112.477 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 39.1 t80 -127.03 99.48 5.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.931 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.6 mt -91.98 109.06 20.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.132 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 7.6 ttmt -47.6 -33.44 6.6 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.682 0.277 . . . . 0.0 111.468 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.6 p -174.01 163.53 4.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.925 0.393 . . . . 0.0 111.217 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.71 -6.97 19.08 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.008 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.52 5.56 10.55 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 117.626 0.713 . . . . 0.0 112.003 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -132.78 157.65 44.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.109 0.481 . . . . 0.0 111.434 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -148.59 118.15 6.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.003 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.404 ' O ' ' CG2' ' A' ' 57' ' ' ILE . 10.1 tt -77.56 98.45 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.086 0.47 . . . . 0.0 111.389 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.6 163.29 0.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.031 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.17 -22.39 65.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.592 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -96.23 32.87 1.86 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.763 0.316 . . . . 0.0 111.234 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.53 36.55 71.2 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.738 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.84 158.04 18.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 0.0 111.014 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.3 tp -99.39 121.8 41.62 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.586 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.43 108.21 18.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.793 0.33 . . . . 0.0 111.141 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.401 ' CG1' HG21 ' A' ' 14' ' ' ILE . 2.3 mt -86.95 138.91 18.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.41 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -85.07 -47.12 10.5 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.057 0.456 . . . . 0.0 111.855 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -143.6 111.43 6.06 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.233 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.448 ' CD1' ' O ' ' A' ' 9' ' ' ALA . 5.3 mt -53.28 144.07 17.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.894 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.0 p -141.76 159.97 41.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.923 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.11 -56.23 15.81 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -55.72 -19.48 11.14 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.578 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.22 -14.3 59.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.568 0.223 . . . . 0.0 111.475 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 98.5 p -85.23 128.43 34.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.629 0.252 . . . . 0.0 110.753 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.32 -135.08 4.34 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.542 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.7 m -124.29 130.4 52.44 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.556 0.678 . . . . 0.0 110.714 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.43 ' CE1' HD13 ' A' ' 95' ' ' LEU . 16.3 m-85 -107.41 151.6 25.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.979 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -133.59 124.66 27.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.314 . . . . 0.0 111.593 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.452 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.09 133.54 53.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.283 179.045 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.04 103.39 9.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.671 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.9 t -93.7 129.66 43.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.42 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.497 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 97.9 m-85 -121.71 154.93 36.24 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.151 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.98 178.3 6.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.588 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.407 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 27.0 p -64.26 -22.97 67.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.068 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -95.74 23.48 6.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.098 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.52 25.87 61.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.524 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.5 152.29 18.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.8 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -74.82 119.9 19.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.718 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 32.8 mm -92.79 -67.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.381 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.403 ' CD2' ' CG ' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -146.06 133.28 20.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.147 0.499 . . . . 0.0 111.85 -179.304 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.22 107.41 14.41 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.403 ' CG ' ' CD2' ' A' ' 89' ' ' LEU . 25.4 mmtt -117.55 156.61 27.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.428 0.633 . . . . 0.0 112.662 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.98 122.69 18.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.084 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.412 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -119.68 160.76 21.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.079 0.466 . . . . 0.0 111.607 -179.211 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -110.05 116.13 31.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.158 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.641 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -100.07 100.71 11.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.362 -179.441 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -96.72 115.16 26.95 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.096 0.474 . . . . 0.0 110.353 179.277 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.436 ' CD1' HD21 ' A' ' 68' ' ' LEU . 3.8 mt -116.33 120.14 64.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.838 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.3 mt . . . . . 0 N--CA 1.441 -0.877 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.684 179.33 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.721 HG11 ' HA ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 120.792 0.33 . . . . 0.0 110.484 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.455 ' CE2' ' HD3' ' A' ' 96' ' ' ARG . 82.9 m95 -112.05 127.52 55.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.609 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.18 -178.18 22.27 Favored Glycine 0 N--CA 1.459 0.217 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.887 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.445 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -125.14 133.34 52.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.048 0.451 . . . . 0.0 111.123 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.4 HD13 ' CA ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -53.93 133.14 43.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.027 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.69 -6.35 83.72 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.757 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.542 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.42 167.31 10.13 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.994 0.397 . . . . 0.0 110.006 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.575 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.43 -175.69 18.44 Favored Glycine 0 C--O 1.228 -0.264 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.622 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.1 tp 167.33 136.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.897 0.38 . . . . 0.0 110.726 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -121.81 132.11 54.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.187 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.4 108.95 20.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.855 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -91.71 123.36 35.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.225 0.536 . . . . 0.0 112.209 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.447 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.4 mt -80.82 120.07 77.9 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.112 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.78 130.95 37.26 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.301 2.0 . . . . 0.0 112.975 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 42.67 64.96 1.01 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -140.87 149.55 42.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.593 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -146.29 116.35 7.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -78.67 81.64 4.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.947 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.35 -175.14 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -57.57 -32.81 67.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.897 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -63.74 -23.73 67.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.144 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.4 mm -81.11 127.84 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.414 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.42 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -105.96 -38.36 6.35 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 122.231 -0.293 . . . . 0.0 111.728 -179.319 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 17.8 mt-10 -141.09 152.64 44.93 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.662 0.744 . . . . 0.0 112.448 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -145.68 117.98 2.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.125 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 6.8 mtm180 -115.19 133.65 55.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.024 0.44 . . . . 0.0 112.155 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.416 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 68.6 m95 -110.73 83.65 1.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -98.65 146.29 26.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.298 0.57 . . . . 0.0 112.288 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -137.19 116.93 13.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.532 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.05 -115.9 7.58 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.734 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.8 m -117.3 43.73 2.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.833 0.349 . . . . 0.0 110.71 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.5 m -153.6 160.05 42.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.282 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.515 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.6 mt -102.2 147.08 27.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 48.2 t -118.4 -42.7 2.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.258 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -166.47 111.55 0.8 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.562 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -117.69 119.69 35.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.941 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 51.5 t80 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.79 179.985 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 N--CA 1.463 -0.31 0 CA-C-O 120.947 0.311 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.515 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 75.6 t80 -139.18 104.02 4.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.319 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 mt -98.45 109.33 22.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 10.3 ttmt -44.57 -39.77 5.2 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.774 0.321 . . . . 0.0 111.529 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.4 p -177.83 163.98 1.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 111.122 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.28 -11.46 4.95 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.025 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.415 ' HA ' ' CD ' ' A' ' 66' ' ' LYS . . . -74.29 0.42 14.31 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 117.786 0.793 . . . . 0.0 112.233 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -130.79 156.87 44.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.161 0.505 . . . . 0.0 111.303 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -150.73 117.4 5.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.098 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 57' ' ' ILE . 12.0 tt -75.72 97.29 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.45 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -47.01 168.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.184 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.59 -24.57 65.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.592 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -96.83 33.63 1.84 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.737 0.303 . . . . 0.0 111.21 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.65 34.18 69.38 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.56 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.39 165.09 11.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 0.0 111.043 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.5 tp -106.13 120.56 42.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.499 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.26 111.2 23.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.725 0.298 . . . . 0.0 110.991 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.42 ' CD1' ' CG2' ' A' ' 14' ' ' ILE . 2.4 mt -90.92 135.88 25.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.369 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.427 ' HG3' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -80.7 -45.96 16.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.074 0.464 . . . . 0.0 111.991 -179.044 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.427 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -145.8 113.31 6.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.468 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.458 ' HB3' ' CG2' ' A' ' 97' ' ' ILE . 4.2 mt -53.85 145.57 15.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.513 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.4 ' CA ' HD13 ' A' ' 10' ' ' LEU . 4.7 p -145.67 158.75 43.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.004 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -55.92 14.12 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.417 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.06 -22.81 11.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.411 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.3 -14.58 60.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.248 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.8 t -79.39 119.92 23.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.706 0.288 . . . . 0.0 110.521 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.13 -147.27 12.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.144 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.5 m -116.62 130.78 56.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.102 0.451 . . . . 0.0 110.59 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.453 ' CE1' HD13 ' A' ' 95' ' ' LEU . 29.0 m-85 -106.72 129.77 54.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.38 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -112.85 123.9 51.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.569 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.447 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -105.99 133.92 49.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.031 178.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.37 96.93 5.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.877 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 82.8 t -87.29 127.76 40.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.1 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.465 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 2.5 m-30 -112.81 152.6 28.99 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.298 0.57 . . . . 0.0 111.02 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.72 176.7 6.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.366 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.42 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 2.1 p -67.4 -18.34 65.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.236 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -89.94 12.13 18.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.422 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.74 25.05 74.95 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.631 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -103.11 -169.4 1.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.644 0.259 . . . . 0.0 110.595 179.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 -119.76 99.73 6.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.938 0.399 . . . . 0.0 110.783 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.5 mm -58.0 -61.31 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.423 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.14 140.47 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.226 0.536 . . . . 0.0 112.019 -179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -121.65 109.23 14.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.807 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.38 160.85 21.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.37 122.65 17.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.159 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -119.61 161.98 19.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 111.233 -179.466 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.06 146.1 33.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.265 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.721 ' HA ' HG11 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -136.4 119.1 16.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.213 -179.533 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.455 ' HD3' ' CE2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -119.87 124.6 46.46 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.318 0.58 . . . . 0.0 111.038 179.215 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.458 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 3.9 mp -103.44 103.9 15.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.784 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.3 mt . . . . . 0 N--CA 1.44 -0.955 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.319 179.051 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' A' ' 95' ' ' LEU . 2.6 m . . . . . 0 N--CA 1.433 -1.304 0 CA-C-O 121.848 0.832 . . . . 0.0 112.496 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.433 ' CE3' ' HB2' ' A' ' 96' ' ' ARG . 69.5 m95 -147.56 162.26 39.45 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.543 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.25 178.48 44.39 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.494 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -119.8 135.05 55.02 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 120.883 0.373 . . . . 0.0 110.827 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.4 HD13 ' CA ' ' A' ' 69' ' ' THR . 1.2 tp -57.11 133.27 54.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.03 -2.84 87.15 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.593 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.576 ' NE2' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -106.56 168.33 9.24 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.576 ' O ' ' NE2' ' A' ' 12' ' ' HIS . . . -82.66 163.47 42.33 Favored Glycine 0 C--O 1.223 -0.556 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.098 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.412 ' CG2' ' CD1' ' A' ' 65' ' ' ILE . 1.5 tp -176.11 137.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.952 0.406 . . . . 0.0 111.183 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -116.99 119.74 36.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.079 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.94 114.45 19.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.957 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -94.1 124.03 37.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.168 0.509 . . . . 0.0 111.925 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.44 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.4 mt -80.4 119.78 77.41 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.023 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.39 130.85 37.64 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.281 1.987 . . . . 0.0 112.931 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 42.7 65.17 0.98 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -141.96 151.14 42.27 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.869 0.366 . . . . 0.0 110.638 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -141.35 117.98 10.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.71 78.4 7.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.009 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.5 p -110.77 -172.88 2.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.25 -30.53 68.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -61.46 -27.28 68.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.016 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.0 mm -81.76 127.52 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.451 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.95 -43.64 3.56 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 60.1 tt0 -128.39 116.38 19.68 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.196 -0.601 . . . . 0.0 112.412 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.7 t -116.22 117.12 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.886 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -118.17 133.53 55.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.202 0.525 . . . . 0.0 112.384 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -109.63 84.52 1.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.767 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -95.06 149.94 20.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.382 0.61 . . . . 0.0 112.432 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -139.66 113.47 8.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.408 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.47 -114.77 6.24 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.613 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -117.01 43.62 2.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.77 0.319 . . . . 0.0 110.629 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 66.4 m -153.74 160.08 42.17 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.332 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.527 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.5 mt -101.42 147.12 26.73 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 51.1 t -118.21 -43.25 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.189 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.4 112.45 0.83 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.294 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.28 120.08 35.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.195 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.0 t80 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.471 179.603 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.69 0.204 . . . . 0.0 112.218 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.527 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 70.5 t80 -137.46 98.89 3.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.756 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.5 mt -93.89 113.81 25.9 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 6.5 tptp -36.43 -90.06 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.7 m -118.56 21.45 12.57 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.08 -1.52 55.19 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.125 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.81 3.42 29.56 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 117.546 0.673 . . . . 0.0 111.008 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -124.31 158.05 33.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.782 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -140.95 120.53 13.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.202 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.412 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 4.7 tt -76.99 103.33 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.12 0.486 . . . . 0.0 111.375 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.5 166.58 0.42 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.102 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.3 -23.48 64.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.72 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -96.53 33.3 1.84 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.734 0.302 . . . . 0.0 111.214 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.97 34.01 64.9 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.632 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.3 173.87 6.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 0.0 111.034 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 tp -114.22 121.07 42.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.57 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -107.61 104.07 13.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.823 0.344 . . . . 0.0 111.051 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.412 ' CD1' ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -82.27 127.18 39.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.625 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -76.0 -45.65 33.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.065 0.459 . . . . 0.0 111.322 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.11 111.9 4.82 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.235 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.422 ' HB3' ' CG2' ' A' ' 97' ' ' ILE . 4.5 mt -56.21 152.01 11.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.12 0.486 . . . . 0.0 111.681 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.4 ' CA ' HD13 ' A' ' 10' ' ' LEU . 8.7 p -153.17 163.35 40.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.123 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.4 mmt85 -51.42 -54.76 23.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.476 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -58.56 -19.22 36.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.321 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.41 -15.8 34.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.37 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.44 ' CB ' HD12 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -82.7 130.83 35.19 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.823 0.344 . . . . 0.0 110.586 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.56 -130.83 3.26 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.325 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 1.3 m -125.82 126.65 44.85 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 117.753 0.776 . . . . 0.0 111.063 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -97.03 149.93 21.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.21 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -132.94 120.53 21.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.201 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.44 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -107.91 128.54 63.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.174 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.73 97.4 5.83 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.2 t -87.01 126.79 40.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.52 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.474 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 97.2 m-85 -118.71 151.56 37.76 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.236 0.541 . . . . 0.0 111.024 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.72 173.62 8.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.406 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.3 p -59.95 -29.51 68.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.926 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -77.77 -4.07 44.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.491 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.86 27.2 51.3 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.531 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.17 165.16 11.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 110.79 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.37 115.37 21.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.644 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.9 mt -91.16 -67.71 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.322 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 tt -136.41 130.14 32.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.062 0.458 . . . . 0.0 111.71 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -120.71 108.68 14.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.333 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.61 153.51 35.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.275 0.56 . . . . 0.0 112.337 -178.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.91 121.69 16.48 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.496 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 75' ' ' THR . 0.5 OUTLIER -120.63 164.85 15.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.243 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.24 107.24 10.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.66 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.558 ' HA ' HG21 ' A' ' 6' ' ' VAL . 7.2 tt -101.8 113.89 27.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.017 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.433 ' HB2' ' CE3' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -96.77 111.93 23.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.874 0.369 . . . . 0.0 110.479 179.299 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.44 HD12 ' CB ' ' A' ' 73' ' ' SER . 5.6 mt -95.33 109.14 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.873 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mt . . . . . 0 N--CA 1.439 -1.002 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.416 178.889 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.66 HG13 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 120.713 0.292 . . . . 0.0 110.648 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -116.49 127.43 54.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.877 0.37 . . . . 0.0 110.737 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.55 177.42 29.48 Favored Glycine 0 C--N 1.329 0.161 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.662 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.408 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -122.18 135.6 54.8 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.913 0.387 . . . . 0.0 110.75 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.44 HD11 ' N ' ' A' ' 70' ' ' ARG . 1.1 tp -54.46 130.01 38.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.714 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.85 -9.27 68.33 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.762 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.569 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.6 170.74 7.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 117.002 0.401 . . . . 0.0 109.927 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -79.87 175.2 55.05 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.119 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.0 tp 178.13 139.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.691 0.281 . . . . 0.0 110.906 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -116.08 126.21 53.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.94 0.4 . . . . 0.0 111.317 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.401 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -86.54 105.57 16.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.806 179.304 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -88.3 123.75 33.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.144 0.497 . . . . 0.0 112.194 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.442 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.3 mt -80.25 120.05 78.34 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.055 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.82 130.98 37.31 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.313 2.008 . . . . 0.0 112.859 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 43.09 65.22 1.0 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -142.0 150.96 42.02 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.801 0.334 . . . . 0.0 110.617 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -140.61 117.68 11.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.98 84.08 7.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.956 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.0 p -119.66 -173.01 2.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -57.45 -30.03 64.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.955 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -63.14 -28.02 69.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.4 mm -87.38 127.02 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.44 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -112.76 -42.37 3.62 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.053 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 34.1 tt0 -124.99 118.74 26.91 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.146 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.3 t -123.74 112.79 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.262 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -112.62 139.0 48.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.205 0.526 . . . . 0.0 112.071 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.461 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 71.7 m95 -112.39 82.99 1.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.865 178.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -94.69 142.92 26.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.337 0.589 . . . . 0.0 112.286 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 118.23 18.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.418 178.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.97 -113.73 5.01 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.654 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.5 p -119.55 44.82 2.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.738 0.304 . . . . 0.0 110.663 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.8 m -156.46 159.64 38.83 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.887 0.375 . . . . 0.0 111.315 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.491 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 4.8 mt -99.81 147.49 25.43 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.697 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.427 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 40.3 t -118.37 -41.14 2.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.481 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -172.97 117.54 0.31 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.679 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -122.53 156.94 33.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 110.617 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.5 t80 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.717 -179.727 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo . . . . . 0 CA--C 1.527 0.148 0 CA-C-O 120.666 0.194 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 84.9 t80 -136.67 113.7 10.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.869 0.366 . . . . 0.0 111.481 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.1 mt -108.69 112.64 25.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.98 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 24.3 tttm -44.67 -49.22 10.5 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.732 0.301 . . . . 0.0 111.381 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.52 168.69 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.085 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.82 -12.46 1.7 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.445 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.74 0.3 13.44 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 117.847 0.824 . . . . 0.0 112.336 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -136.99 156.89 47.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 111.269 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -150.8 120.46 6.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.232 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.406 ' O ' ' CG2' ' A' ' 57' ' ' ILE . 4.7 tt -75.59 103.9 3.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.047 0.451 . . . . 0.0 111.368 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.6 mp -54.15 169.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.069 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.33 -24.44 64.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.624 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -96.48 33.22 1.84 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.79 0.329 . . . . 0.0 111.157 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.04 31.0 64.43 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.723 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.47 174.03 6.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.886 0.374 . . . . 0.0 111.117 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.1 tp -113.7 121.11 43.12 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.53 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -106.87 106.32 16.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.755 0.312 . . . . 0.0 111.196 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.43 ' CD1' ' CG2' ' A' ' 14' ' ' ILE . 2.7 mt -86.4 135.41 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.067 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -90.75 -40.72 11.67 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -143.63 109.19 5.13 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.758 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.439 HD21 ' CD1' ' A' ' 97' ' ' ILE . 5.3 mt -58.54 145.89 37.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.129 0.49 . . . . 0.0 111.339 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.5 p -148.78 158.48 44.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.238 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.44 ' N ' HD11 ' A' ' 10' ' ' LEU . 9.9 mmm-85 -50.5 -57.1 8.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.185 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -54.42 -22.29 12.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.094 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.4 -14.81 56.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.319 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.0 p -83.55 138.2 33.5 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.647 0.26 . . . . 0.0 110.845 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.07 -126.02 2.32 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.681 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 m -132.99 129.61 38.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.864 0.832 . . . . 0.0 110.921 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -103.91 151.28 23.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.293 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -132.63 122.42 24.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.371 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.442 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -108.0 127.85 63.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.056 179.288 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.98 97.09 6.03 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 80.7 t -88.16 130.25 38.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.304 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.522 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 96.8 m-85 -124.02 154.45 39.86 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.269 0.556 . . . . 0.0 111.184 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.98 175.85 7.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.381 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 20.3 p -62.65 -22.03 66.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.165 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -96.0 24.97 5.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.191 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.63 26.83 53.82 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.581 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.69 157.84 15.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.816 0.341 . . . . 0.0 110.816 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.12 111.41 14.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.4 mm -92.98 -49.72 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.33 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 tt -154.01 149.15 26.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.283 0.563 . . . . 0.0 111.773 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -140.62 108.32 5.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.173 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -120.52 159.2 25.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.83 121.71 14.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.039 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.41 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -120.91 161.89 20.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.892 0.377 . . . . 0.0 111.695 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.59 125.81 53.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.199 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.66 ' HA ' HG13 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -106.31 101.51 10.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.233 -179.44 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.36 108.95 21.78 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.22 0.533 . . . . 0.0 110.412 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.439 ' CD1' HD21 ' A' ' 68' ' ' LEU . 3.6 mt -110.44 113.41 44.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.731 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mt . . . . . 0 N--CA 1.442 -0.859 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.534 179.323 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.507 HG21 ' HA ' ' A' ' 95' ' ' LEU . 2.9 m . . . . . 0 N--CA 1.432 -1.359 0 CA-C-O 121.78 0.8 . . . . 0.0 112.345 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.431 ' CE3' ' HB2' ' A' ' 96' ' ' ARG . 73.3 m95 -145.42 161.97 38.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.55 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.48 179.16 41.15 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.427 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.413 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -122.63 134.42 54.5 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.976 0.417 . . . . 0.0 111.25 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.0 134.09 56.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.692 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.0 -4.11 83.89 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.393 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.614 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.4 OUTLIER -108.99 167.94 9.73 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.614 ' O ' ' CE1' ' A' ' 12' ' ' HIS . . . -78.73 -173.4 43.02 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.659 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.606 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.1 tp 164.18 136.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.756 0.312 . . . . 0.0 110.38 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -116.93 118.7 33.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.89 0.376 . . . . 0.0 111.391 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.23 102.93 10.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.849 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -85.97 124.73 32.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.192 0.52 . . . . 0.0 111.724 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.437 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.4 mt -78.42 119.93 79.16 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.154 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -58.26 130.15 36.33 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.37 2.047 . . . . 0.0 113.094 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 42.44 64.61 1.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -140.7 149.0 41.64 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.817 0.341 . . . . 0.0 110.585 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -139.42 117.16 11.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.961 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.35 81.14 7.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.868 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.54 -174.53 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.829 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -56.8 -30.78 64.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.961 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.02 -27.85 69.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.6 mm -83.67 127.88 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.429 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.73 -44.06 3.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 13.9 tp10 -125.91 134.58 51.53 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.317 -179.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -135.41 108.01 8.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.723 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 2.1 mtp180 -105.17 132.03 51.9 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -109.01 82.88 1.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -99.17 157.92 16.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.394 0.616 . . . . 0.0 112.467 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -149.3 113.8 5.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.509 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.46 -117.03 9.4 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.741 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 p -115.0 42.47 2.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.741 0.305 . . . . 0.0 110.705 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.0 m -150.66 160.4 43.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.237 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.512 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 6.2 mt -106.82 147.94 29.11 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 53.7 t -119.03 -43.76 2.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.235 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.39 113.26 1.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.527 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -118.51 113.58 21.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.051 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.5 t80 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.882 179.962 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.46 -0.482 0 CA-C-O 120.629 0.179 . . . . 0.0 111.939 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.512 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 69.8 t80 -125.34 99.87 6.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.337 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.1 mt -96.24 105.66 17.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.931 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 39.8 tttm -43.92 -59.2 2.38 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.586 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.6 p -144.74 162.75 35.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 0.0 111.193 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.08 -8.16 21.67 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.022 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.42 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . . . -78.39 3.41 15.78 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 117.559 0.679 . . . . 0.0 111.952 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -125.5 157.36 37.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.273 0.559 . . . . 0.0 111.743 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -154.55 124.65 6.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.212 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.419 ' O ' ' CG2' ' A' ' 57' ' ' ILE . 3.0 tt -83.49 106.66 14.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.308 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 mp -65.7 172.79 3.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.904 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.3 -44.83 64.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.156 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -57.33 -25.13 58.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.06 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.69 33.42 3.84 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.547 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -113.39 154.61 26.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.841 0.353 . . . . 0.0 110.964 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 tp -84.39 122.05 28.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.459 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.99 111.33 23.61 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.831 0.348 . . . . 0.0 111.421 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 65' ' ' ILE . 2.8 mt -97.13 122.64 48.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.114 179.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 54' ' ' ALA . 1.6 ptpp? -89.27 -33.76 16.84 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.471 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -140.8 104.82 4.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.601 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.413 ' CD1' ' O ' ' A' ' 9' ' ' ALA . 6.2 mt -63.01 154.43 30.68 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.13 0.49 . . . . 0.0 111.458 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.1 p -152.35 157.04 40.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.209 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.11 -55.98 12.77 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.363 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -52.63 -24.6 8.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.132 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.01 -15.36 44.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.255 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.4 p -77.86 126.2 30.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.415 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 154.21 -131.08 3.09 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.447 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 1.3 m -126.03 129.19 48.68 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 117.711 0.756 . . . . 0.0 111.143 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -99.82 148.4 24.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.035 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -130.05 122.23 27.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.769 0.319 . . . . 0.0 111.356 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.437 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.57 130.55 62.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.274 179.34 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.94 96.72 5.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.818 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.0 t -86.56 134.07 28.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.243 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.457 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 81.0 m-85 -127.39 156.69 41.65 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.347 0.594 . . . . 0.0 111.199 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.02 174.96 7.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.448 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.3 -24.94 66.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.15 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -95.9 27.1 3.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.198 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.7 23.61 37.32 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.719 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.61 156.32 18.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.731 0.3 . . . . 0.0 110.823 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.58 118.42 22.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.541 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.9 mt -102.05 -67.1 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.425 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.1 tt -134.18 148.8 50.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.322 0.582 . . . . 0.0 111.875 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.69 109.21 5.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.061 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -122.53 153.33 39.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.85 122.95 16.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.284 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 75' ' ' THR . 0.3 OUTLIER -122.82 165.28 16.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.267 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.22 106.32 9.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.73 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.507 ' HA ' HG21 ' A' ' 6' ' ' VAL . 7.1 tt -101.16 114.86 29.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.897 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.431 ' HB2' ' CE3' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -96.79 108.33 20.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.408 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.406 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 8.6 mt -90.88 108.94 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.776 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mt . . . . . 0 N--CA 1.442 -0.872 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.571 179.254 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.594 HG13 ' HA ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.447 -0.593 0 CA-C-O 120.623 0.249 . . . . 0.0 110.884 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -115.73 139.35 50.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.81 0.338 . . . . 0.0 110.957 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.57 176.59 28.21 Favored Glycine 0 C--O 1.228 -0.221 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.972 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.61 135.12 54.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.172 0.486 . . . . 0.0 111.121 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.436 ' CD1' ' HA ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -54.02 130.38 37.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.713 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.11 -8.95 75.64 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.887 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.549 ' NE2' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -106.57 170.97 7.62 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.549 ' O ' ' NE2' ' A' ' 12' ' ' HIS . . . -86.55 174.36 46.56 Favored Glycine 0 C--O 1.224 -0.477 0 C-N-CA 120.705 -0.759 . . . . 0.0 113.468 -178.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.427 ' CG2' ' CD1' ' A' ' 65' ' ' ILE . 3.3 tp 179.59 144.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.6 0.238 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -120.69 129.94 53.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.951 0.405 . . . . 0.0 111.639 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.52 104.08 16.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.713 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -86.19 123.9 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.188 0.518 . . . . 0.0 111.911 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.44 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.4 mt -79.55 120.19 79.43 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.184 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.25 130.63 36.92 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.26 1.973 . . . . 0.0 113.0 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 43.08 64.78 1.1 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -141.67 150.5 41.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.784 0.326 . . . . 0.0 110.551 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -142.07 117.55 10.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.881 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.97 76.87 6.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.978 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.1 p -105.86 -172.51 2.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -59.08 -31.45 68.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.966 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.01 -26.94 68.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.99 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.1 mm -79.01 129.21 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.43 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.418 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.9 OUTLIER -112.68 -44.11 3.37 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.082 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 69.2 tt0 -132.45 116.39 16.73 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.001 -0.68 . . . . 0.0 112.655 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.31 114.69 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -112.17 130.73 55.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.172 0.51 . . . . 0.0 112.36 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -112.73 85.37 2.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.987 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -98.97 148.75 23.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.252 0.548 . . . . 0.0 112.229 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.0 114.69 9.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.609 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.45 -117.73 11.5 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.809 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.5 m -114.64 42.36 2.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.764 0.316 . . . . 0.0 110.665 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.7 m -151.95 160.18 43.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.235 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.507 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.5 mt -102.94 146.15 28.75 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 46.9 t -117.59 -42.47 2.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.941 0.401 . . . . 0.0 110.243 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -165.83 112.17 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.492 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -120.36 112.67 19.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.066 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 22.4 t80 . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.761 179.927 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo . . . . . 0 N--CA 1.462 -0.357 0 CA-C-O 120.815 0.256 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.507 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 78.7 t80 -138.83 106.17 5.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.415 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.9 mt -100.95 110.66 22.73 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 36.2 tttt -44.84 -49.14 10.99 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.73 0.3 . . . . 0.0 111.607 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.1 p -169.84 164.98 9.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.956 0.408 . . . . 0.0 111.319 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.77 -12.1 4.78 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.138 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.28 0.93 12.69 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 117.782 0.791 . . . . 0.0 112.083 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -131.94 157.54 43.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.052 0.453 . . . . 0.0 111.09 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -154.09 127.21 8.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.512 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.43 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 7.1 tt -86.02 101.26 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.178 0.513 . . . . 0.0 111.276 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.68 171.16 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.957 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.7 -44.64 77.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.185 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -58.2 -25.1 61.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.07 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.75 34.17 3.88 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.568 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -112.96 154.73 25.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.789 0.328 . . . . 0.0 110.968 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.0 tp -82.72 123.13 29.01 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.632 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -106.38 110.09 22.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.906 0.384 . . . . 0.0 111.219 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.427 ' CD1' ' CG2' ' A' ' 14' ' ' ILE . 2.9 mt -92.21 121.2 42.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.148 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -81.14 -36.21 30.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.894 0.378 . . . . 0.0 111.798 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -144.25 107.52 4.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.706 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.425 ' CD2' ' CD1' ' A' ' 97' ' ' ILE . 4.4 mt -59.03 143.73 47.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.058 0.456 . . . . 0.0 111.337 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.436 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 9.2 p -143.33 165.09 28.45 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.856 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.7 mmt85 -50.5 -54.94 18.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.256 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -53.45 -23.87 11.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.41 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -73.5 -13.57 61.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.567 0.222 . . . . 0.0 111.427 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.403 ' HB3' ' CG1' ' A' ' 97' ' ' ILE . 5.0 p -82.78 116.05 21.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.68 0.276 . . . . 0.0 110.647 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.27 -144.93 10.3 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.21 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -120.38 131.02 54.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.145 0.472 . . . . 0.0 110.621 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -103.96 131.99 50.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.411 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -114.39 123.4 49.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.286 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.44 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -106.11 129.06 59.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.275 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.47 97.66 6.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 77.7 t -88.0 123.23 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.436 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.418 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 93.4 m-85 -113.81 151.15 32.46 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.224 0.535 . . . . 0.0 111.053 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.79 172.87 8.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.545 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 16.9 p -60.81 -19.18 59.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.351 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -94.39 24.67 4.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.218 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.82 23.29 44.4 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.6 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.94 176.11 5.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.783 0.325 . . . . 0.0 110.735 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -98.31 126.47 43.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.676 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 51.4 mt -101.24 -61.42 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.416 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 tt -140.06 129.53 24.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.113 0.483 . . . . 0.0 111.855 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -120.54 108.54 14.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.17 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -121.05 159.69 25.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.352 0.596 . . . . 0.0 112.439 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.83 121.75 15.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.45 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.49 165.39 14.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.865 0.364 . . . . 0.0 111.152 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.47 134.31 53.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.639 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.594 ' HA ' HG13 ' A' ' 6' ' ' VAL . 8.5 tt -129.73 132.37 46.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.023 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.8 132.29 54.28 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.931 0.396 . . . . 0.0 111.062 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.45 ' CD1' ' CD2' ' A' ' 95' ' ' LEU . 7.0 mm -101.12 100.9 11.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.615 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.8 mt . . . . . 0 N--CA 1.44 -0.927 0 CA-C-O 120.971 0.415 . . . . 0.0 110.479 179.348 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.749 HG13 ' HA ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.531 0 CA-C-O 120.698 0.285 . . . . 0.0 110.706 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -118.53 128.57 54.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.659 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.07 179.66 21.24 Favored Glycine 0 N--CA 1.46 0.296 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.733 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.41 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -124.72 134.7 52.74 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.929 0.395 . . . . 0.0 111.116 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 70' ' ' ARG . 1.0 OUTLIER -52.81 134.57 36.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.158 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.73 -6.44 82.75 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.928 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -105.97 168.66 8.97 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 117.144 0.472 . . . . 0.0 109.988 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.529 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -77.11 163.59 52.27 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.203 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.43 HG21 ' CD1' ' A' ' 65' ' ' ILE . 1.6 tp -176.97 138.96 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 122.635 -0.332 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -125.48 133.3 52.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.928 0.394 . . . . 0.0 111.352 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.439 HD12 ' HG ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -87.24 122.4 30.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.563 179.156 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -103.59 124.49 48.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.134 0.492 . . . . 0.0 111.687 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.429 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.2 mt -80.51 119.46 76.37 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.349 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.26 131.33 38.19 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.357 2.038 . . . . 0.0 113.066 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.15 64.81 1.01 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -139.69 149.32 43.54 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.809 0.337 . . . . 0.0 110.517 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -135.38 117.01 14.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.8 tpt -87.53 83.62 7.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.9 p -115.47 -173.13 2.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.849 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -58.61 -31.62 68.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.47 -24.91 67.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.945 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.417 HG22 HD12 ' A' ' 27' ' ' ILE . 34.6 mm -79.86 127.89 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.43 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.436 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 1.3 t0 -103.9 -38.37 7.04 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 122.267 -0.27 . . . . 0.0 111.673 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 8.8 mt-10 -141.96 151.81 42.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.722 0.772 . . . . 0.0 112.574 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.5 t -145.29 106.87 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.955 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -101.53 126.05 48.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.079 0.466 . . . . 0.0 112.232 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -105.16 84.39 2.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.03 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -103.99 156.13 18.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.233 0.539 . . . . 0.0 112.211 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.58 117.73 7.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.734 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.99 -118.12 12.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.826 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.9 t -115.19 42.52 2.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.758 0.313 . . . . 0.0 110.721 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.9 m -149.93 159.94 43.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.136 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.503 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 6.3 mt -105.57 145.69 30.62 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.872 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.2 t -117.04 -43.6 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.086 0.47 . . . . 0.0 110.089 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.91 112.36 0.89 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.713 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -116.5 111.79 20.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.076 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.6 t80 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.943 -179.984 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo . . . . . 0 N--CA 1.464 -0.214 0 CA-C-O 120.671 0.196 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.503 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 64.4 t80 -129.87 98.71 4.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.433 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.1 mt -95.82 108.68 21.05 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -42.19 -37.83 1.57 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.707 0.289 . . . . 0.0 111.7 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.52 165.4 1.36 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 111.07 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.64 -10.49 4.52 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.338 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.65 2.01 10.88 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.748 0.774 . . . . 0.0 112.185 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -132.1 157.59 43.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.092 0.473 . . . . 0.0 111.262 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -155.94 123.87 5.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.421 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.417 ' O ' ' CG2' ' A' ' 57' ' ' ILE . 6.6 tt -81.25 101.73 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.224 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.88 173.35 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.993 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.78 -45.19 65.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.199 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -58.15 -21.88 48.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.67 35.06 4.18 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.611 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -116.1 155.17 28.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.841 0.353 . . . . 0.0 111.036 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.1 tp -81.77 122.46 27.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.671 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -104.83 110.26 22.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.752 0.311 . . . . 0.0 111.111 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.43 ' CD1' HG21 ' A' ' 14' ' ' ILE . 3.1 mt -91.38 134.35 30.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.339 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -82.73 -45.94 13.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.015 0.436 . . . . 0.0 111.692 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.77 112.31 5.6 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.249 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.434 ' HB3' ' CG2' ' A' ' 97' ' ' ILE . 4.4 mt -51.37 146.49 6.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.166 0.508 . . . . 0.0 111.974 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.7 p -143.98 155.23 43.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.826 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.4 ' N ' HD12 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -50.11 -56.33 11.33 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.363 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -52.98 -23.8 8.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.162 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.32 -16.17 59.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.303 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.414 ' CB ' HG12 ' A' ' 97' ' ' ILE . 22.1 p -76.95 117.48 18.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.641 0.258 . . . . 0.0 110.711 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.54 -151.33 21.17 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.169 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -110.05 131.34 55.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.783 0.325 . . . . 0.0 110.512 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -105.21 151.72 23.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.266 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -133.8 125.0 27.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.355 . . . . 0.0 111.434 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.429 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -107.47 134.23 49.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.256 179.195 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.39 95.03 4.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.649 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 88' ' ' ILE . 64.8 t -85.31 130.97 35.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.015 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.51 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 2.7 m-30 -116.87 152.99 33.32 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.31 0.576 . . . . 0.0 110.764 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.48 179.24 5.58 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.884 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.436 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 0.8 OUTLIER -64.78 -23.61 67.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.088 179.619 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -84.69 -5.12 59.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.52 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.56 19.23 55.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.812 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.88 141.82 37.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.749 0.309 . . . . 0.0 110.861 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.39 111.04 2.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.95 0.405 . . . . 0.0 111.014 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 80' ' ' VAL . 26.1 mm -80.14 -40.29 20.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.159 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 tt -152.82 127.36 9.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.107 0.479 . . . . 0.0 111.885 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -117.35 108.12 15.2 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -119.32 159.4 24.22 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.73 122.41 17.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.071 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -119.88 162.15 19.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.015 0.435 . . . . 0.0 111.57 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -111.25 122.6 48.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.449 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.749 ' HA ' HG13 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -117.2 101.95 8.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.051 -179.585 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.42 125.18 38.9 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.129 0.49 . . . . 0.0 110.929 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.434 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 2.8 mm -108.72 112.49 40.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.999 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.1 mt . . . . . 0 N--CA 1.439 -0.99 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.416 179.166 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.702 HG11 ' HA ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.48 0 CA-C-O 120.702 0.287 . . . . 0.0 110.866 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -115.13 130.09 56.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.802 0.334 . . . . 0.0 110.752 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.57 -179.62 23.74 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.781 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.434 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -129.79 134.43 47.57 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.972 0.415 . . . . 0.0 111.192 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -53.63 135.86 39.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.992 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.88 -8.77 74.64 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.73 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.527 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.61 167.37 10.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.593 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.89 -171.75 11.34 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.472 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER 163.04 136.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.94 0.4 . . . . 0.0 110.531 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -119.33 134.02 55.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.067 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.414 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -92.18 105.27 17.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.173 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -88.45 122.09 31.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.183 0.516 . . . . 0.0 112.116 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.449 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.3 mt -80.58 119.46 76.34 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.229 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.68 131.76 39.4 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.316 2.011 . . . . 0.0 112.878 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 43.26 65.37 0.98 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -142.75 149.31 38.57 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.791 0.329 . . . . 0.0 110.625 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -142.75 116.95 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.948 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.07 78.82 5.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.2 p -107.37 -173.49 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.31 -34.87 71.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.923 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -59.76 -24.77 64.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.994 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.9 mm -78.61 129.08 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.448 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.72 -45.11 3.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -135.36 118.24 16.23 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.786 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 t -110.08 115.08 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.922 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -112.82 132.87 55.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.297 0.57 . . . . 0.0 112.426 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.453 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 70.3 m95 -112.28 86.48 2.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.784 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -100.44 145.67 27.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.272 0.558 . . . . 0.0 112.386 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.8 ttp85 -136.98 118.43 14.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.403 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.95 -114.7 5.98 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.685 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.4 m -119.3 44.69 2.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.763 0.316 . . . . 0.0 110.663 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.8 m -154.78 159.98 40.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.309 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.492 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.7 mt -101.47 146.76 27.2 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.461 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 41.8 t -117.05 -41.25 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.992 0.425 . . . . 0.0 110.494 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -170.42 113.62 0.45 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.676 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.72 149.36 40.87 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.046 0.45 . . . . 0.0 110.422 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.41 ' HA ' ' HB3' ' A' ' 48' ' ' PRO . 55.2 t80 . . . . . 0 C--N 1.321 -0.663 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.932 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 93.4 Cg_endo . . . . . 0 N--CA 1.462 -0.373 0 CA-C-O 120.825 0.26 . . . . 0.0 112.691 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.492 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 61.0 t80 -130.62 106.77 8.71 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.156 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.4 mt -99.49 113.89 26.53 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.197 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.461 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 22.6 tttt -46.91 -44.83 20.09 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.71 0.291 . . . . 0.0 111.431 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 p -176.54 165.78 2.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.02 -12.09 3.59 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.159 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.71 0.94 13.58 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.746 0.773 . . . . 0.0 112.133 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -132.93 156.81 46.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.102 0.477 . . . . 0.0 111.195 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -151.23 118.43 5.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.348 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 57' ' ' ILE . 8.8 tt -75.04 99.31 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.064 0.459 . . . . 0.0 111.319 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.59 167.02 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.245 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.74 -23.92 65.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.555 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -96.59 33.18 1.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.836 0.351 . . . . 0.0 111.183 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.54 34.33 69.07 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.713 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.51 166.4 10.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.876 0.369 . . . . 0.0 111.007 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.404 HD22 HD21 ' A' ' 16' ' ' LEU . 10.4 tp -107.24 120.72 42.91 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.515 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.38 110.64 22.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 110.875 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.4 ' CG1' HG21 ' A' ' 14' ' ' ILE . 2.8 mt -89.56 137.53 21.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.363 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -84.79 -47.11 10.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.974 0.416 . . . . 0.0 112.006 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.35 110.86 5.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.403 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.434 ' CD1' ' O ' ' A' ' 9' ' ' ALA . 6.7 mt -55.2 150.78 10.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.71 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.4 p -152.14 158.6 43.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.924 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.403 ' N ' HD12 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -50.53 -56.27 12.37 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.2 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -55.03 -22.41 15.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.129 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.16 -14.41 58.49 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.313 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.404 ' N ' HD11 ' A' ' 97' ' ' ILE . 2.3 t -79.59 127.34 32.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.644 0.259 . . . . 0.0 110.581 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.56 -167.85 32.07 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.226 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.55 125.33 36.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.763 0.316 . . . . 0.0 111.487 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.406 ' CE1' HD22 ' A' ' 95' ' ' LEU . 15.6 m-85 -103.32 130.7 50.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.29 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -113.29 126.07 54.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.857 0.36 . . . . 0.0 111.562 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.449 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -108.01 126.14 64.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.027 179.178 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.88 97.91 6.85 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.0 t -90.41 124.24 42.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.441 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -112.93 151.22 30.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.169 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.75 173.8 7.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.551 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.5 p -61.23 -18.46 58.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.385 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -93.01 22.98 4.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.325 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.57 19.52 48.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.656 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.55 -178.73 3.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.703 0.287 . . . . 0.0 110.616 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -101.08 126.3 47.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.778 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.7 mm -98.95 -54.44 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.417 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.3 tt -144.98 126.12 14.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.105 0.479 . . . . 0.0 111.98 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -118.01 107.41 14.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.1 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -120.17 162.79 18.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.85 120.56 12.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.091 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -115.11 156.47 25.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.87 0.367 . . . . 0.0 111.531 -179.139 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.02 121.45 43.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.244 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.702 ' HA ' HG11 ' A' ' 6' ' ' VAL . 9.7 tp -108.85 98.59 8.06 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.286 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -96.59 110.73 23.08 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.125 0.488 . . . . 0.0 110.322 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.415 HG12 HD23 ' A' ' 68' ' ' LEU . 4.6 mt -104.9 113.16 41.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.895 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.8 mt . . . . . 0 N--CA 1.442 -0.863 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.549 179.271 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.684 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 120.639 0.257 . . . . 0.0 110.619 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -112.68 129.56 56.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.799 0.333 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -153.98 177.6 31.34 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.76 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.76 135.62 54.93 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.969 0.414 . . . . 0.0 110.848 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tp -56.92 129.34 41.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.53 -4.69 76.68 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.502 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.559 ' NE2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.9 168.7 9.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.559 ' O ' ' NE2' ' A' ' 12' ' ' HIS . . . -77.74 160.67 49.02 Favored Glycine 0 C--O 1.224 -0.524 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.083 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.6 tp -176.14 138.06 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.834 0.349 . . . . 0.0 111.237 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -117.92 129.24 55.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.208 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.55 106.09 17.29 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -88.72 126.28 35.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.304 0.573 . . . . 0.0 112.008 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.434 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.3 mt -80.79 119.82 77.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.153 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.33 131.26 37.66 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.318 2.012 . . . . 0.0 112.862 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 m120 43.27 65.37 0.99 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -142.7 151.3 41.2 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 110.55 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -141.94 114.97 8.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.29 83.27 5.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.14 -174.07 2.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.86 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -56.08 -30.02 61.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.953 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -63.67 -27.87 69.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.999 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.1 mm -87.39 127.04 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.399 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.408 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -113.03 -42.16 3.6 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.069 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 43.2 tt0 -124.63 118.38 26.38 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.174 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.6 t -122.43 115.09 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.152 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -114.59 137.34 52.0 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.2 0.524 . . . . 0.0 112.261 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.449 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 71.9 m95 -112.19 85.58 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.86 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -97.28 142.39 29.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.287 0.565 . . . . 0.0 112.264 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.77 118.55 19.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.424 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.81 -114.22 5.45 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.687 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 m -119.68 44.94 2.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.732 0.301 . . . . 0.0 110.686 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.0 m -155.26 159.68 40.23 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.906 0.384 . . . . 0.0 111.357 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.504 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 4.5 mt -97.82 147.29 24.56 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.7 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.2 t -119.13 -43.09 2.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.341 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -172.45 114.39 0.3 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.725 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -125.05 156.61 37.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.078 0.466 . . . . 0.0 111.005 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 40.4 t80 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.845 -179.873 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.231 0.139 0 CA-C-O 120.847 0.27 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 46.5 t80 -111.61 103.54 11.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.177 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.3 mt -94.79 112.89 24.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.289 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -48.07 -46.63 33.82 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.695 0.283 . . . . 0.0 111.23 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -173.41 166.11 4.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 0.0 111.196 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.38 -11.47 3.63 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.376 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.53 -0.09 14.09 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 117.834 0.817 . . . . 0.0 112.236 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -132.84 157.8 44.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.076 0.465 . . . . 0.0 111.073 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -152.07 124.45 8.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.43 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 4.7 tt -84.61 103.9 12.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 111.176 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.73 172.63 1.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.005 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.36 -45.15 63.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -57.43 -22.45 43.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.113 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.01 35.0 4.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.634 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -115.33 155.38 27.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 110.979 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.2 tp -85.48 122.72 30.02 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.798 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.84 108.24 19.62 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.736 0.303 . . . . 0.0 111.073 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.0 mt -89.35 132.59 33.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.449 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -81.13 -46.06 15.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.953 0.406 . . . . 0.0 111.76 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -147.16 112.64 5.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.322 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.422 ' HB3' ' CG2' ' A' ' 97' ' ' ILE . 5.1 mt -54.16 149.62 9.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.166 0.508 . . . . 0.0 111.746 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.2 p -151.32 158.26 43.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.153 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -50.62 -56.82 10.07 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.173 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.37 -20.76 20.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.315 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.17 17.03 11.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.289 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.48 146.99 36.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.684 0.278 . . . . 0.0 110.756 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.32 -117.71 1.76 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.291 -0.957 . . . . 0.0 112.901 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -138.04 130.3 29.0 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 117.717 0.759 . . . . 0.0 110.848 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -103.98 151.92 22.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.359 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -132.57 124.15 27.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.192 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.434 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.46 127.3 66.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.223 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.58 97.18 6.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.715 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.2 t -88.22 131.78 34.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.269 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.518 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 96.0 m-85 -125.35 154.67 41.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.313 0.577 . . . . 0.0 111.198 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.77 175.71 7.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.414 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 2.1 p -62.82 -22.1 66.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.118 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -96.21 24.87 5.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.114 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.92 27.35 56.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.645 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.45 157.14 16.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 0.0 110.866 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.46 111.0 12.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.611 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.2 mm -93.22 -51.55 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.403 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 tt -151.02 149.78 29.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.212 0.53 . . . . 0.0 111.697 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.7 108.35 5.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.176 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -122.06 156.19 34.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.378 0.608 . . . . 0.0 112.516 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.42 123.65 18.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.174 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.408 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -122.51 163.05 20.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 0.0 111.437 -179.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.23 133.05 53.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.482 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.684 ' HA ' HG12 ' A' ' 6' ' ' VAL . 8.1 tp -113.36 97.9 6.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.635 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -95.37 108.13 20.31 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.105 0.478 . . . . 0.0 109.98 178.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.422 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 1.6 mt -106.65 110.51 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.001 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.9 mt . . . . . 0 N--CA 1.439 -1.001 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.289 179.074 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.649 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.519 0 CA-C-O 120.719 0.295 . . . . 0.0 110.775 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -118.16 127.16 53.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.59 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.69 177.7 27.68 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.826 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.4 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -123.56 135.55 54.06 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.889 0.376 . . . . 0.0 110.969 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.433 HD13 ' N ' ' A' ' 70' ' ' ARG . 0.9 OUTLIER -53.17 134.59 38.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.053 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.55 -5.31 84.96 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.852 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.548 ' NE2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.34 168.68 9.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 117.126 0.463 . . . . 0.0 109.958 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.548 ' O ' ' NE2' ' A' ' 12' ' ' HIS . . . -78.57 162.09 48.85 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.287 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.9 tp -176.54 138.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.764 0.316 . . . . 0.0 111.008 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -124.09 128.23 48.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.254 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.93 125.09 30.33 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -104.09 124.23 48.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.275 0.559 . . . . 0.0 111.914 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.459 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.4 mt -82.1 119.94 76.18 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.417 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.97 131.15 37.88 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.37 2.047 . . . . 0.0 112.96 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.65 65.23 0.96 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -142.18 149.13 39.31 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.643 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -138.75 117.58 12.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.912 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.26 81.87 8.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.0 p -117.47 -173.01 2.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -57.13 -30.43 64.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.69 -24.52 64.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.012 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.1 mm -85.01 127.44 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.348 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.421 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -111.15 -43.86 3.67 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.172 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 34.6 tt0 -127.77 118.29 23.47 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.125 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 t -119.09 144.33 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.373 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -148.14 132.4 17.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.053 0.454 . . . . 0.0 112.076 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.464 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 54.5 m95 -108.07 89.41 2.99 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -98.36 146.57 25.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.395 0.617 . . . . 0.0 112.481 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.67 116.99 11.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.353 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.1 -114.81 6.14 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.641 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.1 m -119.06 44.66 2.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.807 0.337 . . . . 0.0 110.654 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.5 m -154.27 160.74 41.93 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.294 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.489 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 4.1 mt -102.58 148.22 25.82 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.493 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 43.2 t -119.49 -41.31 2.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.746 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -173.05 114.27 0.25 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.904 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.07 154.71 45.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.183 0.516 . . . . 0.0 110.754 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 73.4 t80 . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.833 -179.931 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo . . . . . 0 N--CA 1.461 -0.429 0 CA-C-O 120.488 0.12 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.489 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 83.5 t80 -127.92 111.16 13.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.811 0.338 . . . . 0.0 111.416 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.2 mt -107.32 112.28 25.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.005 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 8.0 ttmt -46.71 -41.33 14.88 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.673 0.273 . . . . 0.0 111.464 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.2 p -177.03 164.38 2.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.946 0.403 . . . . 0.0 111.231 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.94 -11.95 4.91 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.106 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.86 1.05 13.59 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 117.688 0.744 . . . . 0.0 112.075 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -131.8 157.24 44.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.102 0.477 . . . . 0.0 111.161 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -151.41 119.69 6.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.216 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 7.8 tt -76.79 99.52 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.216 0.531 . . . . 0.0 111.237 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.1 163.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.275 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.58 -21.76 66.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.39 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.61 30.41 2.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.802 0.334 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.26 36.08 67.64 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.892 -0.671 . . . . 0.0 113.02 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -111.67 157.39 20.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 110.963 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.7 tp -93.19 121.25 34.35 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.716 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.77 107.49 18.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.876 0.37 . . . . 0.0 110.948 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 mt -87.48 136.47 23.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.437 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 tttm -86.04 -45.91 10.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.952 0.406 . . . . 0.0 111.713 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.47 110.96 5.6 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.319 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.438 HD21 ' CD1' ' A' ' 97' ' ' ILE . 5.5 mt -53.78 152.39 5.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.169 0.509 . . . . 0.0 111.855 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.0 p -152.92 159.36 42.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.194 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.433 ' N ' HD13 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -51.1 -56.94 10.15 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.078 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -55.28 -20.94 12.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.38 -14.8 56.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.425 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.401 ' HB3' HD12 ' A' ' 97' ' ' ILE . 5.6 p -81.99 137.88 35.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.58 0.229 . . . . 0.0 110.863 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.63 -124.62 2.04 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.835 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -136.92 133.43 35.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 117.9 0.85 . . . . 0.0 110.595 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -108.69 135.55 49.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.44 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -115.44 121.93 44.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.162 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.459 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -104.58 130.94 54.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.304 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.97 104.23 10.69 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.7 t -95.91 125.44 48.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.7 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.518 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 77.9 m-85 -119.31 147.54 44.19 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.28 0.562 . . . . 0.0 111.058 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.85 178.75 6.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.491 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.421 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -64.06 -18.65 64.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.208 179.628 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -94.73 20.88 8.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.234 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.85 30.05 56.08 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.756 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.56 153.66 20.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.344 . . . . 0.0 110.901 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.21 106.04 6.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.707 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.4 mm -78.23 -64.68 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.404 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 tt -145.1 133.26 21.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.155 0.502 . . . . 0.0 111.814 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.2 108.33 14.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.168 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -121.2 158.08 28.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.39 122.43 17.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.238 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.412 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -118.45 160.77 21.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.963 0.411 . . . . 0.0 111.421 -179.39 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -106.79 131.82 53.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.383 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.649 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -117.39 99.16 6.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.319 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.84 111.92 23.67 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.188 0.518 . . . . 0.0 110.524 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.438 ' CD1' HD21 ' A' ' 68' ' ' LEU . 4.0 mt -110.67 114.18 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.753 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mt . . . . . 0 N--CA 1.442 -0.861 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.652 179.308 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.763 0.316 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -100.03 78.94 2.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.85 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -83.03 -74.94 0.34 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.58 159.5 9.04 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.481 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -139.93 154.9 47.34 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.317 0.58 . . . . 0.0 111.028 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.718 HG13 ' HA ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -148.04 149.32 15.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.432 -179.539 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -117.68 131.46 56.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.895 0.378 . . . . 0.0 110.92 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.96 -178.04 19.36 Favored Glycine 0 C--O 1.229 -0.163 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.562 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.429 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.23 134.09 48.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.995 0.426 . . . . 0.0 111.178 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.62 130.88 47.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.837 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.89 -7.18 81.55 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.507 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.531 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.88 167.64 9.84 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.6 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.68 -172.69 12.23 Favored Glycine 0 C--O 1.226 -0.366 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.607 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER 163.29 136.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.432 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -120.83 122.13 39.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.545 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.471 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -79.07 103.47 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.788 179.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -87.74 122.25 31.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.226 0.536 . . . . 0.0 112.186 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.445 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.3 mt -79.9 119.91 78.2 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.158 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.11 131.04 36.95 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.272 1.982 . . . . 0.0 112.829 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.4 m120 43.56 65.28 1.02 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -142.71 149.4 38.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.766 0.317 . . . . 0.0 110.576 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -142.88 104.49 4.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.905 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.78 75.2 0.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.83 -173.53 2.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.76 -31.07 62.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.017 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -64.12 -26.64 68.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.966 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 mm -86.04 127.06 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.437 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.406 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -112.32 -42.72 3.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.081 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 36.0 tt0 -126.46 117.28 22.58 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.433 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.9 t -116.88 107.62 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.149 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -105.44 134.76 48.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.233 0.539 . . . . 0.0 112.034 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.471 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 69.0 m95 -112.39 88.1 2.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.209 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -102.11 146.35 28.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.253 0.549 . . . . 0.0 112.295 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.5 116.22 12.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.527 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.14 -116.34 8.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.745 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 p -116.5 43.4 2.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.768 0.318 . . . . 0.0 110.642 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.2 m -152.86 159.76 43.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.271 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.51 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.6 mt -102.43 148.56 25.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.808 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.7 t -119.57 -43.53 2.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.256 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -167.2 113.23 0.76 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.547 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -120.61 113.54 20.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.226 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -102.83 123.61 46.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.742 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -119.74 133.7 55.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.289 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -47.83 -28.9 2.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.409 0.623 . . . . 0.0 111.423 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -82.44 39.4 0.6 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.862 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 41.91 -166.19 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.666 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm 55.04 63.62 6.63 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.698 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.06 -178.35 4.45 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.572 2.181 . . . . 0.0 112.021 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.51 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 70.1 t80 -125.71 101.93 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.688 0.28 . . . . 0.0 111.51 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 mt -98.08 110.99 23.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.423 . . . . 0.0 109.879 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -43.83 -39.5 3.89 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.82 0.343 . . . . 0.0 111.365 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.05 165.97 0.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.943 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.84 -10.56 2.37 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.371 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.88 2.15 10.97 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 117.819 0.809 . . . . 0.0 112.343 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -134.05 156.93 47.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.153 0.502 . . . . 0.0 111.261 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -152.35 118.54 5.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.191 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.409 ' O ' ' CG2' ' A' ' 57' ' ' ILE . 6.6 tt -73.96 101.62 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.122 0.487 . . . . 0.0 111.388 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.6 169.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.177 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.8 -25.06 65.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.581 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -97.06 33.25 1.96 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.753 0.311 . . . . 0.0 111.122 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.55 30.51 65.39 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.672 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.99 170.47 9.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 111.096 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.0 tp -110.08 119.24 38.65 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.469 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -106.73 110.94 23.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.742 0.306 . . . . 0.0 110.746 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.43 ' CG1' HG21 ' A' ' 14' ' ' ILE . 2.6 mt -89.42 138.53 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.468 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -84.26 -49.17 9.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.009 0.433 . . . . 0.0 111.875 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.26 110.65 5.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.494 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.429 ' CD1' ' O ' ' A' ' 9' ' ' ALA . 5.1 mt -54.09 147.9 11.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.273 0.559 . . . . 0.0 111.779 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.0 p -152.3 169.41 22.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.485 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.0 mmm180 -51.33 -52.89 41.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.477 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -56.06 -21.65 23.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.597 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.12 -14.87 52.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.549 0.214 . . . . 0.0 111.498 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -82.82 117.84 22.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.678 0.275 . . . . 0.0 110.601 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.95 -166.26 33.43 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.17 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.44 126.39 39.68 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 122.507 0.323 . . . . 0.0 111.266 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -102.95 148.41 25.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.358 -0.383 . . . . 0.0 109.982 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -129.67 126.17 37.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 0.0 111.707 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.445 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -111.99 132.67 59.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.025 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.03 96.85 5.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.588 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.417 HG11 ' HB ' ' A' ' 88' ' ' ILE . 76.0 t -85.58 128.61 39.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.301 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.511 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.5 m-85 -119.25 153.02 35.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.068 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.25 175.42 7.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.355 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.406 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.1 p -62.69 -28.4 69.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.994 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -77.62 -4.49 46.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.427 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.6 27.91 45.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.6 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.33 165.5 11.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.867 0.365 . . . . 0.0 110.764 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.53 127.08 31.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.592 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.417 ' HB ' HG11 ' A' ' 80' ' ' VAL . 33.0 mm -104.12 -67.31 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.372 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.2 tt -137.37 127.17 25.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.132 0.492 . . . . 0.0 111.799 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -115.75 106.69 14.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.199 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -117.19 161.96 18.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.372 0.606 . . . . 0.0 112.526 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.95 122.07 12.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.993 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.418 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -120.25 156.22 31.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.937 0.399 . . . . 0.0 111.679 -179.045 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.78 110.72 22.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.17 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.718 ' HA ' HG13 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -101.73 98.2 8.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.286 -179.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -92.78 121.83 34.56 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 110.743 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.439 ' CD1' HD23 ' A' ' 95' ' ' LEU . 2.9 mm -107.24 116.38 50.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.991 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.3 mt -74.17 124.23 25.96 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.467 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.875 -179.781 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.0 mtt180 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.87 0.367 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.27 92.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -74.16 -69.0 0.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.947 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.9 160.69 24.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.524 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -144.79 148.95 34.66 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.249 0.547 . . . . 0.0 110.919 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.701 HG11 ' HA ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -140.64 142.88 29.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.737 -179.499 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.481 ' CD2' ' HD3' ' A' ' 96' ' ' ARG . 79.1 m95 -110.85 129.65 55.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.689 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.41 -179.9 26.58 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.062 -1.066 . . . . 0.0 112.969 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.426 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.15 134.55 49.1 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.95 0.405 . . . . 0.0 110.962 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 70' ' ' ARG . 1.4 tp -55.81 133.27 51.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.41 -5.72 84.4 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.47 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.523 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -110.61 168.71 9.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.596 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -72.3 -169.4 12.76 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.5 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER 160.36 136.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 122.647 0.379 . . . . 0.0 110.347 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -118.71 130.1 55.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.949 0.404 . . . . 0.0 111.299 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.94 106.45 18.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.765 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -88.85 123.86 33.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.165 0.507 . . . . 0.0 111.867 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.443 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.4 mt -79.89 119.86 78.05 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.284 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.93 131.3 38.75 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.325 2.017 . . . . 0.0 112.856 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 43.04 65.42 0.96 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -142.65 149.31 38.73 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.579 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -139.26 117.46 11.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -80.24 80.98 6.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.38 -174.23 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.843 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.23 -30.86 62.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.991 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -62.19 -27.86 69.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.962 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.1 mm -88.21 127.21 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.369 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.408 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -113.13 -42.27 3.57 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.053 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 45.9 tt0 -123.94 115.91 22.03 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.365 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.41 112.79 42.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.829 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -111.01 130.6 55.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.024 0.44 . . . . 0.0 112.149 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.401 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 69.4 m95 -112.03 84.06 1.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.934 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -100.73 153.77 19.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.338 0.59 . . . . 0.0 112.297 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.34 116.14 8.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.676 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.24 -117.76 11.43 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.207 -0.997 . . . . 0.0 111.88 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.07 42.61 2.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.818 0.342 . . . . 0.0 110.738 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.1 m -151.14 160.26 43.97 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.155 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.497 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 6.0 mt -104.97 146.08 29.53 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.424 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 52.8 t -117.1 -42.94 3.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.983 0.42 . . . . 0.0 110.227 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -165.76 111.86 0.89 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.519 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -120.77 117.02 26.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.203 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -104.29 147.29 27.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.648 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.82 136.03 22.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.818 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.463 ' HG3' ' N ' ' A' ' 45' ' ' LYS . 6.9 tpp180 -51.71 -88.98 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.243 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.463 ' N ' ' HG3' ' A' ' 44' ' ' ARG . 25.8 mmtm -82.59 48.65 1.34 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.007 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -162.73 146.68 11.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.971 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -67.64 137.61 93.13 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.56 176.32 9.7 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.574 2.183 . . . . 0.0 112.546 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.497 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 58.9 t80 -131.39 103.47 6.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.202 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.3 mt -97.6 111.87 23.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.081 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 33.6 tttm -45.2 -42.64 9.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.745 0.307 . . . . 0.0 111.527 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.8 p -176.63 165.79 2.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.888 0.375 . . . . 0.0 111.154 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.14 -11.34 4.62 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.158 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.17 2.19 11.47 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 117.707 0.753 . . . . 0.0 112.098 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -133.15 157.16 46.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.074 0.464 . . . . 0.0 111.184 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -153.92 120.18 5.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.331 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.41 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 7.9 tt -74.93 99.94 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 0.0 111.282 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.68 163.39 0.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.209 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.88 -22.0 65.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.458 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -96.53 31.91 2.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.761 0.315 . . . . 0.0 111.096 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.66 35.65 68.18 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.901 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.06 157.19 21.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.836 0.35 . . . . 0.0 111.033 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.95 123.25 36.07 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.782 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -108.24 108.57 19.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.693 0.283 . . . . 0.0 110.919 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.407 ' CD1' ' CG2' ' A' ' 14' ' ' ILE . 3.2 mt -88.1 137.47 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.404 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -87.82 -45.98 9.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.974 0.416 . . . . 0.0 111.829 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.53 109.21 5.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.481 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.443 ' HB3' ' CG2' ' A' ' 97' ' ' ILE . 5.7 mt -57.37 152.5 14.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.178 0.514 . . . . 0.0 111.564 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.5 p -154.11 161.35 41.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.136 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.408 ' N ' HD12 ' A' ' 10' ' ' LEU . 26.2 mmm180 -50.62 -56.18 12.98 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.247 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -54.85 -22.19 13.79 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.465 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.39 -15.09 56.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.307 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.8 p -83.13 132.19 35.1 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.72 0.295 . . . . 0.0 110.733 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.45 -131.34 3.25 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.344 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -128.81 130.48 47.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.722 0.761 . . . . 0.0 110.627 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -105.08 148.51 26.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.219 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -130.73 122.35 27.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.767 0.318 . . . . 0.0 111.374 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.443 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -105.75 129.04 59.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.232 179.267 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.6 97.8 6.34 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.655 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.402 HG12 ' HB ' ' A' ' 88' ' ' ILE . 87.2 t -89.36 129.92 39.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.335 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.51 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 96.9 m-85 -123.87 154.01 40.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.403 0.62 . . . . 0.0 111.188 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.79 175.31 7.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.352 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 2.1 p -62.13 -21.69 65.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.115 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -96.27 25.6 4.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.161 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.95 27.72 51.51 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.69 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.15 156.84 16.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.319 . . . . 0.0 110.866 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -77.38 110.26 11.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.783 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.402 ' HB ' HG12 ' A' ' 80' ' ' VAL . 33.3 mm -91.46 -48.33 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.293 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 tt -154.57 149.85 27.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.277 0.56 . . . . 0.0 111.709 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -141.11 108.58 5.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.289 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.59 157.33 30.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.416 0.627 . . . . 0.0 112.598 -178.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.0 124.59 18.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.126 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.41 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -122.34 164.82 17.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.036 0.446 . . . . 0.0 111.674 -179.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -111.94 124.21 51.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.239 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.701 ' HA ' HG11 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -108.84 113.61 26.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.419 -179.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.481 ' HD3' ' CD2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -113.21 117.13 31.02 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.193 0.52 . . . . 0.0 110.447 178.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.443 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 1.2 mt -108.61 110.28 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.924 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.5 mt -64.66 127.72 32.72 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.077 0.465 . . . . 0.0 110.219 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.907 -179.739 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.859 0.361 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 t70 60.38 79.96 0.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.92 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.42 -31.25 13.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.925 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.88 163.88 30.61 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.484 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -140.51 151.73 45.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.199 0.523 . . . . 0.0 110.908 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.653 HG11 ' HA ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER -143.22 151.06 17.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.724 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -120.27 130.16 54.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.56 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -148.9 -179.02 24.46 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.904 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.405 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -132.09 134.85 45.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.071 0.462 . . . . 0.0 111.226 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 70' ' ' ARG . 0.7 OUTLIER -52.84 136.22 34.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.031 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.2 -9.6 72.15 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.702 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.527 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.44 168.35 9.3 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.6 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -71.95 -170.94 14.65 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.424 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER 162.03 136.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.815 0.34 . . . . 0.0 110.43 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -123.72 130.43 52.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.402 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.425 HD12 ' HG ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -84.27 135.73 34.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.692 179.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -116.39 122.02 43.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.275 0.559 . . . . 0.0 111.813 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.445 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.2 mt -81.46 119.6 76.02 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.245 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.65 130.87 37.19 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.364 2.043 . . . . 0.0 112.999 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.0 m120 42.78 65.07 1.0 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -141.43 149.3 40.83 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.772 0.32 . . . . 0.0 110.559 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -137.91 117.43 12.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.939 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.7 tpt -79.57 75.39 6.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.972 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.7 p -107.44 -173.16 2.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.99 -32.34 70.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -59.24 -27.04 65.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.98 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 mm -78.81 128.1 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.492 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -111.3 -44.32 3.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.14 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 73.3 tt0 -130.31 116.32 18.18 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.172 -0.611 . . . . 0.0 112.537 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 t -112.42 111.24 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.743 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 6.5 mtp180 -108.18 130.31 55.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.178 0.513 . . . . 0.0 112.239 -178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -112.68 84.65 2.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.9 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.35 154.16 19.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.316 0.579 . . . . 0.0 112.247 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.403 ' HD3' ' CZ ' ' A' ' 76' ' ' TYR . 10.3 ttp-105 -143.96 118.32 9.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.602 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.01 -117.64 10.9 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.829 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.1 m -115.99 43.02 2.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.743 0.306 . . . . 0.0 110.739 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.7 m -151.14 160.06 44.09 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.171 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.504 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 6.0 mt -103.73 145.66 29.76 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.7 t -117.5 -43.42 3.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.153 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -166.06 111.31 0.84 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.752 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -117.66 112.42 20.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.042 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.42 ' CG ' ' N ' ' A' ' 43' ' ' LYS . 21.1 t80 -101.4 158.84 15.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.85 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 42' ' ' PHE . 2.1 mppt? -149.71 172.83 14.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.819 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.405 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -93.96 103.05 15.15 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.759 0.79 . . . . 0.0 109.797 179.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 44' ' ' ARG . 0.5 OUTLIER 82.48 -47.32 0.17 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.695 -179.435 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.8 ttt -54.01 167.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.863 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.19 128.72 61.17 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.048 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -81.52 -174.44 2.18 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.605 2.203 . . . . 0.0 112.607 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 71.1 t80 -137.49 105.46 5.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.352 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.1 mt -99.73 112.26 24.52 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -44.53 -45.87 9.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.725 0.298 . . . . 0.0 111.368 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.87 166.69 2.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.94 0.4 . . . . 0.0 111.112 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.77 -11.61 2.13 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.401 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.49 2.01 10.58 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 117.79 0.795 . . . . 0.0 112.296 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -135.46 157.16 47.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.084 0.468 . . . . 0.0 111.284 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -153.32 122.06 6.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.249 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.412 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 6.4 tt -76.0 101.52 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.152 0.501 . . . . 0.0 111.213 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.35 160.35 1.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.138 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.19 -21.97 66.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.404 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -96.13 32.81 1.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.052 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.71 34.37 56.25 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.778 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.26 155.3 22.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.866 0.365 . . . . 0.0 111.028 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 tp -92.95 122.71 35.59 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.821 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -108.04 110.06 21.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.71 0.29 . . . . 0.0 110.863 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.421 ' CD1' HG23 ' A' ' 14' ' ' ILE . 2.8 mt -89.18 138.79 18.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.408 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -86.69 -47.67 8.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.008 0.432 . . . . 0.0 111.91 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -142.73 110.73 5.96 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.335 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.46 ' CD2' HG12 ' A' ' 97' ' ' ILE . 7.2 mt -55.65 150.77 11.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.308 0.575 . . . . 0.0 111.795 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.8 p -153.36 161.42 42.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.813 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.43 ' N ' HD12 ' A' ' 10' ' ' LEU . 1.5 ptp180 -50.91 -54.84 20.64 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.429 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -57.43 -20.64 31.53 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.459 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.76 -15.53 51.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.389 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.8 t -82.78 130.69 35.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.582 0.23 . . . . 0.0 110.446 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.51 -166.25 29.63 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.172 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.7 126.4 36.77 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 122.522 0.329 . . . . 0.0 111.538 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.403 ' CZ ' ' HD3' ' A' ' 34' ' ' ARG . 18.9 m-85 -102.93 151.83 22.01 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -131.52 125.77 33.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.754 0.312 . . . . 0.0 111.492 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.445 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -110.1 130.8 62.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.211 179.155 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.02 98.46 6.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.512 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.5 t -91.46 125.73 44.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.748 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.431 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.5 m-85 -118.39 152.79 35.18 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.91 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.67 172.32 8.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.567 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 16.9 p -60.04 -19.46 52.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.377 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -93.97 25.27 3.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.233 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.59 20.95 40.63 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.787 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.62 166.08 11.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.703 0.287 . . . . 0.0 110.696 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -90.89 120.19 31.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.731 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.3 mt -90.71 -58.87 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.498 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.7 tt -147.83 133.68 19.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.117 0.484 . . . . 0.0 111.879 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.23 109.61 15.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.923 178.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -121.5 162.66 20.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.01 121.95 14.52 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.047 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.405 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -113.76 164.71 13.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.03 0.443 . . . . 0.0 111.737 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -114.73 111.82 21.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.271 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.653 ' HA ' HG11 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -99.22 99.38 10.34 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.245 -179.422 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.73 120.47 40.14 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.004 0.431 . . . . 0.0 110.455 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.46 HG12 ' CD2' ' A' ' 68' ' ' LEU . 1.7 mt -128.42 129.13 68.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.794 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.7 mt -82.65 169.55 16.12 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.879 179.885 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.833 0.349 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 68.33 -68.57 0.17 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.014 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.5 m -65.56 144.75 56.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.821 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.3 -150.71 35.6 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.475 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 2.7 m -50.63 147.34 4.76 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.378 0.609 . . . . 0.0 111.33 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.733 HG13 ' HA ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER -141.03 147.32 22.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.717 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -115.89 127.91 55.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.525 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.75 -178.8 21.52 Favored Glycine 0 N--CA 1.459 0.171 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.705 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.429 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.96 134.68 48.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.069 0.461 . . . . 0.0 111.287 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.402 ' HA ' ' CB ' ' A' ' 68' ' ' LEU . 1.0 OUTLIER -55.62 134.82 51.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.741 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.66 -8.58 77.02 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.456 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.53 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -106.95 167.16 10.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.615 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.41 -173.85 14.06 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.551 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.615 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER 161.24 136.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 122.579 0.352 . . . . 0.0 110.367 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -124.85 123.78 40.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.955 0.407 . . . . 0.0 111.525 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.432 HD11 ' HG ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -79.07 112.19 16.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.744 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -93.76 124.89 38.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.191 0.52 . . . . 0.0 111.884 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.442 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.3 mt -81.64 120.04 76.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.252 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.01 131.12 37.63 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.278 1.985 . . . . 0.0 112.901 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.9 m120 43.12 65.16 1.01 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -142.14 149.37 39.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.758 0.313 . . . . 0.0 110.607 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -138.83 117.41 12.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.1 tpt -81.17 76.22 8.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 46.8 p -111.43 -173.03 2.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -57.8 -30.52 65.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.966 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -62.1 -28.12 69.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.6 mm -87.74 126.8 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.383 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.73 -41.92 3.71 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 61.3 tt0 -125.84 118.32 25.24 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.28 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 30.9 t -121.32 117.69 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.019 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.449 ' NH1' ' CE2' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -115.81 136.94 52.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.266 0.555 . . . . 0.0 112.223 -178.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.478 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 74.8 m95 -112.12 87.38 2.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.702 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -101.05 149.91 23.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.355 0.598 . . . . 0.0 112.283 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.7 ttp85 -142.13 117.59 10.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.462 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.81 -115.65 7.13 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.737 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 t -118.59 44.35 2.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.786 0.327 . . . . 0.0 110.683 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.3 m -151.94 160.39 43.51 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.328 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.49 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.5 mt -103.25 146.89 27.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 56.1 t -119.01 -43.52 2.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.959 0.409 . . . . 0.0 110.476 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -174.73 114.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.045 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 1.1 pt-20 -128.35 156.04 43.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.009 0.433 . . . . 0.0 110.947 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -124.39 144.11 50.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.871 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.3 mtmm -145.72 111.25 5.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.649 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.3 tpp85 -47.98 -59.32 3.45 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.734 0.778 . . . . 0.0 111.148 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -82.56 46.72 1.09 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.941 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.7 mtt 177.59 -171.86 0.1 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.928 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -109.09 146.76 34.54 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.821 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.3 155.78 51.1 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.576 2.184 . . . . 0.0 112.585 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.49 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 33.8 t80 -115.86 101.85 9.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.34 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mt -91.29 116.22 28.66 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 12.1 tptm -38.88 -90.33 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.729 0.641 . . . . 0.0 112.729 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 m -117.41 22.68 12.28 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.76 -0.03 52.77 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.089 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.32 5.33 27.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 117.53 0.665 . . . . 0.0 111.02 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -126.24 158.22 36.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.024 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -138.71 119.55 14.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.147 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.416 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 7.4 tt -78.13 99.67 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.182 0.515 . . . . 0.0 111.064 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.47 153.14 7.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.279 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.32 -19.79 56.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.475 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.24 31.94 2.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.861 0.363 . . . . 0.0 111.043 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.37 36.35 57.64 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.847 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -112.97 157.88 20.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.023 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 tp -95.2 122.49 37.93 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.125 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.26 104.71 13.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.715 0.293 . . . . 0.0 110.696 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.437 ' CG1' HG21 ' A' ' 14' ' ' ILE . 2.6 mt -81.02 134.59 26.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.774 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -78.28 -49.06 14.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.09 0.471 . . . . 0.0 111.513 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.53 112.99 5.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.134 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.429 ' CD1' ' O ' ' A' ' 9' ' ' ALA . 5.8 mt -52.73 148.37 7.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.261 0.553 . . . . 0.0 111.873 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 p -152.13 163.1 40.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.78 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.81 -55.22 17.91 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.291 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -52.66 -22.95 5.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.614 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -82.99 -13.87 55.13 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.571 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.7 t -83.45 119.96 25.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.672 0.272 . . . . 0.0 110.582 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.46 -139.06 5.85 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.467 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 m -120.32 130.86 54.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 117.382 0.591 . . . . 0.0 110.648 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.428 ' CE1' HD12 ' A' ' 95' ' ' LEU . 23.0 m-85 -106.43 151.27 25.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.386 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -134.47 121.81 21.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.332 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.442 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -106.8 133.46 51.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.24 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.28 103.6 9.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.549 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 91.1 t -93.81 129.28 44.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.689 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.8 m-85 -121.44 153.64 37.61 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.998 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.99 176.45 7.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.336 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.0 p -64.63 -28.67 69.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.979 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -77.3 -4.53 45.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.421 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.62 27.33 43.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.536 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.6 165.68 11.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 110.783 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.98 134.13 38.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.568 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 37.8 mm -111.52 -66.64 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.397 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 tt -141.09 128.76 21.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.1 0.476 . . . . 0.0 111.845 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.47 107.22 14.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.177 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -118.1 158.57 24.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.389 0.614 . . . . 0.0 112.536 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.63 125.79 18.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.152 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.415 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -125.32 161.53 26.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.047 0.451 . . . . 0.0 111.65 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 5' ' ' THR . 1.6 m-20 -110.32 116.85 32.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.228 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.733 ' HA ' HG13 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -104.8 103.76 13.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.308 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.46 115.26 28.88 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 110.692 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.1 mt -106.4 111.79 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.557 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.25 170.24 16.94 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.246 0.546 . . . . 0.0 110.734 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.9 179.965 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 20.4 tpt85 . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.813 0.34 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.42 -62.26 1.51 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 m -132.13 163.61 28.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.94 163.23 54.19 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.442 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 m -138.92 154.78 48.38 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.261 0.553 . . . . 0.0 110.975 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.702 HG13 ' HA ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -147.34 150.03 15.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.642 -179.484 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -118.84 131.15 56.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.29 -178.53 19.19 Favored Glycine 0 N--CA 1.459 0.21 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.508 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.444 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -126.48 133.25 51.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.048 0.452 . . . . 0.0 111.313 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.408 ' CD1' ' HA ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -55.6 131.06 45.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.874 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.51 -6.42 83.22 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.452 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.524 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.05 167.66 9.84 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.594 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.4 -172.93 11.85 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.597 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.594 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER 163.31 136.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.773 0.32 . . . . 0.0 110.354 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -121.75 122.47 39.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.936 0.398 . . . . 0.0 111.476 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.448 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -77.96 108.82 11.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.773 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -93.3 123.11 36.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.176 0.513 . . . . 0.0 111.967 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.429 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.3 mt -79.37 119.47 77.12 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.262 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.54 131.21 36.94 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.393 2.062 . . . . 0.0 112.976 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 43.27 64.74 1.13 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -140.21 149.07 42.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.834 0.35 . . . . 0.0 110.497 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -132.9 116.72 16.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.1 90.01 7.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.8 p -125.84 -173.04 2.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.937 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.27 -30.53 64.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.941 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -62.07 -25.59 67.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.992 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 mm -79.34 128.47 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.509 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.2 -38.82 7.52 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.234 -0.291 . . . . 0.0 111.325 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 12.7 mt-10 -142.6 153.75 43.78 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-O 121.581 0.705 . . . . 0.0 112.355 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.8 t -148.26 116.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.162 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 4.5 mtm180 -112.24 134.1 53.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.071 0.462 . . . . 0.0 112.05 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.448 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 73.3 m95 -112.33 85.07 2.08 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -102.47 148.17 25.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.3 0.571 . . . . 0.0 112.22 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.04 118.75 13.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.557 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.91 -116.37 8.17 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.773 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.9 m -117.66 43.88 2.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.769 0.319 . . . . 0.0 110.71 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.7 m -152.88 160.0 43.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.265 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.505 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.8 mt -102.79 147.19 27.17 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.798 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.436 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 50.0 t -118.47 -42.92 2.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.285 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -167.47 112.17 0.7 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.597 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -118.51 119.32 34.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.969 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -105.92 157.66 17.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.705 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -152.99 151.42 30.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -59.83 90.27 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.968 0.89 . . . . 0.0 110.63 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 80.85 -45.56 0.24 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.838 -1.528 . . . . 0.0 111.258 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -45.06 142.77 1.76 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.823 0.344 . . . . 0.0 111.293 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.2 122.34 53.41 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.074 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.67 -172.78 1.61 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.597 2.198 . . . . 0.0 112.567 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 68.7 t80 -136.82 104.24 5.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.284 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.1 mt -98.01 110.78 23.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.02 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 28.8 tttm -45.29 -40.58 7.8 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.77 0.319 . . . . 0.0 111.533 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 p -178.21 164.61 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 111.205 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.75 -11.73 4.42 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.166 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.83 1.6 12.21 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 117.593 0.697 . . . . 0.0 112.155 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -131.99 156.97 45.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.184 0.516 . . . . 0.0 111.262 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -151.82 117.24 5.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.196 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.404 ' O ' ' CG2' ' A' ' 57' ' ' ILE . 9.2 tt -73.83 99.48 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.321 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.12 166.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.163 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.9 -23.96 65.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.637 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -96.76 33.33 1.88 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.796 0.331 . . . . 0.0 111.16 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.75 33.9 69.12 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.621 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.08 165.79 10.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.868 0.366 . . . . 0.0 111.012 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 10.3 tp -107.0 119.71 40.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.518 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -105.75 111.25 23.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.309 . . . . 0.0 110.996 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.416 ' CG1' HG21 ' A' ' 14' ' ' ILE . 2.7 mt -90.93 138.22 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.449 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -84.16 -48.19 10.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.066 0.46 . . . . 0.0 111.896 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.11 111.35 5.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.312 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.444 ' CD1' ' O ' ' A' ' 9' ' ' ALA . 4.9 mt -53.61 147.22 11.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.22 0.533 . . . . 0.0 111.736 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.408 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 5.3 p -147.59 160.88 42.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.852 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.74 -56.43 12.04 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.093 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.6 -22.7 9.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.428 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.54 -15.24 57.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.627 0.251 . . . . 0.0 111.308 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.4 t -81.58 120.79 25.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.591 0.234 . . . . 0.0 110.578 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.98 -144.43 9.88 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.373 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.9 m -115.65 130.62 56.93 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.056 0.428 . . . . 0.0 110.663 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -108.26 133.23 52.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.24 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -114.98 124.37 51.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.458 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.429 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -107.02 133.52 51.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.192 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.36 96.37 5.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.695 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.9 t -86.74 126.9 40.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.234 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.488 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 2.6 m-30 -112.8 151.33 30.48 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.346 0.593 . . . . 0.0 110.612 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.42 178.99 5.53 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.199 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 73.5 p -68.51 -23.51 64.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.044 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -75.91 -5.22 45.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.592 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.29 24.57 47.08 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.666 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.64 -170.59 1.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.757 0.313 . . . . 0.0 110.683 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -105.31 115.62 30.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.971 0.415 . . . . 0.0 110.811 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 74.4 mt -78.89 -51.66 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.343 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.83 136.25 16.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.204 0.526 . . . . 0.0 111.9 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.4 106.98 13.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.884 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -116.48 156.97 25.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.14 122.45 18.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.132 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.409 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -117.98 159.41 23.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.896 0.379 . . . . 0.0 111.538 -179.239 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -109.16 110.76 22.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.381 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.702 ' HA ' HG13 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -102.27 100.2 10.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.071 -179.451 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -95.16 123.43 38.66 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.071 0.462 . . . . 0.0 110.89 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.429 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 2.9 mm -107.81 117.47 53.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.999 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.5 mt -74.98 123.38 25.03 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.422 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.946 -179.868 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.873 0.368 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -108.07 154.3 21.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 m 60.48 108.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.9 160.92 15.15 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.518 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.9 m -137.46 154.17 49.96 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.249 0.547 . . . . 0.0 110.969 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.637 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -146.62 153.33 12.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.855 -179.204 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -121.89 136.39 54.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.033 0.444 . . . . 0.0 111.255 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.45 178.68 28.65 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.303 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.442 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.03 133.8 49.15 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.049 0.452 . . . . 0.0 111.221 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.41 ' HA ' ' CB ' ' A' ' 68' ' ' LEU . 1.2 tp -53.51 134.88 40.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.65 -10.94 71.81 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.632 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.524 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -106.66 168.0 9.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.594 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -72.02 -169.61 12.37 Favored Glycine 0 C--O 1.227 -0.315 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.491 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.594 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER 163.79 136.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.963 0.411 . . . . 0.0 110.632 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -117.97 130.1 56.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.043 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.5 102.99 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -88.68 123.5 33.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.174 0.511 . . . . 0.0 112.3 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.449 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.3 mt -79.2 119.96 78.95 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.022 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.03 131.04 37.15 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.262 1.975 . . . . 0.0 112.903 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 43.38 65.09 1.04 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -142.03 150.9 41.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.79 0.328 . . . . 0.0 110.595 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -139.44 117.75 12.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -82.78 78.37 9.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.7 p -112.51 -173.02 2.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -57.9 -30.66 66.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.967 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.49 -27.74 68.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.971 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.4 mm -84.38 127.62 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.447 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.5 OUTLIER -111.63 -44.08 3.55 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.247 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 45.8 tp10 -123.69 121.27 35.07 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.187 -0.605 . . . . 0.0 112.117 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.82 114.25 42.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.904 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -112.85 132.38 55.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.133 0.492 . . . . 0.0 112.289 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.416 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 71.7 m95 -113.3 87.77 2.68 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -101.7 148.13 25.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.313 0.578 . . . . 0.0 112.478 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -139.26 116.46 11.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.522 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.07 -116.52 8.46 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.729 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.5 t -117.39 43.87 2.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.866 0.365 . . . . 0.0 110.651 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.0 m -152.27 160.38 43.36 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.224 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.499 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.8 mt -101.7 146.5 27.65 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.443 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 52.9 t -118.52 -43.02 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.97 0.414 . . . . 0.0 110.199 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -166.6 110.17 0.75 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.579 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.44 121.76 40.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.79 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -103.36 146.63 28.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.041 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -153.06 117.9 5.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.69 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.4 ttm-85 -55.68 -56.7 17.35 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.845 0.831 . . . . 0.0 111.298 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -82.19 46.35 1.02 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.191 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.19 -172.4 0.08 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.894 0.378 . . . . 0.0 111.015 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.6 mttm -104.64 142.36 24.48 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.657 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.1 155.18 47.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.462 2.108 . . . . 0.0 112.709 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.499 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 48.9 t80 -113.21 100.73 8.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.131 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.7 mt -94.08 111.15 22.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.069 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 36.3 tttt -45.99 -36.73 5.84 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.702 0.287 . . . . 0.0 111.452 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.0 p -178.74 164.29 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 111.222 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.74 -10.2 6.08 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.142 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.63 2.72 11.16 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.651 0.726 . . . . 0.0 112.188 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -132.08 156.89 45.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.107 0.48 . . . . 0.0 111.239 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -151.5 116.33 5.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.367 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.401 ' O ' ' CG2' ' A' ' 57' ' ' ILE . 9.7 tt -73.98 99.22 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.105 0.479 . . . . 0.0 111.295 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.19 165.75 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.154 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.46 -23.67 65.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.566 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -96.21 33.11 1.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.188 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.02 34.71 73.41 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.604 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.31 171.16 7.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.899 0.38 . . . . 0.0 110.874 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.6 tp -112.81 122.35 47.39 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -109.04 108.88 19.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.683 0.278 . . . . 0.0 110.947 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.421 ' CD1' ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -87.2 141.0 14.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.413 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -85.76 -50.86 6.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.025 0.441 . . . . 0.0 112.1 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.65 110.84 6.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.5 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.46 HD22 ' CD1' ' A' ' 97' ' ' ILE . 5.4 mt -53.83 147.58 11.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.643 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.1 p -152.7 161.3 42.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.786 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 mmm-85 -50.48 -56.12 12.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.331 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -57.6 -20.28 31.53 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.629 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.31 -15.75 45.47 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.533 0.206 . . . . 0.0 111.425 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 t -82.7 133.36 35.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.603 0.24 . . . . 0.0 110.483 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.07 -166.97 30.02 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.134 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.06 126.63 35.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.896 0.379 . . . . 0.0 111.435 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.418 ' CE1' HD21 ' A' ' 95' ' ' LEU . 24.5 m-85 -106.84 128.2 54.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.33 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -112.07 129.16 56.31 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.853 0.359 . . . . 0.0 111.657 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.449 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -112.08 130.59 65.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.98 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.65 98.9 6.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.8 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 82.0 t -92.02 128.71 43.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.462 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.499 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.3 m-85 -124.02 153.45 41.3 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.291 0.567 . . . . 0.0 111.108 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.93 174.81 7.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.408 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.4 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.1 p -61.07 -22.34 64.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.169 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.83 26.46 4.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.168 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.74 25.77 37.53 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.691 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.24 155.59 16.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.778 0.323 . . . . 0.0 110.889 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.53 116.35 18.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.649 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.2 mt -93.95 -69.3 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.339 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.402 ' CD2' ' CG ' ' A' ' 91' ' ' LYS . 2.6 tt -142.34 126.78 17.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.152 0.501 . . . . 0.0 111.903 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.3 106.95 14.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.402 ' CG ' ' CD2' ' A' ' 89' ' ' LEU . 5.7 mmpt? -118.15 162.49 18.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.464 0.65 . . . . 0.0 112.702 -178.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.6 119.96 10.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.067 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -114.45 157.83 22.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.836 0.351 . . . . 0.0 111.407 -179.235 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.09 115.23 29.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.361 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.637 ' HA ' HG12 ' A' ' 6' ' ' VAL . 38.3 tp -101.11 98.14 8.6 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.958 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.2 OUTLIER -101.1 123.37 45.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.031 0.443 . . . . 0.0 110.599 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.46 ' CD1' HD22 ' A' ' 68' ' ' LEU . 1.9 mm -122.61 126.65 74.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.065 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.7 mt -82.99 168.92 16.53 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.564 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.882 179.916 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.905 0.383 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.27 28.55 2.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.048 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.03 158.07 14.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.705 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.56 -150.89 6.08 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.928 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 m -119.43 150.02 40.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.225 0.536 . . . . 0.0 110.964 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.698 HG13 ' HA ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -128.62 147.33 33.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.094 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -119.98 130.45 54.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.562 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.43 -178.07 18.92 Favored Glycine 0 N--CA 1.459 0.196 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.502 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.426 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -130.12 133.99 47.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.07 0.462 . . . . 0.0 111.551 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.416 ' CD1' ' HA ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -54.0 131.84 41.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.798 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.36 -10.65 74.3 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.58 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -107.07 168.97 8.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.599 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -73.52 -168.94 16.14 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.576 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.599 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER 161.7 137.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 122.675 0.39 . . . . 0.0 110.062 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.8 124.33 44.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.935 0.397 . . . . 0.0 111.812 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.42 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -82.02 105.98 13.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.482 178.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -90.83 123.07 34.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.287 0.565 . . . . 0.0 112.304 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.448 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.3 mt -80.38 120.35 79.13 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.176 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.27 130.71 37.27 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.32 2.013 . . . . 0.0 112.938 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 42.8 65.05 1.0 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -141.96 149.04 39.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.787 0.327 . . . . 0.0 110.501 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -141.7 117.15 10.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.941 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.38 80.44 3.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.01 -175.65 2.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.18 -33.09 68.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.912 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.79 -26.8 66.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.6 mm -79.41 128.32 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.405 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.9 OUTLIER -111.36 -44.44 3.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -179.089 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.416 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 42.6 tt0 -130.43 116.88 18.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.572 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -112.48 113.0 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.794 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -111.56 132.48 54.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.12 0.485 . . . . 0.0 112.206 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.42 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 70.3 m95 -113.31 86.53 2.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.954 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -102.62 148.1 25.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.316 0.579 . . . . 0.0 112.295 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.52 117.59 11.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.51 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.96 -116.62 8.53 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.768 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 t -117.28 43.76 2.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.76 0.315 . . . . 0.0 110.672 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.0 m -152.33 159.95 43.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.238 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.508 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.8 mt -103.11 146.83 27.8 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.441 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 51.3 t -118.45 -43.1 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.164 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -166.64 111.57 0.78 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.551 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -118.56 114.77 23.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.417 ' CG ' ' N ' ' A' ' 43' ' ' LYS . 25.4 t80 -100.8 157.97 16.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.859 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.417 ' N ' ' CG ' ' A' ' 42' ' ' PHE . 61.0 mtpt -153.35 140.28 19.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.77 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.401 ' HG2' ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -55.76 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.772 0.796 . . . . 0.0 110.823 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt 81.66 -46.98 0.21 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.11 -1.405 . . . . 0.0 111.229 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.409 ' HB2' ' HB3' ' A' ' 43' ' ' LYS . 1.3 mpt? -51.46 142.99 12.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.835 0.35 . . . . 0.0 111.056 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.28 126.17 73.37 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.192 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.416 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 89.8 Cg_endo -84.26 -171.19 0.97 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.643 2.228 . . . . 0.0 112.547 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.508 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 73.3 t80 -137.11 104.36 5.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.338 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.9 mt -98.57 111.18 23.63 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.441 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 12.8 tptm -44.38 -54.58 5.73 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.807 0.336 . . . . 0.0 111.484 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.0 165.07 22.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.146 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.16 -11.69 3.49 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.112 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.41 2.24 11.91 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 117.674 0.737 . . . . 0.0 112.163 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -131.99 156.48 46.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.124 0.488 . . . . 0.0 111.392 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -152.57 119.59 5.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.252 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.414 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 8.1 tt -75.0 100.26 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.112 0.482 . . . . 0.0 111.325 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.63 167.57 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.169 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.74 -24.54 65.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.651 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -96.57 33.12 1.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.736 0.303 . . . . 0.0 111.18 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.8 33.37 67.84 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.563 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.38 165.39 11.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 111.049 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 tp -105.14 121.46 43.86 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.47 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -107.91 110.18 21.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 111.13 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.426 HD13 HG23 ' A' ' 65' ' ' ILE . 2.6 mt -90.38 138.24 19.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.063 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -93.3 -41.64 9.76 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.2 106.93 5.36 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.582 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.426 ' CD1' ' O ' ' A' ' 9' ' ' ALA . 7.8 mt -57.35 143.73 38.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.13 0.491 . . . . 0.0 111.461 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.416 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 5.1 p -144.36 159.53 42.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.037 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.32 -56.46 12.93 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.022 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -54.25 -21.83 10.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.429 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.39 -14.44 58.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.3 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.4 t -80.57 129.11 34.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.65 0.262 . . . . 0.0 110.475 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.01 -165.06 30.18 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.12 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -93.98 126.65 39.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.702 0.287 . . . . 0.0 111.349 -179.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -104.44 130.86 52.31 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.129 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -112.84 125.8 54.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.881 0.372 . . . . 0.0 111.603 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.448 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.26 130.04 62.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.12 179.146 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.12 98.44 6.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.597 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 91.9 t -91.71 123.34 43.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.583 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.416 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 99.0 m-85 -116.33 152.68 33.39 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.172 0.511 . . . . 0.0 111.135 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.5 172.96 8.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.526 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.404 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 7.5 p -57.1 -22.63 41.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.234 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -96.02 26.42 4.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.147 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.87 25.52 30.53 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.718 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.4 156.65 16.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.832 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -79.01 107.52 11.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.695 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.435 HG21 HD13 ' A' ' 88' ' ' ILE . 38.6 mt -82.2 -70.71 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.347 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.5 tt -141.43 128.18 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.112 0.482 . . . . 0.0 111.892 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.85 106.57 14.33 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -117.36 162.45 17.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.446 0.641 . . . . 0.0 112.631 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.87 120.88 10.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.162 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.421 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -116.78 161.12 19.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.81 0.338 . . . . 0.0 111.403 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.81 112.22 24.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.201 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.698 ' HA ' HG13 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -102.26 101.84 12.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.279 -179.485 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.31 119.81 37.63 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.06 0.457 . . . . 0.0 110.67 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.423 HG12 ' CD2' ' A' ' 68' ' ' LEU . 3.8 mt -112.79 118.24 57.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.732 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.8 mt -69.8 118.65 12.91 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.683 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.829 -179.809 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.835 0.35 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -88.59 -65.18 1.04 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.6 160.85 6.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.88 -149.61 39.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.499 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -46.33 147.96 1.02 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.325 0.583 . . . . 0.0 111.328 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.649 HG13 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -140.22 144.64 27.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.773 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -114.71 126.14 54.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.437 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.17 -179.62 22.49 Favored Glycine 0 N--CA 1.459 0.197 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.76 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.436 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -130.26 134.85 47.53 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.05 0.452 . . . . 0.0 111.353 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -53.07 136.3 35.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.006 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.33 -8.34 74.74 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.668 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.534 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.12 167.8 9.75 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.611 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -71.23 -173.86 17.23 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.565 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.611 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER 162.19 136.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 122.493 0.317 . . . . 0.0 110.401 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -122.86 128.18 50.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.964 0.412 . . . . 0.0 111.489 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.444 HD13 ' HG ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -85.14 106.6 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.858 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -89.22 124.45 34.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.152 0.501 . . . . 0.0 111.911 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.428 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.3 mt -79.97 119.62 77.23 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.138 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.16 131.38 38.69 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.367 2.045 . . . . 0.0 112.945 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m120 42.81 65.03 1.01 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -141.6 149.29 40.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.817 0.342 . . . . 0.0 110.56 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -143.87 116.43 8.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.02 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.0 ttt -80.68 77.69 7.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.15 -174.44 2.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.2 -30.73 62.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.08 -24.74 65.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.02 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 45.2 mm -85.52 126.54 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.457 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.413 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -111.59 -42.65 3.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 122.142 -0.349 . . . . 0.0 111.742 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.485 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 6.7 mp0 -117.57 158.75 24.05 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.001 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.6 t -154.28 108.7 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.884 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.457 ' NH1' ' CE2' ' A' ' 81' ' ' TYR . 0.6 OUTLIER -111.15 129.82 55.82 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -110.62 86.11 2.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.848 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -103.13 153.66 20.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.342 0.591 . . . . 0.0 112.303 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -145.48 116.24 7.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.503 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.08 -117.67 11.04 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.75 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 m -115.59 42.85 2.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.785 0.326 . . . . 0.0 110.659 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.4 m -150.59 160.62 43.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.145 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.519 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.7 mt -106.68 147.89 29.03 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.421 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 55.6 t -119.45 -44.16 2.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.255 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.34 112.55 1.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.43 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.48 114.62 22.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.081 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -107.5 144.25 34.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.888 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -143.98 134.89 25.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.413 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -47.96 -29.03 3.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.495 0.664 . . . . 0.0 111.536 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.24 39.1 0.57 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.852 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 41.25 -165.19 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.582 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 mttm 54.76 65.19 5.23 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.694 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.87 -170.41 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.564 2.176 . . . . 0.0 111.945 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.519 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 73.7 t80 -133.1 98.51 4.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.575 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.7 mt -95.24 112.78 24.44 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 19.3 tttm -34.82 -89.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.1 t -118.76 23.45 11.45 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.24 0.18 51.25 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.973 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.32 6.29 26.92 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 117.534 0.667 . . . . 0.0 111.012 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -126.57 158.37 36.41 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.975 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -140.27 118.66 12.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.203 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.4 tt -76.09 101.79 2.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.214 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.28 163.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.098 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.64 -21.79 64.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.72 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -97.88 33.31 2.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.779 0.323 . . . . 0.0 111.103 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.89 36.43 80.24 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.738 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.49 166.86 10.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 0.0 110.92 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.9 tp -107.71 121.41 44.65 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.893 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -109.15 103.87 12.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.735 0.302 . . . . 0.0 110.814 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.41 ' CD1' HG22 ' A' ' 14' ' ' ILE . 2.7 mt -79.91 134.54 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.533 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -79.47 -48.46 13.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.025 0.441 . . . . 0.0 111.675 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.31 113.29 5.79 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.243 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.439 HD21 ' CD1' ' A' ' 97' ' ' ILE . 5.7 mt -53.5 149.04 8.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 111.716 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.1 p -151.94 160.45 43.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.03 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.435 ' N ' HD12 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -51.28 -56.53 12.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.075 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -55.26 -20.82 12.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.346 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.33 -15.39 55.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.413 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.4 t -79.03 128.96 33.93 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.608 0.242 . . . . 0.0 110.576 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.46 -167.33 30.27 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.331 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.76 125.77 36.6 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.529 -0.336 . . . . 0.0 111.418 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -101.45 149.2 24.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.177 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -131.28 123.13 27.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.694 0.283 . . . . 0.0 111.567 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.428 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -108.65 128.81 64.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.036 179.159 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.13 97.9 6.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.64 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.427 HG11 ' HB ' ' A' ' 88' ' ' ILE . 82.0 t -86.25 137.97 19.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.139 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.466 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 84.2 m-85 -132.16 153.56 50.4 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.58 0.705 . . . . 0.0 111.602 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.64 -179.62 6.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.43 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.413 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 41.7 p -65.81 -35.5 80.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.942 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -77.91 -3.67 42.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.434 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.37 24.68 42.47 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.533 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.4 160.06 14.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.346 . . . . 0.0 110.699 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 106.71 11.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.682 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.427 ' HB ' HG11 ' A' ' 80' ' ' VAL . 40.2 mm -87.35 -43.67 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.304 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 tt -157.69 149.97 22.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.218 0.533 . . . . 0.0 111.822 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.92 109.9 5.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.003 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -121.63 162.24 21.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.482 0.658 . . . . 0.0 112.77 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.16 121.95 11.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.9 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.403 ' CD1' ' N ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -120.17 163.2 18.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 0.0 111.688 -179.189 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -111.13 114.27 27.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.369 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.649 ' HA ' HG13 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -100.94 103.71 14.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.396 -179.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.46 113.22 25.82 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.08 0.467 . . . . 0.0 110.551 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.439 ' CD1' HD21 ' A' ' 68' ' ' LEU . 3.7 mt -109.34 115.05 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.523 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.0 mt -78.97 169.96 17.41 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.24 0.543 . . . . 0.0 110.761 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.897 179.93 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 29.9 ttt-85 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.824 0.345 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -66.27 81.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.8 t -84.55 104.63 14.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.35 -150.36 19.37 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.591 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -47.71 139.62 7.14 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.496 0.665 . . . . 0.0 111.439 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.76 HG11 ' HA ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -134.8 155.72 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.393 -179.652 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -122.77 128.49 50.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.826 0.346 . . . . 0.0 111.005 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.7 178.51 24.31 Favored Glycine 0 N--CA 1.459 0.233 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.454 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.411 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -125.34 135.11 52.11 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.941 0.4 . . . . 0.0 111.106 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.7 132.41 36.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.792 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.66 -12.45 69.45 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.83 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.512 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -104.74 169.78 8.26 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.219 0.509 . . . . 0.0 110.016 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.512 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -79.68 168.78 52.87 Favored Glycine 0 C--O 1.224 -0.515 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.25 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.422 HG22 ' CD1' ' A' ' 65' ' ' ILE . 2.2 tp -179.09 140.26 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.696 0.284 . . . . 0.0 110.765 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -124.08 131.52 53.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.031 0.443 . . . . 0.0 111.647 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.405 HD11 ' HG ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -88.09 113.68 23.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.586 179.135 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -97.83 125.63 42.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.193 0.521 . . . . 0.0 111.931 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.451 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.2 mt -81.62 119.95 76.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.299 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.23 131.0 36.52 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.355 2.037 . . . . 0.0 112.865 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.6 m120 43.42 65.14 1.04 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -142.3 149.3 39.33 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.804 0.335 . . . . 0.0 110.531 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -138.65 117.46 12.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.931 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -80.87 82.41 6.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.78 -174.27 2.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.765 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -56.82 -30.94 64.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.954 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -60.98 -28.01 68.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.4 mm -81.57 127.75 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.444 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.55 -44.16 3.55 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 122.214 -0.304 . . . . 0.0 111.736 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.467 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 72.6 tt0 -127.43 116.23 20.13 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.217 -0.593 . . . . 0.0 112.31 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 t -113.2 114.28 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.974 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -113.08 132.12 55.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.084 0.469 . . . . 0.0 112.192 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.406 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 70.2 m95 -113.18 83.26 1.8 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -99.17 150.9 21.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.299 0.571 . . . . 0.0 112.274 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.47 116.01 9.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.62 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.29 -117.36 10.29 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.76 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.25 42.77 2.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.837 0.351 . . . . 0.0 110.759 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.2 m -152.0 160.03 43.58 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.215 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.502 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.8 mt -104.09 146.94 28.01 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.426 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 52.0 t -117.89 -42.83 2.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.293 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -166.21 113.11 0.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.455 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -120.53 116.32 25.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.094 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -99.83 152.07 20.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.666 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -142.47 145.84 34.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.841 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -59.45 91.75 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 122.177 0.989 . . . . 0.0 110.555 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 81.37 -46.86 0.23 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.628 -1.624 . . . . 0.0 111.158 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -50.27 146.3 5.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.098 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -57.87 127.29 78.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.114 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -83.23 -171.14 1.04 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.656 2.238 . . . . 0.0 112.467 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.502 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 69.4 t80 -135.03 104.64 6.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.343 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.1 mt -99.27 111.09 23.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.0 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 55.6 tttm -44.94 -42.46 8.16 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.579 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.0 p -176.66 164.96 2.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.966 0.412 . . . . 0.0 111.213 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.36 -12.37 4.36 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.732 -0.746 . . . . 0.0 113.118 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.44 1.06 12.69 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 117.75 0.775 . . . . 0.0 112.182 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -131.1 157.38 43.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.11 0.481 . . . . 0.0 111.214 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -153.95 125.24 7.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.513 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.436 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 6.9 tt -84.04 101.53 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.32 166.97 3.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.991 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.04 -45.58 80.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.205 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -56.32 -22.88 33.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.137 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.85 35.05 4.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.59 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -116.03 154.48 29.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.878 0.371 . . . . 0.0 110.924 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 12.7 tp -83.46 122.94 29.19 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.463 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -104.46 109.79 21.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.701 0.286 . . . . 0.0 111.38 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.422 ' CD1' HG22 ' A' ' 14' ' ' ILE . 2.8 mt -93.29 127.34 45.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.939 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 ttpp -85.63 -36.31 20.41 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -147.16 110.23 4.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.812 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.411 ' CD1' ' O ' ' A' ' 9' ' ' ALA . 4.9 mt -56.62 144.88 30.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.056 0.455 . . . . 0.0 111.469 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.5 p -149.25 163.79 36.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.843 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.84 -55.52 16.55 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.223 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -52.9 -23.01 6.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.539 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.53 -14.01 59.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.472 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.409 ' CB ' HG12 ' A' ' 97' ' ' ILE . 2.6 t -81.15 124.74 29.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.685 0.279 . . . . 0.0 110.707 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.1 -166.87 29.47 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.296 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.94 130.34 38.55 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.56 0.344 . . . . 0.0 111.139 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -106.21 148.65 27.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.063 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.7 m-20 -132.42 127.2 34.85 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.834 0.35 . . . . 0.0 111.641 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.451 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.3 OUTLIER -109.76 131.13 61.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.202 179.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.0 98.61 6.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.476 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.5 t -92.05 123.29 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.65 -178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.467 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 99.3 m-85 -117.17 152.11 35.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.271 0.558 . . . . 0.0 111.027 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.96 173.64 8.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.532 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.8 p -57.38 -24.31 54.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.191 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -96.01 27.5 3.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.169 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.78 25.13 28.59 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.686 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.04 144.26 25.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.799 0.333 . . . . 0.0 110.818 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.78 107.04 3.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.643 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.0 mt -80.97 -69.9 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.373 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 tt -141.68 129.76 22.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.192 0.52 . . . . 0.0 111.87 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.28 107.23 14.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.472 -0.786 . . . . 0.0 108.897 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -117.84 158.71 24.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.43 0.633 . . . . 0.0 112.676 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.19 122.33 18.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.146 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -120.63 162.98 18.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.984 0.421 . . . . 0.0 111.519 -179.286 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.92 136.85 48.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.335 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.76 ' HA ' HG11 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -131.78 100.8 5.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.273 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 1.1 mmm180 -92.81 124.04 36.52 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.038 0.446 . . . . 0.0 110.945 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.451 ' CD1' HD23 ' A' ' 95' ' ' LEU . 4.4 mm -106.46 103.73 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.841 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 mt -67.66 120.15 13.57 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.598 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.892 -179.754 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.779 0.323 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -64.82 88.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.944 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.83 153.59 17.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.829 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.82 -150.49 41.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.514 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -48.21 146.71 2.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.21 0.529 . . . . 0.0 111.36 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.666 HG13 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -142.02 153.64 18.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.62 -179.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -121.38 131.33 54.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.926 0.393 . . . . 0.0 110.697 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.69 -179.71 25.75 Favored Glycine 0 N--CA 1.459 0.226 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.812 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.49 135.34 51.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.938 0.399 . . . . 0.0 110.735 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.402 ' CD1' ' HA ' ' A' ' 69' ' ' THR . 1.2 tp -55.49 130.32 42.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.003 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.49 -6.96 77.97 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.656 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.534 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -106.28 169.18 8.66 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 117.122 0.461 . . . . 0.0 109.941 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.534 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -76.77 166.63 54.17 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.139 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.412 ' CG2' ' CD1' ' A' ' 65' ' ' ILE . 1.6 tp -177.56 138.34 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 0.0 110.986 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -120.6 120.48 35.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.44 -179.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.474 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -77.44 105.08 8.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.767 179.299 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -88.93 124.84 34.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.228 0.537 . . . . 0.0 112.152 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.444 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.3 mt -81.8 119.96 76.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.118 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.93 131.8 39.02 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.221 1.947 . . . . 0.0 112.877 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 43.61 65.45 0.99 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -143.28 149.44 37.86 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.742 0.306 . . . . 0.0 110.549 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -141.08 117.14 10.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.958 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.82 79.91 6.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.31 -173.74 2.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.64 -30.46 61.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.0 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -62.56 -28.83 70.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.2 mm -86.05 127.16 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.476 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.406 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -112.82 -42.78 3.53 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.091 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.514 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 37.9 tt0 -127.67 118.22 23.44 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.155 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.81 118.52 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.21 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -117.43 135.83 53.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.271 0.558 . . . . 0.0 112.17 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.474 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 69.9 m95 -111.13 88.24 2.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.971 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -98.7 141.8 31.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.364 0.602 . . . . 0.0 112.267 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -132.12 114.92 15.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.396 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.26 -114.02 5.41 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.64 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.2 t -118.38 44.28 2.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.731 0.3 . . . . 0.0 110.652 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.1 m -154.95 159.56 40.49 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.906 0.384 . . . . 0.0 111.332 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.505 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 4.6 mt -99.18 148.17 24.37 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.804 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.454 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 48.4 t -119.32 -42.26 2.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.444 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -173.5 114.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.724 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -124.73 156.55 37.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.092 0.472 . . . . 0.0 110.907 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -129.44 144.33 51.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.753 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.64 114.29 5.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.644 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -51.78 -59.41 4.34 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.721 0.772 . . . . 0.0 111.097 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -82.76 46.89 1.13 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.849 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 177.98 -172.21 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.839 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -108.1 142.33 25.06 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.718 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.05 154.62 47.53 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.504 2.136 . . . . 0.0 112.479 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.505 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 43.6 t80 -112.7 103.09 11.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.158 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.9 mt -93.53 113.36 25.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.2 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 31.0 tttt -47.94 -45.39 30.99 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.745 0.307 . . . . 0.0 111.365 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.1 p -175.27 165.13 3.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.91 0.386 . . . . 0.0 111.191 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.92 -12.43 3.73 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.214 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.02 -1.48 17.35 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.727 0.763 . . . . 0.0 112.063 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -131.38 157.03 44.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.063 0.458 . . . . 0.0 111.206 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -151.3 119.18 6.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.134 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.413 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 4.2 tt -74.5 103.89 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.115 0.483 . . . . 0.0 111.223 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -51.77 173.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.313 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.5 -26.81 67.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.346 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -96.13 32.4 1.95 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.048 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.08 26.3 58.24 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.58 173.54 8.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 111.04 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.5 tp -109.93 118.35 36.21 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.633 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -106.63 108.71 20.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.83 0.347 . . . . 0.0 110.957 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.412 ' CD1' ' CG2' ' A' ' 14' ' ' ILE . 2.4 mt -87.65 135.77 24.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.435 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -82.62 -46.37 13.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.038 0.447 . . . . 0.0 111.831 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.72 112.04 5.78 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.132 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.484 ' CD2' HG12 ' A' ' 97' ' ' ILE . 6.1 mt -53.76 151.03 6.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.289 0.566 . . . . 0.0 111.865 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.402 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 7.1 p -154.3 162.42 41.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.815 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.78 -56.4 12.27 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.037 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -57.02 -20.86 26.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.327 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.06 -14.89 40.18 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.426 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.3 t -90.96 129.62 36.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.649 0.261 . . . . 0.0 110.609 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 154.08 -130.66 2.98 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.588 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 m -123.11 128.73 50.5 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 117.814 0.807 . . . . 0.0 110.931 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -109.06 149.09 29.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.235 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 -131.26 125.57 33.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.849 0.356 . . . . 0.0 111.582 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.444 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.98 131.58 60.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.038 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.95 96.35 5.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.599 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 74.1 t -85.75 128.06 39.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.468 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.514 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 83.0 m-85 -117.61 151.56 36.93 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.062 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.73 174.26 8.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.494 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.406 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -61.76 -18.67 60.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.265 179.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -94.08 23.45 4.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.207 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.65 21.71 50.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.668 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.42 176.49 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.736 0.303 . . . . 0.0 110.617 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.09 116.46 30.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.708 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 31.9 mm -90.47 -46.93 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.362 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.6 tt -153.6 148.4 26.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 111.796 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -136.79 108.58 7.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.197 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 46.3 mmtt -121.13 156.6 31.96 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.37 122.24 17.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.966 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -118.2 158.97 24.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.018 0.437 . . . . 0.0 111.728 -179.09 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -111.81 107.99 17.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.263 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.666 ' HA ' HG13 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -94.29 98.46 10.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.095 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.02 126.05 43.26 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.995 0.426 . . . . 0.0 110.498 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.484 HG12 ' CD2' ' A' ' 68' ' ' LEU . 2.3 mp -134.34 133.58 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.91 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.52 169.02 14.89 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.712 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.96 179.857 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.867 0.365 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -106.5 -40.03 5.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 p -60.16 175.84 0.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.68 167.18 32.03 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.578 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.0 m -142.97 147.63 35.48 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.26 0.553 . . . . 0.0 110.939 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER -139.19 150.51 23.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.812 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -120.89 128.87 53.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.669 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.24 -178.82 22.82 Favored Glycine 0 N--CA 1.46 0.254 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.748 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.448 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -130.11 133.63 46.79 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.146 0.498 . . . . 0.0 111.597 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.08 131.7 32.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.179 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.94 -7.96 80.72 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.74 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.528 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.01 168.33 9.36 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.6 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.91 -174.24 16.93 Favored Glycine 0 C--O 1.228 -0.249 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.502 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.6 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER 163.13 136.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.803 0.335 . . . . 0.0 110.386 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -126.25 125.22 42.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.919 0.39 . . . . 0.0 111.436 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.409 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -77.37 122.49 25.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.735 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -103.71 123.05 46.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.177 0.513 . . . . 0.0 111.963 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.452 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.3 mt -81.78 119.53 75.55 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.145 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.71 130.92 37.27 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.386 2.057 . . . . 0.0 112.98 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 42.79 65.13 0.99 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -141.72 149.13 40.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.79 0.329 . . . . 0.0 110.553 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -145.01 115.24 7.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.967 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.5 ttt -78.19 76.45 4.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.849 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.19 -173.74 2.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.822 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -56.86 -30.79 64.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.03 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -65.4 -26.74 68.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.009 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.6 mm -85.58 127.28 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.347 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.407 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -113.02 -42.05 3.62 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.182 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 6.6 tm-20 -128.26 138.78 52.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.881 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.2 t -145.27 124.37 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.295 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.446 ' NH1' ' CE2' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -118.84 139.16 52.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.136 0.493 . . . . 0.0 112.222 -179.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.482 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 69.2 m95 -111.49 83.28 1.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -96.54 151.59 19.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.408 0.623 . . . . 0.0 112.351 -178.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.422 ' HD2' ' CE1' ' A' ' 76' ' ' TYR . 6.0 ttp-105 -143.93 116.75 8.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.439 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.92 -114.82 6.09 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.18 -1.009 . . . . 0.0 111.671 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.2 m -118.47 44.25 2.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.754 0.311 . . . . 0.0 110.701 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.9 m -153.29 160.37 42.71 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.287 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.485 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.5 mt -104.4 147.86 27.07 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 46.9 t -119.14 -42.06 2.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.581 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -174.2 116.09 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.022 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.36 159.47 30.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.009 0.433 . . . . 0.0 110.792 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -126.36 149.89 48.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.884 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -159.42 111.71 2.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.672 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -51.63 -59.62 4.08 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.737 0.78 . . . . 0.0 111.014 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.4 tttp -82.77 47.28 1.18 Allowed 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.837 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.09 -172.68 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.2 mtpt -108.59 156.69 38.32 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.772 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.36 161.27 17.4 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.919 2.413 . . . . 0.0 112.477 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 39.1 t80 -127.03 99.48 5.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.931 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.6 mt -91.98 109.06 20.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.132 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 7.6 ttmt -47.6 -33.44 6.6 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.682 0.277 . . . . 0.0 111.468 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.6 p -174.01 163.53 4.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.925 0.393 . . . . 0.0 111.217 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.71 -6.97 19.08 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.008 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.52 5.56 10.55 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 117.626 0.713 . . . . 0.0 112.003 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -132.78 157.65 44.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.109 0.481 . . . . 0.0 111.434 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -148.59 118.15 6.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.003 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.404 ' O ' ' CG2' ' A' ' 57' ' ' ILE . 10.1 tt -77.56 98.45 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.086 0.47 . . . . 0.0 111.389 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.6 163.29 0.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.031 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.17 -22.39 65.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.592 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -96.23 32.87 1.86 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.763 0.316 . . . . 0.0 111.234 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.53 36.55 71.2 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.738 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.84 158.04 18.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 0.0 111.014 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.3 tp -99.39 121.8 41.62 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.586 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.43 108.21 18.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.793 0.33 . . . . 0.0 111.141 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.401 ' CG1' HG21 ' A' ' 14' ' ' ILE . 2.3 mt -86.95 138.91 18.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.41 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -85.07 -47.12 10.5 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.057 0.456 . . . . 0.0 111.855 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -143.6 111.43 6.06 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.233 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.448 ' CD1' ' O ' ' A' ' 9' ' ' ALA . 5.3 mt -53.28 144.07 17.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.894 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.0 p -141.76 159.97 41.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.923 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.11 -56.23 15.81 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -55.72 -19.48 11.14 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.578 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.22 -14.3 59.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.568 0.223 . . . . 0.0 111.475 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 98.5 p -85.23 128.43 34.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.629 0.252 . . . . 0.0 110.753 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.32 -135.08 4.34 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.542 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.7 m -124.29 130.4 52.44 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.556 0.678 . . . . 0.0 110.714 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.43 ' CE1' HD13 ' A' ' 95' ' ' LEU . 16.3 m-85 -107.41 151.6 25.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.979 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -133.59 124.66 27.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.314 . . . . 0.0 111.593 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.452 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.09 133.54 53.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.283 179.045 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.04 103.39 9.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.671 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.9 t -93.7 129.66 43.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.42 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.497 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 97.9 m-85 -121.71 154.93 36.24 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.151 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.98 178.3 6.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.588 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.407 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 27.0 p -64.26 -22.97 67.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.068 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -95.74 23.48 6.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.098 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.52 25.87 61.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.524 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.5 152.29 18.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.8 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -74.82 119.9 19.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.718 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 32.8 mm -92.79 -67.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.381 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.403 ' CD2' ' CG ' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -146.06 133.28 20.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.147 0.499 . . . . 0.0 111.85 -179.304 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.22 107.41 14.41 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.403 ' CG ' ' CD2' ' A' ' 89' ' ' LEU . 25.4 mmtt -117.55 156.61 27.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.428 0.633 . . . . 0.0 112.662 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.98 122.69 18.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.084 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.412 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -119.68 160.76 21.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.079 0.466 . . . . 0.0 111.607 -179.211 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -110.05 116.13 31.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.158 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.641 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -100.07 100.71 11.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.362 -179.441 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -96.72 115.16 26.95 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.096 0.474 . . . . 0.0 110.353 179.277 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.436 ' CD1' HD21 ' A' ' 68' ' ' LEU . 3.8 mt -116.33 120.14 64.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.838 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.29 119.65 14.79 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.684 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.85 -179.813 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.873 0.368 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.41 -39.43 94.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -59.33 136.67 58.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.942 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.4 -149.28 41.87 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.561 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.5 m -45.99 137.03 6.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.408 0.623 . . . . 0.0 111.466 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.721 HG11 ' HA ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER -130.02 146.63 33.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.484 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.455 ' CE2' ' HD3' ' A' ' 96' ' ' ARG . 82.9 m95 -112.05 127.52 55.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.609 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.18 -178.18 22.27 Favored Glycine 0 N--CA 1.459 0.217 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.887 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.445 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -125.14 133.34 52.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.048 0.451 . . . . 0.0 111.123 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.4 HD13 ' CA ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -53.93 133.14 43.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.027 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.69 -6.35 83.72 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.757 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.542 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.42 167.31 10.13 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.994 0.397 . . . . 0.0 110.006 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.575 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.43 -175.69 18.44 Favored Glycine 0 C--O 1.228 -0.264 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.622 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.1 tp 167.33 136.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.897 0.38 . . . . 0.0 110.726 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -121.81 132.11 54.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.187 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.4 108.95 20.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.855 179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -91.71 123.36 35.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.225 0.536 . . . . 0.0 112.209 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.447 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.4 mt -80.82 120.07 77.9 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.112 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.78 130.95 37.26 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.301 2.0 . . . . 0.0 112.975 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 42.67 64.96 1.01 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -140.87 149.55 42.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.593 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -146.29 116.35 7.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -78.67 81.64 4.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.947 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.35 -175.14 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -57.57 -32.81 67.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.897 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -63.74 -23.73 67.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.144 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.4 mm -81.11 127.84 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.414 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.42 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -105.96 -38.36 6.35 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 122.231 -0.293 . . . . 0.0 111.728 -179.319 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 17.8 mt-10 -141.09 152.64 44.93 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.662 0.744 . . . . 0.0 112.448 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -145.68 117.98 2.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.125 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 6.8 mtm180 -115.19 133.65 55.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.024 0.44 . . . . 0.0 112.155 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.416 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 68.6 m95 -110.73 83.65 1.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -98.65 146.29 26.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.298 0.57 . . . . 0.0 112.288 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -137.19 116.93 13.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.532 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.05 -115.9 7.58 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.734 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.8 m -117.3 43.73 2.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.833 0.349 . . . . 0.0 110.71 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.5 m -153.6 160.05 42.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.282 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.515 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.6 mt -102.2 147.08 27.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 48.2 t -118.4 -42.7 2.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.258 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -166.47 111.55 0.8 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.562 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -117.69 119.69 35.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.941 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -104.55 157.98 16.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.79 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.4 ttmt -151.75 145.45 25.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.942 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.59 91.55 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.967 0.889 . . . . 0.0 110.705 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 81.66 -47.21 0.21 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.164 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.92 144.51 4.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.083 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -57.2 127.29 76.16 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.273 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.49 -167.94 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.721 2.28 . . . . 0.0 112.493 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.515 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 75.6 t80 -139.18 104.02 4.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.319 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 mt -98.45 109.33 22.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 10.3 ttmt -44.57 -39.77 5.2 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.774 0.321 . . . . 0.0 111.529 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.4 p -177.83 163.98 1.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 111.122 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.28 -11.46 4.95 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.025 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.415 ' HA ' ' CD ' ' A' ' 66' ' ' LYS . . . -74.29 0.42 14.31 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 117.786 0.793 . . . . 0.0 112.233 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -130.79 156.87 44.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.161 0.505 . . . . 0.0 111.303 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -150.73 117.4 5.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.098 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 57' ' ' ILE . 12.0 tt -75.72 97.29 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.45 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -47.01 168.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.184 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.59 -24.57 65.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.592 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -96.83 33.63 1.84 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.737 0.303 . . . . 0.0 111.21 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.65 34.18 69.38 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.56 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.39 165.09 11.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 0.0 111.043 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.5 tp -106.13 120.56 42.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.499 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.26 111.2 23.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.725 0.298 . . . . 0.0 110.991 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.42 ' CD1' ' CG2' ' A' ' 14' ' ' ILE . 2.4 mt -90.92 135.88 25.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.369 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.427 ' HG3' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -80.7 -45.96 16.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.074 0.464 . . . . 0.0 111.991 -179.044 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.427 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -145.8 113.31 6.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.468 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.458 ' HB3' ' CG2' ' A' ' 97' ' ' ILE . 4.2 mt -53.85 145.57 15.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.513 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.4 ' CA ' HD13 ' A' ' 10' ' ' LEU . 4.7 p -145.67 158.75 43.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.004 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -55.92 14.12 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.417 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.06 -22.81 11.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.411 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.3 -14.58 60.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.248 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.8 t -79.39 119.92 23.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.706 0.288 . . . . 0.0 110.521 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.13 -147.27 12.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.144 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.5 m -116.62 130.78 56.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.102 0.451 . . . . 0.0 110.59 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.453 ' CE1' HD13 ' A' ' 95' ' ' LEU . 29.0 m-85 -106.72 129.77 54.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.38 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -112.85 123.9 51.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.569 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.447 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -105.99 133.92 49.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.031 178.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.37 96.93 5.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.877 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 82.8 t -87.29 127.76 40.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.1 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.465 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 2.5 m-30 -112.81 152.6 28.99 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.298 0.57 . . . . 0.0 111.02 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.72 176.7 6.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.366 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.42 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 2.1 p -67.4 -18.34 65.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.236 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -89.94 12.13 18.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.422 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.74 25.05 74.95 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.631 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -103.11 -169.4 1.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.644 0.259 . . . . 0.0 110.595 179.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 -119.76 99.73 6.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.938 0.399 . . . . 0.0 110.783 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.5 mm -58.0 -61.31 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.423 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.14 140.47 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.226 0.536 . . . . 0.0 112.019 -179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -121.65 109.23 14.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.807 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.38 160.85 21.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.37 122.65 17.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.159 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -119.61 161.98 19.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 111.233 -179.466 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.06 146.1 33.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.265 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.721 ' HA ' HG11 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -136.4 119.1 16.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.213 -179.533 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.455 ' HD3' ' CE2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -119.87 124.6 46.46 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.318 0.58 . . . . 0.0 111.038 179.215 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.458 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 3.9 mp -103.44 103.9 15.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.784 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.79 125.63 25.42 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.319 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.966 -179.837 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.774 0.321 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 64.23 -79.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.1 p -86.37 99.09 11.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.874 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.89 161.47 54.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.53 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.4 m -136.41 118.88 15.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.883 0.373 . . . . 0.0 110.802 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' A' ' 95' ' ' LEU . 2.6 m -98.11 178.49 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 121.848 0.832 . . . . 0.0 112.496 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.433 ' CE3' ' HB2' ' A' ' 96' ' ' ARG . 69.5 m95 -147.56 162.26 39.45 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.543 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.25 178.48 44.39 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.494 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -119.8 135.05 55.02 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 120.883 0.373 . . . . 0.0 110.827 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.4 HD13 ' CA ' ' A' ' 69' ' ' THR . 1.2 tp -57.11 133.27 54.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.03 -2.84 87.15 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.593 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.576 ' NE2' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -106.56 168.33 9.24 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.576 ' O ' ' NE2' ' A' ' 12' ' ' HIS . . . -82.66 163.47 42.33 Favored Glycine 0 C--O 1.223 -0.556 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.098 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.412 ' CG2' ' CD1' ' A' ' 65' ' ' ILE . 1.5 tp -176.11 137.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.952 0.406 . . . . 0.0 111.183 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -116.99 119.74 36.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.079 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.94 114.45 19.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.957 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -94.1 124.03 37.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.168 0.509 . . . . 0.0 111.925 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.44 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.4 mt -80.4 119.78 77.41 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.023 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.39 130.85 37.64 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.281 1.987 . . . . 0.0 112.931 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 42.7 65.17 0.98 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -141.96 151.14 42.27 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.869 0.366 . . . . 0.0 110.638 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -141.35 117.98 10.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.71 78.4 7.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.009 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.5 p -110.77 -172.88 2.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.25 -30.53 68.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -61.46 -27.28 68.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.016 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.0 mm -81.76 127.52 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.451 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.95 -43.64 3.56 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 60.1 tt0 -128.39 116.38 19.68 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.196 -0.601 . . . . 0.0 112.412 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.7 t -116.22 117.12 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.886 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -118.17 133.53 55.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.202 0.525 . . . . 0.0 112.384 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -109.63 84.52 1.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.767 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -95.06 149.94 20.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.382 0.61 . . . . 0.0 112.432 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -139.66 113.47 8.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.408 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.47 -114.77 6.24 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.613 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -117.01 43.62 2.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.77 0.319 . . . . 0.0 110.629 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 66.4 m -153.74 160.08 42.17 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.332 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.527 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.5 mt -101.42 147.12 26.73 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 51.1 t -118.21 -43.25 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.189 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.4 112.45 0.83 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.294 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.28 120.08 35.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.195 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -97.48 152.41 19.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.471 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.404 ' CG ' ' HB2' ' A' ' 46' ' ' MET . 1.0 OUTLIER -150.47 121.78 7.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.863 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.34 95.8 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.975 0.893 . . . . 0.0 111.377 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 81.51 -47.36 0.23 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.844 -1.525 . . . . 0.0 111.119 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.404 ' HB2' ' CG ' ' A' ' 43' ' ' LYS . 3.7 mtt -50.02 156.55 0.75 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.913 0.387 . . . . 0.0 111.097 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -68.42 114.3 20.88 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.482 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -69.18 -173.2 0.6 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.516 2.144 . . . . 0.0 112.218 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.527 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 70.5 t80 -137.46 98.89 3.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.756 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.5 mt -93.89 113.81 25.9 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 6.5 tptp -36.43 -90.06 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.7 m -118.56 21.45 12.57 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.08 -1.52 55.19 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.125 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.81 3.42 29.56 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 117.546 0.673 . . . . 0.0 111.008 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -124.31 158.05 33.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.782 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -140.95 120.53 13.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.202 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.412 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 4.7 tt -76.99 103.33 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.12 0.486 . . . . 0.0 111.375 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.5 166.58 0.42 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.102 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.3 -23.48 64.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.72 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -96.53 33.3 1.84 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.734 0.302 . . . . 0.0 111.214 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.97 34.01 64.9 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.632 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.3 173.87 6.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 0.0 111.034 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 tp -114.22 121.07 42.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.57 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -107.61 104.07 13.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.823 0.344 . . . . 0.0 111.051 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.412 ' CD1' ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -82.27 127.18 39.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.625 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -76.0 -45.65 33.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.065 0.459 . . . . 0.0 111.322 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.11 111.9 4.82 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.235 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.422 ' HB3' ' CG2' ' A' ' 97' ' ' ILE . 4.5 mt -56.21 152.01 11.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.12 0.486 . . . . 0.0 111.681 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.4 ' CA ' HD13 ' A' ' 10' ' ' LEU . 8.7 p -153.17 163.35 40.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.123 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.4 mmt85 -51.42 -54.76 23.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.476 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -58.56 -19.22 36.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.321 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.41 -15.8 34.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.37 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.44 ' CB ' HD12 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -82.7 130.83 35.19 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.823 0.344 . . . . 0.0 110.586 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.56 -130.83 3.26 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.325 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 1.3 m -125.82 126.65 44.85 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 117.753 0.776 . . . . 0.0 111.063 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -97.03 149.93 21.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.21 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -132.94 120.53 21.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.201 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.44 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -107.91 128.54 63.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.174 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.73 97.4 5.83 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 71.2 t -87.01 126.79 40.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.52 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.474 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 97.2 m-85 -118.71 151.56 37.76 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.236 0.541 . . . . 0.0 111.024 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.72 173.62 8.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.406 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.3 p -59.95 -29.51 68.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.926 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -77.77 -4.07 44.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.491 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.86 27.2 51.3 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.531 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.17 165.16 11.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 110.79 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.37 115.37 21.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.644 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.9 mt -91.16 -67.71 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.322 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.5 tt -136.41 130.14 32.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.062 0.458 . . . . 0.0 111.71 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -120.71 108.68 14.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.333 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -119.61 153.51 35.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.275 0.56 . . . . 0.0 112.337 -178.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.91 121.69 16.48 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.496 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 75' ' ' THR . 0.5 OUTLIER -120.63 164.85 15.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.243 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.24 107.24 10.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.66 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.558 ' HA ' HG21 ' A' ' 6' ' ' VAL . 7.2 tt -101.8 113.89 27.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.017 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.433 ' HB2' ' CE3' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -96.77 111.93 23.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.874 0.369 . . . . 0.0 110.479 179.299 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.44 HD12 ' CB ' ' A' ' 73' ' ' SER . 5.6 mt -95.33 109.14 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.873 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mt -67.76 125.32 25.87 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.416 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.879 -179.762 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.798 0.332 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -73.61 -44.69 56.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.923 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.55 120.5 39.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.44 166.67 21.98 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.556 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.6 m -147.11 147.68 30.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 110.972 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.66 HG13 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -138.72 145.17 28.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.648 -179.469 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -116.49 127.43 54.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.877 0.37 . . . . 0.0 110.737 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.55 177.42 29.48 Favored Glycine 0 C--N 1.329 0.161 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.662 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.408 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -122.18 135.6 54.8 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.913 0.387 . . . . 0.0 110.75 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.44 HD11 ' N ' ' A' ' 70' ' ' ARG . 1.1 tp -54.46 130.01 38.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.714 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.85 -9.27 68.33 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.762 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.569 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.6 170.74 7.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 117.002 0.401 . . . . 0.0 109.927 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -79.87 175.2 55.05 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.119 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 2.0 tp 178.13 139.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.691 0.281 . . . . 0.0 110.906 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -116.08 126.21 53.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.94 0.4 . . . . 0.0 111.317 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.401 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -86.54 105.57 16.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.806 179.304 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -88.3 123.75 33.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.144 0.497 . . . . 0.0 112.194 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.442 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.3 mt -80.25 120.05 78.34 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.055 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.82 130.98 37.31 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.313 2.008 . . . . 0.0 112.859 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 43.09 65.22 1.0 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -142.0 150.96 42.02 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.801 0.334 . . . . 0.0 110.617 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -140.61 117.68 11.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.98 84.08 7.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.956 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.0 p -119.66 -173.01 2.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -57.45 -30.03 64.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.955 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -63.14 -28.02 69.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.4 mm -87.38 127.02 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.44 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -112.76 -42.37 3.62 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.053 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 34.1 tt0 -124.99 118.74 26.91 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.146 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.3 t -123.74 112.79 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.262 178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -112.62 139.0 48.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.205 0.526 . . . . 0.0 112.071 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.461 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 71.7 m95 -112.39 82.99 1.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.865 178.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -94.69 142.92 26.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.337 0.589 . . . . 0.0 112.286 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 118.23 18.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.418 178.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.97 -113.73 5.01 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.654 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.5 p -119.55 44.82 2.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.738 0.304 . . . . 0.0 110.663 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.8 m -156.46 159.64 38.83 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.887 0.375 . . . . 0.0 111.315 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.491 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 4.8 mt -99.81 147.49 25.43 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.697 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.427 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 40.3 t -118.37 -41.14 2.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.481 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -172.97 117.54 0.31 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.679 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -122.53 156.94 33.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 110.617 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -121.53 134.54 55.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.717 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.37 113.44 14.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.753 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -44.7 95.73 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 122.165 0.983 . . . . 0.0 111.114 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.4 mttt 81.44 -47.12 0.23 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 113.493 -1.685 . . . . 0.0 110.968 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.5 mtt -55.78 150.36 13.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.94 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.34 111.06 3.68 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.152 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -69.71 -166.53 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.466 2.11 . . . . 0.0 112.043 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 84.9 t80 -136.67 113.7 10.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.869 0.366 . . . . 0.0 111.481 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.1 mt -108.69 112.64 25.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.98 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 24.3 tttm -44.67 -49.22 10.5 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.732 0.301 . . . . 0.0 111.381 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.52 168.69 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.085 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.82 -12.46 1.7 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.445 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.74 0.3 13.44 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 117.847 0.824 . . . . 0.0 112.336 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -136.99 156.89 47.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 111.269 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -150.8 120.46 6.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.232 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.406 ' O ' ' CG2' ' A' ' 57' ' ' ILE . 4.7 tt -75.59 103.9 3.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.047 0.451 . . . . 0.0 111.368 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.6 mp -54.15 169.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.069 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.33 -24.44 64.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.624 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -96.48 33.22 1.84 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.79 0.329 . . . . 0.0 111.157 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.04 31.0 64.43 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.723 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.47 174.03 6.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.886 0.374 . . . . 0.0 111.117 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.1 tp -113.7 121.11 43.12 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.53 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.1 tmtp? -106.87 106.32 16.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.755 0.312 . . . . 0.0 111.196 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.43 ' CD1' ' CG2' ' A' ' 14' ' ' ILE . 2.7 mt -86.4 135.41 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.067 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -90.75 -40.72 11.67 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -143.63 109.19 5.13 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.758 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.439 HD21 ' CD1' ' A' ' 97' ' ' ILE . 5.3 mt -58.54 145.89 37.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.129 0.49 . . . . 0.0 111.339 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.5 p -148.78 158.48 44.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.238 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.44 ' N ' HD11 ' A' ' 10' ' ' LEU . 9.9 mmm-85 -50.5 -57.1 8.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.185 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -54.42 -22.29 12.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.094 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.4 -14.81 56.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.319 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.0 p -83.55 138.2 33.5 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.647 0.26 . . . . 0.0 110.845 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.07 -126.02 2.32 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.681 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 m -132.99 129.61 38.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.864 0.832 . . . . 0.0 110.921 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -103.91 151.28 23.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.293 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -132.63 122.42 24.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.371 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.442 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -108.0 127.85 63.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.056 179.288 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.98 97.09 6.03 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 80.7 t -88.16 130.25 38.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.304 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.522 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 96.8 m-85 -124.02 154.45 39.86 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.269 0.556 . . . . 0.0 111.184 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.98 175.85 7.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.381 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 20.3 p -62.65 -22.03 66.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.165 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -96.0 24.97 5.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.191 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.63 26.83 53.82 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.581 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.69 157.84 15.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.816 0.341 . . . . 0.0 110.816 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.12 111.41 14.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.4 mm -92.98 -49.72 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.33 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 tt -154.01 149.15 26.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.283 0.563 . . . . 0.0 111.773 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -140.62 108.32 5.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.173 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -120.52 159.2 25.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.83 121.71 14.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.039 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.41 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -120.91 161.89 20.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.892 0.377 . . . . 0.0 111.695 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.59 125.81 53.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.199 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.66 ' HA ' HG13 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -106.31 101.51 10.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.233 -179.44 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.36 108.95 21.78 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.22 0.533 . . . . 0.0 110.412 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.439 ' CD1' HD21 ' A' ' 68' ' ' LEU . 3.6 mt -110.44 113.41 44.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.731 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mt -67.69 121.0 14.98 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.534 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.912 -179.872 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.812 0.339 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -131.31 -65.86 0.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.897 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.3 115.34 3.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.87 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.41 160.65 13.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.495 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 97.3 m -64.58 118.72 9.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 0.0 110.887 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.507 HG21 ' HA ' ' A' ' 95' ' ' LEU . 2.9 m -95.74 178.57 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 CA-C-O 121.78 0.8 . . . . 0.0 112.345 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.431 ' CE3' ' HB2' ' A' ' 96' ' ' ARG . 73.3 m95 -145.42 161.97 38.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.55 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.48 179.16 41.15 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.427 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.413 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -122.63 134.42 54.5 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.976 0.417 . . . . 0.0 111.25 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.0 134.09 56.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.692 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.0 -4.11 83.89 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.393 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.614 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.4 OUTLIER -108.99 167.94 9.73 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.614 ' O ' ' CE1' ' A' ' 12' ' ' HIS . . . -78.73 -173.4 43.02 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.659 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.606 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.1 tp 164.18 136.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.756 0.312 . . . . 0.0 110.38 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -116.93 118.7 33.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.89 0.376 . . . . 0.0 111.391 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.23 102.93 10.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.849 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -85.97 124.73 32.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.192 0.52 . . . . 0.0 111.724 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.437 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.4 mt -78.42 119.93 79.16 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.154 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -58.26 130.15 36.33 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.37 2.047 . . . . 0.0 113.094 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 42.44 64.61 1.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -140.7 149.0 41.64 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.817 0.341 . . . . 0.0 110.585 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -139.42 117.16 11.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.961 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.35 81.14 7.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.868 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.54 -174.53 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.829 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -56.8 -30.78 64.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.961 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.02 -27.85 69.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.6 mm -83.67 127.88 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.429 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.73 -44.06 3.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 13.9 tp10 -125.91 134.58 51.53 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.317 -179.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -135.41 108.01 8.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.723 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 2.1 mtp180 -105.17 132.03 51.9 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -109.01 82.88 1.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -99.17 157.92 16.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.394 0.616 . . . . 0.0 112.467 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -149.3 113.8 5.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.509 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.46 -117.03 9.4 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.741 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 p -115.0 42.47 2.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.741 0.305 . . . . 0.0 110.705 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.0 m -150.66 160.4 43.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.237 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.512 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 6.2 mt -106.82 147.94 29.11 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 53.7 t -119.03 -43.76 2.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.235 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.39 113.26 1.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.527 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -118.51 113.58 21.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.051 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -103.82 120.99 42.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.882 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -120.07 132.68 55.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.466 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.9 tpp85 -47.72 -28.43 2.46 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.497 0.665 . . . . 0.0 111.684 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.8 tttm -82.73 41.9 0.75 Allowed 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.906 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 41.58 -164.8 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.501 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm 54.69 69.45 2.08 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.57 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.48 176.56 7.81 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.978 2.452 . . . . 0.0 111.939 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.512 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 69.8 t80 -125.34 99.87 6.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.337 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.1 mt -96.24 105.66 17.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.931 178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 39.8 tttm -43.92 -59.2 2.38 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.586 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.6 p -144.74 162.75 35.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 0.0 111.193 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.08 -8.16 21.67 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.022 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.42 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . . . -78.39 3.41 15.78 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 117.559 0.679 . . . . 0.0 111.952 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -125.5 157.36 37.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.273 0.559 . . . . 0.0 111.743 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -154.55 124.65 6.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.212 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.419 ' O ' ' CG2' ' A' ' 57' ' ' ILE . 3.0 tt -83.49 106.66 14.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.308 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 mp -65.7 172.79 3.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.904 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.3 -44.83 64.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.156 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -57.33 -25.13 58.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.06 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.69 33.42 3.84 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.547 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -113.39 154.61 26.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.841 0.353 . . . . 0.0 110.964 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 tp -84.39 122.05 28.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.459 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.99 111.33 23.61 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.831 0.348 . . . . 0.0 111.421 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 65' ' ' ILE . 2.8 mt -97.13 122.64 48.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.114 179.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 54' ' ' ALA . 1.6 ptpp? -89.27 -33.76 16.84 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.471 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -140.8 104.82 4.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.601 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.413 ' CD1' ' O ' ' A' ' 9' ' ' ALA . 6.2 mt -63.01 154.43 30.68 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.13 0.49 . . . . 0.0 111.458 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.1 p -152.35 157.04 40.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.209 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.11 -55.98 12.77 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.363 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -52.63 -24.6 8.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.132 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.01 -15.36 44.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.255 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.4 p -77.86 126.2 30.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.415 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 154.21 -131.08 3.09 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.447 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 1.3 m -126.03 129.19 48.68 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 117.711 0.756 . . . . 0.0 111.143 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -99.82 148.4 24.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.035 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -130.05 122.23 27.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.769 0.319 . . . . 0.0 111.356 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.437 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.57 130.55 62.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.274 179.34 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.94 96.72 5.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.818 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.0 t -86.56 134.07 28.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.243 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.457 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 81.0 m-85 -127.39 156.69 41.65 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.347 0.594 . . . . 0.0 111.199 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.02 174.96 7.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.448 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.3 -24.94 66.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.15 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -95.9 27.1 3.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.198 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.7 23.61 37.32 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.719 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.61 156.32 18.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.731 0.3 . . . . 0.0 110.823 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.58 118.42 22.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.541 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.9 mt -102.05 -67.1 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.425 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.1 tt -134.18 148.8 50.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.322 0.582 . . . . 0.0 111.875 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.69 109.21 5.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.061 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 58.4 mmtt -122.53 153.33 39.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.85 122.95 16.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.284 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 75' ' ' THR . 0.3 OUTLIER -122.82 165.28 16.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.267 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.22 106.32 9.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.73 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.507 ' HA ' HG21 ' A' ' 6' ' ' VAL . 7.1 tt -101.16 114.86 29.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.897 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.431 ' HB2' ' CE3' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -96.79 108.33 20.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.408 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.406 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 8.6 mt -90.88 108.94 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.776 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.91 120.38 13.5 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.571 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.872 -179.835 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.876 0.369 . . . . 0.0 111.269 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -158.75 169.24 24.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 m -60.47 -175.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.74 160.81 24.66 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.537 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 5.8 m -138.78 154.64 48.52 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.292 0.568 . . . . 0.0 111.067 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.594 HG13 ' HA ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -153.61 141.56 13.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.884 -178.604 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -115.73 139.35 50.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.81 0.338 . . . . 0.0 110.957 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.57 176.59 28.21 Favored Glycine 0 C--O 1.228 -0.221 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.972 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.61 135.12 54.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.172 0.486 . . . . 0.0 111.121 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.436 ' CD1' ' HA ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -54.02 130.38 37.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.713 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.11 -8.95 75.64 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.887 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.549 ' NE2' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -106.57 170.97 7.62 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.549 ' O ' ' NE2' ' A' ' 12' ' ' HIS . . . -86.55 174.36 46.56 Favored Glycine 0 C--O 1.224 -0.477 0 C-N-CA 120.705 -0.759 . . . . 0.0 113.468 -178.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.427 ' CG2' ' CD1' ' A' ' 65' ' ' ILE . 3.3 tp 179.59 144.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.6 0.238 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -120.69 129.94 53.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.951 0.405 . . . . 0.0 111.639 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.52 104.08 16.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.713 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -86.19 123.9 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.188 0.518 . . . . 0.0 111.911 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.44 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.4 mt -79.55 120.19 79.43 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.184 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.25 130.63 36.92 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.26 1.973 . . . . 0.0 113.0 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 43.08 64.78 1.1 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -141.67 150.5 41.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.784 0.326 . . . . 0.0 110.551 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -142.07 117.55 10.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.881 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.97 76.87 6.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.978 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.1 p -105.86 -172.51 2.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -59.08 -31.45 68.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.966 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.01 -26.94 68.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.99 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.1 mm -79.01 129.21 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.43 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.418 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.9 OUTLIER -112.68 -44.11 3.37 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.082 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 69.2 tt0 -132.45 116.39 16.73 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.001 -0.68 . . . . 0.0 112.655 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.31 114.69 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -112.17 130.73 55.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.172 0.51 . . . . 0.0 112.36 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -112.73 85.37 2.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.987 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -98.97 148.75 23.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.252 0.548 . . . . 0.0 112.229 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.0 114.69 9.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.609 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.45 -117.73 11.5 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.809 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.5 m -114.64 42.36 2.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.764 0.316 . . . . 0.0 110.665 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.7 m -151.95 160.18 43.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.235 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.507 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.5 mt -102.94 146.15 28.75 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 46.9 t -117.59 -42.47 2.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.941 0.401 . . . . 0.0 110.243 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -165.83 112.17 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.492 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -120.36 112.67 19.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.066 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 43' ' ' LYS . 22.4 t80 -102.34 158.88 15.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.761 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.412 ' N ' ' CD1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -147.93 174.4 11.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.927 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 44' ' ' ARG . 2.7 tpp180 -99.58 105.7 17.61 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.82 0.819 . . . . 0.0 109.791 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 44' ' ' ARG . 2.3 tmtt? 82.77 -47.95 0.16 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.706 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -56.91 178.18 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.742 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.45 132.52 31.65 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.209 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -84.29 -175.31 2.13 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.767 2.311 . . . . 0.0 112.52 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.507 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 78.7 t80 -138.83 106.17 5.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.415 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.9 mt -100.95 110.66 22.73 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 36.2 tttt -44.84 -49.14 10.99 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.73 0.3 . . . . 0.0 111.607 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.1 p -169.84 164.98 9.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.956 0.408 . . . . 0.0 111.319 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.77 -12.1 4.78 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.138 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.28 0.93 12.69 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 117.782 0.791 . . . . 0.0 112.083 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -131.94 157.54 43.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.052 0.453 . . . . 0.0 111.09 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -154.09 127.21 8.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.512 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.43 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 7.1 tt -86.02 101.26 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.178 0.513 . . . . 0.0 111.276 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.68 171.16 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.957 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.7 -44.64 77.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.185 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -58.2 -25.1 61.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.07 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.75 34.17 3.88 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.568 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -112.96 154.73 25.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.789 0.328 . . . . 0.0 110.968 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.0 tp -82.72 123.13 29.01 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.632 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.4 tptt -106.38 110.09 22.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.906 0.384 . . . . 0.0 111.219 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.427 ' CD1' ' CG2' ' A' ' 14' ' ' ILE . 2.9 mt -92.21 121.2 42.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.148 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -81.14 -36.21 30.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.894 0.378 . . . . 0.0 111.798 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -144.25 107.52 4.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.706 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.425 ' CD2' ' CD1' ' A' ' 97' ' ' ILE . 4.4 mt -59.03 143.73 47.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.058 0.456 . . . . 0.0 111.337 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.436 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 9.2 p -143.33 165.09 28.45 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.856 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.7 mmt85 -50.5 -54.94 18.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.256 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -53.45 -23.87 11.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.41 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -73.5 -13.57 61.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.567 0.222 . . . . 0.0 111.427 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.403 ' HB3' ' CG1' ' A' ' 97' ' ' ILE . 5.0 p -82.78 116.05 21.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.68 0.276 . . . . 0.0 110.647 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.27 -144.93 10.3 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.21 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -120.38 131.02 54.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.145 0.472 . . . . 0.0 110.621 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -103.96 131.99 50.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.411 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -114.39 123.4 49.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.286 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.44 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -106.11 129.06 59.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.275 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.47 97.66 6.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 77.7 t -88.0 123.23 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.436 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.418 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 93.4 m-85 -113.81 151.15 32.46 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.224 0.535 . . . . 0.0 111.053 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.79 172.87 8.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.545 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 16.9 p -60.81 -19.18 59.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.351 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -94.39 24.67 4.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.218 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.82 23.29 44.4 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.6 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.94 176.11 5.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.783 0.325 . . . . 0.0 110.735 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -98.31 126.47 43.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.676 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 51.4 mt -101.24 -61.42 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.416 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.0 tt -140.06 129.53 24.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.113 0.483 . . . . 0.0 111.855 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -120.54 108.54 14.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.17 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -121.05 159.69 25.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.352 0.596 . . . . 0.0 112.439 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.83 121.75 15.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.45 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.49 165.39 14.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.865 0.364 . . . . 0.0 111.152 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 5' ' ' THR . 0.7 OUTLIER -123.47 134.31 53.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.639 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.594 ' HA ' HG13 ' A' ' 6' ' ' VAL . 8.5 tt -129.73 132.37 46.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.023 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.8 132.29 54.28 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.931 0.396 . . . . 0.0 111.062 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.45 ' CD1' ' CD2' ' A' ' 95' ' ' LEU . 7.0 mm -101.12 100.9 11.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.615 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.8 mt -74.86 122.81 23.95 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 120.971 0.415 . . . . 0.0 110.479 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.318 -0.848 . . . . 0.0 110.912 -179.829 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.731 0.3 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -107.48 -67.12 0.98 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.87 -166.81 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.821 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.65 -150.24 42.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.397 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 1.8 m -47.07 146.07 1.89 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.252 0.548 . . . . 0.0 111.267 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.749 HG13 ' HA ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -142.01 148.86 20.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.706 -179.187 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -118.53 128.57 54.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.659 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.07 179.66 21.24 Favored Glycine 0 N--CA 1.46 0.296 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.733 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.41 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -124.72 134.7 52.74 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.929 0.395 . . . . 0.0 111.116 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 70' ' ' ARG . 1.0 OUTLIER -52.81 134.57 36.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.158 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.73 -6.44 82.75 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.928 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -105.97 168.66 8.97 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 117.144 0.472 . . . . 0.0 109.988 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.529 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -77.11 163.59 52.27 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.203 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.43 HG21 ' CD1' ' A' ' 65' ' ' ILE . 1.6 tp -176.97 138.96 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 122.635 -0.332 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -125.48 133.3 52.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.928 0.394 . . . . 0.0 111.352 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.439 HD12 ' HG ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -87.24 122.4 30.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.563 179.156 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -103.59 124.49 48.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.134 0.492 . . . . 0.0 111.687 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.429 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.2 mt -80.51 119.46 76.37 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.349 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.26 131.33 38.19 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.357 2.038 . . . . 0.0 113.066 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.15 64.81 1.01 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -139.69 149.32 43.54 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.809 0.337 . . . . 0.0 110.517 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -135.38 117.01 14.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.8 tpt -87.53 83.62 7.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.9 p -115.47 -173.13 2.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.849 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -58.61 -31.62 68.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.47 -24.91 67.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.945 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.417 HG22 HD12 ' A' ' 27' ' ' ILE . 34.6 mm -79.86 127.89 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.43 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.436 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 1.3 t0 -103.9 -38.37 7.04 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 122.267 -0.27 . . . . 0.0 111.673 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 8.8 mt-10 -141.96 151.81 42.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.722 0.772 . . . . 0.0 112.574 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.5 t -145.29 106.87 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.955 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -101.53 126.05 48.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.079 0.466 . . . . 0.0 112.232 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -105.16 84.39 2.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.03 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -103.99 156.13 18.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.233 0.539 . . . . 0.0 112.211 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.58 117.73 7.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.734 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.99 -118.12 12.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.826 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.9 t -115.19 42.52 2.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.758 0.313 . . . . 0.0 110.721 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.9 m -149.93 159.94 43.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.136 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.503 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 6.3 mt -105.57 145.69 30.62 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.872 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.2 t -117.04 -43.6 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.086 0.47 . . . . 0.0 110.089 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.91 112.36 0.89 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.713 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -116.5 111.79 20.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.076 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -110.19 115.35 29.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.943 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -120.08 142.7 48.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.472 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -50.76 -24.93 3.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.235 0.54 . . . . 0.0 111.878 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.41 37.88 0.47 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.225 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.4 ttm 40.05 -163.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.63 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.5 mttt 52.47 65.18 6.4 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.65 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -78.66 179.76 6.2 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.548 2.165 . . . . 0.0 112.055 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.503 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 64.4 t80 -129.87 98.71 4.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.433 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.1 mt -95.82 108.68 21.05 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -42.19 -37.83 1.57 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.707 0.289 . . . . 0.0 111.7 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.52 165.4 1.36 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 111.07 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.64 -10.49 4.52 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.338 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.65 2.01 10.88 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.748 0.774 . . . . 0.0 112.185 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -132.1 157.59 43.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.092 0.473 . . . . 0.0 111.262 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -155.94 123.87 5.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.421 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.417 ' O ' ' CG2' ' A' ' 57' ' ' ILE . 6.6 tt -81.25 101.73 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.224 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.88 173.35 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.993 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.78 -45.19 65.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.199 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -58.15 -21.88 48.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.67 35.06 4.18 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.611 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -116.1 155.17 28.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.841 0.353 . . . . 0.0 111.036 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.1 tp -81.77 122.46 27.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.671 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -104.83 110.26 22.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.752 0.311 . . . . 0.0 111.111 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.43 ' CD1' HG21 ' A' ' 14' ' ' ILE . 3.1 mt -91.38 134.35 30.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.339 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -82.73 -45.94 13.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.015 0.436 . . . . 0.0 111.692 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.77 112.31 5.6 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.249 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.434 ' HB3' ' CG2' ' A' ' 97' ' ' ILE . 4.4 mt -51.37 146.49 6.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.166 0.508 . . . . 0.0 111.974 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.7 p -143.98 155.23 43.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.826 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.4 ' N ' HD12 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -50.11 -56.33 11.33 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.363 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -52.98 -23.8 8.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.162 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.32 -16.17 59.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.303 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.414 ' CB ' HG12 ' A' ' 97' ' ' ILE . 22.1 p -76.95 117.48 18.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.641 0.258 . . . . 0.0 110.711 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.54 -151.33 21.17 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.169 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -110.05 131.34 55.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.783 0.325 . . . . 0.0 110.512 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -105.21 151.72 23.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.266 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -133.8 125.0 27.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.355 . . . . 0.0 111.434 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.429 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -107.47 134.23 49.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.256 179.195 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.39 95.03 4.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.649 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 88' ' ' ILE . 64.8 t -85.31 130.97 35.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.015 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.51 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 2.7 m-30 -116.87 152.99 33.32 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.31 0.576 . . . . 0.0 110.764 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.48 179.24 5.58 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.884 179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.436 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 0.8 OUTLIER -64.78 -23.61 67.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.088 179.619 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -84.69 -5.12 59.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.52 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.56 19.23 55.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.812 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.88 141.82 37.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.749 0.309 . . . . 0.0 110.861 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.39 111.04 2.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.95 0.405 . . . . 0.0 111.014 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 80' ' ' VAL . 26.1 mm -80.14 -40.29 20.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.159 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.4 tt -152.82 127.36 9.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.107 0.479 . . . . 0.0 111.885 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -117.35 108.12 15.2 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt -119.32 159.4 24.22 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.73 122.41 17.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.071 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -119.88 162.15 19.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.015 0.435 . . . . 0.0 111.57 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 5' ' ' THR . 29.0 m-20 -111.25 122.6 48.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.449 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.749 ' HA ' HG13 ' A' ' 6' ' ' VAL . 0.5 OUTLIER -117.2 101.95 8.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.051 -179.585 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.42 125.18 38.9 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.129 0.49 . . . . 0.0 110.929 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.434 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 2.8 mm -108.72 112.49 40.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.999 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.1 mt -73.68 123.54 24.26 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.416 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.883 -179.793 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.776 0.322 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.49 149.38 44.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.882 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.5 p -78.78 -76.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.62 158.84 30.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.574 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.1 m -142.74 152.69 42.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.22 0.534 . . . . 0.0 110.92 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.702 HG11 ' HA ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER -142.63 145.47 23.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.866 -179.308 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -115.13 130.09 56.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.802 0.334 . . . . 0.0 110.752 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.57 -179.62 23.74 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.781 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.434 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -129.79 134.43 47.57 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.972 0.415 . . . . 0.0 111.192 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -53.63 135.86 39.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.992 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.88 -8.77 74.64 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.73 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.527 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.61 167.37 10.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.593 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.89 -171.75 11.34 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.472 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.593 ' HB ' ' O ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER 163.04 136.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.94 0.4 . . . . 0.0 110.531 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -119.33 134.02 55.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.067 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.414 ' HB3' ' CH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -92.18 105.27 17.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.173 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -88.45 122.09 31.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.183 0.516 . . . . 0.0 112.116 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.449 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.3 mt -80.58 119.46 76.34 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.229 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.68 131.76 39.4 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.316 2.011 . . . . 0.0 112.878 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 43.26 65.37 0.98 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -142.75 149.31 38.57 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.791 0.329 . . . . 0.0 110.625 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -142.75 116.95 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.948 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.07 78.82 5.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.2 p -107.37 -173.49 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.31 -34.87 71.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.923 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -59.76 -24.77 64.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.994 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.9 mm -78.61 129.08 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.448 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.72 -45.11 3.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -135.36 118.24 16.23 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.786 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 t -110.08 115.08 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.922 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -112.82 132.87 55.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.297 0.57 . . . . 0.0 112.426 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.453 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 70.3 m95 -112.28 86.48 2.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.784 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -100.44 145.67 27.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.272 0.558 . . . . 0.0 112.386 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.8 ttp85 -136.98 118.43 14.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.403 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.95 -114.7 5.98 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.685 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.4 m -119.3 44.69 2.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.763 0.316 . . . . 0.0 110.663 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.8 m -154.78 159.98 40.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.309 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.492 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.7 mt -101.47 146.76 27.2 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.461 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 41.8 t -117.05 -41.25 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.992 0.425 . . . . 0.0 110.494 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -170.42 113.62 0.45 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.676 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.72 149.36 40.87 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.046 0.45 . . . . 0.0 110.422 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.41 ' HA ' ' HB3' ' A' ' 48' ' ' PRO . 55.2 t80 -127.75 158.17 38.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.932 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.49 169.94 17.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.678 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.409 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -93.47 102.08 14.29 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.757 0.789 . . . . 0.0 109.543 179.263 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 44' ' ' ARG . 29.0 tttt 82.93 -47.42 0.15 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.588 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.2 ttt -55.92 169.83 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.757 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -86.51 134.24 38.41 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.173 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 93.4 Cg_endo -82.83 -176.07 2.72 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.694 2.263 . . . . 0.0 112.691 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.492 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 61.0 t80 -130.62 106.77 8.71 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.156 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.4 mt -99.49 113.89 26.53 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.197 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.461 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 22.6 tttt -46.91 -44.83 20.09 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.71 0.291 . . . . 0.0 111.431 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 p -176.54 165.78 2.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.02 -12.09 3.59 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.159 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.71 0.94 13.58 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.746 0.773 . . . . 0.0 112.133 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -132.93 156.81 46.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.102 0.477 . . . . 0.0 111.195 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -151.23 118.43 5.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.348 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 57' ' ' ILE . 8.8 tt -75.04 99.31 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.064 0.459 . . . . 0.0 111.319 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -49.59 167.02 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.245 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.74 -23.92 65.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.555 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -96.59 33.18 1.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.836 0.351 . . . . 0.0 111.183 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.54 34.33 69.07 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.713 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.51 166.4 10.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.876 0.369 . . . . 0.0 111.007 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.404 HD22 HD21 ' A' ' 16' ' ' LEU . 10.4 tp -107.24 120.72 42.91 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.515 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.38 110.64 22.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 110.875 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.4 ' CG1' HG21 ' A' ' 14' ' ' ILE . 2.8 mt -89.56 137.53 21.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.363 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -84.79 -47.11 10.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.974 0.416 . . . . 0.0 112.006 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.35 110.86 5.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.403 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.434 ' CD1' ' O ' ' A' ' 9' ' ' ALA . 6.7 mt -55.2 150.78 10.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.71 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.4 p -152.14 158.6 43.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.924 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.403 ' N ' HD12 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -50.53 -56.27 12.37 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.2 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -55.03 -22.41 15.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.129 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.16 -14.41 58.49 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.313 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.404 ' N ' HD11 ' A' ' 97' ' ' ILE . 2.3 t -79.59 127.34 32.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.644 0.259 . . . . 0.0 110.581 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.56 -167.85 32.07 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.226 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.55 125.33 36.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.763 0.316 . . . . 0.0 111.487 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.406 ' CE1' HD22 ' A' ' 95' ' ' LEU . 15.6 m-85 -103.32 130.7 50.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.29 179.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -113.29 126.07 54.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.857 0.36 . . . . 0.0 111.562 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.449 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -108.01 126.14 64.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.027 179.178 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.88 97.91 6.85 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.0 t -90.41 124.24 42.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.441 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -112.93 151.22 30.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.169 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.75 173.8 7.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.551 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.5 p -61.23 -18.46 58.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.385 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -93.01 22.98 4.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.325 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.57 19.52 48.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.656 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.55 -178.73 3.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.703 0.287 . . . . 0.0 110.616 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -101.08 126.3 47.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.778 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.7 mm -98.95 -54.44 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.417 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.3 tt -144.98 126.12 14.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.105 0.479 . . . . 0.0 111.98 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -118.01 107.41 14.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.1 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -120.17 162.79 18.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.85 120.56 12.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.091 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -115.11 156.47 25.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.87 0.367 . . . . 0.0 111.531 -179.139 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.02 121.45 43.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.244 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.702 ' HA ' HG11 ' A' ' 6' ' ' VAL . 9.7 tp -108.85 98.59 8.06 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.286 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.407 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -96.59 110.73 23.08 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.125 0.488 . . . . 0.0 110.322 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.415 HG12 HD23 ' A' ' 68' ' ' LEU . 4.6 mt -104.9 113.16 41.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.895 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.8 mt -69.0 121.01 15.76 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.549 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.939 -179.84 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.876 0.369 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.02 -39.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.837 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.4 t -58.04 125.32 22.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.923 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.23 -148.81 19.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.552 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -45.2 145.83 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.411 0.624 . . . . 0.0 111.454 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.684 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.6 OUTLIER -137.88 144.56 30.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.619 -179.261 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -112.68 129.56 56.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.799 0.333 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -153.98 177.6 31.34 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.76 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.76 135.62 54.93 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.969 0.414 . . . . 0.0 110.848 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tp -56.92 129.34 41.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.53 -4.69 76.68 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.502 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.559 ' NE2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.9 168.7 9.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.559 ' O ' ' NE2' ' A' ' 12' ' ' HIS . . . -77.74 160.67 49.02 Favored Glycine 0 C--O 1.224 -0.524 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.083 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.6 tp -176.14 138.06 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.834 0.349 . . . . 0.0 111.237 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -117.92 129.24 55.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.208 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.55 106.09 17.29 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -88.72 126.28 35.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.304 0.573 . . . . 0.0 112.008 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.434 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.3 mt -80.79 119.82 77.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.153 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.33 131.26 37.66 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.318 2.012 . . . . 0.0 112.862 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 m120 43.27 65.37 0.99 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -142.7 151.3 41.2 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 110.55 179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -141.94 114.97 8.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.29 83.27 5.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.14 -174.07 2.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.86 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -56.08 -30.02 61.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.953 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -63.67 -27.87 69.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.999 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 35.1 mm -87.39 127.04 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.399 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.408 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -113.03 -42.16 3.6 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.069 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 43.2 tt0 -124.63 118.38 26.38 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.174 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.6 t -122.43 115.09 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.152 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -114.59 137.34 52.0 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.2 0.524 . . . . 0.0 112.261 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.449 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 71.9 m95 -112.19 85.58 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.86 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -97.28 142.39 29.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.287 0.565 . . . . 0.0 112.264 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.77 118.55 19.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.424 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.81 -114.22 5.45 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.687 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 m -119.68 44.94 2.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.732 0.301 . . . . 0.0 110.686 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.0 m -155.26 159.68 40.23 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.906 0.384 . . . . 0.0 111.357 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.504 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 4.5 mt -97.82 147.29 24.56 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.7 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.2 t -119.13 -43.09 2.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.341 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -172.45 114.39 0.3 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.725 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -125.05 156.61 37.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.078 0.466 . . . . 0.0 111.005 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -127.54 142.2 51.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.845 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -146.61 113.19 5.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.697 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -51.65 -59.31 4.43 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.795 0.807 . . . . 0.0 111.114 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -82.5 46.57 1.07 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.908 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.85 -172.11 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.816 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -107.55 141.04 22.16 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.755 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.61 155.17 59.45 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.445 2.097 . . . . 0.0 112.48 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 46.5 t80 -111.61 103.54 11.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.177 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.3 mt -94.79 112.89 24.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.289 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -48.07 -46.63 33.82 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.695 0.283 . . . . 0.0 111.23 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -173.41 166.11 4.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 0.0 111.196 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.38 -11.47 3.63 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.376 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.53 -0.09 14.09 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 117.834 0.817 . . . . 0.0 112.236 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -132.84 157.8 44.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.076 0.465 . . . . 0.0 111.073 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -152.07 124.45 8.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.43 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 4.7 tt -84.61 103.9 12.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 111.176 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.73 172.63 1.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.005 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.36 -45.15 63.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -57.43 -22.45 43.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.113 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.01 35.0 4.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.634 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -115.33 155.38 27.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 110.979 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.2 tp -85.48 122.72 30.02 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.798 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.84 108.24 19.62 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.736 0.303 . . . . 0.0 111.073 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.0 mt -89.35 132.59 33.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.449 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -81.13 -46.06 15.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.953 0.406 . . . . 0.0 111.76 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -147.16 112.64 5.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.322 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.422 ' HB3' ' CG2' ' A' ' 97' ' ' ILE . 5.1 mt -54.16 149.62 9.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.166 0.508 . . . . 0.0 111.746 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.2 p -151.32 158.26 43.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.153 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.5 mmt180 -50.62 -56.82 10.07 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.173 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.37 -20.76 20.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.315 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.17 17.03 11.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.289 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.48 146.99 36.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.684 0.278 . . . . 0.0 110.756 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.32 -117.71 1.76 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.291 -0.957 . . . . 0.0 112.901 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -138.04 130.3 29.0 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 117.717 0.759 . . . . 0.0 110.848 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -103.98 151.92 22.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.359 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -132.57 124.15 27.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.192 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.434 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.46 127.3 66.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.223 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.58 97.18 6.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.715 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 73.2 t -88.22 131.78 34.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.269 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.518 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 96.0 m-85 -125.35 154.67 41.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.313 0.577 . . . . 0.0 111.198 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.77 175.71 7.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.414 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 2.1 p -62.82 -22.1 66.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.118 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -96.21 24.87 5.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.114 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.92 27.35 56.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.645 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.45 157.14 16.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 0.0 110.866 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.46 111.0 12.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.611 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.2 mm -93.22 -51.55 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.403 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 tt -151.02 149.78 29.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.212 0.53 . . . . 0.0 111.697 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.7 108.35 5.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.176 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -122.06 156.19 34.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.378 0.608 . . . . 0.0 112.516 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.42 123.65 18.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.174 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.408 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -122.51 163.05 20.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 0.0 111.437 -179.344 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.23 133.05 53.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.482 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.684 ' HA ' HG12 ' A' ' 6' ' ' VAL . 8.1 tp -113.36 97.9 6.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.635 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -95.37 108.13 20.31 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.105 0.478 . . . . 0.0 109.98 178.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.422 ' CG2' ' HB3' ' A' ' 68' ' ' LEU . 1.6 mt -106.65 110.51 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.001 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.9 mt -66.68 126.68 29.73 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.289 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.927 -179.749 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.817 0.341 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -103.0 114.64 29.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.23 165.22 2.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.844 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 66.53 -149.29 51.3 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.499 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -45.84 140.72 3.41 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.267 0.556 . . . . 0.0 111.461 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.649 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -133.69 149.53 30.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.775 -179.521 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -118.16 127.16 53.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.59 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.69 177.7 27.68 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.826 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.4 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -123.56 135.55 54.06 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.889 0.376 . . . . 0.0 110.969 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.433 HD13 ' N ' ' A' ' 70' ' ' ARG . 0.9 OUTLIER -53.17 134.59 38.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.053 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.55 -5.31 84.96 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.852 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.548 ' NE2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.34 168.68 9.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 117.126 0.463 . . . . 0.0 109.958 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.548 ' O ' ' NE2' ' A' ' 12' ' ' HIS . . . -78.57 162.09 48.85 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.287 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.9 tp -176.54 138.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.764 0.316 . . . . 0.0 111.008 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -124.09 128.23 48.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.254 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.93 125.09 30.33 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -104.09 124.23 48.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.275 0.559 . . . . 0.0 111.914 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.459 ' CD1' ' CG1' ' A' ' 78' ' ' VAL . 3.4 mt -82.1 119.94 76.18 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.417 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.97 131.15 37.88 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.37 2.047 . . . . 0.0 112.96 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.65 65.23 0.96 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -142.18 149.13 39.31 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.643 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -138.75 117.58 12.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.912 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.26 81.87 8.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.0 p -117.47 -173.01 2.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -57.13 -30.43 64.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.69 -24.52 64.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.012 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.1 mm -85.01 127.44 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.348 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.421 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -111.15 -43.86 3.67 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.172 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 34.6 tt0 -127.77 118.29 23.47 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.125 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 t -119.09 144.33 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.373 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -148.14 132.4 17.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.053 0.454 . . . . 0.0 112.076 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.464 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 54.5 m95 -108.07 89.41 2.99 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -98.36 146.57 25.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.395 0.617 . . . . 0.0 112.481 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.67 116.99 11.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.353 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.1 -114.81 6.14 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.641 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.1 m -119.06 44.66 2.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.807 0.337 . . . . 0.0 110.654 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.5 m -154.27 160.74 41.93 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.294 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.489 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 4.1 mt -102.58 148.22 25.82 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.493 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 43.2 t -119.49 -41.31 2.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.746 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -173.05 114.27 0.25 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.904 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.07 154.71 45.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.183 0.516 . . . . 0.0 110.754 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -117.86 156.02 29.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.833 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -151.96 119.12 5.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.342 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.445 ' C ' ' H ' ' A' ' 46' ' ' MET . 0.0 OUTLIER -48.67 -25.6 1.86 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.329 0.585 . . . . 0.0 111.547 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -77.47 28.73 0.15 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.124 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.445 ' H ' ' C ' ' A' ' 44' ' ' ARG . 1.4 ttt 52.26 169.9 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.201 0.524 . . . . 0.0 111.68 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt 62.4 78.06 0.31 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.973 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -83.12 -166.92 0.41 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.614 2.209 . . . . 0.0 111.928 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.489 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 83.5 t80 -127.92 111.16 13.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.811 0.338 . . . . 0.0 111.416 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.2 mt -107.32 112.28 25.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.005 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 8.0 ttmt -46.71 -41.33 14.88 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.673 0.273 . . . . 0.0 111.464 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.2 p -177.03 164.38 2.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.946 0.403 . . . . 0.0 111.231 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.94 -11.95 4.91 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.106 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.86 1.05 13.59 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 117.688 0.744 . . . . 0.0 112.075 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -131.8 157.24 44.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.102 0.477 . . . . 0.0 111.161 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -151.41 119.69 6.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.216 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 57' ' ' ILE . 7.8 tt -76.79 99.52 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.216 0.531 . . . . 0.0 111.237 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.1 163.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.275 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.58 -21.76 66.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.39 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.61 30.41 2.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.802 0.334 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.26 36.08 67.64 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.892 -0.671 . . . . 0.0 113.02 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -111.67 157.39 20.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 110.963 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.7 tp -93.19 121.25 34.35 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.716 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.77 107.49 18.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.876 0.37 . . . . 0.0 110.948 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 mt -87.48 136.47 23.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.437 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 tttm -86.04 -45.91 10.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.952 0.406 . . . . 0.0 111.713 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.47 110.96 5.6 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.319 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.438 HD21 ' CD1' ' A' ' 97' ' ' ILE . 5.5 mt -53.78 152.39 5.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.169 0.509 . . . . 0.0 111.855 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.0 p -152.92 159.36 42.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.194 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.433 ' N ' HD13 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -51.1 -56.94 10.15 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.078 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -55.28 -20.94 12.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.38 -14.8 56.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.425 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.401 ' HB3' HD12 ' A' ' 97' ' ' ILE . 5.6 p -81.99 137.88 35.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.58 0.229 . . . . 0.0 110.863 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.63 -124.62 2.04 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.835 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -136.92 133.43 35.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 117.9 0.85 . . . . 0.0 110.595 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -108.69 135.55 49.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.44 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -115.44 121.93 44.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.162 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.459 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -104.58 130.94 54.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.304 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.97 104.23 10.69 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.7 t -95.91 125.44 48.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.7 -178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.518 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 77.9 m-85 -119.31 147.54 44.19 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.28 0.562 . . . . 0.0 111.058 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.85 178.75 6.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.491 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.421 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -64.06 -18.65 64.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.208 179.628 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -94.73 20.88 8.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.234 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.85 30.05 56.08 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.756 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.56 153.66 20.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.344 . . . . 0.0 110.901 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.21 106.04 6.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.707 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.4 mm -78.23 -64.68 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.404 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.0 tt -145.1 133.26 21.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.155 0.502 . . . . 0.0 111.814 -179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.2 108.33 14.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.168 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.9 mmpt? -121.2 158.08 28.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.39 122.43 17.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.238 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.412 ' N ' ' CD1' ' A' ' 93' ' ' LEU . 0.1 OUTLIER -118.45 160.77 21.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.963 0.411 . . . . 0.0 111.421 -179.39 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -106.79 131.82 53.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.383 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.649 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -117.39 99.16 6.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.319 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.84 111.92 23.67 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.188 0.518 . . . . 0.0 110.524 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.438 ' CD1' HD21 ' A' ' 68' ' ' LEU . 4.0 mt -110.67 114.18 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.753 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mt -68.08 119.49 12.77 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.652 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.938 -179.842 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.942 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.486 0 CA-C-O 120.657 0.265 . . . . 0.0 110.432 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -117.68 131.46 56.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.895 0.378 . . . . 0.0 110.92 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.96 -178.04 19.36 Favored Glycine 0 C--O 1.229 -0.163 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.562 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.429 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.23 134.09 48.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.995 0.426 . . . . 0.0 111.178 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.648 HD11 ' C ' ' A' ' 69' ' ' THR . 1.3 tp -56.62 130.88 47.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.837 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.89 -7.18 81.55 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.507 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.531 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.88 167.64 9.84 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.604 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.68 -172.69 12.23 Favored Glycine 0 C--O 1.226 -0.366 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.607 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.833 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.0 OUTLIER 163.29 136.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.432 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -120.83 122.13 39.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.545 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.773 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -79.07 103.47 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.788 179.215 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.44 ' O ' HD21 ' A' ' 93' ' ' LEU . 68.7 m-20 -87.74 122.25 31.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.226 0.536 . . . . 0.0 112.186 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.935 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -79.9 119.91 78.2 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.158 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.11 131.04 36.95 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.272 1.982 . . . . 0.0 112.829 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.4 m120 43.56 65.28 1.02 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -142.71 149.4 38.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.766 0.317 . . . . 0.0 110.576 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -142.88 104.49 4.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.905 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.78 75.2 0.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.83 -173.53 2.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.76 -31.07 62.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.017 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -64.12 -26.64 68.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.966 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.641 HD12 ' CG1' ' A' ' 80' ' ' VAL . 27.4 mm -86.04 127.06 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.437 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.408 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -112.32 -42.72 3.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.081 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.541 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 36.0 tt0 -126.46 117.28 22.58 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.433 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.9 t -116.88 107.62 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.149 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -105.44 134.76 48.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.233 0.539 . . . . 0.0 112.034 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.483 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 69.0 m95 -112.39 88.1 2.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.209 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -102.11 146.35 28.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.253 0.549 . . . . 0.0 112.295 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.5 116.22 12.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.527 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.14 -116.34 8.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.745 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 p -116.5 43.4 2.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.768 0.318 . . . . 0.0 110.642 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.2 m -152.86 159.76 43.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.271 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.54 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.6 mt -102.43 148.56 25.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.808 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.415 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 54.7 t -119.57 -43.53 2.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.256 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -167.2 113.23 0.76 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.547 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -120.61 113.54 20.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.226 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.517 ' HB2' HD13 ' A' ' 57' ' ' ILE . 13.3 t80 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.742 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 0 N--CA 1.463 -0.288 0 CA-C-O 120.557 0.149 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.54 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 70.1 t80 -125.71 101.93 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.688 0.28 . . . . 0.0 111.51 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.7 mt -98.08 110.99 23.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.423 . . . . 0.0 109.879 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 51.7 tptt -43.83 -39.5 3.89 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.82 0.343 . . . . 0.0 111.365 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.05 165.97 0.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.943 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.84 -10.56 2.37 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.371 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.88 2.15 10.97 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 117.819 0.809 . . . . 0.0 112.343 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -134.05 156.93 47.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.153 0.502 . . . . 0.0 111.261 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -152.35 118.54 5.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.191 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 57' ' ' ILE . 6.6 tt -73.96 101.62 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.122 0.487 . . . . 0.0 111.388 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.453 HD13 ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -50.6 169.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.177 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.8 -25.06 65.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.581 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.504 ' ND2' ' HB2' ' A' ' 62' ' ' ASP . 5.9 p-10 -97.06 33.25 1.96 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.753 0.311 . . . . 0.0 111.122 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.55 30.51 65.39 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.672 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.504 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -96.99 170.47 9.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 111.096 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 10.0 tp -110.08 119.24 38.65 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.469 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.453 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.5 OUTLIER -106.73 110.94 23.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.742 0.306 . . . . 0.0 110.746 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.833 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -89.42 138.53 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.468 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -84.26 -49.17 9.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.009 0.433 . . . . 0.0 111.875 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.26 110.65 5.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.494 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.035 HD22 HD12 ' A' ' 97' ' ' ILE . 5.1 mt -54.09 147.9 11.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.273 0.559 . . . . 0.0 111.779 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.648 ' C ' HD11 ' A' ' 10' ' ' LEU . 12.0 p -152.3 169.41 22.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.485 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.4 ' N ' HD11 ' A' ' 10' ' ' LEU . 7.0 mmm180 -51.33 -52.89 41.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.477 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -56.06 -21.65 23.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.597 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.12 -14.87 52.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.549 0.214 . . . . 0.0 111.498 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -82.82 117.84 22.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.678 0.275 . . . . 0.0 110.601 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.95 -166.26 33.43 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.17 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.44 126.39 39.68 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 122.507 0.323 . . . . 0.0 111.266 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -102.95 148.41 25.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.358 -0.383 . . . . 0.0 109.982 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -129.67 126.17 37.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 0.0 111.707 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.935 HG11 HD11 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -111.99 132.67 59.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.025 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.03 96.85 5.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.588 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.641 ' CG1' HD12 ' A' ' 27' ' ' ILE . 76.0 t -85.58 128.61 39.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.301 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.541 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.5 m-85 -119.25 153.02 35.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.068 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.658 ' OG ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -88.25 175.42 7.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.355 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.1 p -62.69 -28.4 69.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.994 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -77.62 -4.49 46.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.427 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.6 27.91 45.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.6 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.33 165.5 11.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.867 0.365 . . . . 0.0 110.764 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.53 127.08 31.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.592 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.658 HD11 ' OG ' ' A' ' 82' ' ' SER . 33.0 mm -104.12 -67.31 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.372 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.918 HD21 ' HG3' ' A' ' 91' ' ' LYS . 3.2 tt -137.37 127.17 25.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.132 0.492 . . . . 0.0 111.799 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -115.75 106.69 14.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.199 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.918 ' HG3' HD21 ' A' ' 89' ' ' LEU . 5.7 mmpt? -117.19 161.96 18.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.372 0.606 . . . . 0.0 112.526 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.95 122.07 12.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.993 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -120.25 156.22 31.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.937 0.399 . . . . 0.0 111.679 -179.045 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.78 110.72 22.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.17 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.942 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -101.73 98.2 8.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.286 -179.325 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.44 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -92.78 121.83 34.56 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 110.743 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.035 HD12 HD22 ' A' ' 68' ' ' LEU . 2.9 mm -107.24 116.38 50.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.991 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.3 mt . . . . . 0 N--CA 1.439 -0.979 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.467 179.044 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.893 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 120.8 0.333 . . . . 0.0 110.737 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.487 ' CD2' ' HD3' ' A' ' 96' ' ' ARG . 79.1 m95 -110.85 129.65 55.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.689 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.41 -179.9 26.58 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.062 -1.066 . . . . 0.0 112.969 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.426 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.15 134.55 49.1 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.95 0.405 . . . . 0.0 110.962 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.733 HD11 ' C ' ' A' ' 69' ' ' THR . 1.4 tp -55.81 133.27 51.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.41 -5.72 84.4 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.47 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.523 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -110.61 168.71 9.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.594 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -72.3 -169.4 12.76 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.5 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.937 HG21 HD21 ' A' ' 68' ' ' LEU . 0.9 OUTLIER 160.36 136.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 122.647 0.379 . . . . 0.0 110.347 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.563 ' OD2' HD22 ' A' ' 58' ' ' LEU . 17.5 t70 -118.71 130.1 55.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.949 0.404 . . . . 0.0 111.299 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -88.94 106.45 18.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.765 179.305 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -88.85 123.86 33.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.165 0.507 . . . . 0.0 111.867 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.93 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.4 mt -79.89 119.86 78.05 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.284 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.93 131.3 38.75 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.325 2.017 . . . . 0.0 112.856 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 43.04 65.42 0.96 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -142.65 149.31 38.73 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.579 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -139.26 117.46 11.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -80.24 80.98 6.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.38 -174.23 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.843 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.23 -30.86 62.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.991 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -62.19 -27.86 69.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.962 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.639 HD12 ' CG1' ' A' ' 80' ' ' VAL . 35.1 mm -88.21 127.21 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.369 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -113.13 -42.27 3.57 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.053 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.543 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 45.9 tt0 -123.94 115.91 22.03 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.365 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.41 112.79 42.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.829 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -111.01 130.6 55.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.024 0.44 . . . . 0.0 112.149 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -112.03 84.06 1.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.934 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -100.73 153.77 19.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.338 0.59 . . . . 0.0 112.297 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.34 116.14 8.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.676 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.24 -117.76 11.43 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.207 -0.997 . . . . 0.0 111.88 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.07 42.61 2.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.818 0.342 . . . . 0.0 110.738 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.1 m -151.14 160.26 43.97 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.155 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.633 HD21 ' OE2' ' A' ' 41' ' ' GLU . 6.0 mt -104.97 146.08 29.53 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.448 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 52.8 t -117.1 -42.94 3.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.983 0.42 . . . . 0.0 110.227 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.76 111.86 0.89 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.519 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.633 ' OE2' HD21 ' A' ' 38' ' ' LEU . 2.4 mt-10 -120.77 117.02 26.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.203 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 23.8 t80 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.648 179.867 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 N--CA 1.463 -0.308 0 CA-C-O 120.878 0.283 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.528 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 58.9 t80 -131.39 103.47 6.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.202 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.3 mt -97.6 111.87 23.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.081 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 33.6 tttm -45.2 -42.64 9.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.745 0.307 . . . . 0.0 111.527 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.8 p -176.63 165.79 2.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.888 0.375 . . . . 0.0 111.154 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.14 -11.34 4.62 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.158 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.17 2.19 11.47 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 117.707 0.753 . . . . 0.0 112.098 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -133.15 157.16 46.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.074 0.464 . . . . 0.0 111.184 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -153.92 120.18 5.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.331 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.641 HG23 ' O ' ' A' ' 57' ' ' ILE . 7.9 tt -74.93 99.94 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 0.0 111.282 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.563 HD22 ' OD2' ' A' ' 15' ' ' ASP . 0.7 OUTLIER -51.68 163.39 0.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.209 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.88 -22.0 65.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.458 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -96.53 31.91 2.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.761 0.315 . . . . 0.0 111.096 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.66 35.65 68.18 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.901 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.06 157.19 21.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.836 0.35 . . . . 0.0 111.033 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.95 123.25 36.07 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.782 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.524 ' HB2' HD13 ' A' ' 58' ' ' LEU . 2.1 ttpt -108.24 108.57 19.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.693 0.283 . . . . 0.0 110.919 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.859 HD12 ' CG2' ' A' ' 14' ' ' ILE . 3.2 mt -88.1 137.47 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.404 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -87.82 -45.98 9.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.974 0.416 . . . . 0.0 111.829 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.53 109.21 5.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.481 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.937 HD21 HG21 ' A' ' 14' ' ' ILE . 5.7 mt -57.37 152.5 14.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.178 0.514 . . . . 0.0 111.564 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.733 ' C ' HD11 ' A' ' 10' ' ' LEU . 7.5 p -154.11 161.35 41.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.136 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.583 ' N ' HD11 ' A' ' 10' ' ' LEU . 26.2 mmm180 -50.62 -56.18 12.98 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.247 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -54.85 -22.19 13.79 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.465 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.697 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -81.39 -15.09 56.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.307 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.8 p -83.13 132.19 35.1 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.72 0.295 . . . . 0.0 110.733 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.45 -131.34 3.25 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.344 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -128.81 130.48 47.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.722 0.761 . . . . 0.0 110.627 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.484 ' CE1' HD12 ' A' ' 95' ' ' LEU . 25.7 m-85 -105.08 148.51 26.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.219 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.662 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 13.6 m-20 -130.73 122.35 27.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.767 0.318 . . . . 0.0 111.374 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.93 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -105.75 129.04 59.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.232 179.267 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.6 97.8 6.34 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.655 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.639 ' CG1' HD12 ' A' ' 27' ' ' ILE . 87.2 t -89.36 129.92 39.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.335 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.543 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 96.9 m-85 -123.87 154.01 40.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.403 0.62 . . . . 0.0 111.188 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.533 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -87.79 175.31 7.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.352 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 2.1 p -62.13 -21.69 65.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.115 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -96.27 25.6 4.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.161 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.95 27.72 51.51 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.69 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.15 156.84 16.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.319 . . . . 0.0 110.866 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -77.38 110.26 11.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.783 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.533 HD11 ' HB3' ' A' ' 82' ' ' SER . 33.3 mm -91.46 -48.33 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.293 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.483 HD21 ' CG ' ' A' ' 91' ' ' LYS . 2.6 tt -154.57 149.85 27.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.277 0.56 . . . . 0.0 111.709 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -141.11 108.58 5.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.289 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.483 ' CG ' HD21 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -121.59 157.33 30.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.416 0.627 . . . . 0.0 112.598 -178.254 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.662 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -140.0 124.59 18.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.126 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.644 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -122.34 164.82 17.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.036 0.446 . . . . 0.0 111.674 -179.292 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -111.94 124.21 51.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.239 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.893 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -108.84 113.61 26.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.419 -179.408 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.487 ' HD3' ' CD2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -113.21 117.13 31.02 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.193 0.52 . . . . 0.0 110.447 178.881 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.918 HG21 ' HB3' ' A' ' 68' ' ' LEU . 1.2 mt -108.61 110.28 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.924 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.5 mt . . . . . 0 N--CA 1.439 -0.979 0 CA-C-O 121.077 0.465 . . . . 0.0 110.219 178.906 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.939 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 120.751 0.31 . . . . 0.0 110.724 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -120.27 130.16 54.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.56 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.735 ' C ' HG23 ' A' ' 97' ' ' ILE . . . -148.9 -179.02 24.46 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.904 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.527 ' N ' HG23 ' A' ' 97' ' ' ILE . . . -132.09 134.85 45.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.071 0.462 . . . . 0.0 111.226 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.649 HD11 ' N ' ' A' ' 70' ' ' ARG . 0.7 OUTLIER -52.84 136.22 34.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.031 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.2 -9.6 72.15 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.702 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.527 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.44 168.35 9.3 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.601 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -71.95 -170.94 14.65 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.424 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.893 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 162.03 136.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.815 0.34 . . . . 0.0 110.43 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.411 ' OD2' HD22 ' A' ' 58' ' ' LEU . 65.7 t0 -123.72 130.43 52.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.402 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.426 HD11 ' HG ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -84.27 135.73 34.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.692 179.137 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.479 ' O ' HD21 ' A' ' 93' ' ' LEU . 73.5 m-20 -116.39 122.02 43.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.275 0.559 . . . . 0.0 111.813 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.925 HD11 HG11 ' A' ' 78' ' ' VAL . 3.2 mt -81.46 119.6 76.02 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.245 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.65 130.87 37.19 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.364 2.043 . . . . 0.0 112.999 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.0 m120 42.78 65.07 1.0 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -141.43 149.3 40.83 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.772 0.32 . . . . 0.0 110.559 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -137.91 117.43 12.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.939 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.564 ' SD ' HG21 ' A' ' 30' ' ' VAL . 1.7 tpt -79.57 75.39 6.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.972 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.7 p -107.44 -173.16 2.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.99 -32.34 70.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -59.24 -27.04 65.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.98 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.535 HD12 ' CG1' ' A' ' 80' ' ' VAL . 19.2 mm -78.81 128.1 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.492 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.483 ' OD1' HG22 ' A' ' 83' ' ' THR . 0.4 OUTLIER -111.3 -44.32 3.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.14 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 73.3 tt0 -130.31 116.32 18.18 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.172 -0.611 . . . . 0.0 112.537 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.564 HG21 ' SD ' ' A' ' 23' ' ' MET . 2.8 t -112.42 111.24 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.743 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -108.18 130.31 55.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.178 0.513 . . . . 0.0 112.239 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -112.68 84.65 2.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.9 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.35 154.16 19.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.316 0.579 . . . . 0.0 112.247 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.424 ' HD3' ' CZ ' ' A' ' 76' ' ' TYR . 10.3 ttp-105 -143.96 118.32 9.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.602 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.01 -117.64 10.9 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.829 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.1 m -115.99 43.02 2.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.743 0.306 . . . . 0.0 110.739 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.7 m -151.14 160.06 44.09 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.171 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.537 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 6.0 mt -103.73 145.66 29.76 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.402 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 55.7 t -117.5 -43.42 3.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.153 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -166.06 111.31 0.84 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.752 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -117.66 112.42 20.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.042 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.407 ' HA ' ' HB3' ' A' ' 48' ' ' PRO . 21.1 t80 . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.85 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.407 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 97.9 Cg_endo . . . . . 0 N--CA 1.463 -0.29 0 CA-C-O 120.898 0.291 . . . . 0.0 112.607 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.537 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 71.1 t80 -137.49 105.46 5.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.352 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.1 mt -99.73 112.26 24.52 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.402 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 78.0 tttt -44.53 -45.87 9.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.725 0.298 . . . . 0.0 111.368 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.87 166.69 2.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.94 0.4 . . . . 0.0 111.112 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.77 -11.61 2.13 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.401 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.49 2.01 10.58 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 117.79 0.795 . . . . 0.0 112.296 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -135.46 157.16 47.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.084 0.468 . . . . 0.0 111.284 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -153.32 122.06 6.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.249 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 57' ' ' ILE . 6.4 tt -76.0 101.52 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.152 0.501 . . . . 0.0 111.213 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.666 HD13 ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -54.35 160.35 1.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.138 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.19 -21.97 66.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.404 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -96.13 32.81 1.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.052 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.71 34.37 56.25 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.778 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.26 155.3 22.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.866 0.365 . . . . 0.0 111.028 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 tp -92.95 122.71 35.59 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.821 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.666 ' HB2' HD13 ' A' ' 58' ' ' LEU . 4.4 tmtt? -108.04 110.06 21.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.71 0.29 . . . . 0.0 110.863 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.84 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.8 mt -89.18 138.79 18.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.408 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -86.69 -47.67 8.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.008 0.432 . . . . 0.0 111.91 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -142.73 110.73 5.96 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.335 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 14' ' ' ILE . 7.2 mt -55.65 150.77 11.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.308 0.575 . . . . 0.0 111.795 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.648 ' C ' HD11 ' A' ' 10' ' ' LEU . 6.8 p -153.36 161.42 42.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.813 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.649 ' N ' HD11 ' A' ' 10' ' ' LEU . 1.5 ptp180 -50.91 -54.84 20.64 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.429 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -57.43 -20.64 31.53 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.459 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.693 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -82.76 -15.53 51.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.389 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.8 t -82.78 130.69 35.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.582 0.23 . . . . 0.0 110.446 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.51 -166.25 29.63 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.172 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.7 126.4 36.77 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 122.522 0.329 . . . . 0.0 111.538 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.424 ' CZ ' ' HD3' ' A' ' 34' ' ' ARG . 18.9 m-85 -102.93 151.83 22.01 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -131.52 125.77 33.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.754 0.312 . . . . 0.0 111.492 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.925 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -110.1 130.8 62.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.211 179.155 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.419 HG23 ' OD1' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -118.02 98.46 6.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.512 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.535 ' CG1' HD12 ' A' ' 27' ' ' ILE . 93.5 t -91.46 125.73 44.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.748 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.459 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.5 m-85 -118.39 152.79 35.18 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.91 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.658 ' HA ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -90.67 172.32 8.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.567 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.483 HG22 ' OD1' ' A' ' 28' ' ' ASP . 16.9 p -60.04 -19.46 52.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.377 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -93.97 25.27 3.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.233 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.59 20.95 40.63 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.787 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.62 166.08 11.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.703 0.287 . . . . 0.0 110.696 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -90.89 120.19 31.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.731 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' A' ' 82' ' ' SER . 38.3 mt -90.71 -58.87 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.498 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.811 HD11 ' HE2' ' A' ' 91' ' ' LYS . 2.7 tt -147.83 133.68 19.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.117 0.484 . . . . 0.0 111.879 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.419 ' OD1' HG23 ' A' ' 79' ' ' THR . 0.1 OUTLIER -121.23 109.61 15.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.923 178.648 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.811 ' HE2' HD11 ' A' ' 89' ' ' LEU . 31.5 mmtm -121.5 162.66 20.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.01 121.95 14.52 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.047 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.642 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -113.76 164.71 13.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.03 0.443 . . . . 0.0 111.737 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -114.73 111.82 21.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.271 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.939 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -99.22 99.38 10.34 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.245 -179.422 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.73 120.47 40.14 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.004 0.431 . . . . 0.0 110.455 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.759 HG12 HD22 ' A' ' 68' ' ' LEU . 1.7 mt -128.42 129.13 68.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.794 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 N--CA 1.436 -1.134 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.71 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.812 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.521 0 CA-C-O 120.708 0.289 . . . . 0.0 110.717 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -115.89 127.91 55.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.525 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.75 -178.8 21.52 Favored Glycine 0 N--CA 1.459 0.171 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.705 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.429 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.96 134.68 48.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.069 0.461 . . . . 0.0 111.287 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.712 HD11 ' C ' ' A' ' 69' ' ' THR . 1.0 OUTLIER -55.62 134.82 51.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.741 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.66 -8.58 77.02 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.456 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.53 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -106.95 167.16 10.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.614 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.41 -173.85 14.06 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.551 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.814 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 161.24 136.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 122.579 0.352 . . . . 0.0 110.367 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.546 ' OD2' HD22 ' A' ' 58' ' ' LEU . 7.4 t0 -124.85 123.78 40.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.955 0.407 . . . . 0.0 111.525 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.726 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -79.07 112.19 16.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.744 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -93.76 124.89 38.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.191 0.52 . . . . 0.0 111.884 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.937 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -81.64 120.04 76.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.252 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.01 131.12 37.63 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.278 1.985 . . . . 0.0 112.901 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.9 m120 43.12 65.16 1.01 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -142.14 149.37 39.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.758 0.313 . . . . 0.0 110.607 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -138.83 117.41 12.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.407 ' SD ' HG21 ' A' ' 30' ' ' VAL . 4.1 tpt -81.17 76.22 8.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 46.8 p -111.43 -173.03 2.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -57.8 -30.52 65.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.966 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -62.1 -28.12 69.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.641 HD12 ' CG1' ' A' ' 80' ' ' VAL . 33.6 mm -87.74 126.8 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.383 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.73 -41.92 3.71 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 61.3 tt0 -125.84 118.32 25.24 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.28 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 30.9 t -121.32 117.69 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.019 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.449 ' NH1' ' CE2' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -115.81 136.94 52.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.266 0.555 . . . . 0.0 112.223 -178.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.478 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 74.8 m95 -112.12 87.38 2.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.702 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -101.05 149.91 23.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.355 0.598 . . . . 0.0 112.283 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.7 ttp85 -142.13 117.59 10.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.462 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.81 -115.65 7.13 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.737 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 t -118.59 44.35 2.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.786 0.327 . . . . 0.0 110.683 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.3 m -151.94 160.39 43.51 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.328 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.607 HD22 ' OE1' ' A' ' 41' ' ' GLU . 5.5 mt -103.25 146.89 27.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.479 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 56.1 t -119.01 -43.52 2.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.959 0.409 . . . . 0.0 110.476 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -174.73 114.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.045 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.607 ' OE1' HD22 ' A' ' 38' ' ' LEU . 1.1 pt-20 -128.35 156.04 43.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.009 0.433 . . . . 0.0 110.947 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 57.0 t80 . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.871 -179.723 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.923 0.301 . . . . 0.0 112.585 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.521 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 33.8 t80 -115.86 101.85 9.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.34 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 50' ' ' LEU . 11.2 mt -91.29 116.22 28.66 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.479 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 12.1 tptm -38.88 -90.33 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.729 0.641 . . . . 0.0 112.729 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 m -117.41 22.68 12.28 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.76 -0.03 52.77 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.089 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.32 5.33 27.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 117.53 0.665 . . . . 0.0 111.02 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -126.24 158.22 36.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.024 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -138.71 119.55 14.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.147 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.649 HG23 ' O ' ' A' ' 57' ' ' ILE . 7.4 tt -78.13 99.67 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.182 0.515 . . . . 0.0 111.064 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.546 HD22 ' OD2' ' A' ' 15' ' ' ASP . 0.5 OUTLIER -55.47 153.14 7.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.279 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.32 -19.79 56.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.475 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.24 31.94 2.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.861 0.363 . . . . 0.0 111.043 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.37 36.35 57.64 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.847 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -112.97 157.88 20.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.023 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 12.0 tp -95.2 122.49 37.93 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.125 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.507 ' HB2' HD13 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -110.26 104.71 13.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.715 0.293 . . . . 0.0 110.696 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.806 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -81.02 134.59 26.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.774 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -78.28 -49.06 14.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.09 0.471 . . . . 0.0 111.513 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.53 112.99 5.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.134 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.814 HD21 HG21 ' A' ' 14' ' ' ILE . 5.8 mt -52.73 148.37 7.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.261 0.553 . . . . 0.0 111.873 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.712 ' C ' HD11 ' A' ' 10' ' ' LEU . 7.1 p -152.13 163.1 40.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.78 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.579 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -50.81 -55.22 17.91 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.291 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -52.66 -22.95 5.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.614 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -82.99 -13.87 55.13 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.571 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.7 t -83.45 119.96 25.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.672 0.272 . . . . 0.0 110.582 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.46 -139.06 5.85 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.467 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 m -120.32 130.86 54.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 117.382 0.591 . . . . 0.0 110.648 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -106.43 151.27 25.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.386 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.652 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 4.0 m-20 -134.47 121.81 21.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.332 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.937 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -106.8 133.46 51.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.24 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.28 103.6 9.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.549 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.641 ' CG1' HD12 ' A' ' 27' ' ' ILE . 91.1 t -93.81 129.28 44.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.689 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.564 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.8 m-85 -121.44 153.64 37.61 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.998 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.714 ' OG ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -87.99 176.45 7.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.336 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.0 p -64.63 -28.67 69.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.979 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -77.3 -4.53 45.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.421 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.62 27.33 43.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.536 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.6 165.68 11.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 110.783 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.98 134.13 38.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.568 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.714 HD11 ' OG ' ' A' ' 82' ' ' SER . 37.8 mm -111.52 -66.64 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.397 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.914 HD21 ' HG3' ' A' ' 91' ' ' LYS . 3.5 tt -141.09 128.76 21.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.1 0.476 . . . . 0.0 111.845 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.47 107.22 14.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.177 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.914 ' HG3' HD21 ' A' ' 89' ' ' LEU . 16.0 mmtt -118.1 158.57 24.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.389 0.614 . . . . 0.0 112.536 -178.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.652 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -140.63 125.79 18.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.152 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.646 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -125.32 161.53 26.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.047 0.451 . . . . 0.0 111.65 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -110.32 116.85 32.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.228 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.812 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -104.8 103.76 13.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.308 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.46 115.26 28.88 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 110.692 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.736 HG12 HD22 ' A' ' 68' ' ' LEU . 3.1 mt -106.4 111.79 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.557 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 N--CA 1.437 -1.114 0 CA-C-O 121.246 0.546 . . . . 0.0 110.734 179.692 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.943 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 120.64 0.257 . . . . 0.0 110.642 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -118.84 131.15 56.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.29 -178.53 19.19 Favored Glycine 0 N--CA 1.459 0.21 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.508 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.444 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -126.48 133.25 51.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.048 0.452 . . . . 0.0 111.313 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.421 ' CD1' ' HA ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -55.6 131.06 45.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.874 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.51 -6.42 83.22 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.452 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.524 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.05 167.66 9.84 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.596 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.4 -172.93 11.85 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.597 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.836 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.0 OUTLIER 163.31 136.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.773 0.32 . . . . 0.0 110.354 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.467 ' OD2' HD22 ' A' ' 58' ' ' LEU . 2.1 t70 -121.75 122.47 39.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.936 0.398 . . . . 0.0 111.476 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.741 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -77.96 108.82 11.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.773 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -93.3 123.11 36.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.176 0.513 . . . . 0.0 111.967 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.978 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -79.37 119.47 77.12 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.262 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.54 131.21 36.94 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.393 2.062 . . . . 0.0 112.976 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 43.27 64.74 1.13 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -140.21 149.07 42.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.834 0.35 . . . . 0.0 110.497 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -132.9 116.72 16.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.1 90.01 7.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.8 p -125.84 -173.04 2.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.937 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.27 -30.53 64.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.941 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.712 ' O ' HG23 ' A' ' 83' ' ' THR . 2.0 t70 -62.07 -25.59 67.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.992 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.484 HD12 ' CG1' ' A' ' 80' ' ' VAL . 33.8 mm -79.34 128.47 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.509 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.2 -38.82 7.52 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.234 -0.291 . . . . 0.0 111.325 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 12.7 mt-10 -142.6 153.75 43.78 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-O 121.581 0.705 . . . . 0.0 112.355 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.8 t -148.26 116.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.162 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -112.24 134.1 53.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.071 0.462 . . . . 0.0 112.05 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.46 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 73.3 m95 -112.33 85.07 2.08 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -102.47 148.17 25.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.3 0.571 . . . . 0.0 112.22 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.04 118.75 13.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.557 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.91 -116.37 8.17 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.773 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.9 m -117.66 43.88 2.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.769 0.319 . . . . 0.0 110.71 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.7 m -152.88 160.0 43.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.265 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.536 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.8 mt -102.79 147.19 27.17 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.798 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 50.0 t -118.47 -42.92 2.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.285 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -167.47 112.17 0.7 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.597 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -118.51 119.32 34.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.969 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.708 ' HB2' HD13 ' A' ' 57' ' ' ILE . 49.1 t80 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.705 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo . . . . . 0 N--CA 1.463 -0.284 0 CA-C-O 120.897 0.29 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.536 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 68.7 t80 -136.82 104.24 5.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.284 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.1 mt -98.01 110.78 23.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.02 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 28.8 tttm -45.29 -40.58 7.8 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.77 0.319 . . . . 0.0 111.533 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 p -178.21 164.61 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 111.205 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.75 -11.73 4.42 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.166 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.83 1.6 12.21 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 117.593 0.697 . . . . 0.0 112.155 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -131.99 156.97 45.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.184 0.516 . . . . 0.0 111.262 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -151.82 117.24 5.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.196 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.708 HD13 ' HB2' ' A' ' 42' ' ' PHE . 9.2 tt -73.83 99.48 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.321 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.467 HD22 ' OD2' ' A' ' 15' ' ' ASP . 0.7 OUTLIER -51.12 166.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.163 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.9 -23.96 65.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.637 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.492 ' ND2' ' HB2' ' A' ' 62' ' ' ASP . 5.7 p-10 -96.76 33.33 1.88 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.796 0.331 . . . . 0.0 111.16 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.75 33.9 69.12 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.621 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.492 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -103.08 165.79 10.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.868 0.366 . . . . 0.0 111.012 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 10.3 tp -107.0 119.71 40.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.518 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HB2' HD13 ' A' ' 58' ' ' LEU . 1.5 ttpt -105.75 111.25 23.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.309 . . . . 0.0 110.996 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.836 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.7 mt -90.93 138.22 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.449 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -84.16 -48.19 10.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.066 0.46 . . . . 0.0 111.896 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.11 111.35 5.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.312 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.045 HD22 HD12 ' A' ' 97' ' ' ILE . 4.9 mt -53.61 147.22 11.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.22 0.533 . . . . 0.0 111.736 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.421 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 5.3 p -147.59 160.88 42.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.852 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.74 -56.43 12.04 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.093 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.6 -22.7 9.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.428 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.688 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -80.54 -15.24 57.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.627 0.251 . . . . 0.0 111.308 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.415 ' CB ' HG12 ' A' ' 97' ' ' ILE . 2.4 t -81.58 120.79 25.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.591 0.234 . . . . 0.0 110.578 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.98 -144.43 9.88 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.373 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.9 m -115.65 130.62 56.93 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.056 0.428 . . . . 0.0 110.663 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -108.26 133.23 52.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.24 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.724 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 17.4 m-20 -114.98 124.37 51.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.458 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.978 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -107.02 133.52 51.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.192 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.36 96.37 5.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.695 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.492 HG12 ' HB ' ' A' ' 88' ' ' ILE . 70.9 t -86.74 126.9 40.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.234 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.517 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 2.6 m-30 -112.8 151.33 30.48 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.346 0.593 . . . . 0.0 110.612 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.73 ' HA ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -93.42 178.99 5.53 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.199 179.749 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 26' ' ' ASP . 73.5 p -68.51 -23.51 64.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.044 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -75.91 -5.22 45.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.592 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.29 24.57 47.08 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.666 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.64 -170.59 1.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.757 0.313 . . . . 0.0 110.683 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -105.31 115.62 30.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.971 0.415 . . . . 0.0 110.811 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.73 HD11 ' HA ' ' A' ' 82' ' ' SER . 74.4 mt -78.89 -51.66 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.343 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.688 HD21 ' HG3' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -151.83 136.25 16.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.204 0.526 . . . . 0.0 111.9 -179.246 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.4 106.98 13.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.884 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.688 ' HG3' HD21 ' A' ' 89' ' ' LEU . 7.4 mmpt? -116.48 156.97 25.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.724 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.14 122.45 18.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.132 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -117.98 159.41 23.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.896 0.379 . . . . 0.0 111.538 -179.239 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -109.16 110.76 22.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.381 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.943 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -102.27 100.2 10.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.071 -179.451 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.527 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.5 OUTLIER -95.16 123.43 38.66 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.071 0.462 . . . . 0.0 110.89 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.045 HD12 HD22 ' A' ' 68' ' ' LEU . 2.9 mm -107.81 117.47 53.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.999 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 N--CA 1.439 -0.988 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.422 179.205 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.975 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 120.648 0.261 . . . . 0.0 110.855 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -121.89 136.39 54.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.033 0.444 . . . . 0.0 111.255 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.485 ' C ' HG23 ' A' ' 97' ' ' ILE . . . -151.45 178.68 28.65 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.303 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.442 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.03 133.8 49.15 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.049 0.452 . . . . 0.0 111.221 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.644 HD11 ' C ' ' A' ' 69' ' ' THR . 1.2 tp -53.51 134.88 40.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.65 -10.94 71.81 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.632 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.524 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -106.66 168.0 9.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.598 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -72.02 -169.61 12.37 Favored Glycine 0 C--O 1.227 -0.315 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.491 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.834 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.0 OUTLIER 163.79 136.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.963 0.411 . . . . 0.0 110.632 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -117.97 130.1 56.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.043 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -91.5 102.99 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.356 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -88.68 123.5 33.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.174 0.511 . . . . 0.0 112.3 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.947 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -79.2 119.96 78.95 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.022 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.03 131.04 37.15 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.262 1.975 . . . . 0.0 112.903 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 43.38 65.09 1.04 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -142.03 150.9 41.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.79 0.328 . . . . 0.0 110.595 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -139.44 117.75 12.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -82.78 78.37 9.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.7 p -112.51 -173.02 2.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -57.9 -30.66 66.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.967 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.49 -27.74 68.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.971 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.611 HD12 ' CG1' ' A' ' 80' ' ' VAL . 31.4 mm -84.38 127.62 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.447 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.5 OUTLIER -111.63 -44.08 3.55 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.247 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 45.8 tp10 -123.69 121.27 35.07 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.187 -0.605 . . . . 0.0 112.117 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.82 114.25 42.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.904 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -112.85 132.38 55.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.133 0.492 . . . . 0.0 112.289 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.413 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 71.7 m95 -113.3 87.77 2.68 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -101.7 148.13 25.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.313 0.578 . . . . 0.0 112.478 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -139.26 116.46 11.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.522 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.07 -116.52 8.46 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.729 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.5 t -117.39 43.87 2.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.866 0.365 . . . . 0.0 110.651 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.0 m -152.27 160.38 43.36 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.224 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.533 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.8 mt -101.7 146.5 27.65 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.464 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 52.9 t -118.52 -43.02 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.97 0.414 . . . . 0.0 110.199 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -166.6 110.17 0.75 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.579 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.44 121.76 40.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.79 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 39.3 t80 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.041 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 N--CA 1.465 -0.181 0 CA-C-O 120.937 0.307 . . . . 0.0 112.709 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 48.9 t80 -113.21 100.73 8.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.131 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 50' ' ' LEU . 9.7 mt -94.08 111.15 22.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.069 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 36.3 tttt -45.99 -36.73 5.84 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.702 0.287 . . . . 0.0 111.452 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.0 p -178.74 164.29 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 111.222 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.74 -10.2 6.08 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.142 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.63 2.72 11.16 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.651 0.726 . . . . 0.0 112.188 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -132.08 156.89 45.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.107 0.48 . . . . 0.0 111.239 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -151.5 116.33 5.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.367 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.646 HG23 ' O ' ' A' ' 57' ' ' ILE . 9.7 tt -73.98 99.22 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.105 0.479 . . . . 0.0 111.295 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.499 HD13 ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -49.19 165.75 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.154 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.46 -23.67 65.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.566 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.472 ' ND2' ' HB2' ' A' ' 62' ' ' ASP . 5.5 p-10 -96.21 33.11 1.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.188 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.02 34.71 73.41 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.604 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.472 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -104.31 171.16 7.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.899 0.38 . . . . 0.0 110.874 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 11.6 tp -112.81 122.35 47.39 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.499 ' HB2' HD13 ' A' ' 58' ' ' LEU . 16.1 tttt -109.04 108.88 19.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.683 0.278 . . . . 0.0 110.947 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.834 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -87.2 141.0 14.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.413 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -85.76 -50.86 6.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.025 0.441 . . . . 0.0 112.1 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.65 110.84 6.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.5 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.69 HD21 HG21 ' A' ' 14' ' ' ILE . 5.4 mt -53.83 147.58 11.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.643 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.644 ' C ' HD11 ' A' ' 10' ' ' LEU . 6.1 p -152.7 161.3 42.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.786 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.528 ' N ' HD11 ' A' ' 10' ' ' LEU . 13.3 mmm-85 -50.48 -56.12 12.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.331 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -57.6 -20.28 31.53 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.629 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.596 ' OD1' HD13 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -84.31 -15.75 45.47 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.533 0.206 . . . . 0.0 111.425 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 t -82.7 133.36 35.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.603 0.24 . . . . 0.0 110.483 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.07 -166.97 30.02 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.134 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.06 126.63 35.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.896 0.379 . . . . 0.0 111.435 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -106.84 128.2 54.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.33 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -112.07 129.16 56.31 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.853 0.359 . . . . 0.0 111.657 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.947 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -112.08 130.59 65.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.98 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.65 98.9 6.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.8 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.611 ' CG1' HD12 ' A' ' 27' ' ' ILE . 82.0 t -92.02 128.71 43.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.462 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.532 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.3 m-85 -124.02 153.45 41.3 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.291 0.567 . . . . 0.0 111.108 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.631 ' CA ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -88.93 174.81 7.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.408 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.1 p -61.07 -22.34 64.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.169 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.83 26.46 4.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.168 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.74 25.77 37.53 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.691 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.24 155.59 16.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.778 0.323 . . . . 0.0 110.889 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.53 116.35 18.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.649 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.631 HD11 ' CA ' ' A' ' 82' ' ' SER . 36.2 mt -93.95 -69.3 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.339 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.906 HD21 ' HG3' ' A' ' 91' ' ' LYS . 2.6 tt -142.34 126.78 17.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.152 0.501 . . . . 0.0 111.903 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.3 106.95 14.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.906 ' HG3' HD21 ' A' ' 89' ' ' LEU . 5.7 mmpt? -118.15 162.49 18.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.464 0.65 . . . . 0.0 112.702 -178.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.6 119.96 10.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.067 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -114.45 157.83 22.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.836 0.351 . . . . 0.0 111.407 -179.235 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.09 115.23 29.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.361 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.975 ' HA ' HG12 ' A' ' 6' ' ' VAL . 38.3 tp -101.11 98.14 8.6 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.958 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.802 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -101.1 123.37 45.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.031 0.443 . . . . 0.0 110.599 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.823 HD11 ' HG ' ' A' ' 95' ' ' LEU . 1.9 mm -122.61 126.65 74.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.065 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 98' ' ' LEU . 12.7 mt . . . . . 0 N--CA 1.435 -1.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.564 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.93 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 120.735 0.303 . . . . 0.0 111.094 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -119.98 130.45 54.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.562 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.43 -178.07 18.92 Favored Glycine 0 N--CA 1.459 0.196 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.502 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.426 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -130.12 133.99 47.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.07 0.462 . . . . 0.0 111.551 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.431 ' CD1' ' HA ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -54.0 131.84 41.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.798 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.36 -10.65 74.3 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.58 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -107.07 168.97 8.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.6 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -73.52 -168.94 16.14 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.576 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.913 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 161.7 137.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 122.675 0.39 . . . . 0.0 110.062 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.8 124.33 44.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.935 0.397 . . . . 0.0 111.812 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.718 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -82.02 105.98 13.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.482 178.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.408 ' O ' HD21 ' A' ' 93' ' ' LEU . 69.8 m-20 -90.83 123.07 34.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.287 0.565 . . . . 0.0 112.304 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.949 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -80.38 120.35 79.13 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.176 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.27 130.71 37.27 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.32 2.013 . . . . 0.0 112.938 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 42.8 65.05 1.0 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -141.96 149.04 39.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.787 0.327 . . . . 0.0 110.501 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -141.7 117.15 10.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.941 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.38 80.44 3.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.01 -175.65 2.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.18 -33.09 68.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.912 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.79 -26.8 66.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.586 HD12 ' CG1' ' A' ' 80' ' ' VAL . 22.6 mm -79.41 128.32 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.405 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.9 OUTLIER -111.36 -44.44 3.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -179.089 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 42.6 tt0 -130.43 116.88 18.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.572 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -112.48 113.0 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.794 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -111.56 132.48 54.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.12 0.485 . . . . 0.0 112.206 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.431 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 70.3 m95 -113.31 86.53 2.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.954 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -102.62 148.1 25.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.316 0.579 . . . . 0.0 112.295 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.52 117.59 11.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.51 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.96 -116.62 8.53 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.768 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 t -117.28 43.76 2.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.76 0.315 . . . . 0.0 110.672 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.0 m -152.33 159.95 43.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.238 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.539 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.8 mt -103.11 146.83 27.8 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.465 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 51.3 t -118.45 -43.1 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.164 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -166.64 111.57 0.78 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.551 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -118.56 114.77 23.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.567 ' HB2' HD13 ' A' ' 57' ' ' ILE . 25.4 t80 . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.859 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.442 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 89.8 Cg_endo . . . . . 0 N--CA 1.461 -0.384 0 CA-C-O 120.865 0.277 . . . . 0.0 112.547 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.539 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 73.3 t80 -137.11 104.36 5.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.338 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 50' ' ' LEU . 7.9 mt -98.57 111.18 23.63 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 12.8 tptm -44.38 -54.58 5.73 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.807 0.336 . . . . 0.0 111.484 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.0 165.07 22.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.146 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.16 -11.69 3.49 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.112 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.41 2.24 11.91 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 117.674 0.737 . . . . 0.0 112.163 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -131.99 156.48 46.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.124 0.488 . . . . 0.0 111.392 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -152.57 119.59 5.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.252 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.644 HG23 ' O ' ' A' ' 57' ' ' ILE . 8.1 tt -75.0 100.26 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.112 0.482 . . . . 0.0 111.325 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.445 HD13 ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -50.63 167.57 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.169 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.74 -24.54 65.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.651 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.493 ' ND2' ' HB2' ' A' ' 62' ' ' ASP . 5.6 p-10 -96.57 33.12 1.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.736 0.303 . . . . 0.0 111.18 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.8 33.37 67.84 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.563 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.493 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -102.38 165.39 11.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 111.049 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 tp -105.14 121.46 43.86 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.47 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.445 ' HB2' HD13 ' A' ' 58' ' ' LEU . 2.1 tmtp? -107.91 110.18 21.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 111.13 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.851 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -90.38 138.24 19.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.063 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -93.3 -41.64 9.76 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.2 106.93 5.36 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.582 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.913 HD21 HG21 ' A' ' 14' ' ' ILE . 7.8 mt -57.35 143.73 38.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.13 0.491 . . . . 0.0 111.461 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.431 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 5.1 p -144.36 159.53 42.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.037 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.32 -56.46 12.93 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.022 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -54.25 -21.83 10.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.429 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.623 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -79.39 -14.44 58.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.3 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.4 t -80.57 129.11 34.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.65 0.262 . . . . 0.0 110.475 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.01 -165.06 30.18 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.12 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -93.98 126.65 39.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.702 0.287 . . . . 0.0 111.349 -179.522 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -104.44 130.86 52.31 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.129 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -112.84 125.8 54.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.881 0.372 . . . . 0.0 111.603 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.949 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.26 130.04 62.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.12 179.146 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.12 98.44 6.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.597 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.586 ' CG1' HD12 ' A' ' 27' ' ' ILE . 91.9 t -91.71 123.34 43.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.583 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.446 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 99.0 m-85 -116.33 152.68 33.39 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.172 0.511 . . . . 0.0 111.135 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.638 ' CA ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -90.5 172.96 8.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.526 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.403 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 7.5 p -57.1 -22.63 41.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.234 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -96.02 26.42 4.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.147 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.87 25.52 30.53 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.718 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.4 156.65 16.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.832 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -79.01 107.52 11.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.695 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.638 HD11 ' CA ' ' A' ' 82' ' ' SER . 38.6 mt -82.2 -70.71 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.347 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.799 HD21 ' HG3' ' A' ' 91' ' ' LYS . 1.5 tt -141.43 128.18 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.112 0.482 . . . . 0.0 111.892 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.85 106.57 14.33 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.799 ' HG3' HD21 ' A' ' 89' ' ' LEU . 5.2 mmtt -117.36 162.45 17.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.446 0.641 . . . . 0.0 112.631 -178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.87 120.88 10.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.162 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.642 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -116.78 161.12 19.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.81 0.338 . . . . 0.0 111.403 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.81 112.22 24.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.201 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.93 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -102.26 101.84 12.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.279 -179.485 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.31 119.81 37.63 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.06 0.457 . . . . 0.0 110.67 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.77 HG21 ' HB3' ' A' ' 68' ' ' LEU . 3.8 mt -112.79 118.24 57.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.732 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 98' ' ' LEU . 8.8 mt . . . . . 0 N--CA 1.443 -0.781 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.683 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.85 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.515 0 CA-C-O 120.798 0.332 . . . . 0.0 110.773 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -114.71 126.14 54.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.437 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.17 -179.62 22.49 Favored Glycine 0 N--CA 1.459 0.197 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.76 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.436 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -130.26 134.85 47.53 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.05 0.452 . . . . 0.0 111.353 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.675 HD11 ' C ' ' A' ' 69' ' ' THR . 0.8 OUTLIER -53.07 136.3 35.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.006 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.33 -8.34 74.74 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.668 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.534 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.12 167.8 9.75 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.612 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -71.23 -173.86 17.23 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.565 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.819 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 162.19 136.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 122.493 0.317 . . . . 0.0 110.401 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -122.86 128.18 50.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.964 0.412 . . . . 0.0 111.489 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -85.14 106.6 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.858 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -89.22 124.45 34.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.152 0.501 . . . . 0.0 111.911 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.967 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -79.97 119.62 77.23 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.138 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.16 131.38 38.69 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.367 2.045 . . . . 0.0 112.945 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m120 42.81 65.03 1.01 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.416 ' HB2' HD13 ' A' ' 89' ' ' LEU . 8.9 t80 -141.6 149.29 40.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.817 0.342 . . . . 0.0 110.56 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -143.87 116.43 8.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.02 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.0 ttt -80.68 77.69 7.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.15 -174.44 2.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.2 -30.73 62.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.08 -24.74 65.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.02 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.538 HD12 ' CG1' ' A' ' 80' ' ' VAL . 45.2 mm -85.52 126.54 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.457 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.415 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -111.59 -42.65 3.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 122.142 -0.349 . . . . 0.0 111.742 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.493 ' OE1' ' HB2' ' A' ' 81' ' ' TYR . 6.7 mp0 -117.57 158.75 24.05 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.001 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.6 t -154.28 108.7 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.884 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.457 ' NH1' ' CE2' ' A' ' 81' ' ' TYR . 0.6 OUTLIER -111.15 129.82 55.82 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.689 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -110.62 86.11 2.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.848 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -103.13 153.66 20.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.342 0.591 . . . . 0.0 112.303 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -145.48 116.24 7.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.503 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.08 -117.67 11.04 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.75 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 m -115.59 42.85 2.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.785 0.326 . . . . 0.0 110.659 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.4 m -150.59 160.62 43.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.145 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.722 HD21 ' OE2' ' A' ' 41' ' ' GLU . 5.7 mt -106.68 147.89 29.03 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.447 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 55.6 t -119.45 -44.16 2.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.255 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.34 112.55 1.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.43 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.722 ' OE2' HD21 ' A' ' 38' ' ' LEU . 2.2 mt-10 -119.48 114.62 22.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.081 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.788 ' HB2' HD13 ' A' ' 57' ' ' ILE . 26.0 t80 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.888 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 N--CA 1.464 -0.221 0 CA-C-O 120.664 0.193 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.553 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 73.7 t80 -133.1 98.51 4.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.575 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 50' ' ' LEU . 10.7 mt -95.24 112.78 24.44 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.447 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 19.3 tttm -34.82 -89.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.1 t -118.76 23.45 11.45 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.24 0.18 51.25 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.973 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.32 6.29 26.92 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 117.534 0.667 . . . . 0.0 111.012 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -126.57 158.37 36.41 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.975 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -140.27 118.66 12.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.203 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.788 HD13 ' HB2' ' A' ' 42' ' ' PHE . 6.4 tt -76.09 101.79 2.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.214 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.555 HD13 ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -53.28 163.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.098 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.64 -21.79 64.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.72 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -97.88 33.31 2.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.779 0.323 . . . . 0.0 111.103 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.89 36.43 80.24 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.738 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.49 166.86 10.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 0.0 110.92 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 11.9 tp -107.71 121.41 44.65 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.893 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.555 ' HB2' HD13 ' A' ' 58' ' ' LEU . 4.3 tmtt? -109.15 103.87 12.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.735 0.302 . . . . 0.0 110.814 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.776 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.7 mt -79.91 134.54 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.533 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -79.47 -48.46 13.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.025 0.441 . . . . 0.0 111.675 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.31 113.29 5.79 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.243 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.819 HD21 HG21 ' A' ' 14' ' ' ILE . 5.7 mt -53.5 149.04 8.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 111.716 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.675 ' C ' HD11 ' A' ' 10' ' ' LEU . 6.1 p -151.94 160.45 43.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.03 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.656 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -51.28 -56.53 12.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.075 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -55.26 -20.82 12.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.346 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.657 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -81.33 -15.39 55.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.413 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.4 t -79.03 128.96 33.93 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.608 0.242 . . . . 0.0 110.576 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.46 -167.33 30.27 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.331 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.76 125.77 36.6 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.529 -0.336 . . . . 0.0 111.418 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -101.45 149.2 24.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.177 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -131.28 123.13 27.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.694 0.283 . . . . 0.0 111.567 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.967 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -108.65 128.81 64.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.036 179.159 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.13 97.9 6.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.64 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.538 ' CG1' HD12 ' A' ' 27' ' ' ILE . 82.0 t -86.25 137.97 19.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.139 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.493 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 84.2 m-85 -132.16 153.56 50.4 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.58 0.705 . . . . 0.0 111.602 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.585 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -87.64 -179.62 6.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.43 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.415 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 41.7 p -65.81 -35.5 80.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.942 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -77.91 -3.67 42.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.434 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.37 24.68 42.47 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.533 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.4 160.06 14.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.346 . . . . 0.0 110.699 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 106.71 11.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.682 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.585 HD11 ' HB3' ' A' ' 82' ' ' SER . 40.2 mm -87.35 -43.67 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.304 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.608 HD11 ' HE2' ' A' ' 91' ' ' LYS . 3.1 tt -157.69 149.97 22.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.218 0.533 . . . . 0.0 111.822 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -141.92 109.9 5.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.003 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.608 ' HE2' HD11 ' A' ' 89' ' ' LEU . 20.7 mmtm -121.63 162.24 21.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.482 0.658 . . . . 0.0 112.77 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.16 121.95 11.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.9 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.646 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -120.17 163.2 18.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 0.0 111.688 -179.189 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -111.13 114.27 27.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.369 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.85 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -100.94 103.71 14.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.396 -179.428 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.46 113.22 25.82 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.08 0.467 . . . . 0.0 110.551 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.691 HG21 ' HB3' ' A' ' 68' ' ' LEU . 3.7 mt -109.34 115.05 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.523 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 N--CA 1.438 -1.062 0 CA-C-O 121.24 0.543 . . . . 0.0 110.761 179.698 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.793 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.447 -0.623 0 CA-C-O 120.717 0.294 . . . . 0.0 110.393 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -122.77 128.49 50.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.826 0.346 . . . . 0.0 111.005 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.7 178.51 24.31 Favored Glycine 0 N--CA 1.459 0.233 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.454 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.411 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -125.34 135.11 52.11 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.941 0.4 . . . . 0.0 111.106 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.834 HD12 HG21 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -52.7 132.41 36.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.792 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.484 ' HA2' ' ND2' ' A' ' 67' ' ' ASN . . . 93.66 -12.45 69.45 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.83 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.512 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -104.74 169.78 8.26 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.219 0.509 . . . . 0.0 110.016 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.512 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -79.68 168.78 52.87 Favored Glycine 0 C--O 1.224 -0.515 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.25 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.869 ' CG2' HD12 ' A' ' 65' ' ' ILE . 2.2 tp -179.09 140.26 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.696 0.284 . . . . 0.0 110.765 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -124.08 131.52 53.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.031 0.443 . . . . 0.0 111.647 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.833 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -88.09 113.68 23.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.586 179.135 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -97.83 125.63 42.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.193 0.521 . . . . 0.0 111.931 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.947 HD11 HG11 ' A' ' 78' ' ' VAL . 3.2 mt -81.62 119.95 76.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.299 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.23 131.0 36.52 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.355 2.037 . . . . 0.0 112.865 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.6 m120 43.42 65.14 1.04 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -142.3 149.3 39.33 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.804 0.335 . . . . 0.0 110.531 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -138.65 117.46 12.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.931 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -80.87 82.41 6.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.78 -174.27 2.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.765 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -56.82 -30.94 64.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.954 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -60.98 -28.01 68.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.596 HD12 ' CG1' ' A' ' 80' ' ' VAL . 23.4 mm -81.57 127.75 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.444 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.55 -44.16 3.55 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 122.214 -0.304 . . . . 0.0 111.736 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 72.6 tt0 -127.43 116.23 20.13 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.217 -0.593 . . . . 0.0 112.31 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 t -113.2 114.28 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.974 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -113.08 132.12 55.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.084 0.469 . . . . 0.0 112.192 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.402 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 70.2 m95 -113.18 83.26 1.8 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -99.17 150.9 21.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.299 0.571 . . . . 0.0 112.274 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.47 116.01 9.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.62 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.29 -117.36 10.29 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.76 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.25 42.77 2.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.837 0.351 . . . . 0.0 110.759 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.2 m -152.0 160.03 43.58 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.215 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.56 HD21 ' OE2' ' A' ' 41' ' ' GLU . 5.8 mt -104.09 146.94 28.01 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.452 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 52.0 t -117.89 -42.83 2.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.293 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -166.21 113.11 0.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.455 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.56 ' OE2' HD21 ' A' ' 38' ' ' LEU . 2.4 mt-10 -120.53 116.32 25.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.094 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.46 ' HB2' HD13 ' A' ' 57' ' ' ILE . 32.1 t80 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.666 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.415 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 87.1 Cg_endo . . . . . 0 N--CA 1.463 -0.276 0 CA-C-O 120.862 0.276 . . . . 0.0 112.467 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.531 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 69.4 t80 -135.03 104.64 6.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.343 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.1 mt -99.27 111.09 23.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.0 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 55.6 tttm -44.94 -42.46 8.16 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.579 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.0 p -176.66 164.96 2.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.966 0.412 . . . . 0.0 111.213 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.36 -12.37 4.36 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.732 -0.746 . . . . 0.0 113.118 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.44 1.06 12.69 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 117.75 0.775 . . . . 0.0 112.182 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -131.1 157.38 43.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.11 0.481 . . . . 0.0 111.214 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -153.95 125.24 7.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.513 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.665 HG23 ' O ' ' A' ' 57' ' ' ILE . 6.9 tt -84.04 101.53 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.657 HD23 HD21 ' A' ' 60' ' ' ASN . 1.2 mp -61.32 166.97 3.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.991 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.04 -45.58 80.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.205 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.657 HD21 HD23 ' A' ' 58' ' ' LEU . 3.5 p30 -56.32 -22.88 33.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.137 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.85 35.05 4.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.59 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -116.03 154.48 29.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.878 0.371 . . . . 0.0 110.924 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 12.7 tp -83.46 122.94 29.19 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.463 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -104.46 109.79 21.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.701 0.286 . . . . 0.0 111.38 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.869 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.8 mt -93.29 127.34 45.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.939 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 ttpp -85.63 -36.31 20.41 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.484 ' ND2' ' HA2' ' A' ' 11' ' ' GLY . 21.7 t-20 -147.16 110.23 4.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.812 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.078 HD22 HD12 ' A' ' 97' ' ' ILE . 4.9 mt -56.62 144.88 30.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.056 0.455 . . . . 0.0 111.469 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.677 ' C ' HD11 ' A' ' 10' ' ' LEU . 7.5 p -149.25 163.79 36.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.843 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.582 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -50.84 -55.52 16.55 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.223 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -52.9 -23.01 6.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.539 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.646 ' OD1' HD13 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -79.53 -14.01 59.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.472 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.436 ' CB ' HG12 ' A' ' 97' ' ' ILE . 2.6 t -81.15 124.74 29.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.685 0.279 . . . . 0.0 110.707 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.1 -166.87 29.47 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.296 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.94 130.34 38.55 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.56 0.344 . . . . 0.0 111.139 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -106.21 148.65 27.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.063 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 14.7 m-20 -132.42 127.2 34.85 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.834 0.35 . . . . 0.0 111.641 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.947 HG11 HD11 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -109.76 131.13 61.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.202 179.067 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.0 98.61 6.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.476 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.596 ' CG1' HD12 ' A' ' 27' ' ' ILE . 93.5 t -92.05 123.29 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.65 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.496 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 99.3 m-85 -117.17 152.11 35.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.271 0.558 . . . . 0.0 111.027 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.646 ' CA ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -89.96 173.64 8.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.532 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.8 p -57.38 -24.31 54.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.191 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -96.01 27.5 3.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.169 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.78 25.13 28.59 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.686 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.04 144.26 25.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.799 0.333 . . . . 0.0 110.818 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.78 107.04 3.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.643 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.646 HD11 ' CA ' ' A' ' 82' ' ' SER . 40.0 mt -80.97 -69.9 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.373 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.915 HD21 ' HG3' ' A' ' 91' ' ' LYS . 1.9 tt -141.68 129.76 22.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.192 0.52 . . . . 0.0 111.87 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.28 107.23 14.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.472 -0.786 . . . . 0.0 108.897 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.915 ' HG3' HD21 ' A' ' 89' ' ' LEU . 5.0 mmpt? -117.84 158.71 24.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.43 0.633 . . . . 0.0 112.676 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.655 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.19 122.33 18.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.146 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.653 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -120.63 162.98 18.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.984 0.421 . . . . 0.0 111.519 -179.286 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.92 136.85 48.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.335 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.833 HD12 HD21 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -131.78 100.8 5.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.273 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 1.1 mmm180 -92.81 124.04 36.52 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.038 0.446 . . . . 0.0 110.945 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.078 HD12 HD22 ' A' ' 68' ' ' LEU . 4.4 mm -106.46 103.73 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.841 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 mt . . . . . 0 N--CA 1.441 -0.902 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.598 179.353 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.903 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 120.729 0.299 . . . . 0.0 110.62 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -121.38 131.33 54.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.926 0.393 . . . . 0.0 110.697 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.786 ' C ' HG23 ' A' ' 97' ' ' ILE . . . -149.69 -179.71 25.75 Favored Glycine 0 N--CA 1.459 0.226 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.812 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.562 ' N ' HG23 ' A' ' 97' ' ' ILE . . . -126.49 135.34 51.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.938 0.399 . . . . 0.0 110.735 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.732 HD11 ' C ' ' A' ' 69' ' ' THR . 1.2 tp -55.49 130.32 42.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.003 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.49 -6.96 77.97 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.656 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.534 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -106.28 169.18 8.66 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 117.122 0.461 . . . . 0.0 109.941 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.534 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -76.77 166.63 54.17 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.139 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.832 HG21 HD21 ' A' ' 68' ' ' LEU . 1.6 tp -177.56 138.34 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 0.0 110.986 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.493 ' OD2' HD22 ' A' ' 58' ' ' LEU . 3.1 t70 -120.6 120.48 35.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.44 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.722 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -77.44 105.08 8.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.767 179.299 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.456 ' O ' HD21 ' A' ' 93' ' ' LEU . 54.0 m-20 -88.93 124.84 34.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.228 0.537 . . . . 0.0 112.152 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.924 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -81.8 119.96 76.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.118 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.93 131.8 39.02 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.221 1.947 . . . . 0.0 112.877 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 43.61 65.45 0.99 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -143.28 149.44 37.86 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.742 0.306 . . . . 0.0 110.549 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -141.08 117.14 10.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.958 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.82 79.91 6.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.31 -173.74 2.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.64 -30.46 61.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.0 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -62.56 -28.83 70.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.626 HD12 ' CG1' ' A' ' 80' ' ' VAL . 23.2 mm -86.05 127.16 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.476 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.408 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -112.82 -42.78 3.53 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.091 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 37.9 tt0 -127.67 118.22 23.44 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.155 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.81 118.52 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.21 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -117.43 135.83 53.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.271 0.558 . . . . 0.0 112.17 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.487 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 69.9 m95 -111.13 88.24 2.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.971 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -98.7 141.8 31.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.364 0.602 . . . . 0.0 112.267 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -132.12 114.92 15.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.396 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.26 -114.02 5.41 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.64 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.2 t -118.38 44.28 2.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.731 0.3 . . . . 0.0 110.652 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.1 m -154.95 159.56 40.49 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.906 0.384 . . . . 0.0 111.332 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.534 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 4.6 mt -99.18 148.17 24.37 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.804 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.481 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 48.4 t -119.32 -42.26 2.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.444 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -173.5 114.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.724 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -124.73 156.55 37.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.092 0.472 . . . . 0.0 110.907 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 47.7 t80 . . . . . 0 N--CA 1.45 -0.463 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.753 -179.76 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.909 0.295 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.534 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 43.6 t80 -112.7 103.09 11.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.158 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 50' ' ' LEU . 7.9 mt -93.53 113.36 25.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.2 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.481 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 31.0 tttt -47.94 -45.39 30.99 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.745 0.307 . . . . 0.0 111.365 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.1 p -175.27 165.13 3.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.91 0.386 . . . . 0.0 111.191 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.92 -12.43 3.73 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.214 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.02 -1.48 17.35 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.727 0.763 . . . . 0.0 112.063 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -131.38 157.03 44.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.063 0.458 . . . . 0.0 111.206 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -151.3 119.18 6.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.134 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' ' 57' ' ' ILE . 4.2 tt -74.5 103.89 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.115 0.483 . . . . 0.0 111.223 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.639 HD13 ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -51.77 173.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.313 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.5 -26.81 67.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.346 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -96.13 32.4 1.95 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.048 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.08 26.3 58.24 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.58 173.54 8.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 111.04 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.468 HD11 HG12 ' A' ' 39' ' ' VAL . 8.5 tp -109.93 118.35 36.21 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.633 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.639 ' HB2' HD13 ' A' ' 58' ' ' LEU . 12.8 tttp -106.63 108.71 20.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.83 0.347 . . . . 0.0 110.957 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.831 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.4 mt -87.65 135.77 24.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.435 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -82.62 -46.37 13.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.038 0.447 . . . . 0.0 111.831 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.72 112.04 5.78 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.132 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.875 HD22 HG12 ' A' ' 97' ' ' ILE . 6.1 mt -53.76 151.03 6.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.289 0.566 . . . . 0.0 111.865 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.732 ' C ' HD11 ' A' ' 10' ' ' LEU . 7.1 p -154.3 162.42 41.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.815 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.59 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -50.78 -56.4 12.27 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.037 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -57.02 -20.86 26.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.327 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.632 ' OD1' HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -87.06 -14.89 40.18 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.426 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.3 t -90.96 129.62 36.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.649 0.261 . . . . 0.0 110.609 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 154.08 -130.66 2.98 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.588 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 m -123.11 128.73 50.5 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 117.814 0.807 . . . . 0.0 110.931 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -109.06 149.09 29.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.235 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 12.9 m-20 -131.26 125.57 33.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.849 0.356 . . . . 0.0 111.582 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.924 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.98 131.58 60.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.038 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.485 HG23 ' OD1' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -119.95 96.35 5.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.599 178.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.626 ' CG1' HD12 ' A' ' 27' ' ' ILE . 74.1 t -85.75 128.06 39.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.468 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.547 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 83.0 m-85 -117.61 151.56 36.93 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.062 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.614 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -88.73 174.26 8.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.494 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -61.76 -18.67 60.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.265 179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -94.08 23.45 4.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.207 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.65 21.71 50.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.668 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.42 176.49 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.736 0.303 . . . . 0.0 110.617 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.09 116.46 30.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.708 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.614 HD11 ' HB3' ' A' ' 82' ' ' SER . 31.9 mm -90.47 -46.93 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.362 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.631 HD11 ' HE3' ' A' ' 91' ' ' LYS . 1.6 tt -153.6 148.4 26.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 111.796 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.485 ' OD1' HG23 ' A' ' 79' ' ' THR . 56.5 t30 -136.79 108.58 7.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.197 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.631 ' HE3' HD11 ' A' ' 89' ' ' LEU . 46.3 mmtt -121.13 156.6 31.96 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.655 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.37 122.24 17.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.966 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.65 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -118.2 158.97 24.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.018 0.437 . . . . 0.0 111.728 -179.09 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -111.81 107.99 17.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.263 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.934 HD22 HD11 ' A' ' 97' ' ' ILE . 0.5 OUTLIER -94.29 98.46 10.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.095 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -98.02 126.05 43.26 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.995 0.426 . . . . 0.0 110.498 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.934 HD11 HD22 ' A' ' 95' ' ' LEU . 2.3 mp -134.34 133.58 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.91 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 N--CA 1.436 -1.128 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.712 179.689 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.891 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 120.766 0.317 . . . . 0.0 110.812 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -120.89 128.87 53.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.669 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.24 -178.82 22.82 Favored Glycine 0 N--CA 1.46 0.254 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.748 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.448 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -130.11 133.63 46.79 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.146 0.498 . . . . 0.0 111.597 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.41 ' CD1' ' HA ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -52.08 131.7 32.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.179 179.784 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.94 -7.96 80.72 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.74 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.528 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.01 168.33 9.36 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.603 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.91 -174.24 16.93 Favored Glycine 0 C--O 1.228 -0.249 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.502 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.815 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 163.13 136.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.803 0.335 . . . . 0.0 110.386 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -126.25 125.22 42.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.919 0.39 . . . . 0.0 111.436 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.481 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -77.37 122.49 25.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.735 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -103.71 123.05 46.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.177 0.513 . . . . 0.0 111.963 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.938 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -81.78 119.53 75.55 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.145 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.71 130.92 37.27 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.386 2.057 . . . . 0.0 112.98 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 42.79 65.13 0.99 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -141.72 149.13 40.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.79 0.329 . . . . 0.0 110.553 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -145.01 115.24 7.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.967 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.5 ttt -78.19 76.45 4.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.849 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.19 -173.74 2.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.822 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -56.86 -30.79 64.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.03 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -65.4 -26.74 68.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.009 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.602 HD12 ' CG1' ' A' ' 80' ' ' VAL . 43.6 mm -85.58 127.28 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.347 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.411 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -113.02 -42.05 3.62 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.182 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 6.6 tm-20 -128.26 138.78 52.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.881 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.2 t -145.27 124.37 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.295 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.446 ' NH1' ' CE2' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -118.84 139.16 52.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.136 0.493 . . . . 0.0 112.222 -179.285 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.48 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 69.2 m95 -111.49 83.28 1.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -96.54 151.59 19.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.408 0.623 . . . . 0.0 112.351 -178.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.445 ' HD2' ' CE1' ' A' ' 76' ' ' TYR . 6.0 ttp-105 -143.93 116.75 8.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.439 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.92 -114.82 6.09 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.18 -1.009 . . . . 0.0 111.671 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.2 m -118.47 44.25 2.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.754 0.311 . . . . 0.0 110.701 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.9 m -153.29 160.37 42.71 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.287 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.657 HD13 ' OE1' ' A' ' 41' ' ' GLU . 5.5 mt -104.4 147.86 27.07 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.475 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 46.9 t -119.14 -42.06 2.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.581 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -174.2 116.09 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.022 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.657 ' OE1' HD13 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -124.36 159.47 30.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.009 0.433 . . . . 0.0 110.792 179.24 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.1 t80 . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.884 -179.645 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.46 -0.456 0 CA-C-O 120.974 0.322 . . . . 0.0 112.477 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.517 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 39.1 t80 -127.03 99.48 5.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.931 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 50' ' ' LEU . 11.6 mt -91.98 109.06 20.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.132 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 7.6 ttmt -47.6 -33.44 6.6 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.682 0.277 . . . . 0.0 111.468 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.6 p -174.01 163.53 4.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.925 0.393 . . . . 0.0 111.217 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.71 -6.97 19.08 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.008 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.52 5.56 10.55 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 117.626 0.713 . . . . 0.0 112.003 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -132.78 157.65 44.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.109 0.481 . . . . 0.0 111.434 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -148.59 118.15 6.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.003 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.644 HG23 ' O ' ' A' ' 57' ' ' ILE . 10.1 tt -77.56 98.45 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.086 0.47 . . . . 0.0 111.389 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -51.6 163.29 0.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.031 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.17 -22.39 65.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.592 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.465 ' ND2' ' HB2' ' A' ' 62' ' ' ASP . 2.2 p-10 -96.23 32.87 1.86 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.763 0.316 . . . . 0.0 111.234 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.53 36.55 71.2 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.738 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.465 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -108.84 158.04 18.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 0.0 111.014 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.3 tp -99.39 121.8 41.62 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.586 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.43 108.21 18.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.793 0.33 . . . . 0.0 111.141 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.799 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.3 mt -86.95 138.91 18.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.41 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -85.07 -47.12 10.5 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.057 0.456 . . . . 0.0 111.855 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -143.6 111.43 6.06 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.233 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.815 HD21 HG21 ' A' ' 14' ' ' ILE . 5.3 mt -53.28 144.07 17.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.894 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.41 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 5.0 p -141.76 159.97 41.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.923 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.11 -56.23 15.81 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -55.72 -19.48 11.14 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.578 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.594 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -79.22 -14.3 59.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.568 0.223 . . . . 0.0 111.475 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 98.5 p -85.23 128.43 34.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.629 0.252 . . . . 0.0 110.753 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.32 -135.08 4.34 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.542 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.7 m -124.29 130.4 52.44 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.556 0.678 . . . . 0.0 110.714 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.445 ' CE1' ' HD2' ' A' ' 34' ' ' ARG . 16.3 m-85 -107.41 151.6 25.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.979 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.642 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 12.4 m-20 -133.59 124.66 27.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.314 . . . . 0.0 111.593 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.938 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.09 133.54 53.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.283 179.045 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.04 103.39 9.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.671 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.602 ' CG1' HD12 ' A' ' 27' ' ' ILE . 94.9 t -93.7 129.66 43.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.42 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 97.9 m-85 -121.71 154.93 36.24 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.151 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.557 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -89.98 178.3 6.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.588 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.411 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 27.0 p -64.26 -22.97 67.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.068 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -95.74 23.48 6.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.098 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.52 25.87 61.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.524 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.5 152.29 18.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.8 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -74.82 119.9 19.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.718 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.557 HD11 ' HB3' ' A' ' 82' ' ' SER . 32.8 mm -92.79 -67.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.381 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.919 HD21 ' HG3' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -146.06 133.28 20.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.147 0.499 . . . . 0.0 111.85 -179.304 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.22 107.41 14.41 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.919 ' HG3' HD21 ' A' ' 89' ' ' LEU . 25.4 mmtt -117.55 156.61 27.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.428 0.633 . . . . 0.0 112.662 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.642 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -137.98 122.69 18.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.084 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.649 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -119.68 160.76 21.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.079 0.466 . . . . 0.0 111.607 -179.211 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -110.05 116.13 31.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.158 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.891 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -100.07 100.71 11.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.362 -179.441 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -96.72 115.16 26.95 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.096 0.474 . . . . 0.0 110.353 179.277 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.696 HG12 HD22 ' A' ' 68' ' ' LEU . 3.8 mt -116.33 120.14 64.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.838 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.3 mt . . . . . 0 N--CA 1.441 -0.877 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.684 179.33 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.729 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 120.792 0.33 . . . . 0.0 110.484 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.474 ' CE2' ' HD3' ' A' ' 96' ' ' ARG . 82.9 m95 -112.05 127.52 55.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.609 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.18 -178.18 22.27 Favored Glycine 0 N--CA 1.459 0.217 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.887 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.445 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -125.14 133.34 52.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.048 0.451 . . . . 0.0 111.123 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.729 HD12 HG21 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -53.93 133.14 43.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.027 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.69 -6.35 83.72 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.757 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.542 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.42 167.31 10.13 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.994 0.397 . . . . 0.0 110.006 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.586 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.43 -175.69 18.44 Favored Glycine 0 C--O 1.228 -0.264 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.622 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.829 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.1 tp 167.33 136.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.897 0.38 . . . . 0.0 110.726 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.509 ' OD2' HD22 ' A' ' 58' ' ' LEU . 1.3 t70 -121.81 132.11 54.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.187 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.617 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -90.4 108.95 20.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.855 179.359 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -91.71 123.36 35.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.225 0.536 . . . . 0.0 112.209 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.945 HD11 HG11 ' A' ' 78' ' ' VAL . 3.4 mt -80.82 120.07 77.9 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.112 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.78 130.95 37.26 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.301 2.0 . . . . 0.0 112.975 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 42.67 64.96 1.01 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -140.87 149.55 42.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.593 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -146.29 116.35 7.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -78.67 81.64 4.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.947 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.35 -175.14 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -57.57 -32.81 67.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.897 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -63.74 -23.73 67.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.144 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.563 HD12 ' CG1' ' A' ' 80' ' ' VAL . 37.4 mm -81.11 127.84 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.414 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -105.96 -38.36 6.35 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 122.231 -0.293 . . . . 0.0 111.728 -179.319 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 17.8 mt-10 -141.09 152.64 44.93 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.662 0.744 . . . . 0.0 112.448 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -145.68 117.98 2.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.125 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -115.19 133.65 55.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.024 0.44 . . . . 0.0 112.155 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.414 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 68.6 m95 -110.73 83.65 1.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -98.65 146.29 26.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.298 0.57 . . . . 0.0 112.288 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -137.19 116.93 13.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.532 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.05 -115.9 7.58 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.734 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.8 m -117.3 43.73 2.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.833 0.349 . . . . 0.0 110.71 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.5 m -153.6 160.05 42.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.282 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.548 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.6 mt -102.2 147.08 27.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.464 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 48.2 t -118.4 -42.7 2.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.258 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -166.47 111.55 0.8 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.562 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -117.69 119.69 35.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.941 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.705 ' HB2' HD13 ' A' ' 57' ' ' ILE . 51.5 t80 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.79 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 N--CA 1.463 -0.31 0 CA-C-O 120.947 0.311 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.548 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 75.6 t80 -139.18 104.02 4.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.319 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.2 mt -98.45 109.33 22.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 10.3 ttmt -44.57 -39.77 5.2 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.774 0.321 . . . . 0.0 111.529 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.4 p -177.83 163.98 1.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 111.122 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.28 -11.46 4.95 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.025 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.413 ' HA ' ' CD ' ' A' ' 66' ' ' LYS . . . -74.29 0.42 14.31 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 117.786 0.793 . . . . 0.0 112.233 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -130.79 156.87 44.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.161 0.505 . . . . 0.0 111.303 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -150.73 117.4 5.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.098 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.705 HD13 ' HB2' ' A' ' 42' ' ' PHE . 12.0 tt -75.72 97.29 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.45 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.509 HD22 ' OD2' ' A' ' 15' ' ' ASP . 0.8 OUTLIER -47.01 168.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.184 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.59 -24.57 65.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.592 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.478 ' ND2' ' HB2' ' A' ' 62' ' ' ASP . 5.8 p-10 -96.83 33.63 1.84 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.737 0.303 . . . . 0.0 111.21 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.65 34.18 69.38 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.56 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.478 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -101.39 165.09 11.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 0.0 111.043 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.41 HD11 HG12 ' A' ' 39' ' ' VAL . 10.5 tp -106.13 120.56 42.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.499 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.26 111.2 23.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.725 0.298 . . . . 0.0 110.991 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.829 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.4 mt -90.92 135.88 25.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.369 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.443 ' HG3' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -80.7 -45.96 16.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.074 0.464 . . . . 0.0 111.991 -179.044 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.443 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -145.8 113.31 6.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.468 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.638 HD22 ' CG1' ' A' ' 97' ' ' ILE . 4.2 mt -53.85 145.57 15.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.513 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.44 ' HA ' HD11 ' A' ' 10' ' ' LEU . 4.7 p -145.67 158.75 43.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.004 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -55.92 14.12 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.417 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.06 -22.81 11.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.411 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.617 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -76.3 -14.58 60.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.248 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.445 ' CB ' HD12 ' A' ' 97' ' ' ILE . 2.8 t -79.39 119.92 23.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.706 0.288 . . . . 0.0 110.521 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.13 -147.27 12.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.144 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.5 m -116.62 130.78 56.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.102 0.451 . . . . 0.0 110.59 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -106.72 129.77 54.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.38 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.708 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 2.0 m-20 -112.85 123.9 51.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.569 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.945 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -105.99 133.92 49.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.031 178.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.37 96.93 5.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.877 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.563 ' CG1' HD12 ' A' ' 27' ' ' ILE . 82.8 t -87.29 127.76 40.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.1 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.489 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 2.5 m-30 -112.81 152.6 28.99 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.298 0.57 . . . . 0.0 111.02 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.857 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -92.72 176.7 6.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.366 179.646 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.427 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 2.1 p -67.4 -18.34 65.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.236 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -89.94 12.13 18.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.422 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.74 25.05 74.95 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.631 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.11 -169.4 1.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.644 0.259 . . . . 0.0 110.595 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 -119.76 99.73 6.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.938 0.399 . . . . 0.0 110.783 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.857 HD11 ' HB3' ' A' ' 82' ' ' SER . 38.5 mm -58.0 -61.31 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.423 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.639 HD21 ' CG ' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -144.14 140.47 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.226 0.536 . . . . 0.0 112.019 -179.032 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -121.65 109.23 14.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.807 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.639 ' CG ' HD21 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -119.38 160.85 21.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.024 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.708 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -139.37 122.65 17.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.159 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.661 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -119.61 161.98 19.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 111.233 -179.466 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.06 146.1 33.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.265 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.729 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -136.4 119.1 16.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.213 -179.533 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.474 ' HD3' ' CE2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -119.87 124.6 46.46 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.318 0.58 . . . . 0.0 111.038 179.215 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.729 HG21 HD12 ' A' ' 10' ' ' LEU . 3.9 mp -103.44 103.9 15.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.784 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.3 mt . . . . . 0 N--CA 1.44 -0.955 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.319 179.051 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.91 HG23 ' HA ' ' A' ' 95' ' ' LEU . 2.6 m . . . . . 0 N--CA 1.433 -1.304 0 CA-C-O 121.848 0.832 . . . . 0.0 112.496 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.437 ' CE3' ' HB2' ' A' ' 96' ' ' ARG . 69.5 m95 -147.56 162.26 39.45 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.543 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.25 178.48 44.39 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.494 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -119.8 135.05 55.02 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 120.883 0.373 . . . . 0.0 110.827 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.686 HD11 ' C ' ' A' ' 69' ' ' THR . 1.2 tp -57.11 133.27 54.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.03 -2.84 87.15 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.593 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.776 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -106.56 168.33 9.24 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.776 ' O ' ' CE1' ' A' ' 12' ' ' HIS . . . -82.66 163.47 42.33 Favored Glycine 0 C--O 1.223 -0.556 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.098 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.832 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.5 tp -176.11 137.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.952 0.406 . . . . 0.0 111.183 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.46 ' OD2' HD22 ' A' ' 58' ' ' LEU . 2.6 t70 -116.99 119.74 36.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.079 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.433 ' CD1' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -80.94 114.45 19.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.957 179.589 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -94.1 124.03 37.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.168 0.509 . . . . 0.0 111.925 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.925 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.4 mt -80.4 119.78 77.41 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.023 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.449 ' O ' HD11 ' A' ' 89' ' ' LEU . 32.1 Cg_exo -59.39 130.85 37.64 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.281 1.987 . . . . 0.0 112.931 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 42.7 65.17 0.98 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -141.96 151.14 42.27 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.869 0.366 . . . . 0.0 110.638 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -141.35 117.98 10.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.71 78.4 7.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.009 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.5 p -110.77 -172.88 2.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.25 -30.53 68.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -61.46 -27.28 68.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.016 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.603 HD12 ' CG1' ' A' ' 80' ' ' VAL . 21.0 mm -81.76 127.52 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.451 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.95 -43.64 3.56 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 60.1 tt0 -128.39 116.38 19.68 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.196 -0.601 . . . . 0.0 112.412 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.7 t -116.22 117.12 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.886 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -118.17 133.53 55.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.202 0.525 . . . . 0.0 112.384 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -109.63 84.52 1.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.767 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -95.06 149.94 20.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.382 0.61 . . . . 0.0 112.432 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -139.66 113.47 8.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.408 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.47 -114.77 6.24 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.613 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -117.01 43.62 2.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.77 0.319 . . . . 0.0 110.629 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 66.4 m -153.74 160.08 42.17 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.332 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.557 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.5 mt -101.42 147.12 26.73 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.431 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 51.1 t -118.21 -43.25 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.189 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.4 112.45 0.83 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.294 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.28 120.08 35.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.195 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.771 ' HB2' HD13 ' A' ' 57' ' ' ILE . 14.0 t80 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.471 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.69 0.204 . . . . 0.0 112.218 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.557 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 70.5 t80 -137.46 98.89 3.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.756 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 50' ' ' LEU . 9.5 mt -93.89 113.81 25.9 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 6.5 tptp -36.43 -90.06 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.7 m -118.56 21.45 12.57 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.08 -1.52 55.19 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.125 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.81 3.42 29.56 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 117.546 0.673 . . . . 0.0 111.008 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -124.31 158.05 33.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.782 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -140.95 120.53 13.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.202 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.771 HD13 ' HB2' ' A' ' 42' ' ' PHE . 4.7 tt -76.99 103.33 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.12 0.486 . . . . 0.0 111.375 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.46 HD22 ' OD2' ' A' ' 15' ' ' ASP . 0.7 OUTLIER -54.5 166.58 0.42 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.102 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.3 -23.48 64.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.72 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' A' ' 62' ' ' ASP . 5.7 p-10 -96.53 33.3 1.84 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.734 0.302 . . . . 0.0 111.214 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.97 34.01 64.9 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.632 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.496 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -101.3 173.87 6.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 0.0 111.034 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 tp -114.22 121.07 42.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.57 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.412 ' HB2' HD13 ' A' ' 58' ' ' LEU . 17.2 tttt -107.61 104.07 13.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.823 0.344 . . . . 0.0 111.051 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.832 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -82.27 127.18 39.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.625 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -76.0 -45.65 33.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.065 0.459 . . . . 0.0 111.322 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.11 111.9 4.82 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.235 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.829 HD22 HG12 ' A' ' 97' ' ' ILE . 4.5 mt -56.21 152.01 11.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.12 0.486 . . . . 0.0 111.681 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.686 ' C ' HD11 ' A' ' 10' ' ' LEU . 8.7 p -153.17 163.35 40.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.123 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.635 ' N ' HD11 ' A' ' 10' ' ' LEU . 21.4 mmt85 -51.42 -54.76 23.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.476 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -58.56 -19.22 36.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.321 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.41 -15.8 34.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.37 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.479 ' CB ' HD12 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -82.7 130.83 35.19 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.823 0.344 . . . . 0.0 110.586 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.56 -130.83 3.26 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.325 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 1.3 m -125.82 126.65 44.85 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 117.753 0.776 . . . . 0.0 111.063 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.428 ' CD1' HD21 ' A' ' 16' ' ' LEU . 61.2 m-85 -97.03 149.93 21.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.21 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.648 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 11.5 m-20 -132.94 120.53 21.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.201 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.925 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -107.91 128.54 63.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.174 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.73 97.4 5.83 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.603 ' CG1' HD12 ' A' ' 27' ' ' ILE . 71.2 t -87.01 126.79 40.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.52 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.507 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 97.2 m-85 -118.71 151.56 37.76 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.236 0.541 . . . . 0.0 111.024 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.629 ' CB ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -89.72 173.62 8.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.406 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.3 p -59.95 -29.51 68.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.926 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -77.77 -4.07 44.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.491 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.86 27.2 51.3 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.531 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.17 165.16 11.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 110.79 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.37 115.37 21.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.644 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.629 HD11 ' CB ' ' A' ' 82' ' ' SER . 34.9 mt -91.16 -67.71 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.322 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.724 HD21 ' CG ' ' A' ' 91' ' ' LYS . 4.5 tt -136.41 130.14 32.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.062 0.458 . . . . 0.0 111.71 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -120.71 108.68 14.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.333 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.724 ' CG ' HD21 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -119.61 153.51 35.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.275 0.56 . . . . 0.0 112.337 -178.514 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.648 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.91 121.69 16.48 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.496 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.641 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -120.63 164.85 15.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.243 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.24 107.24 10.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.66 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.91 ' HA ' HG23 ' A' ' 6' ' ' VAL . 7.2 tt -101.8 113.89 27.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.017 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.437 ' HB2' ' CE3' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -96.77 111.93 23.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.874 0.369 . . . . 0.0 110.479 179.299 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.829 HG12 HD22 ' A' ' 68' ' ' LEU . 5.6 mt -95.33 109.14 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.873 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mt . . . . . 0 N--CA 1.439 -1.002 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.416 178.889 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.881 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 120.713 0.292 . . . . 0.0 110.648 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -116.49 127.43 54.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.877 0.37 . . . . 0.0 110.737 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.55 177.42 29.48 Favored Glycine 0 C--N 1.329 0.161 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.662 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.408 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -122.18 135.6 54.8 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.913 0.387 . . . . 0.0 110.75 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.725 HD11 ' C ' ' A' ' 69' ' ' THR . 1.1 tp -54.46 130.01 38.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.714 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.85 -9.27 68.33 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.762 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.569 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.6 170.74 7.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 117.002 0.401 . . . . 0.0 109.927 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -79.87 175.2 55.05 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.119 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.856 ' CG2' HD12 ' A' ' 65' ' ' ILE . 2.0 tp 178.13 139.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.691 0.281 . . . . 0.0 110.906 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -116.08 126.21 53.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.94 0.4 . . . . 0.0 111.317 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -86.54 105.57 16.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.806 179.304 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -88.3 123.75 33.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.144 0.497 . . . . 0.0 112.194 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.923 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.3 mt -80.25 120.05 78.34 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.055 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.82 130.98 37.31 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.313 2.008 . . . . 0.0 112.859 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 43.09 65.22 1.0 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -142.0 150.96 42.02 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.801 0.334 . . . . 0.0 110.617 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -140.61 117.68 11.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.98 84.08 7.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.956 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.0 p -119.66 -173.01 2.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -57.45 -30.03 64.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.955 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -63.14 -28.02 69.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.637 HD12 ' CG1' ' A' ' 80' ' ' VAL . 36.4 mm -87.38 127.02 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.44 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.405 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -112.76 -42.37 3.62 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.053 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 34.1 tt0 -124.99 118.74 26.91 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.146 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 42' ' ' PHE . 39.3 t -123.74 112.79 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.262 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -112.62 139.0 48.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.205 0.526 . . . . 0.0 112.071 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.461 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 71.7 m95 -112.39 82.99 1.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.865 178.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -94.69 142.92 26.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.337 0.589 . . . . 0.0 112.286 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 118.23 18.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.418 178.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.97 -113.73 5.01 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.654 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.5 p -119.55 44.82 2.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.738 0.304 . . . . 0.0 110.663 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.8 m -156.46 159.64 38.83 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.887 0.375 . . . . 0.0 111.315 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.52 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 4.8 mt -99.81 147.49 25.43 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.697 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 40.3 t -118.37 -41.14 2.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.481 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -172.97 117.54 0.31 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.679 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -122.53 156.94 33.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 110.617 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 30' ' ' VAL . 63.5 t80 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.717 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo . . . . . 0 CA--C 1.527 0.148 0 CA-C-O 120.666 0.194 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.52 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 84.9 t80 -136.67 113.7 10.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.869 0.366 . . . . 0.0 111.481 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 50' ' ' LEU . 10.1 mt -108.69 112.64 25.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.98 179.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 24.3 tttm -44.67 -49.22 10.5 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.732 0.301 . . . . 0.0 111.381 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.52 168.69 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.085 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.82 -12.46 1.7 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.445 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.74 0.3 13.44 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 117.847 0.824 . . . . 0.0 112.336 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -136.99 156.89 47.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 111.269 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -150.8 120.46 6.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.232 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.627 HG23 ' O ' ' A' ' 57' ' ' ILE . 4.7 tt -75.59 103.9 3.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.047 0.451 . . . . 0.0 111.368 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.481 HD11 ' HG3' ' A' ' 64' ' ' LYS . 1.6 mp -54.15 169.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.069 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.33 -24.44 64.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.624 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' A' ' 62' ' ' ASP . 5.8 p-10 -96.48 33.22 1.84 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.79 0.329 . . . . 0.0 111.157 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.04 31.0 64.43 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.723 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.512 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -97.47 174.03 6.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.886 0.374 . . . . 0.0 111.117 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 11.1 tp -113.7 121.11 43.12 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.53 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HG3' HD11 ' A' ' 58' ' ' LEU . 3.1 tmtp? -106.87 106.32 16.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.755 0.312 . . . . 0.0 111.196 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.856 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.7 mt -86.4 135.41 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.067 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -90.75 -40.72 11.67 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -143.63 109.19 5.13 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.758 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.848 ' HB3' HG21 ' A' ' 97' ' ' ILE . 5.3 mt -58.54 145.89 37.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.129 0.49 . . . . 0.0 111.339 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.725 ' C ' HD11 ' A' ' 10' ' ' LEU . 4.5 p -148.78 158.48 44.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.238 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.681 ' N ' HD11 ' A' ' 10' ' ' LEU . 9.9 mmm-85 -50.5 -57.1 8.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.185 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -54.42 -22.29 12.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.094 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.559 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -81.4 -14.81 56.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.319 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.445 ' HB3' HD12 ' A' ' 97' ' ' ILE . 5.0 p -83.55 138.2 33.5 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.647 0.26 . . . . 0.0 110.845 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.07 -126.02 2.32 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.681 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 m -132.99 129.61 38.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.864 0.832 . . . . 0.0 110.921 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.53 ' CE1' HD12 ' A' ' 95' ' ' LEU . 23.6 m-85 -103.91 151.28 23.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.293 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -132.63 122.42 24.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.371 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.923 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -108.0 127.85 63.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.056 179.288 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.98 97.09 6.03 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.637 ' CG1' HD12 ' A' ' 27' ' ' ILE . 80.7 t -88.16 130.25 38.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.304 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.555 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 96.8 m-85 -124.02 154.45 39.86 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.269 0.556 . . . . 0.0 111.184 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.534 ' CB ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -87.98 175.85 7.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.381 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.405 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 20.3 p -62.65 -22.03 66.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.165 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -96.0 24.97 5.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.191 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.63 26.83 53.82 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.581 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.69 157.84 15.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.816 0.341 . . . . 0.0 110.816 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.12 111.41 14.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.534 HD11 ' CB ' ' A' ' 82' ' ' SER . 34.4 mm -92.98 -49.72 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.33 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.518 HD21 ' CG ' ' A' ' 91' ' ' LYS . 2.6 tt -154.01 149.15 26.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.283 0.563 . . . . 0.0 111.773 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -140.62 108.32 5.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.173 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.518 ' CG ' HD21 ' A' ' 89' ' ' LEU . 7.4 mmpt? -120.52 159.2 25.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.83 121.71 14.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.039 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.647 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -120.91 161.89 20.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.892 0.377 . . . . 0.0 111.695 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.59 125.81 53.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.199 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.881 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -106.31 101.51 10.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.233 -179.44 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.36 108.95 21.78 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.22 0.533 . . . . 0.0 110.412 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.848 HG21 ' HB3' ' A' ' 68' ' ' LEU . 3.6 mt -110.44 113.41 44.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.731 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mt . . . . . 0 N--CA 1.442 -0.859 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.534 179.323 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.89 HG23 ' HA ' ' A' ' 95' ' ' LEU . 2.9 m . . . . . 0 N--CA 1.432 -1.359 0 CA-C-O 121.78 0.8 . . . . 0.0 112.345 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.433 ' CE3' ' HB2' ' A' ' 96' ' ' ARG . 73.3 m95 -145.42 161.97 38.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.55 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.48 179.16 41.15 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.427 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.413 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -122.63 134.42 54.5 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.976 0.417 . . . . 0.0 111.25 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.686 HD11 ' N ' ' A' ' 70' ' ' ARG . 1.2 tp -58.0 134.09 56.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.692 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.0 -4.11 83.89 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.393 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.614 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.4 OUTLIER -108.99 167.94 9.73 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.614 ' O ' ' CE1' ' A' ' 12' ' ' HIS . . . -78.73 -173.4 43.02 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.659 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.895 HG21 HD21 ' A' ' 68' ' ' LEU . 1.1 tp 164.18 136.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.756 0.312 . . . . 0.0 110.38 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -116.93 118.7 33.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.89 0.376 . . . . 0.0 111.391 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.475 HD21 ' CD1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -81.23 102.93 10.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.849 179.299 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -85.97 124.73 32.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.192 0.52 . . . . 0.0 111.724 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.94 HD11 HG11 ' A' ' 78' ' ' VAL . 3.4 mt -78.42 119.93 79.16 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.154 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -58.26 130.15 36.33 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.37 2.047 . . . . 0.0 113.094 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 42.44 64.61 1.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.518 ' HB2' HD13 ' A' ' 89' ' ' LEU . 9.6 t80 -140.7 149.0 41.64 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.817 0.341 . . . . 0.0 110.585 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -139.42 117.16 11.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.961 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.35 81.14 7.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.868 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.54 -174.53 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.829 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -56.8 -30.78 64.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.961 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.02 -27.85 69.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.565 HD12 ' CG1' ' A' ' 80' ' ' VAL . 33.6 mm -83.67 127.88 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.429 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.73 -44.06 3.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 13.9 tp10 -125.91 134.58 51.53 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.317 -179.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -135.41 108.01 8.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.723 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -105.17 132.03 51.9 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -109.01 82.88 1.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -99.17 157.92 16.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.394 0.616 . . . . 0.0 112.467 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -149.3 113.8 5.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.509 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.46 -117.03 9.4 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.741 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 p -115.0 42.47 2.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.741 0.305 . . . . 0.0 110.705 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.0 m -150.66 160.4 43.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.237 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.541 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 6.2 mt -106.82 147.94 29.11 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.444 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 53.7 t -119.03 -43.76 2.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.235 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.39 113.26 1.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.527 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.528 ' OE2' HD21 ' A' ' 38' ' ' LEU . 2.2 mt-10 -118.51 113.58 21.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.051 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.561 ' HB2' HD13 ' A' ' 57' ' ' ILE . 16.5 t80 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.882 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.46 -0.482 0 CA-C-O 120.629 0.179 . . . . 0.0 111.939 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.541 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 69.8 t80 -125.34 99.87 6.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.337 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 50' ' ' LEU . 9.1 mt -96.24 105.66 17.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.931 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 39.8 tttm -43.92 -59.2 2.38 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.586 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.6 p -144.74 162.75 35.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 0.0 111.193 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.08 -8.16 21.67 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.022 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.432 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . . . -78.39 3.41 15.78 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 117.559 0.679 . . . . 0.0 111.952 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -125.5 157.36 37.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.273 0.559 . . . . 0.0 111.743 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -154.55 124.65 6.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.212 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 57' ' ' ILE . 3.0 tt -83.49 106.66 14.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.308 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.66 HD23 HD21 ' A' ' 60' ' ' ASN . 1.2 mp -65.7 172.79 3.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.904 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.3 -44.83 64.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.156 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.66 HD21 HD23 ' A' ' 58' ' ' LEU . 4.7 p30 -57.33 -25.13 58.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.06 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.69 33.42 3.84 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.547 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -113.39 154.61 26.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.841 0.353 . . . . 0.0 110.964 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 tp -84.39 122.05 28.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.459 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -102.99 111.33 23.61 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.831 0.348 . . . . 0.0 111.421 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.865 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.8 mt -97.13 122.64 48.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.114 179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.432 ' HD2' ' HA ' ' A' ' 54' ' ' ALA . 1.6 ptpp? -89.27 -33.76 16.84 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.471 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -140.8 104.82 4.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.601 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.895 HD21 HG21 ' A' ' 14' ' ' ILE . 6.2 mt -63.01 154.43 30.68 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.13 0.49 . . . . 0.0 111.458 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.545 ' C ' HD11 ' A' ' 10' ' ' LEU . 5.1 p -152.35 157.04 40.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.209 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.686 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -50.11 -55.98 12.77 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.363 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -52.63 -24.6 8.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.132 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.01 -15.36 44.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.255 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.403 ' N ' HD12 ' A' ' 97' ' ' ILE . 14.4 p -77.86 126.2 30.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.415 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 154.21 -131.08 3.09 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.447 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 1.3 m -126.03 129.19 48.68 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 117.711 0.756 . . . . 0.0 111.143 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.475 ' CD1' HD21 ' A' ' 16' ' ' LEU . 63.9 m-85 -99.82 148.4 24.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.035 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.651 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 12.8 m-20 -130.05 122.23 27.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.769 0.319 . . . . 0.0 111.356 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.94 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.57 130.55 62.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.274 179.34 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.94 96.72 5.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.818 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.565 ' CG1' HD12 ' A' ' 27' ' ' ILE . 55.0 t -86.56 134.07 28.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.243 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.491 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 81.0 m-85 -127.39 156.69 41.65 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.347 0.594 . . . . 0.0 111.199 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.661 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -90.02 174.96 7.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.448 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.3 -24.94 66.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.15 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -95.9 27.1 3.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.198 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.7 23.61 37.32 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.719 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.61 156.32 18.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.731 0.3 . . . . 0.0 110.823 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.58 118.42 22.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.541 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.661 HD11 ' HB3' ' A' ' 82' ' ' SER . 45.9 mt -102.05 -67.1 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.425 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.569 HD21 ' CG ' ' A' ' 91' ' ' LYS . 5.1 tt -134.18 148.8 50.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.322 0.582 . . . . 0.0 111.875 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.69 109.21 5.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.061 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.569 ' CG ' HD21 ' A' ' 89' ' ' LEU . 58.4 mmtt -122.53 153.33 39.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.651 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -139.85 122.95 16.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.284 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.647 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -122.82 165.28 16.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.267 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.22 106.32 9.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.73 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.89 ' HA ' HG23 ' A' ' 6' ' ' VAL . 7.1 tt -101.16 114.86 29.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.897 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -96.79 108.33 20.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.408 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.748 HG12 HD22 ' A' ' 68' ' ' LEU . 8.6 mt -90.88 108.94 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.776 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mt . . . . . 0 N--CA 1.442 -0.872 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.571 179.254 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.743 HG11 HD12 ' A' ' 95' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.447 -0.593 0 CA-C-O 120.623 0.249 . . . . 0.0 110.884 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -115.73 139.35 50.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.81 0.338 . . . . 0.0 110.957 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.57 176.59 28.21 Favored Glycine 0 C--O 1.228 -0.221 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.972 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.61 135.12 54.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.172 0.486 . . . . 0.0 111.121 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.565 HD12 HG21 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -54.02 130.38 37.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.713 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.11 -8.95 75.64 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.887 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.549 ' NE2' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -106.57 170.97 7.62 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.549 ' O ' ' NE2' ' A' ' 12' ' ' HIS . . . -86.55 174.36 46.56 Favored Glycine 0 C--O 1.224 -0.477 0 C-N-CA 120.705 -0.759 . . . . 0.0 113.468 -178.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.815 ' CG2' HD12 ' A' ' 65' ' ' ILE . 3.3 tp 179.59 144.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.6 0.238 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -120.69 129.94 53.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.951 0.405 . . . . 0.0 111.639 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -91.52 104.08 16.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.713 179.222 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -86.19 123.9 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.188 0.518 . . . . 0.0 111.911 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.934 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.4 mt -79.55 120.19 79.43 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.184 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.25 130.63 36.92 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.26 1.973 . . . . 0.0 113.0 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 43.08 64.78 1.1 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -141.67 150.5 41.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.784 0.326 . . . . 0.0 110.551 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -142.07 117.55 10.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.881 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.97 76.87 6.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.978 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.1 p -105.86 -172.51 2.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -59.08 -31.45 68.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.966 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.01 -26.94 68.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.99 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.552 HD12 ' CG1' ' A' ' 80' ' ' VAL . 22.1 mm -79.01 129.21 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.43 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.418 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.9 OUTLIER -112.68 -44.11 3.37 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.082 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 69.2 tt0 -132.45 116.39 16.73 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.001 -0.68 . . . . 0.0 112.655 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.31 114.69 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -112.17 130.73 55.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.172 0.51 . . . . 0.0 112.36 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -112.73 85.37 2.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.987 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -98.97 148.75 23.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.252 0.548 . . . . 0.0 112.229 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.0 114.69 9.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.609 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.45 -117.73 11.5 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.809 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.5 m -114.64 42.36 2.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.764 0.316 . . . . 0.0 110.665 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.7 m -151.95 160.18 43.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.235 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.542 HD21 ' OE2' ' A' ' 41' ' ' GLU . 5.5 mt -102.94 146.15 28.75 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.463 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 46.9 t -117.59 -42.47 2.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.941 0.401 . . . . 0.0 110.243 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -165.83 112.17 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.492 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.542 ' OE2' HD21 ' A' ' 38' ' ' LEU . 2.2 mt-10 -120.36 112.67 19.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.066 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.43 ' HB2' HD13 ' A' ' 57' ' ' ILE . 22.4 t80 . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.761 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.412 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 91.7 Cg_endo . . . . . 0 N--CA 1.462 -0.357 0 CA-C-O 120.815 0.256 . . . . 0.0 112.52 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.536 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 78.7 t80 -138.83 106.17 5.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.415 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 50' ' ' LEU . 7.9 mt -100.95 110.66 22.73 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 36.2 tttt -44.84 -49.14 10.99 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.73 0.3 . . . . 0.0 111.607 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.1 p -169.84 164.98 9.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.956 0.408 . . . . 0.0 111.319 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.77 -12.1 4.78 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.138 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.28 0.93 12.69 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 117.782 0.791 . . . . 0.0 112.083 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -131.94 157.54 43.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.052 0.453 . . . . 0.0 111.09 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -154.09 127.21 8.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.512 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.661 HG23 ' O ' ' A' ' 57' ' ' ILE . 7.1 tt -86.02 101.26 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.178 0.513 . . . . 0.0 111.276 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.633 HD23 HD21 ' A' ' 60' ' ' ASN . 1.2 mp -58.68 171.16 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.957 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.7 -44.64 77.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.185 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.633 HD21 HD23 ' A' ' 58' ' ' LEU . 4.9 p30 -58.2 -25.1 61.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.07 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.75 34.17 3.88 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.568 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -112.96 154.73 25.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.789 0.328 . . . . 0.0 110.968 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.0 tp -82.72 123.13 29.01 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.632 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.413 ' HB2' HD13 ' A' ' 58' ' ' LEU . 1.4 tptt -106.38 110.09 22.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.906 0.384 . . . . 0.0 111.219 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.815 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.9 mt -92.21 121.2 42.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.148 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -81.14 -36.21 30.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.894 0.378 . . . . 0.0 111.798 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -144.25 107.52 4.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.706 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.605 HD22 ' CD1' ' A' ' 97' ' ' ILE . 4.4 mt -59.03 143.73 47.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.058 0.456 . . . . 0.0 111.337 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.448 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 9.2 p -143.33 165.09 28.45 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.856 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.7 mmt85 -50.5 -54.94 18.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.256 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -53.45 -23.87 11.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.41 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -73.5 -13.57 61.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.567 0.222 . . . . 0.0 111.427 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.418 ' HB3' ' CG1' ' A' ' 97' ' ' ILE . 5.0 p -82.78 116.05 21.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.68 0.276 . . . . 0.0 110.647 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.27 -144.93 10.3 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.21 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -120.38 131.02 54.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.145 0.472 . . . . 0.0 110.621 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -103.96 131.99 50.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.411 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.708 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 1.9 m-20 -114.39 123.4 49.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.286 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.934 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -106.11 129.06 59.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.275 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.47 97.66 6.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.552 ' CG1' HD12 ' A' ' 27' ' ' ILE . 77.7 t -88.0 123.23 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.436 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.445 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 93.4 m-85 -113.81 151.15 32.46 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.224 0.535 . . . . 0.0 111.053 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.61 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -90.79 172.87 8.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.545 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 16.9 p -60.81 -19.18 59.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.351 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -94.39 24.67 4.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.218 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.82 23.29 44.4 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.6 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.94 176.11 5.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.783 0.325 . . . . 0.0 110.735 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -98.31 126.47 43.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.676 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.61 HD11 ' HB3' ' A' ' 82' ' ' SER . 51.4 mt -101.24 -61.42 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.416 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.749 HD21 ' CG ' ' A' ' 91' ' ' LYS . 5.0 tt -140.06 129.53 24.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.113 0.483 . . . . 0.0 111.855 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -120.54 108.54 14.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.17 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.749 ' CG ' HD21 ' A' ' 89' ' ' LEU . 26.2 mmtt -121.05 159.69 25.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.352 0.596 . . . . 0.0 112.439 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.708 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -139.83 121.75 15.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.45 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 93' ' ' LEU . 1.4 mp -119.49 165.39 14.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.865 0.364 . . . . 0.0 111.152 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.47 134.31 53.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.639 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.743 HD12 HG11 ' A' ' 6' ' ' VAL . 8.5 tt -129.73 132.37 46.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.023 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -109.8 132.29 54.28 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.931 0.396 . . . . 0.0 111.062 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.605 ' CD1' HD22 ' A' ' 68' ' ' LEU . 7.0 mm -101.12 100.9 11.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.615 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.8 mt . . . . . 0 N--CA 1.44 -0.927 0 CA-C-O 120.971 0.415 . . . . 0.0 110.479 179.348 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.815 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.531 0 CA-C-O 120.698 0.285 . . . . 0.0 110.706 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -118.53 128.57 54.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.659 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.07 179.66 21.24 Favored Glycine 0 N--CA 1.46 0.296 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.733 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.41 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -124.72 134.7 52.74 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.929 0.395 . . . . 0.0 111.116 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.683 HD11 ' N ' ' A' ' 70' ' ' ARG . 1.0 OUTLIER -52.81 134.57 36.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.158 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.73 -6.44 82.75 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.928 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -105.97 168.66 8.97 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 117.144 0.472 . . . . 0.0 109.988 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.529 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -77.11 163.59 52.27 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.203 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.872 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.6 tp -176.97 138.96 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 122.635 -0.332 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -125.48 133.3 52.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.928 0.394 . . . . 0.0 111.352 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.836 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -87.24 122.4 30.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.563 179.156 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.458 ' O ' HD21 ' A' ' 93' ' ' LEU . 77.4 m-20 -103.59 124.49 48.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.134 0.492 . . . . 0.0 111.687 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.957 HD11 HG11 ' A' ' 78' ' ' VAL . 3.2 mt -80.51 119.46 76.37 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.349 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.26 131.33 38.19 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.357 2.038 . . . . 0.0 113.066 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.15 64.81 1.01 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -139.69 149.32 43.54 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.809 0.337 . . . . 0.0 110.517 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -135.38 117.01 14.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.511 ' SD ' HG21 ' A' ' 30' ' ' VAL . 1.8 tpt -87.53 83.62 7.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.9 p -115.47 -173.13 2.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.849 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -58.61 -31.62 68.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.47 -24.91 67.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.945 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.492 HD12 ' CG1' ' A' ' 80' ' ' VAL . 34.6 mm -79.86 127.89 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.43 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.441 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 1.3 t0 -103.9 -38.37 7.04 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 122.267 -0.27 . . . . 0.0 111.673 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 8.8 mt-10 -141.96 151.81 42.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.722 0.772 . . . . 0.0 112.574 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.511 HG21 ' SD ' ' A' ' 23' ' ' MET . 45.5 t -145.29 106.87 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.955 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -101.53 126.05 48.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.079 0.466 . . . . 0.0 112.232 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -105.16 84.39 2.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.03 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -103.99 156.13 18.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.233 0.539 . . . . 0.0 112.211 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.58 117.73 7.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.734 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.99 -118.12 12.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.826 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.9 t -115.19 42.52 2.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.758 0.313 . . . . 0.0 110.721 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.9 m -149.93 159.94 43.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.136 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.533 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 6.3 mt -105.57 145.69 30.62 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.872 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.407 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 54.2 t -117.04 -43.6 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.086 0.47 . . . . 0.0 110.089 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.91 112.36 0.89 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.713 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -116.5 111.79 20.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.076 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.6 t80 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.943 -179.984 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo . . . . . 0 N--CA 1.464 -0.214 0 CA-C-O 120.671 0.196 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 64.4 t80 -129.87 98.71 4.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.433 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 50' ' ' LEU . 10.1 mt -95.82 108.68 21.05 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 38.8 tttt -42.19 -37.83 1.57 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.707 0.289 . . . . 0.0 111.7 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.52 165.4 1.36 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 111.07 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.64 -10.49 4.52 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.338 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.65 2.01 10.88 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.748 0.774 . . . . 0.0 112.185 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -132.1 157.59 43.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.092 0.473 . . . . 0.0 111.262 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -155.94 123.87 5.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.421 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.648 HG23 ' O ' ' A' ' 57' ' ' ILE . 6.6 tt -81.25 101.73 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.224 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.676 HD23 HD21 ' A' ' 60' ' ' ASN . 0.8 OUTLIER -58.88 173.35 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.993 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.78 -45.19 65.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.199 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.676 HD21 HD23 ' A' ' 58' ' ' LEU . 4.6 p30 -58.15 -21.88 48.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.67 35.06 4.18 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.611 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -116.1 155.17 28.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.841 0.353 . . . . 0.0 111.036 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 12.1 tp -81.77 122.46 27.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.671 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -104.83 110.26 22.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.752 0.311 . . . . 0.0 111.111 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.872 HD12 ' CG2' ' A' ' 14' ' ' ILE . 3.1 mt -91.38 134.35 30.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.339 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -82.73 -45.94 13.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.015 0.436 . . . . 0.0 111.692 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.77 112.31 5.6 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.249 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.066 HD22 HD12 ' A' ' 97' ' ' ILE . 4.4 mt -51.37 146.49 6.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.166 0.508 . . . . 0.0 111.974 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.581 ' C ' HD11 ' A' ' 10' ' ' LEU . 2.7 p -143.98 155.23 43.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.826 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.683 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -50.11 -56.33 11.33 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.363 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -52.98 -23.8 8.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.162 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.553 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -77.32 -16.17 59.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.303 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.438 ' CB ' HG12 ' A' ' 97' ' ' ILE . 22.1 p -76.95 117.48 18.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.641 0.258 . . . . 0.0 110.711 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.54 -151.33 21.17 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.169 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -110.05 131.34 55.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.783 0.325 . . . . 0.0 110.512 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -105.21 151.72 23.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.266 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.661 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 12.1 m-20 -133.8 125.0 27.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.355 . . . . 0.0 111.434 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.957 HG11 HD11 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -107.47 134.23 49.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.256 179.195 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.39 95.03 4.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.649 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.493 HG12 ' HB ' ' A' ' 88' ' ' ILE . 64.8 t -85.31 130.97 35.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.015 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.538 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 2.7 m-30 -116.87 152.99 33.32 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.31 0.576 . . . . 0.0 110.764 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.507 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -92.48 179.24 5.58 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.884 179.393 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 0.8 OUTLIER -64.78 -23.61 67.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.088 179.619 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -84.69 -5.12 59.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.52 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.56 19.23 55.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.812 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.88 141.82 37.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.749 0.309 . . . . 0.0 110.861 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.39 111.04 2.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.95 0.405 . . . . 0.0 111.014 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.507 HD11 ' HB3' ' A' ' 82' ' ' SER . 26.1 mm -80.14 -40.29 20.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.159 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.913 HD21 ' HG3' ' A' ' 91' ' ' LYS . 4.4 tt -152.82 127.36 9.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.107 0.479 . . . . 0.0 111.885 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -117.35 108.12 15.2 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.913 ' HG3' HD21 ' A' ' 89' ' ' LEU . 15.5 mmtt -119.32 159.4 24.22 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.661 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.73 122.41 17.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.071 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.643 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -119.88 162.15 19.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.015 0.435 . . . . 0.0 111.57 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -111.25 122.6 48.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.449 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.836 HD12 HD21 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -117.2 101.95 8.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.051 -179.585 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.545 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -94.42 125.18 38.9 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.129 0.49 . . . . 0.0 110.929 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.066 HD12 HD22 ' A' ' 68' ' ' LEU . 2.8 mm -108.72 112.49 40.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.999 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 98' ' ' LEU . 10.1 mt . . . . . 0 N--CA 1.439 -0.99 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.416 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.955 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.48 0 CA-C-O 120.702 0.287 . . . . 0.0 110.866 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -115.13 130.09 56.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.802 0.334 . . . . 0.0 110.752 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.57 -179.62 23.74 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.781 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.434 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -129.79 134.43 47.57 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.972 0.415 . . . . 0.0 111.192 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.66 HD11 ' N ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -53.63 135.86 39.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.992 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.88 -8.77 74.64 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.73 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.527 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.61 167.37 10.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.594 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.89 -171.75 11.34 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.472 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.893 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 163.04 136.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.94 0.4 . . . . 0.0 110.531 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -119.33 134.02 55.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.067 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -92.18 105.27 17.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.173 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.42 ' O ' HD21 ' A' ' 93' ' ' LEU . 61.9 m-20 -88.45 122.09 31.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.183 0.516 . . . . 0.0 112.116 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.941 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.3 mt -80.58 119.46 76.34 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.229 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.68 131.76 39.4 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.316 2.011 . . . . 0.0 112.878 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 43.26 65.37 0.98 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -142.75 149.31 38.57 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.791 0.329 . . . . 0.0 110.625 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -142.75 116.95 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.948 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.07 78.82 5.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.2 p -107.37 -173.49 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.31 -34.87 71.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.923 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -59.76 -24.77 64.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.994 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.548 HD12 ' CG1' ' A' ' 80' ' ' VAL . 26.9 mm -78.61 129.08 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.448 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.72 -45.11 3.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 63.6 tt0 -135.36 118.24 16.23 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.786 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 t -110.08 115.08 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.922 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -112.82 132.87 55.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.297 0.57 . . . . 0.0 112.426 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.451 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 70.3 m95 -112.28 86.48 2.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.784 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -100.44 145.67 27.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.272 0.558 . . . . 0.0 112.386 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.8 ttp85 -136.98 118.43 14.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.403 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.95 -114.7 5.98 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.685 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.4 m -119.3 44.69 2.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.763 0.316 . . . . 0.0 110.663 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.8 m -154.78 159.98 40.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.309 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.525 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.7 mt -101.47 146.76 27.2 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.482 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 41.8 t -117.05 -41.25 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.992 0.425 . . . . 0.0 110.494 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -170.42 113.62 0.45 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.676 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.72 149.36 40.87 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.046 0.45 . . . . 0.0 110.422 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.434 ' HA ' ' HB3' ' A' ' 48' ' ' PRO . 55.2 t80 . . . . . 0 C--N 1.321 -0.663 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.932 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.434 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 93.4 Cg_endo . . . . . 0 N--CA 1.462 -0.373 0 CA-C-O 120.825 0.26 . . . . 0.0 112.691 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 61.0 t80 -130.62 106.77 8.71 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.156 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.4 mt -99.49 113.89 26.53 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.197 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.482 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 22.6 tttt -46.91 -44.83 20.09 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.71 0.291 . . . . 0.0 111.431 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 p -176.54 165.78 2.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.02 -12.09 3.59 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.159 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.71 0.94 13.58 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.746 0.773 . . . . 0.0 112.133 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -132.93 156.81 46.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.102 0.477 . . . . 0.0 111.195 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -151.23 118.43 5.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.348 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.642 HG23 ' O ' ' A' ' 57' ' ' ILE . 8.8 tt -75.04 99.31 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.064 0.459 . . . . 0.0 111.319 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -49.59 167.02 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.245 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.74 -23.92 65.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.555 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.49 ' ND2' ' HB2' ' A' ' 62' ' ' ASP . 5.7 p-10 -96.59 33.18 1.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.836 0.351 . . . . 0.0 111.183 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.54 34.33 69.07 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.713 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.49 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -103.51 166.4 10.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.876 0.369 . . . . 0.0 111.007 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 10.4 tp -107.24 120.72 42.91 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.515 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -107.38 110.64 22.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 110.875 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.801 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.8 mt -89.56 137.53 21.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.363 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -84.79 -47.11 10.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.974 0.416 . . . . 0.0 112.006 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.35 110.86 5.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.403 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 14' ' ' ILE . 6.7 mt -55.2 150.78 10.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.71 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.596 ' C ' HD11 ' A' ' 10' ' ' LEU . 5.4 p -152.14 158.6 43.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.924 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.66 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -50.53 -56.27 12.37 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.2 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -55.03 -22.41 15.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.129 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.643 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -80.16 -14.41 58.49 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.313 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.3 t -79.59 127.34 32.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.644 0.259 . . . . 0.0 110.581 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.56 -167.85 32.07 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.226 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.55 125.33 36.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.763 0.316 . . . . 0.0 111.487 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -103.32 130.7 50.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.29 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -113.29 126.07 54.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.857 0.36 . . . . 0.0 111.562 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.941 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -108.01 126.14 64.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.027 179.178 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.88 97.91 6.85 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.548 ' CG1' HD12 ' A' ' 27' ' ' ILE . 69.0 t -90.41 124.24 42.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.441 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.404 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 85.1 m-85 -112.93 151.22 30.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.169 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.633 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -90.75 173.8 7.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.551 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.5 p -61.23 -18.46 58.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.385 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -93.01 22.98 4.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.325 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.57 19.52 48.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.656 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.55 -178.73 3.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.703 0.287 . . . . 0.0 110.616 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -101.08 126.3 47.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.778 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.633 HD11 ' HB3' ' A' ' 82' ' ' SER . 33.7 mm -98.95 -54.44 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.417 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.744 HD21 ' CG ' ' A' ' 91' ' ' LYS . 5.3 tt -144.98 126.12 14.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.105 0.479 . . . . 0.0 111.98 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -118.01 107.41 14.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.1 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.744 ' CG ' HD21 ' A' ' 89' ' ' LEU . 8.2 mmpt? -120.17 162.79 18.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.85 120.56 12.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.091 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.639 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -115.11 156.47 25.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.87 0.367 . . . . 0.0 111.531 -179.139 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.02 121.45 43.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.244 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.955 ' HA ' HG12 ' A' ' 6' ' ' VAL . 9.7 tp -108.85 98.59 8.06 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.286 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -96.59 110.73 23.08 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.125 0.488 . . . . 0.0 110.322 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.749 HG21 ' HB3' ' A' ' 68' ' ' LEU . 4.6 mt -104.9 113.16 41.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.895 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 98' ' ' LEU . 8.8 mt . . . . . 0 N--CA 1.442 -0.863 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.549 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.899 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 120.639 0.257 . . . . 0.0 110.619 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -112.68 129.56 56.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.799 0.333 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -153.98 177.6 31.34 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.76 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.76 135.62 54.93 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.969 0.414 . . . . 0.0 110.848 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.801 HD11 ' C ' ' A' ' 69' ' ' THR . 1.7 tp -56.92 129.34 41.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.901 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.53 -4.69 76.68 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.502 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.559 ' NE2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.9 168.7 9.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.559 ' O ' ' NE2' ' A' ' 12' ' ' HIS . . . -77.74 160.67 49.02 Favored Glycine 0 C--O 1.224 -0.524 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.083 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.815 HG21 HD21 ' A' ' 68' ' ' LEU . 1.6 tp -176.14 138.06 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.834 0.349 . . . . 0.0 111.237 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -117.92 129.24 55.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.208 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -86.55 106.09 17.29 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.22 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.484 ' O ' HD21 ' A' ' 93' ' ' LEU . 67.5 m-20 -88.72 126.28 35.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.304 0.573 . . . . 0.0 112.008 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.913 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.3 mt -80.79 119.82 77.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.153 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.33 131.26 37.66 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.318 2.012 . . . . 0.0 112.862 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 m120 43.27 65.37 0.99 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.469 ' HB2' HD13 ' A' ' 89' ' ' LEU . 9.3 t80 -142.7 151.3 41.2 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 110.55 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -141.94 114.97 8.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.29 83.27 5.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.14 -174.07 2.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.86 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -56.08 -30.02 61.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.953 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -63.67 -27.87 69.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.999 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.643 HD12 ' CG1' ' A' ' 80' ' ' VAL . 35.1 mm -87.39 127.04 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.399 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -113.03 -42.16 3.6 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.069 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 43.2 tt0 -124.63 118.38 26.38 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.174 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 24.6 t -122.43 115.09 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.152 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -114.59 137.34 52.0 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.2 0.524 . . . . 0.0 112.261 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.446 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 71.9 m95 -112.19 85.58 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.86 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -97.28 142.39 29.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.287 0.565 . . . . 0.0 112.264 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.77 118.55 19.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.424 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.81 -114.22 5.45 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.687 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 m -119.68 44.94 2.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.732 0.301 . . . . 0.0 110.686 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.0 m -155.26 159.68 40.23 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.906 0.384 . . . . 0.0 111.357 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.535 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 4.5 mt -97.82 147.29 24.56 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.7 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 55.2 t -119.13 -43.09 2.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.341 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -172.45 114.39 0.3 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.725 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 1.1 pt-20 -125.05 156.61 37.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.078 0.466 . . . . 0.0 111.005 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 40.4 t80 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.845 -179.873 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.231 0.139 0 CA-C-O 120.847 0.27 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.535 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 46.5 t80 -111.61 103.54 11.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.177 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.3 mt -94.79 112.89 24.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.289 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 19.9 tttp -48.07 -46.63 33.82 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.695 0.283 . . . . 0.0 111.23 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -173.41 166.11 4.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 0.0 111.196 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.38 -11.47 3.63 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.376 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.53 -0.09 14.09 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 117.834 0.817 . . . . 0.0 112.236 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -132.84 157.8 44.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.076 0.465 . . . . 0.0 111.073 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -152.07 124.45 8.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.43 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.649 HG23 ' O ' ' A' ' 57' ' ' ILE . 4.7 tt -84.61 103.9 12.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 111.176 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.668 HD23 HD21 ' A' ' 60' ' ' ASN . 1.4 mp -62.73 172.63 1.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.005 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.36 -45.15 63.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.668 HD21 HD23 ' A' ' 58' ' ' LEU . 4.5 p30 -57.43 -22.45 43.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.113 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.01 35.0 4.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.634 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -115.33 155.38 27.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 110.979 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.2 tp -85.48 122.72 30.02 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.798 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -104.84 108.24 19.62 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.736 0.303 . . . . 0.0 111.073 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.794 HD12 ' CG2' ' A' ' 14' ' ' ILE . 4.0 mt -89.35 132.59 33.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.449 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -81.13 -46.06 15.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.953 0.406 . . . . 0.0 111.76 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.16 112.64 5.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.322 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.834 ' HB3' HG21 ' A' ' 97' ' ' ILE . 5.1 mt -54.16 149.62 9.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.166 0.508 . . . . 0.0 111.746 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.801 ' C ' HD11 ' A' ' 10' ' ' LEU . 5.2 p -151.32 158.26 43.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.153 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.612 ' N ' HD11 ' A' ' 10' ' ' LEU . 5.5 mmt180 -50.62 -56.82 10.07 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.173 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.37 -20.76 20.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.315 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.621 ' O ' HD23 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -93.17 17.03 11.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.289 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.48 146.99 36.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.684 0.278 . . . . 0.0 110.756 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.32 -117.71 1.76 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.291 -0.957 . . . . 0.0 112.901 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -138.04 130.3 29.0 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 117.717 0.759 . . . . 0.0 110.848 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -103.98 151.92 22.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.359 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.668 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 11.6 m-20 -132.57 124.15 27.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.192 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.913 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.46 127.3 66.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.223 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.58 97.18 6.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.715 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.643 ' CG1' HD12 ' A' ' 27' ' ' ILE . 73.2 t -88.22 131.78 34.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.269 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.551 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 96.0 m-85 -125.35 154.67 41.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.313 0.577 . . . . 0.0 111.198 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.534 ' CB ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -87.77 175.71 7.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.414 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 2.1 p -62.82 -22.1 66.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.118 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -96.21 24.87 5.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.114 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.92 27.35 56.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.645 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.45 157.14 16.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 0.0 110.866 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.46 111.0 12.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.611 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.534 HD11 ' CB ' ' A' ' 82' ' ' SER . 35.2 mm -93.22 -51.55 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.403 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.469 HD13 ' HB2' ' A' ' 21' ' ' PHE . 2.5 tt -151.02 149.78 29.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.212 0.53 . . . . 0.0 111.697 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.7 108.35 5.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.176 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.466 ' CG ' HD21 ' A' ' 89' ' ' LEU . 4.1 mmpt? -122.06 156.19 34.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.378 0.608 . . . . 0.0 112.516 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.668 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -139.42 123.65 18.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.174 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.655 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -122.51 163.05 20.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 0.0 111.437 -179.344 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.23 133.05 53.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.482 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.899 ' HA ' HG12 ' A' ' 6' ' ' VAL . 8.1 tp -113.36 97.9 6.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.635 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -95.37 108.13 20.31 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.105 0.478 . . . . 0.0 109.98 178.898 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.834 HG21 ' HB3' ' A' ' 68' ' ' LEU . 1.6 mt -106.65 110.51 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.001 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.9 mt . . . . . 0 N--CA 1.439 -1.001 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.289 179.074 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.872 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.519 0 CA-C-O 120.719 0.295 . . . . 0.0 110.775 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -118.16 127.16 53.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.59 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.69 177.7 27.68 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.826 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.4 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -123.56 135.55 54.06 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.889 0.376 . . . . 0.0 110.969 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.675 HD11 ' C ' ' A' ' 69' ' ' THR . 0.9 OUTLIER -53.17 134.59 38.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.053 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.55 -5.31 84.96 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.852 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.548 ' NE2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.34 168.68 9.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 117.126 0.463 . . . . 0.0 109.958 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.548 ' O ' ' NE2' ' A' ' 12' ' ' HIS . . . -78.57 162.09 48.85 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.287 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.879 HG21 HD21 ' A' ' 68' ' ' LEU . 1.9 tp -176.54 138.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.764 0.316 . . . . 0.0 111.008 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.667 ' OD2' HD22 ' A' ' 58' ' ' LEU . 8.0 t0 -124.09 128.23 48.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.254 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.428 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -81.93 125.09 30.33 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.157 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -104.09 124.23 48.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.275 0.559 . . . . 0.0 111.914 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.958 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.4 mt -82.1 119.94 76.18 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.417 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.97 131.15 37.88 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.37 2.047 . . . . 0.0 112.96 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.65 65.23 0.96 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -142.18 149.13 39.31 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.643 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -138.75 117.58 12.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.912 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.26 81.87 8.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.0 p -117.47 -173.01 2.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -57.13 -30.43 64.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.69 -24.52 64.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.012 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.557 HD12 ' CG1' ' A' ' 80' ' ' VAL . 37.1 mm -85.01 127.44 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.348 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -111.15 -43.86 3.67 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.172 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 34.6 tt0 -127.77 118.29 23.47 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.125 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 t -119.09 144.33 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.373 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -148.14 132.4 17.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.053 0.454 . . . . 0.0 112.076 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.46 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 54.5 m95 -108.07 89.41 2.99 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -98.36 146.57 25.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.395 0.617 . . . . 0.0 112.481 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.67 116.99 11.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.353 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.1 -114.81 6.14 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.641 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.1 m -119.06 44.66 2.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.807 0.337 . . . . 0.0 110.654 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.5 m -154.27 160.74 41.93 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.294 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.593 HD13 ' OE1' ' A' ' 41' ' ' GLU . 4.1 mt -102.58 148.22 25.82 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.525 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 43.2 t -119.49 -41.31 2.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.746 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -173.05 114.27 0.25 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.904 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.593 ' OE1' HD13 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -128.07 154.71 45.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.183 0.516 . . . . 0.0 110.754 179.311 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 73.4 t80 . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.833 -179.931 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo . . . . . 0 N--CA 1.461 -0.429 0 CA-C-O 120.488 0.12 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.52 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 83.5 t80 -127.92 111.16 13.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.811 0.338 . . . . 0.0 111.416 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 50' ' ' LEU . 9.2 mt -107.32 112.28 25.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.005 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 8.0 ttmt -46.71 -41.33 14.88 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.673 0.273 . . . . 0.0 111.464 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.2 p -177.03 164.38 2.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.946 0.403 . . . . 0.0 111.231 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.94 -11.95 4.91 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.106 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.86 1.05 13.59 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 117.688 0.744 . . . . 0.0 112.075 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -131.8 157.24 44.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.102 0.477 . . . . 0.0 111.161 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -151.41 119.69 6.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.216 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 57' ' ' ILE . 7.8 tt -76.79 99.52 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.216 0.531 . . . . 0.0 111.237 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.667 HD22 ' OD2' ' A' ' 15' ' ' ASP . 0.7 OUTLIER -53.1 163.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.275 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.58 -21.76 66.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.39 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.61 30.41 2.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.802 0.334 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.26 36.08 67.64 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.892 -0.671 . . . . 0.0 113.02 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -111.67 157.39 20.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 110.963 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.404 HD11 HG12 ' A' ' 39' ' ' VAL . 10.7 tp -93.19 121.25 34.35 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.716 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.584 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -106.77 107.49 18.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.876 0.37 . . . . 0.0 110.948 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.839 HD12 ' CG2' ' A' ' 14' ' ' ILE . 3.4 mt -87.48 136.47 23.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.437 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 tttm -86.04 -45.91 10.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.952 0.406 . . . . 0.0 111.713 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.47 110.96 5.6 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.319 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.879 HD21 HG21 ' A' ' 14' ' ' ILE . 5.5 mt -53.78 152.39 5.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.169 0.509 . . . . 0.0 111.855 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.675 ' C ' HD11 ' A' ' 10' ' ' LEU . 6.0 p -152.92 159.36 42.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.194 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.673 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -51.1 -56.94 10.15 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.078 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -55.28 -20.94 12.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.735 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -81.38 -14.8 56.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.425 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.407 ' HB3' HD12 ' A' ' 97' ' ' ILE . 5.6 p -81.99 137.88 35.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.58 0.229 . . . . 0.0 110.863 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.63 -124.62 2.04 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.835 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -136.92 133.43 35.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 117.9 0.85 . . . . 0.0 110.595 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.541 ' CE1' HD12 ' A' ' 95' ' ' LEU . 29.3 m-85 -108.69 135.55 49.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.44 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.726 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 17.2 m-20 -115.44 121.93 44.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.162 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.958 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -104.58 130.94 54.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.304 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.97 104.23 10.69 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.557 ' CG1' HD12 ' A' ' 27' ' ' ILE . 89.7 t -95.91 125.44 48.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.7 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.553 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 77.9 m-85 -119.31 147.54 44.19 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.28 0.562 . . . . 0.0 111.058 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.551 ' OG ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -88.85 178.75 6.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.491 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.427 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -64.06 -18.65 64.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.208 179.628 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -94.73 20.88 8.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.234 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.85 30.05 56.08 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.756 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.56 153.66 20.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.344 . . . . 0.0 110.901 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.21 106.04 6.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.707 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.551 HD11 ' OG ' ' A' ' 82' ' ' SER . 28.4 mm -78.23 -64.68 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.404 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.917 HD21 ' HG3' ' A' ' 91' ' ' LYS . 3.0 tt -145.1 133.26 21.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.155 0.502 . . . . 0.0 111.814 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.2 108.33 14.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.168 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.917 ' HG3' HD21 ' A' ' 89' ' ' LEU . 7.9 mmpt? -121.2 158.08 28.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.726 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.39 122.43 17.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.238 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -118.45 160.77 21.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.963 0.411 . . . . 0.0 111.421 -179.39 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -106.79 131.82 53.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.383 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.872 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -117.39 99.16 6.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.319 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -94.84 111.92 23.67 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.188 0.518 . . . . 0.0 110.524 179.238 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.782 HG21 ' HB3' ' A' ' 68' ' ' LEU . 4.0 mt -110.67 114.18 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.753 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mt . . . . . 0 N--CA 1.442 -0.861 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.652 179.308 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.763 0.316 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -100.03 78.94 2.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.85 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -83.03 -74.94 0.34 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.58 159.5 9.04 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.481 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -139.93 154.9 47.34 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.317 0.58 . . . . 0.0 111.028 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.942 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -148.04 149.32 15.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.432 -179.539 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -117.68 131.46 56.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.895 0.378 . . . . 0.0 110.92 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.96 -178.04 19.36 Favored Glycine 0 C--O 1.229 -0.163 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.562 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.429 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.23 134.09 48.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.995 0.426 . . . . 0.0 111.178 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.648 HD11 ' C ' ' A' ' 69' ' ' THR . 1.3 tp -56.62 130.88 47.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.837 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.89 -7.18 81.55 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.507 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.531 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.88 167.64 9.84 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.604 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.68 -172.69 12.23 Favored Glycine 0 C--O 1.226 -0.366 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.607 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.833 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.0 OUTLIER 163.29 136.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.432 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -120.83 122.13 39.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.545 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.773 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -79.07 103.47 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.788 179.215 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.44 ' O ' HD21 ' A' ' 93' ' ' LEU . 68.7 m-20 -87.74 122.25 31.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.226 0.536 . . . . 0.0 112.186 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.935 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -79.9 119.91 78.2 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.158 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.11 131.04 36.95 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.272 1.982 . . . . 0.0 112.829 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.4 m120 43.56 65.28 1.02 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -142.71 149.4 38.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.766 0.317 . . . . 0.0 110.576 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -142.88 104.49 4.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.905 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.78 75.2 0.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.83 -173.53 2.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.76 -31.07 62.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.017 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -64.12 -26.64 68.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.966 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.641 HD12 ' CG1' ' A' ' 80' ' ' VAL . 27.4 mm -86.04 127.06 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.437 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.408 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -112.32 -42.72 3.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.081 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.541 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 36.0 tt0 -126.46 117.28 22.58 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.433 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.9 t -116.88 107.62 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.149 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -105.44 134.76 48.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.233 0.539 . . . . 0.0 112.034 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.483 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 69.0 m95 -112.39 88.1 2.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.209 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -102.11 146.35 28.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.253 0.549 . . . . 0.0 112.295 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.5 116.22 12.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.527 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.14 -116.34 8.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.745 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 p -116.5 43.4 2.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.768 0.318 . . . . 0.0 110.642 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.2 m -152.86 159.76 43.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.271 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.54 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.6 mt -102.43 148.56 25.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.808 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.415 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 54.7 t -119.57 -43.53 2.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.256 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -167.2 113.23 0.76 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.547 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -120.61 113.54 20.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.226 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.517 ' HB2' HD13 ' A' ' 57' ' ' ILE . 13.3 t80 -102.83 123.61 46.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.742 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -119.74 133.7 55.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.289 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -47.83 -28.9 2.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.409 0.623 . . . . 0.0 111.423 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -82.44 39.4 0.6 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.862 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 41.91 -166.19 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.666 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm 55.04 63.62 6.63 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.698 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.06 -178.35 4.45 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.572 2.181 . . . . 0.0 112.021 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.54 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 70.1 t80 -125.71 101.93 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.688 0.28 . . . . 0.0 111.51 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.7 mt -98.08 110.99 23.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.423 . . . . 0.0 109.879 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 51.7 tptt -43.83 -39.5 3.89 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.82 0.343 . . . . 0.0 111.365 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.05 165.97 0.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.943 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.84 -10.56 2.37 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.371 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.88 2.15 10.97 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 117.819 0.809 . . . . 0.0 112.343 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -134.05 156.93 47.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.153 0.502 . . . . 0.0 111.261 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -152.35 118.54 5.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.191 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 57' ' ' ILE . 6.6 tt -73.96 101.62 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.122 0.487 . . . . 0.0 111.388 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.453 HD13 ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -50.6 169.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.177 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.8 -25.06 65.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.581 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.504 ' ND2' ' HB2' ' A' ' 62' ' ' ASP . 5.9 p-10 -97.06 33.25 1.96 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.753 0.311 . . . . 0.0 111.122 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.55 30.51 65.39 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.672 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.504 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -96.99 170.47 9.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 111.096 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 10.0 tp -110.08 119.24 38.65 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.469 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.453 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.5 OUTLIER -106.73 110.94 23.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.742 0.306 . . . . 0.0 110.746 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.833 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -89.42 138.53 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.468 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -84.26 -49.17 9.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.009 0.433 . . . . 0.0 111.875 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.26 110.65 5.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.494 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.035 HD22 HD12 ' A' ' 97' ' ' ILE . 5.1 mt -54.09 147.9 11.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.273 0.559 . . . . 0.0 111.779 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.648 ' C ' HD11 ' A' ' 10' ' ' LEU . 12.0 p -152.3 169.41 22.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.485 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.4 ' N ' HD11 ' A' ' 10' ' ' LEU . 7.0 mmm180 -51.33 -52.89 41.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.477 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -56.06 -21.65 23.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.597 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.12 -14.87 52.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.549 0.214 . . . . 0.0 111.498 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -82.82 117.84 22.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.678 0.275 . . . . 0.0 110.601 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.95 -166.26 33.43 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.17 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.44 126.39 39.68 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 122.507 0.323 . . . . 0.0 111.266 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -102.95 148.41 25.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.358 -0.383 . . . . 0.0 109.982 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -129.67 126.17 37.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 0.0 111.707 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.935 HG11 HD11 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -111.99 132.67 59.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.025 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.03 96.85 5.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.588 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.641 ' CG1' HD12 ' A' ' 27' ' ' ILE . 76.0 t -85.58 128.61 39.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.301 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.541 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.5 m-85 -119.25 153.02 35.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.068 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.658 ' OG ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -88.25 175.42 7.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.355 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.1 p -62.69 -28.4 69.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.994 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -77.62 -4.49 46.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.427 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.6 27.91 45.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.6 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.33 165.5 11.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.867 0.365 . . . . 0.0 110.764 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.53 127.08 31.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.592 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.658 HD11 ' OG ' ' A' ' 82' ' ' SER . 33.0 mm -104.12 -67.31 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.372 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.918 HD21 ' HG3' ' A' ' 91' ' ' LYS . 3.2 tt -137.37 127.17 25.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.132 0.492 . . . . 0.0 111.799 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -115.75 106.69 14.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.199 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.918 ' HG3' HD21 ' A' ' 89' ' ' LEU . 5.7 mmpt? -117.19 161.96 18.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.372 0.606 . . . . 0.0 112.526 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.95 122.07 12.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.993 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -120.25 156.22 31.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.937 0.399 . . . . 0.0 111.679 -179.045 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.78 110.72 22.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.17 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.942 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -101.73 98.2 8.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.286 -179.325 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.44 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -92.78 121.83 34.56 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 110.743 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.035 HD12 HD22 ' A' ' 68' ' ' LEU . 2.9 mm -107.24 116.38 50.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.991 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.3 mt -74.17 124.23 25.96 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.467 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.875 -179.781 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.0 mtt180 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.87 0.367 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.27 92.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -74.16 -69.0 0.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.947 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.9 160.69 24.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.524 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -144.79 148.95 34.66 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.249 0.547 . . . . 0.0 110.919 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.893 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -140.64 142.88 29.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.737 -179.499 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.487 ' CD2' ' HD3' ' A' ' 96' ' ' ARG . 79.1 m95 -110.85 129.65 55.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.689 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.41 -179.9 26.58 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.062 -1.066 . . . . 0.0 112.969 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.426 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.15 134.55 49.1 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.95 0.405 . . . . 0.0 110.962 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.733 HD11 ' C ' ' A' ' 69' ' ' THR . 1.4 tp -55.81 133.27 51.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.41 -5.72 84.4 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.47 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.523 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -110.61 168.71 9.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.594 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -72.3 -169.4 12.76 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.5 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.937 HG21 HD21 ' A' ' 68' ' ' LEU . 0.9 OUTLIER 160.36 136.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 122.647 0.379 . . . . 0.0 110.347 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.563 ' OD2' HD22 ' A' ' 58' ' ' LEU . 17.5 t70 -118.71 130.1 55.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.949 0.404 . . . . 0.0 111.299 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -88.94 106.45 18.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.765 179.305 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -88.85 123.86 33.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.165 0.507 . . . . 0.0 111.867 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.93 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.4 mt -79.89 119.86 78.05 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.284 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.93 131.3 38.75 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.325 2.017 . . . . 0.0 112.856 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 43.04 65.42 0.96 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -142.65 149.31 38.73 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.579 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -139.26 117.46 11.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -80.24 80.98 6.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.38 -174.23 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.843 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.23 -30.86 62.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.991 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -62.19 -27.86 69.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.962 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.639 HD12 ' CG1' ' A' ' 80' ' ' VAL . 35.1 mm -88.21 127.21 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.369 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -113.13 -42.27 3.57 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.053 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.543 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 45.9 tt0 -123.94 115.91 22.03 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.365 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.41 112.79 42.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.829 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -111.01 130.6 55.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.024 0.44 . . . . 0.0 112.149 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -112.03 84.06 1.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.934 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -100.73 153.77 19.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.338 0.59 . . . . 0.0 112.297 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.34 116.14 8.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.676 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.24 -117.76 11.43 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.207 -0.997 . . . . 0.0 111.88 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.07 42.61 2.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.818 0.342 . . . . 0.0 110.738 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.1 m -151.14 160.26 43.97 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.155 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.633 HD21 ' OE2' ' A' ' 41' ' ' GLU . 6.0 mt -104.97 146.08 29.53 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.448 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 52.8 t -117.1 -42.94 3.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.983 0.42 . . . . 0.0 110.227 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.76 111.86 0.89 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.519 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.633 ' OE2' HD21 ' A' ' 38' ' ' LEU . 2.4 mt-10 -120.77 117.02 26.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.203 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -104.29 147.29 27.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.648 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.82 136.03 22.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.818 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 45' ' ' LYS . 6.9 tpp180 -51.71 -88.98 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.243 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' N ' ' HG3' ' A' ' 44' ' ' ARG . 25.8 mmtm -82.59 48.65 1.34 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.007 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -162.73 146.68 11.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.971 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -67.64 137.61 93.13 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.56 176.32 9.7 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.574 2.183 . . . . 0.0 112.546 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.528 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 58.9 t80 -131.39 103.47 6.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.202 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.3 mt -97.6 111.87 23.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.081 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 33.6 tttm -45.2 -42.64 9.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.745 0.307 . . . . 0.0 111.527 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.8 p -176.63 165.79 2.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.888 0.375 . . . . 0.0 111.154 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.14 -11.34 4.62 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.158 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.17 2.19 11.47 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 117.707 0.753 . . . . 0.0 112.098 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -133.15 157.16 46.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.074 0.464 . . . . 0.0 111.184 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -153.92 120.18 5.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.331 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.641 HG23 ' O ' ' A' ' 57' ' ' ILE . 7.9 tt -74.93 99.94 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 0.0 111.282 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.563 HD22 ' OD2' ' A' ' 15' ' ' ASP . 0.7 OUTLIER -51.68 163.39 0.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.209 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.88 -22.0 65.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.458 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -96.53 31.91 2.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.761 0.315 . . . . 0.0 111.096 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.66 35.65 68.18 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.901 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.06 157.19 21.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.836 0.35 . . . . 0.0 111.033 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.95 123.25 36.07 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.782 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.524 ' HB2' HD13 ' A' ' 58' ' ' LEU . 2.1 ttpt -108.24 108.57 19.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.693 0.283 . . . . 0.0 110.919 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.859 HD12 ' CG2' ' A' ' 14' ' ' ILE . 3.2 mt -88.1 137.47 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.404 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -87.82 -45.98 9.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.974 0.416 . . . . 0.0 111.829 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.53 109.21 5.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.481 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.937 HD21 HG21 ' A' ' 14' ' ' ILE . 5.7 mt -57.37 152.5 14.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.178 0.514 . . . . 0.0 111.564 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.733 ' C ' HD11 ' A' ' 10' ' ' LEU . 7.5 p -154.11 161.35 41.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.136 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.583 ' N ' HD11 ' A' ' 10' ' ' LEU . 26.2 mmm180 -50.62 -56.18 12.98 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.247 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -54.85 -22.19 13.79 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.465 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.697 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -81.39 -15.09 56.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.307 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.8 p -83.13 132.19 35.1 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.72 0.295 . . . . 0.0 110.733 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.45 -131.34 3.25 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.344 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -128.81 130.48 47.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.722 0.761 . . . . 0.0 110.627 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.484 ' CE1' HD12 ' A' ' 95' ' ' LEU . 25.7 m-85 -105.08 148.51 26.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.219 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.662 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 13.6 m-20 -130.73 122.35 27.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.767 0.318 . . . . 0.0 111.374 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.93 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -105.75 129.04 59.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.232 179.267 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.6 97.8 6.34 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.655 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.639 ' CG1' HD12 ' A' ' 27' ' ' ILE . 87.2 t -89.36 129.92 39.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.335 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.543 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 96.9 m-85 -123.87 154.01 40.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.403 0.62 . . . . 0.0 111.188 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.533 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -87.79 175.31 7.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.352 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 2.1 p -62.13 -21.69 65.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.115 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -96.27 25.6 4.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.161 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.95 27.72 51.51 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.69 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.15 156.84 16.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.319 . . . . 0.0 110.866 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -77.38 110.26 11.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.783 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.533 HD11 ' HB3' ' A' ' 82' ' ' SER . 33.3 mm -91.46 -48.33 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.293 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.483 HD21 ' CG ' ' A' ' 91' ' ' LYS . 2.6 tt -154.57 149.85 27.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.277 0.56 . . . . 0.0 111.709 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -141.11 108.58 5.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.289 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.483 ' CG ' HD21 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -121.59 157.33 30.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.416 0.627 . . . . 0.0 112.598 -178.254 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.662 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -140.0 124.59 18.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.126 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.644 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -122.34 164.82 17.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.036 0.446 . . . . 0.0 111.674 -179.292 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -111.94 124.21 51.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.239 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.893 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -108.84 113.61 26.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.419 -179.408 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.487 ' HD3' ' CD2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -113.21 117.13 31.02 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.193 0.52 . . . . 0.0 110.447 178.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.918 HG21 ' HB3' ' A' ' 68' ' ' LEU . 1.2 mt -108.61 110.28 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.924 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.5 mt -64.66 127.72 32.72 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.077 0.465 . . . . 0.0 110.219 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.907 -179.739 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.859 0.361 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 t70 60.38 79.96 0.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.92 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.42 -31.25 13.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.925 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.88 163.88 30.61 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.484 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -140.51 151.73 45.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.199 0.523 . . . . 0.0 110.908 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.939 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER -143.22 151.06 17.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.724 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -120.27 130.16 54.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.56 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.735 ' C ' HG23 ' A' ' 97' ' ' ILE . . . -148.9 -179.02 24.46 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.904 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.527 ' N ' HG23 ' A' ' 97' ' ' ILE . . . -132.09 134.85 45.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.071 0.462 . . . . 0.0 111.226 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.649 HD11 ' N ' ' A' ' 70' ' ' ARG . 0.7 OUTLIER -52.84 136.22 34.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.031 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.2 -9.6 72.15 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.702 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.527 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.44 168.35 9.3 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.601 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -71.95 -170.94 14.65 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.424 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.893 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 162.03 136.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.815 0.34 . . . . 0.0 110.43 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.411 ' OD2' HD22 ' A' ' 58' ' ' LEU . 65.7 t0 -123.72 130.43 52.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.402 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.426 HD11 ' HG ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -84.27 135.73 34.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.692 179.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.479 ' O ' HD21 ' A' ' 93' ' ' LEU . 73.5 m-20 -116.39 122.02 43.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.275 0.559 . . . . 0.0 111.813 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.925 HD11 HG11 ' A' ' 78' ' ' VAL . 3.2 mt -81.46 119.6 76.02 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.245 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.65 130.87 37.19 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.364 2.043 . . . . 0.0 112.999 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.0 m120 42.78 65.07 1.0 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -141.43 149.3 40.83 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.772 0.32 . . . . 0.0 110.559 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -137.91 117.43 12.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.939 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.564 ' SD ' HG21 ' A' ' 30' ' ' VAL . 1.7 tpt -79.57 75.39 6.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.972 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.7 p -107.44 -173.16 2.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.99 -32.34 70.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -59.24 -27.04 65.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.98 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.535 HD12 ' CG1' ' A' ' 80' ' ' VAL . 19.2 mm -78.81 128.1 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.492 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.483 ' OD1' HG22 ' A' ' 83' ' ' THR . 0.4 OUTLIER -111.3 -44.32 3.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.14 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 73.3 tt0 -130.31 116.32 18.18 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.172 -0.611 . . . . 0.0 112.537 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.564 HG21 ' SD ' ' A' ' 23' ' ' MET . 2.8 t -112.42 111.24 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.743 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -108.18 130.31 55.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.178 0.513 . . . . 0.0 112.239 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -112.68 84.65 2.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.9 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.35 154.16 19.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.316 0.579 . . . . 0.0 112.247 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.424 ' HD3' ' CZ ' ' A' ' 76' ' ' TYR . 10.3 ttp-105 -143.96 118.32 9.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.602 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.01 -117.64 10.9 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.829 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.1 m -115.99 43.02 2.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.743 0.306 . . . . 0.0 110.739 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.7 m -151.14 160.06 44.09 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.171 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.537 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 6.0 mt -103.73 145.66 29.76 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.402 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 55.7 t -117.5 -43.42 3.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.153 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -166.06 111.31 0.84 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.752 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -117.66 112.42 20.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.042 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.42 ' CG ' ' N ' ' A' ' 43' ' ' LYS . 21.1 t80 -101.4 158.84 15.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.85 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 42' ' ' PHE . 2.1 mppt? -149.71 172.83 14.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.819 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.405 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -93.96 103.05 15.15 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.759 0.79 . . . . 0.0 109.797 179.306 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 44' ' ' ARG . 0.5 OUTLIER 82.48 -47.32 0.17 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.695 -179.435 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.8 ttt -54.01 167.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.863 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.19 128.72 61.17 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.048 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.407 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 97.9 Cg_endo -81.52 -174.44 2.18 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.605 2.203 . . . . 0.0 112.607 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.537 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 71.1 t80 -137.49 105.46 5.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.352 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.1 mt -99.73 112.26 24.52 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.402 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 78.0 tttt -44.53 -45.87 9.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.725 0.298 . . . . 0.0 111.368 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.87 166.69 2.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.94 0.4 . . . . 0.0 111.112 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.77 -11.61 2.13 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.401 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.49 2.01 10.58 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 117.79 0.795 . . . . 0.0 112.296 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -135.46 157.16 47.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.084 0.468 . . . . 0.0 111.284 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -153.32 122.06 6.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.249 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 57' ' ' ILE . 6.4 tt -76.0 101.52 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.152 0.501 . . . . 0.0 111.213 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.666 HD13 ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -54.35 160.35 1.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.138 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.19 -21.97 66.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.404 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -96.13 32.81 1.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.052 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.71 34.37 56.25 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.778 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.26 155.3 22.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.866 0.365 . . . . 0.0 111.028 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 tp -92.95 122.71 35.59 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.821 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.666 ' HB2' HD13 ' A' ' 58' ' ' LEU . 4.4 tmtt? -108.04 110.06 21.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.71 0.29 . . . . 0.0 110.863 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.84 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.8 mt -89.18 138.79 18.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.408 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -86.69 -47.67 8.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.008 0.432 . . . . 0.0 111.91 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -142.73 110.73 5.96 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.335 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 14' ' ' ILE . 7.2 mt -55.65 150.77 11.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.308 0.575 . . . . 0.0 111.795 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.648 ' C ' HD11 ' A' ' 10' ' ' LEU . 6.8 p -153.36 161.42 42.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.813 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.649 ' N ' HD11 ' A' ' 10' ' ' LEU . 1.5 ptp180 -50.91 -54.84 20.64 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.429 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -57.43 -20.64 31.53 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.459 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.693 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -82.76 -15.53 51.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.389 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.8 t -82.78 130.69 35.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.582 0.23 . . . . 0.0 110.446 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.51 -166.25 29.63 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.172 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.7 126.4 36.77 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 122.522 0.329 . . . . 0.0 111.538 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.424 ' CZ ' ' HD3' ' A' ' 34' ' ' ARG . 18.9 m-85 -102.93 151.83 22.01 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -131.52 125.77 33.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.754 0.312 . . . . 0.0 111.492 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.925 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -110.1 130.8 62.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.211 179.155 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.419 HG23 ' OD1' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -118.02 98.46 6.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.512 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.535 ' CG1' HD12 ' A' ' 27' ' ' ILE . 93.5 t -91.46 125.73 44.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.748 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.459 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.5 m-85 -118.39 152.79 35.18 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.91 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.658 ' HA ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -90.67 172.32 8.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.567 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.483 HG22 ' OD1' ' A' ' 28' ' ' ASP . 16.9 p -60.04 -19.46 52.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.377 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -93.97 25.27 3.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.233 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.59 20.95 40.63 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.787 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.62 166.08 11.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.703 0.287 . . . . 0.0 110.696 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -90.89 120.19 31.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.731 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' A' ' 82' ' ' SER . 38.3 mt -90.71 -58.87 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.498 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.811 HD11 ' HE2' ' A' ' 91' ' ' LYS . 2.7 tt -147.83 133.68 19.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.117 0.484 . . . . 0.0 111.879 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.419 ' OD1' HG23 ' A' ' 79' ' ' THR . 0.1 OUTLIER -121.23 109.61 15.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.923 178.648 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.811 ' HE2' HD11 ' A' ' 89' ' ' LEU . 31.5 mmtm -121.5 162.66 20.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.01 121.95 14.52 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.047 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.642 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -113.76 164.71 13.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.03 0.443 . . . . 0.0 111.737 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -114.73 111.82 21.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.271 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.939 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -99.22 99.38 10.34 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.245 -179.422 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.73 120.47 40.14 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.004 0.431 . . . . 0.0 110.455 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.759 HG12 HD22 ' A' ' 68' ' ' LEU . 1.7 mt -128.42 129.13 68.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.794 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.7 mt -82.65 169.55 16.12 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.879 179.885 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.833 0.349 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 68.33 -68.57 0.17 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.014 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.5 m -65.56 144.75 56.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.821 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.3 -150.71 35.6 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.475 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 2.7 m -50.63 147.34 4.76 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.378 0.609 . . . . 0.0 111.33 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.812 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER -141.03 147.32 22.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.717 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -115.89 127.91 55.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.525 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.75 -178.8 21.52 Favored Glycine 0 N--CA 1.459 0.171 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.705 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.429 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.96 134.68 48.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.069 0.461 . . . . 0.0 111.287 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.712 HD11 ' C ' ' A' ' 69' ' ' THR . 1.0 OUTLIER -55.62 134.82 51.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.741 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.66 -8.58 77.02 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.456 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.53 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -106.95 167.16 10.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.614 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.41 -173.85 14.06 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.551 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.814 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 161.24 136.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 122.579 0.352 . . . . 0.0 110.367 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.546 ' OD2' HD22 ' A' ' 58' ' ' LEU . 7.4 t0 -124.85 123.78 40.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.955 0.407 . . . . 0.0 111.525 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.726 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -79.07 112.19 16.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.744 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -93.76 124.89 38.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.191 0.52 . . . . 0.0 111.884 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.937 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -81.64 120.04 76.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.252 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.01 131.12 37.63 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.278 1.985 . . . . 0.0 112.901 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.9 m120 43.12 65.16 1.01 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -142.14 149.37 39.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.758 0.313 . . . . 0.0 110.607 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -138.83 117.41 12.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.407 ' SD ' HG21 ' A' ' 30' ' ' VAL . 4.1 tpt -81.17 76.22 8.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 46.8 p -111.43 -173.03 2.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -57.8 -30.52 65.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.966 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -62.1 -28.12 69.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.641 HD12 ' CG1' ' A' ' 80' ' ' VAL . 33.6 mm -87.74 126.8 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.383 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.73 -41.92 3.71 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 61.3 tt0 -125.84 118.32 25.24 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.28 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 30.9 t -121.32 117.69 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.019 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.449 ' NH1' ' CE2' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -115.81 136.94 52.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.266 0.555 . . . . 0.0 112.223 -178.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.478 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 74.8 m95 -112.12 87.38 2.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.702 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -101.05 149.91 23.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.355 0.598 . . . . 0.0 112.283 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.7 ttp85 -142.13 117.59 10.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.462 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.81 -115.65 7.13 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.737 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 t -118.59 44.35 2.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.786 0.327 . . . . 0.0 110.683 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.3 m -151.94 160.39 43.51 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.328 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.607 HD22 ' OE1' ' A' ' 41' ' ' GLU . 5.5 mt -103.25 146.89 27.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.479 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 56.1 t -119.01 -43.52 2.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.959 0.409 . . . . 0.0 110.476 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -174.73 114.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.045 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.607 ' OE1' HD22 ' A' ' 38' ' ' LEU . 1.1 pt-20 -128.35 156.04 43.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.009 0.433 . . . . 0.0 110.947 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -124.39 144.11 50.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.871 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.3 mtmm -145.72 111.25 5.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.649 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.3 tpp85 -47.98 -59.32 3.45 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.734 0.778 . . . . 0.0 111.148 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -82.56 46.72 1.09 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.941 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.7 mtt 177.59 -171.86 0.1 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.928 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -109.09 146.76 34.54 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.821 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.3 155.78 51.1 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.576 2.184 . . . . 0.0 112.585 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.521 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 33.8 t80 -115.86 101.85 9.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.34 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 50' ' ' LEU . 11.2 mt -91.29 116.22 28.66 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.479 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 12.1 tptm -38.88 -90.33 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.729 0.641 . . . . 0.0 112.729 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 m -117.41 22.68 12.28 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.76 -0.03 52.77 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.089 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.32 5.33 27.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 117.53 0.665 . . . . 0.0 111.02 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -126.24 158.22 36.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.024 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -138.71 119.55 14.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.147 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.649 HG23 ' O ' ' A' ' 57' ' ' ILE . 7.4 tt -78.13 99.67 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.182 0.515 . . . . 0.0 111.064 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.546 HD22 ' OD2' ' A' ' 15' ' ' ASP . 0.5 OUTLIER -55.47 153.14 7.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.279 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.32 -19.79 56.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.475 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.24 31.94 2.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.861 0.363 . . . . 0.0 111.043 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.37 36.35 57.64 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.847 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -112.97 157.88 20.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.023 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 12.0 tp -95.2 122.49 37.93 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.125 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.507 ' HB2' HD13 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -110.26 104.71 13.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.715 0.293 . . . . 0.0 110.696 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.806 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -81.02 134.59 26.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.774 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -78.28 -49.06 14.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.09 0.471 . . . . 0.0 111.513 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.53 112.99 5.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.134 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.814 HD21 HG21 ' A' ' 14' ' ' ILE . 5.8 mt -52.73 148.37 7.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.261 0.553 . . . . 0.0 111.873 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.712 ' C ' HD11 ' A' ' 10' ' ' LEU . 7.1 p -152.13 163.1 40.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.78 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.579 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -50.81 -55.22 17.91 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.291 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -52.66 -22.95 5.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.614 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -82.99 -13.87 55.13 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.571 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.7 t -83.45 119.96 25.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.672 0.272 . . . . 0.0 110.582 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.46 -139.06 5.85 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.467 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 m -120.32 130.86 54.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 117.382 0.591 . . . . 0.0 110.648 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -106.43 151.27 25.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.386 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.652 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 4.0 m-20 -134.47 121.81 21.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.332 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.937 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -106.8 133.46 51.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.24 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.28 103.6 9.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.549 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.641 ' CG1' HD12 ' A' ' 27' ' ' ILE . 91.1 t -93.81 129.28 44.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.689 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.564 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.8 m-85 -121.44 153.64 37.61 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.998 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.714 ' OG ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -87.99 176.45 7.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.336 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.0 p -64.63 -28.67 69.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.979 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -77.3 -4.53 45.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.421 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.62 27.33 43.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.536 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.6 165.68 11.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 110.783 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.98 134.13 38.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.568 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.714 HD11 ' OG ' ' A' ' 82' ' ' SER . 37.8 mm -111.52 -66.64 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.397 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.914 HD21 ' HG3' ' A' ' 91' ' ' LYS . 3.5 tt -141.09 128.76 21.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.1 0.476 . . . . 0.0 111.845 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.47 107.22 14.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.177 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.914 ' HG3' HD21 ' A' ' 89' ' ' LEU . 16.0 mmtt -118.1 158.57 24.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.389 0.614 . . . . 0.0 112.536 -178.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.652 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -140.63 125.79 18.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.152 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.646 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -125.32 161.53 26.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.047 0.451 . . . . 0.0 111.65 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 5' ' ' THR . 1.6 m-20 -110.32 116.85 32.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.228 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.812 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -104.8 103.76 13.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.308 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.46 115.26 28.88 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 110.692 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.736 HG12 HD22 ' A' ' 68' ' ' LEU . 3.1 mt -106.4 111.79 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.557 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.25 170.24 16.94 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.246 0.546 . . . . 0.0 110.734 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.9 179.965 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 20.4 tpt85 . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.813 0.34 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.42 -62.26 1.51 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 m -132.13 163.61 28.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.94 163.23 54.19 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.442 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 m -138.92 154.78 48.38 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.261 0.553 . . . . 0.0 110.975 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.943 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -147.34 150.03 15.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.642 -179.484 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -118.84 131.15 56.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.29 -178.53 19.19 Favored Glycine 0 N--CA 1.459 0.21 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.508 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.444 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -126.48 133.25 51.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.048 0.452 . . . . 0.0 111.313 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.421 ' CD1' ' HA ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -55.6 131.06 45.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.874 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.51 -6.42 83.22 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.452 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.524 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.05 167.66 9.84 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.596 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.4 -172.93 11.85 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.597 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.836 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.0 OUTLIER 163.31 136.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.773 0.32 . . . . 0.0 110.354 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.467 ' OD2' HD22 ' A' ' 58' ' ' LEU . 2.1 t70 -121.75 122.47 39.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.936 0.398 . . . . 0.0 111.476 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.741 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -77.96 108.82 11.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.773 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -93.3 123.11 36.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.176 0.513 . . . . 0.0 111.967 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.978 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -79.37 119.47 77.12 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.262 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.54 131.21 36.94 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.393 2.062 . . . . 0.0 112.976 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 43.27 64.74 1.13 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -140.21 149.07 42.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.834 0.35 . . . . 0.0 110.497 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -132.9 116.72 16.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.1 90.01 7.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.8 p -125.84 -173.04 2.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.937 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.27 -30.53 64.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.941 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.712 ' O ' HG23 ' A' ' 83' ' ' THR . 2.0 t70 -62.07 -25.59 67.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.992 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.484 HD12 ' CG1' ' A' ' 80' ' ' VAL . 33.8 mm -79.34 128.47 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.509 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.2 -38.82 7.52 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.234 -0.291 . . . . 0.0 111.325 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 12.7 mt-10 -142.6 153.75 43.78 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-O 121.581 0.705 . . . . 0.0 112.355 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.8 t -148.26 116.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.162 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -112.24 134.1 53.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.071 0.462 . . . . 0.0 112.05 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.46 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 73.3 m95 -112.33 85.07 2.08 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -102.47 148.17 25.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.3 0.571 . . . . 0.0 112.22 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.04 118.75 13.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.557 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.91 -116.37 8.17 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.773 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.9 m -117.66 43.88 2.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.769 0.319 . . . . 0.0 110.71 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.7 m -152.88 160.0 43.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.265 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.536 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.8 mt -102.79 147.19 27.17 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.798 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 50.0 t -118.47 -42.92 2.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.285 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -167.47 112.17 0.7 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.597 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -118.51 119.32 34.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.969 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.708 ' HB2' HD13 ' A' ' 57' ' ' ILE . 49.1 t80 -105.92 157.66 17.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.705 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -152.99 151.42 30.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -59.83 90.27 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.968 0.89 . . . . 0.0 110.63 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 80.85 -45.56 0.24 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.838 -1.528 . . . . 0.0 111.258 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -45.06 142.77 1.76 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.823 0.344 . . . . 0.0 111.293 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.2 122.34 53.41 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.074 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.67 -172.78 1.61 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.597 2.198 . . . . 0.0 112.567 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.536 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 68.7 t80 -136.82 104.24 5.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.284 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.1 mt -98.01 110.78 23.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.02 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 28.8 tttm -45.29 -40.58 7.8 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.77 0.319 . . . . 0.0 111.533 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 p -178.21 164.61 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 111.205 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.75 -11.73 4.42 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.166 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.83 1.6 12.21 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 117.593 0.697 . . . . 0.0 112.155 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -131.99 156.97 45.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.184 0.516 . . . . 0.0 111.262 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -151.82 117.24 5.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.196 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.708 HD13 ' HB2' ' A' ' 42' ' ' PHE . 9.2 tt -73.83 99.48 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.321 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.467 HD22 ' OD2' ' A' ' 15' ' ' ASP . 0.7 OUTLIER -51.12 166.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.163 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.9 -23.96 65.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.637 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.492 ' ND2' ' HB2' ' A' ' 62' ' ' ASP . 5.7 p-10 -96.76 33.33 1.88 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.796 0.331 . . . . 0.0 111.16 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.75 33.9 69.12 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.621 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.492 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -103.08 165.79 10.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.868 0.366 . . . . 0.0 111.012 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 10.3 tp -107.0 119.71 40.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.518 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HB2' HD13 ' A' ' 58' ' ' LEU . 1.5 ttpt -105.75 111.25 23.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.309 . . . . 0.0 110.996 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.836 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.7 mt -90.93 138.22 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.449 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -84.16 -48.19 10.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.066 0.46 . . . . 0.0 111.896 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.11 111.35 5.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.312 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.045 HD22 HD12 ' A' ' 97' ' ' ILE . 4.9 mt -53.61 147.22 11.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.22 0.533 . . . . 0.0 111.736 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.421 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 5.3 p -147.59 160.88 42.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.852 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.74 -56.43 12.04 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.093 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.6 -22.7 9.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.428 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.688 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -80.54 -15.24 57.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.627 0.251 . . . . 0.0 111.308 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.415 ' CB ' HG12 ' A' ' 97' ' ' ILE . 2.4 t -81.58 120.79 25.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.591 0.234 . . . . 0.0 110.578 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.98 -144.43 9.88 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.373 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.9 m -115.65 130.62 56.93 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.056 0.428 . . . . 0.0 110.663 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -108.26 133.23 52.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.24 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.724 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 17.4 m-20 -114.98 124.37 51.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.458 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.978 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -107.02 133.52 51.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.192 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.36 96.37 5.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.695 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.492 HG12 ' HB ' ' A' ' 88' ' ' ILE . 70.9 t -86.74 126.9 40.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.234 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.517 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 2.6 m-30 -112.8 151.33 30.48 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.346 0.593 . . . . 0.0 110.612 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.73 ' HA ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -93.42 178.99 5.53 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.199 179.749 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 26' ' ' ASP . 73.5 p -68.51 -23.51 64.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.044 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -75.91 -5.22 45.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.592 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.29 24.57 47.08 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.666 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.64 -170.59 1.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.757 0.313 . . . . 0.0 110.683 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -105.31 115.62 30.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.971 0.415 . . . . 0.0 110.811 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.73 HD11 ' HA ' ' A' ' 82' ' ' SER . 74.4 mt -78.89 -51.66 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.343 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.688 HD21 ' HG3' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -151.83 136.25 16.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.204 0.526 . . . . 0.0 111.9 -179.246 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.4 106.98 13.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.884 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.688 ' HG3' HD21 ' A' ' 89' ' ' LEU . 7.4 mmpt? -116.48 156.97 25.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.724 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.14 122.45 18.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.132 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -117.98 159.41 23.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.896 0.379 . . . . 0.0 111.538 -179.239 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -109.16 110.76 22.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.381 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.943 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -102.27 100.2 10.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.071 -179.451 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.527 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.5 OUTLIER -95.16 123.43 38.66 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.071 0.462 . . . . 0.0 110.89 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.045 HD12 HD22 ' A' ' 68' ' ' LEU . 2.9 mm -107.81 117.47 53.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.999 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.5 mt -74.98 123.38 25.03 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.422 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.946 -179.868 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.873 0.368 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -108.07 154.3 21.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 m 60.48 108.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.9 160.92 15.15 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.518 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.417 ' HA ' ' HB2' ' A' ' 94' ' ' ASP . 4.9 m -137.46 154.17 49.96 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.249 0.547 . . . . 0.0 110.969 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.975 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -146.62 153.33 12.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.855 -179.204 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -121.89 136.39 54.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.033 0.444 . . . . 0.0 111.255 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.485 ' C ' HG23 ' A' ' 97' ' ' ILE . . . -151.45 178.68 28.65 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.303 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.442 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.03 133.8 49.15 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.049 0.452 . . . . 0.0 111.221 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.644 HD11 ' C ' ' A' ' 69' ' ' THR . 1.2 tp -53.51 134.88 40.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.65 -10.94 71.81 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.632 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.524 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -106.66 168.0 9.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.598 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -72.02 -169.61 12.37 Favored Glycine 0 C--O 1.227 -0.315 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.491 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.834 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.0 OUTLIER 163.79 136.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.963 0.411 . . . . 0.0 110.632 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -117.97 130.1 56.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.043 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -91.5 102.99 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.356 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -88.68 123.5 33.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.174 0.511 . . . . 0.0 112.3 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.947 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -79.2 119.96 78.95 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.022 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.03 131.04 37.15 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.262 1.975 . . . . 0.0 112.903 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 43.38 65.09 1.04 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -142.03 150.9 41.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.79 0.328 . . . . 0.0 110.595 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -139.44 117.75 12.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -82.78 78.37 9.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.7 p -112.51 -173.02 2.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -57.9 -30.66 66.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.967 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.49 -27.74 68.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.971 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.611 HD12 ' CG1' ' A' ' 80' ' ' VAL . 31.4 mm -84.38 127.62 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.447 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.5 OUTLIER -111.63 -44.08 3.55 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.247 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 45.8 tp10 -123.69 121.27 35.07 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.187 -0.605 . . . . 0.0 112.117 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.82 114.25 42.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.904 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -112.85 132.38 55.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.133 0.492 . . . . 0.0 112.289 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.413 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 71.7 m95 -113.3 87.77 2.68 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -101.7 148.13 25.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.313 0.578 . . . . 0.0 112.478 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -139.26 116.46 11.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.522 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.07 -116.52 8.46 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.729 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.5 t -117.39 43.87 2.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.866 0.365 . . . . 0.0 110.651 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.0 m -152.27 160.38 43.36 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.224 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.533 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.8 mt -101.7 146.5 27.65 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.464 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 52.9 t -118.52 -43.02 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.97 0.414 . . . . 0.0 110.199 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -166.6 110.17 0.75 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.579 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.44 121.76 40.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.79 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -103.36 146.63 28.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.041 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -153.06 117.9 5.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.69 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.4 ttm-85 -55.68 -56.7 17.35 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.845 0.831 . . . . 0.0 111.298 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -82.19 46.35 1.02 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.191 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.19 -172.4 0.08 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.894 0.378 . . . . 0.0 111.015 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.6 mttm -104.64 142.36 24.48 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.657 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.1 155.18 47.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.462 2.108 . . . . 0.0 112.709 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 48.9 t80 -113.21 100.73 8.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.131 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 50' ' ' LEU . 9.7 mt -94.08 111.15 22.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.069 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 36.3 tttt -45.99 -36.73 5.84 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.702 0.287 . . . . 0.0 111.452 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.0 p -178.74 164.29 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 111.222 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.74 -10.2 6.08 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.142 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.63 2.72 11.16 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.651 0.726 . . . . 0.0 112.188 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -132.08 156.89 45.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.107 0.48 . . . . 0.0 111.239 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -151.5 116.33 5.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.367 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.646 HG23 ' O ' ' A' ' 57' ' ' ILE . 9.7 tt -73.98 99.22 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.105 0.479 . . . . 0.0 111.295 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.499 HD13 ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -49.19 165.75 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.154 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.46 -23.67 65.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.566 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.472 ' ND2' ' HB2' ' A' ' 62' ' ' ASP . 5.5 p-10 -96.21 33.11 1.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.188 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.02 34.71 73.41 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.604 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.472 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -104.31 171.16 7.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.899 0.38 . . . . 0.0 110.874 179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 11.6 tp -112.81 122.35 47.39 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.499 ' HB2' HD13 ' A' ' 58' ' ' LEU . 16.1 tttt -109.04 108.88 19.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.683 0.278 . . . . 0.0 110.947 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.834 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -87.2 141.0 14.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.413 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -85.76 -50.86 6.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.025 0.441 . . . . 0.0 112.1 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.65 110.84 6.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.5 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.69 HD21 HG21 ' A' ' 14' ' ' ILE . 5.4 mt -53.83 147.58 11.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.643 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.644 ' C ' HD11 ' A' ' 10' ' ' LEU . 6.1 p -152.7 161.3 42.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.786 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.528 ' N ' HD11 ' A' ' 10' ' ' LEU . 13.3 mmm-85 -50.48 -56.12 12.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.331 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -57.6 -20.28 31.53 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.629 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.596 ' OD1' HD13 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -84.31 -15.75 45.47 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.533 0.206 . . . . 0.0 111.425 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 t -82.7 133.36 35.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.603 0.24 . . . . 0.0 110.483 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.07 -166.97 30.02 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.134 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.06 126.63 35.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.896 0.379 . . . . 0.0 111.435 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -106.84 128.2 54.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.33 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -112.07 129.16 56.31 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.853 0.359 . . . . 0.0 111.657 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.947 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -112.08 130.59 65.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.98 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.65 98.9 6.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.8 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.611 ' CG1' HD12 ' A' ' 27' ' ' ILE . 82.0 t -92.02 128.71 43.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.462 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.532 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.3 m-85 -124.02 153.45 41.3 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.291 0.567 . . . . 0.0 111.108 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.631 ' CA ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -88.93 174.81 7.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.408 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.1 p -61.07 -22.34 64.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.169 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.83 26.46 4.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.168 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.74 25.77 37.53 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.691 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.24 155.59 16.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.778 0.323 . . . . 0.0 110.889 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.53 116.35 18.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.649 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.631 HD11 ' CA ' ' A' ' 82' ' ' SER . 36.2 mt -93.95 -69.3 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.339 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.906 HD21 ' HG3' ' A' ' 91' ' ' LYS . 2.6 tt -142.34 126.78 17.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.152 0.501 . . . . 0.0 111.903 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.3 106.95 14.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.906 ' HG3' HD21 ' A' ' 89' ' ' LEU . 5.7 mmpt? -118.15 162.49 18.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.464 0.65 . . . . 0.0 112.702 -178.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.6 119.96 10.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.067 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -114.45 157.83 22.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.836 0.351 . . . . 0.0 111.407 -179.235 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.417 ' HB2' ' HA ' ' A' ' 5' ' ' THR . 1.0 OUTLIER -107.09 115.23 29.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.361 179.449 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.975 ' HA ' HG12 ' A' ' 6' ' ' VAL . 38.3 tp -101.11 98.14 8.6 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.958 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.802 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -101.1 123.37 45.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.031 0.443 . . . . 0.0 110.599 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.823 HD11 ' HG ' ' A' ' 95' ' ' LEU . 1.9 mm -122.61 126.65 74.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.065 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 98' ' ' LEU . 12.7 mt -82.99 168.92 16.53 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.564 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.882 179.916 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.905 0.383 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.27 28.55 2.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.048 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.03 158.07 14.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.705 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.56 -150.89 6.08 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.928 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 m -119.43 150.02 40.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.225 0.536 . . . . 0.0 110.964 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.93 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -128.62 147.33 33.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.094 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -119.98 130.45 54.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.562 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.43 -178.07 18.92 Favored Glycine 0 N--CA 1.459 0.196 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.502 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.426 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -130.12 133.99 47.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.07 0.462 . . . . 0.0 111.551 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.431 ' CD1' ' HA ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -54.0 131.84 41.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.798 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.36 -10.65 74.3 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.58 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -107.07 168.97 8.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.6 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -73.52 -168.94 16.14 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.576 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.913 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 161.7 137.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 122.675 0.39 . . . . 0.0 110.062 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.8 124.33 44.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.935 0.397 . . . . 0.0 111.812 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.718 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -82.02 105.98 13.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.482 178.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.408 ' O ' HD21 ' A' ' 93' ' ' LEU . 69.8 m-20 -90.83 123.07 34.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.287 0.565 . . . . 0.0 112.304 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.949 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -80.38 120.35 79.13 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.176 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.27 130.71 37.27 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.32 2.013 . . . . 0.0 112.938 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 42.8 65.05 1.0 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -141.96 149.04 39.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.787 0.327 . . . . 0.0 110.501 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -141.7 117.15 10.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.941 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.38 80.44 3.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.01 -175.65 2.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.18 -33.09 68.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.912 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.79 -26.8 66.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.586 HD12 ' CG1' ' A' ' 80' ' ' VAL . 22.6 mm -79.41 128.32 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.405 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.433 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 0.9 OUTLIER -111.36 -44.44 3.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -179.089 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 42.6 tt0 -130.43 116.88 18.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.572 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -112.48 113.0 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.794 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -111.56 132.48 54.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.12 0.485 . . . . 0.0 112.206 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.431 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 70.3 m95 -113.31 86.53 2.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.954 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -102.62 148.1 25.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.316 0.579 . . . . 0.0 112.295 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.52 117.59 11.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.51 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.96 -116.62 8.53 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.768 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 t -117.28 43.76 2.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.76 0.315 . . . . 0.0 110.672 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.0 m -152.33 159.95 43.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.238 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.539 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.8 mt -103.11 146.83 27.8 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.465 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 51.3 t -118.45 -43.1 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.164 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -166.64 111.57 0.78 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.551 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -118.56 114.77 23.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.567 ' HB2' HD13 ' A' ' 57' ' ' ILE . 25.4 t80 -100.8 157.97 16.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.859 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 46' ' ' MET . 61.0 mtpt -153.35 140.28 19.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.77 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -55.76 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.772 0.796 . . . . 0.0 110.823 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt 81.66 -46.98 0.21 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.11 -1.405 . . . . 0.0 111.229 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.452 ' HB2' ' HB3' ' A' ' 43' ' ' LYS . 1.3 mpt? -51.46 142.99 12.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.835 0.35 . . . . 0.0 111.056 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.28 126.17 73.37 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.192 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 89.8 Cg_endo -84.26 -171.19 0.97 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.643 2.228 . . . . 0.0 112.547 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.539 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 73.3 t80 -137.11 104.36 5.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.338 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 50' ' ' LEU . 7.9 mt -98.57 111.18 23.63 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 12.8 tptm -44.38 -54.58 5.73 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.807 0.336 . . . . 0.0 111.484 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.0 165.07 22.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.146 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.16 -11.69 3.49 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.112 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.41 2.24 11.91 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 117.674 0.737 . . . . 0.0 112.163 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -131.99 156.48 46.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.124 0.488 . . . . 0.0 111.392 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -152.57 119.59 5.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.252 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.644 HG23 ' O ' ' A' ' 57' ' ' ILE . 8.1 tt -75.0 100.26 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.112 0.482 . . . . 0.0 111.325 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.445 HD13 ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -50.63 167.57 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.169 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.74 -24.54 65.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.651 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.493 ' ND2' ' HB2' ' A' ' 62' ' ' ASP . 5.6 p-10 -96.57 33.12 1.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.736 0.303 . . . . 0.0 111.18 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.8 33.37 67.84 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.563 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.493 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -102.38 165.39 11.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 111.049 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 tp -105.14 121.46 43.86 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.47 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.445 ' HB2' HD13 ' A' ' 58' ' ' LEU . 2.1 tmtp? -107.91 110.18 21.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 111.13 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.851 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -90.38 138.24 19.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.063 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -93.3 -41.64 9.76 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.2 106.93 5.36 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.582 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.913 HD21 HG21 ' A' ' 14' ' ' ILE . 7.8 mt -57.35 143.73 38.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.13 0.491 . . . . 0.0 111.461 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.431 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 5.1 p -144.36 159.53 42.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.037 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.32 -56.46 12.93 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.022 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -54.25 -21.83 10.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.429 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.623 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -79.39 -14.44 58.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.3 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.4 t -80.57 129.11 34.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.65 0.262 . . . . 0.0 110.475 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.01 -165.06 30.18 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.12 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -93.98 126.65 39.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.702 0.287 . . . . 0.0 111.349 -179.522 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -104.44 130.86 52.31 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.129 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -112.84 125.8 54.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.881 0.372 . . . . 0.0 111.603 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.949 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.26 130.04 62.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.12 179.146 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.12 98.44 6.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.597 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.586 ' CG1' HD12 ' A' ' 27' ' ' ILE . 91.9 t -91.71 123.34 43.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.583 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.446 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 99.0 m-85 -116.33 152.68 33.39 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.172 0.511 . . . . 0.0 111.135 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.638 ' CA ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -90.5 172.96 8.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.526 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.403 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 7.5 p -57.1 -22.63 41.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.234 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -96.02 26.42 4.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.147 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.87 25.52 30.53 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.718 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.4 156.65 16.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.832 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -79.01 107.52 11.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.695 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.638 HD11 ' CA ' ' A' ' 82' ' ' SER . 38.6 mt -82.2 -70.71 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.347 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.799 HD21 ' HG3' ' A' ' 91' ' ' LYS . 1.5 tt -141.43 128.18 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.112 0.482 . . . . 0.0 111.892 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.85 106.57 14.33 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.799 ' HG3' HD21 ' A' ' 89' ' ' LEU . 5.2 mmtt -117.36 162.45 17.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.446 0.641 . . . . 0.0 112.631 -178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.87 120.88 10.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.162 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.642 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -116.78 161.12 19.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.81 0.338 . . . . 0.0 111.403 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.81 112.22 24.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.201 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.93 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -102.26 101.84 12.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.279 -179.485 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.31 119.81 37.63 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.06 0.457 . . . . 0.0 110.67 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.77 HG21 ' HB3' ' A' ' 68' ' ' LEU . 3.8 mt -112.79 118.24 57.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.732 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 98' ' ' LEU . 8.8 mt -69.8 118.65 12.91 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.683 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.829 -179.809 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.835 0.35 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -88.59 -65.18 1.04 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.6 160.85 6.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.88 -149.61 39.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.499 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -46.33 147.96 1.02 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.325 0.583 . . . . 0.0 111.328 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.85 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -140.22 144.64 27.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.773 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -114.71 126.14 54.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.437 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.17 -179.62 22.49 Favored Glycine 0 N--CA 1.459 0.197 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.76 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.436 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -130.26 134.85 47.53 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.05 0.452 . . . . 0.0 111.353 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.675 HD11 ' C ' ' A' ' 69' ' ' THR . 0.8 OUTLIER -53.07 136.3 35.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.006 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.33 -8.34 74.74 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.668 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.534 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.12 167.8 9.75 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.612 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -71.23 -173.86 17.23 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.565 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.819 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 162.19 136.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 122.493 0.317 . . . . 0.0 110.401 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -122.86 128.18 50.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.964 0.412 . . . . 0.0 111.489 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -85.14 106.6 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.858 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -89.22 124.45 34.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.152 0.501 . . . . 0.0 111.911 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.967 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -79.97 119.62 77.23 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.138 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.16 131.38 38.69 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.367 2.045 . . . . 0.0 112.945 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m120 42.81 65.03 1.01 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.416 ' HB2' HD13 ' A' ' 89' ' ' LEU . 8.9 t80 -141.6 149.29 40.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.817 0.342 . . . . 0.0 110.56 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -143.87 116.43 8.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.02 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.0 ttt -80.68 77.69 7.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.15 -174.44 2.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.2 -30.73 62.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.08 -24.74 65.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.02 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.538 HD12 ' CG1' ' A' ' 80' ' ' VAL . 45.2 mm -85.52 126.54 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.457 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.415 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -111.59 -42.65 3.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 122.142 -0.349 . . . . 0.0 111.742 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.493 ' OE1' ' HB2' ' A' ' 81' ' ' TYR . 6.7 mp0 -117.57 158.75 24.05 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.001 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.6 t -154.28 108.7 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.884 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.457 ' NH1' ' CE2' ' A' ' 81' ' ' TYR . 0.6 OUTLIER -111.15 129.82 55.82 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.689 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -110.62 86.11 2.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.848 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -103.13 153.66 20.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.342 0.591 . . . . 0.0 112.303 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -145.48 116.24 7.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.503 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.08 -117.67 11.04 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.75 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 m -115.59 42.85 2.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.785 0.326 . . . . 0.0 110.659 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.4 m -150.59 160.62 43.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.145 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.722 HD21 ' OE2' ' A' ' 41' ' ' GLU . 5.7 mt -106.68 147.89 29.03 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.447 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 55.6 t -119.45 -44.16 2.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.255 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.34 112.55 1.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.43 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.722 ' OE2' HD21 ' A' ' 38' ' ' LEU . 2.2 mt-10 -119.48 114.62 22.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.081 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.788 ' HB2' HD13 ' A' ' 57' ' ' ILE . 26.0 t80 -107.5 144.25 34.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.888 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -143.98 134.89 25.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.413 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -47.96 -29.03 3.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.495 0.664 . . . . 0.0 111.536 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.24 39.1 0.57 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.852 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 41.25 -165.19 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.582 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 mttm 54.76 65.19 5.23 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.694 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.87 -170.41 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.564 2.176 . . . . 0.0 111.945 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.553 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 73.7 t80 -133.1 98.51 4.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.575 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 50' ' ' LEU . 10.7 mt -95.24 112.78 24.44 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.447 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 19.3 tttm -34.82 -89.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.1 t -118.76 23.45 11.45 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.24 0.18 51.25 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.973 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.32 6.29 26.92 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 117.534 0.667 . . . . 0.0 111.012 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -126.57 158.37 36.41 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.975 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -140.27 118.66 12.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.203 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.788 HD13 ' HB2' ' A' ' 42' ' ' PHE . 6.4 tt -76.09 101.79 2.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.214 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.555 HD13 ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -53.28 163.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.098 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.64 -21.79 64.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.72 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -97.88 33.31 2.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.779 0.323 . . . . 0.0 111.103 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.89 36.43 80.24 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.738 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.49 166.86 10.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 0.0 110.92 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 11.9 tp -107.71 121.41 44.65 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.893 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.555 ' HB2' HD13 ' A' ' 58' ' ' LEU . 4.3 tmtt? -109.15 103.87 12.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.735 0.302 . . . . 0.0 110.814 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.776 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.7 mt -79.91 134.54 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.533 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -79.47 -48.46 13.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.025 0.441 . . . . 0.0 111.675 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.31 113.29 5.79 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.243 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.819 HD21 HG21 ' A' ' 14' ' ' ILE . 5.7 mt -53.5 149.04 8.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 111.716 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.675 ' C ' HD11 ' A' ' 10' ' ' LEU . 6.1 p -151.94 160.45 43.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.03 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.656 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -51.28 -56.53 12.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.075 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -55.26 -20.82 12.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.346 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.657 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -81.33 -15.39 55.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.413 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.4 t -79.03 128.96 33.93 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.608 0.242 . . . . 0.0 110.576 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.46 -167.33 30.27 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.331 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.76 125.77 36.6 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.529 -0.336 . . . . 0.0 111.418 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -101.45 149.2 24.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.177 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -131.28 123.13 27.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.694 0.283 . . . . 0.0 111.567 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.967 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -108.65 128.81 64.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.036 179.159 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.13 97.9 6.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.64 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.538 ' CG1' HD12 ' A' ' 27' ' ' ILE . 82.0 t -86.25 137.97 19.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.139 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.493 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 84.2 m-85 -132.16 153.56 50.4 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.58 0.705 . . . . 0.0 111.602 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.585 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -87.64 -179.62 6.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.43 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.415 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 41.7 p -65.81 -35.5 80.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.942 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -77.91 -3.67 42.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.434 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.37 24.68 42.47 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.533 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.4 160.06 14.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.346 . . . . 0.0 110.699 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 106.71 11.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.682 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.585 HD11 ' HB3' ' A' ' 82' ' ' SER . 40.2 mm -87.35 -43.67 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.304 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.608 HD11 ' HE2' ' A' ' 91' ' ' LYS . 3.1 tt -157.69 149.97 22.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.218 0.533 . . . . 0.0 111.822 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -141.92 109.9 5.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.003 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.608 ' HE2' HD11 ' A' ' 89' ' ' LEU . 20.7 mmtm -121.63 162.24 21.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.482 0.658 . . . . 0.0 112.77 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.16 121.95 11.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.9 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.646 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -120.17 163.2 18.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 0.0 111.688 -179.189 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -111.13 114.27 27.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.369 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.85 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -100.94 103.71 14.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.396 -179.428 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.46 113.22 25.82 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.08 0.467 . . . . 0.0 110.551 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.691 HG21 ' HB3' ' A' ' 68' ' ' LEU . 3.7 mt -109.34 115.05 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.523 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.0 mt -78.97 169.96 17.41 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.24 0.543 . . . . 0.0 110.761 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.897 179.93 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 29.9 ttt-85 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.824 0.345 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -66.27 81.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.8 t -84.55 104.63 14.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.35 -150.36 19.37 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.591 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -47.71 139.62 7.14 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.496 0.665 . . . . 0.0 111.439 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.793 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -134.8 155.72 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.393 -179.652 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -122.77 128.49 50.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.826 0.346 . . . . 0.0 111.005 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.7 178.51 24.31 Favored Glycine 0 N--CA 1.459 0.233 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.454 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.411 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -125.34 135.11 52.11 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.941 0.4 . . . . 0.0 111.106 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.834 HD12 HG21 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -52.7 132.41 36.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.792 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.484 ' HA2' ' ND2' ' A' ' 67' ' ' ASN . . . 93.66 -12.45 69.45 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.83 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.512 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -104.74 169.78 8.26 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.219 0.509 . . . . 0.0 110.016 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.512 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -79.68 168.78 52.87 Favored Glycine 0 C--O 1.224 -0.515 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.25 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.869 ' CG2' HD12 ' A' ' 65' ' ' ILE . 2.2 tp -179.09 140.26 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.696 0.284 . . . . 0.0 110.765 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -124.08 131.52 53.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.031 0.443 . . . . 0.0 111.647 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.833 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -88.09 113.68 23.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.586 179.135 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -97.83 125.63 42.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.193 0.521 . . . . 0.0 111.931 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.947 HD11 HG11 ' A' ' 78' ' ' VAL . 3.2 mt -81.62 119.95 76.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.299 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.23 131.0 36.52 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.355 2.037 . . . . 0.0 112.865 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.6 m120 43.42 65.14 1.04 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -142.3 149.3 39.33 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.804 0.335 . . . . 0.0 110.531 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -138.65 117.46 12.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.931 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -80.87 82.41 6.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.78 -174.27 2.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.765 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -56.82 -30.94 64.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.954 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -60.98 -28.01 68.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.596 HD12 ' CG1' ' A' ' 80' ' ' VAL . 23.4 mm -81.57 127.75 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.444 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.55 -44.16 3.55 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 122.214 -0.304 . . . . 0.0 111.736 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 72.6 tt0 -127.43 116.23 20.13 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.217 -0.593 . . . . 0.0 112.31 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 t -113.2 114.28 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.974 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -113.08 132.12 55.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.084 0.469 . . . . 0.0 112.192 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.402 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 70.2 m95 -113.18 83.26 1.8 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -99.17 150.9 21.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.299 0.571 . . . . 0.0 112.274 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.47 116.01 9.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.62 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.29 -117.36 10.29 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.76 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.25 42.77 2.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.837 0.351 . . . . 0.0 110.759 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.2 m -152.0 160.03 43.58 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.215 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.56 HD21 ' OE2' ' A' ' 41' ' ' GLU . 5.8 mt -104.09 146.94 28.01 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.452 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 52.0 t -117.89 -42.83 2.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.293 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -166.21 113.11 0.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.455 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.56 ' OE2' HD21 ' A' ' 38' ' ' LEU . 2.4 mt-10 -120.53 116.32 25.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.094 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.46 ' HB2' HD13 ' A' ' 57' ' ' ILE . 32.1 t80 -99.83 152.07 20.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.666 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -142.47 145.84 34.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.841 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -59.45 91.75 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 122.177 0.989 . . . . 0.0 110.555 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 81.37 -46.86 0.23 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.628 -1.624 . . . . 0.0 111.158 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -50.27 146.3 5.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.098 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -57.87 127.29 78.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.114 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.415 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 87.1 Cg_endo -83.23 -171.14 1.04 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.656 2.238 . . . . 0.0 112.467 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.531 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 69.4 t80 -135.03 104.64 6.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.343 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.1 mt -99.27 111.09 23.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.0 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 55.6 tttm -44.94 -42.46 8.16 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.579 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.0 p -176.66 164.96 2.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.966 0.412 . . . . 0.0 111.213 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.36 -12.37 4.36 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.732 -0.746 . . . . 0.0 113.118 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.44 1.06 12.69 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 117.75 0.775 . . . . 0.0 112.182 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -131.1 157.38 43.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.11 0.481 . . . . 0.0 111.214 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -153.95 125.24 7.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.513 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.665 HG23 ' O ' ' A' ' 57' ' ' ILE . 6.9 tt -84.04 101.53 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.657 HD23 HD21 ' A' ' 60' ' ' ASN . 1.2 mp -61.32 166.97 3.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.991 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.04 -45.58 80.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.205 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.657 HD21 HD23 ' A' ' 58' ' ' LEU . 3.5 p30 -56.32 -22.88 33.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.137 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.85 35.05 4.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.59 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -116.03 154.48 29.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.878 0.371 . . . . 0.0 110.924 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 12.7 tp -83.46 122.94 29.19 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.463 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -104.46 109.79 21.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.701 0.286 . . . . 0.0 111.38 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.869 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.8 mt -93.29 127.34 45.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.939 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 ttpp -85.63 -36.31 20.41 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.484 ' ND2' ' HA2' ' A' ' 11' ' ' GLY . 21.7 t-20 -147.16 110.23 4.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.812 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.078 HD22 HD12 ' A' ' 97' ' ' ILE . 4.9 mt -56.62 144.88 30.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.056 0.455 . . . . 0.0 111.469 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.677 ' C ' HD11 ' A' ' 10' ' ' LEU . 7.5 p -149.25 163.79 36.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.843 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.582 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -50.84 -55.52 16.55 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.223 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -52.9 -23.01 6.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.539 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.646 ' OD1' HD13 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -79.53 -14.01 59.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.472 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.436 ' CB ' HG12 ' A' ' 97' ' ' ILE . 2.6 t -81.15 124.74 29.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.685 0.279 . . . . 0.0 110.707 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.1 -166.87 29.47 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.296 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.94 130.34 38.55 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.56 0.344 . . . . 0.0 111.139 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -106.21 148.65 27.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.063 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 14.7 m-20 -132.42 127.2 34.85 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.834 0.35 . . . . 0.0 111.641 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.947 HG11 HD11 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -109.76 131.13 61.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.202 179.067 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.0 98.61 6.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.476 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.596 ' CG1' HD12 ' A' ' 27' ' ' ILE . 93.5 t -92.05 123.29 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.65 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.496 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 99.3 m-85 -117.17 152.11 35.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.271 0.558 . . . . 0.0 111.027 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.646 ' CA ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -89.96 173.64 8.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.532 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.8 p -57.38 -24.31 54.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.191 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -96.01 27.5 3.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.169 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.78 25.13 28.59 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.686 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.04 144.26 25.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.799 0.333 . . . . 0.0 110.818 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.78 107.04 3.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.643 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.646 HD11 ' CA ' ' A' ' 82' ' ' SER . 40.0 mt -80.97 -69.9 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.373 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.915 HD21 ' HG3' ' A' ' 91' ' ' LYS . 1.9 tt -141.68 129.76 22.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.192 0.52 . . . . 0.0 111.87 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.28 107.23 14.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.472 -0.786 . . . . 0.0 108.897 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.915 ' HG3' HD21 ' A' ' 89' ' ' LEU . 5.0 mmpt? -117.84 158.71 24.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.43 0.633 . . . . 0.0 112.676 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.655 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.19 122.33 18.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.146 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.653 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -120.63 162.98 18.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.984 0.421 . . . . 0.0 111.519 -179.286 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.92 136.85 48.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.335 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.833 HD12 HD21 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -131.78 100.8 5.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.273 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 1.1 mmm180 -92.81 124.04 36.52 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.038 0.446 . . . . 0.0 110.945 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.078 HD12 HD22 ' A' ' 68' ' ' LEU . 4.4 mm -106.46 103.73 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.841 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 mt -67.66 120.15 13.57 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.598 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.892 -179.754 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.779 0.323 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -64.82 88.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.944 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.83 153.59 17.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.829 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.82 -150.49 41.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.514 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -48.21 146.71 2.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.21 0.529 . . . . 0.0 111.36 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.903 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -142.02 153.64 18.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.62 -179.55 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -121.38 131.33 54.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.926 0.393 . . . . 0.0 110.697 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.786 ' C ' HG23 ' A' ' 97' ' ' ILE . . . -149.69 -179.71 25.75 Favored Glycine 0 N--CA 1.459 0.226 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.812 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.562 ' N ' HG23 ' A' ' 97' ' ' ILE . . . -126.49 135.34 51.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.938 0.399 . . . . 0.0 110.735 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.732 HD11 ' C ' ' A' ' 69' ' ' THR . 1.2 tp -55.49 130.32 42.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.003 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.49 -6.96 77.97 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.656 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.534 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -106.28 169.18 8.66 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 117.122 0.461 . . . . 0.0 109.941 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.534 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -76.77 166.63 54.17 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.139 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.832 HG21 HD21 ' A' ' 68' ' ' LEU . 1.6 tp -177.56 138.34 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 0.0 110.986 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.493 ' OD2' HD22 ' A' ' 58' ' ' LEU . 3.1 t70 -120.6 120.48 35.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.44 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.722 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -77.44 105.08 8.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.767 179.299 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.456 ' O ' HD21 ' A' ' 93' ' ' LEU . 54.0 m-20 -88.93 124.84 34.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.228 0.537 . . . . 0.0 112.152 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.924 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -81.8 119.96 76.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.118 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.93 131.8 39.02 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.221 1.947 . . . . 0.0 112.877 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 43.61 65.45 0.99 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -143.28 149.44 37.86 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.742 0.306 . . . . 0.0 110.549 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -141.08 117.14 10.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.958 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.82 79.91 6.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.31 -173.74 2.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.64 -30.46 61.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.0 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -62.56 -28.83 70.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.626 HD12 ' CG1' ' A' ' 80' ' ' VAL . 23.2 mm -86.05 127.16 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.476 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.408 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -112.82 -42.78 3.53 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.091 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 37.9 tt0 -127.67 118.22 23.44 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.155 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.81 118.52 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.21 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -117.43 135.83 53.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.271 0.558 . . . . 0.0 112.17 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.487 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 69.9 m95 -111.13 88.24 2.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.971 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -98.7 141.8 31.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.364 0.602 . . . . 0.0 112.267 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -132.12 114.92 15.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.396 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.26 -114.02 5.41 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.64 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.2 t -118.38 44.28 2.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.731 0.3 . . . . 0.0 110.652 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.1 m -154.95 159.56 40.49 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.906 0.384 . . . . 0.0 111.332 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.534 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 4.6 mt -99.18 148.17 24.37 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.804 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.481 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 48.4 t -119.32 -42.26 2.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.444 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -173.5 114.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.724 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -124.73 156.55 37.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.092 0.472 . . . . 0.0 110.907 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -129.44 144.33 51.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.753 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.64 114.29 5.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.644 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -51.78 -59.41 4.34 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.721 0.772 . . . . 0.0 111.097 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -82.76 46.89 1.13 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.849 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 177.98 -172.21 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.839 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -108.1 142.33 25.06 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.718 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.05 154.62 47.53 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.504 2.136 . . . . 0.0 112.479 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.534 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 43.6 t80 -112.7 103.09 11.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.158 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 50' ' ' LEU . 7.9 mt -93.53 113.36 25.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.2 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.481 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 31.0 tttt -47.94 -45.39 30.99 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.745 0.307 . . . . 0.0 111.365 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.1 p -175.27 165.13 3.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.91 0.386 . . . . 0.0 111.191 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.92 -12.43 3.73 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.214 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.02 -1.48 17.35 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.727 0.763 . . . . 0.0 112.063 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -131.38 157.03 44.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.063 0.458 . . . . 0.0 111.206 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -151.3 119.18 6.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.134 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' ' 57' ' ' ILE . 4.2 tt -74.5 103.89 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.115 0.483 . . . . 0.0 111.223 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.639 HD13 ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -51.77 173.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.313 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.5 -26.81 67.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.346 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -96.13 32.4 1.95 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.048 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.08 26.3 58.24 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.58 173.54 8.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 111.04 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.468 HD11 HG12 ' A' ' 39' ' ' VAL . 8.5 tp -109.93 118.35 36.21 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.633 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.639 ' HB2' HD13 ' A' ' 58' ' ' LEU . 12.8 tttp -106.63 108.71 20.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.83 0.347 . . . . 0.0 110.957 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.831 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.4 mt -87.65 135.77 24.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.435 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -82.62 -46.37 13.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.038 0.447 . . . . 0.0 111.831 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -145.72 112.04 5.78 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.132 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.875 HD22 HG12 ' A' ' 97' ' ' ILE . 6.1 mt -53.76 151.03 6.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.289 0.566 . . . . 0.0 111.865 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.732 ' C ' HD11 ' A' ' 10' ' ' LEU . 7.1 p -154.3 162.42 41.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.815 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.59 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -50.78 -56.4 12.27 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.037 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -57.02 -20.86 26.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.327 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.632 ' OD1' HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -87.06 -14.89 40.18 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.426 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.3 t -90.96 129.62 36.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.649 0.261 . . . . 0.0 110.609 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 154.08 -130.66 2.98 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.588 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 m -123.11 128.73 50.5 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 117.814 0.807 . . . . 0.0 110.931 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -109.06 149.09 29.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.235 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 12.9 m-20 -131.26 125.57 33.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.849 0.356 . . . . 0.0 111.582 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.924 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.98 131.58 60.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.038 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.485 HG23 ' OD1' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -119.95 96.35 5.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.599 178.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.626 ' CG1' HD12 ' A' ' 27' ' ' ILE . 74.1 t -85.75 128.06 39.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.468 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.547 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 83.0 m-85 -117.61 151.56 36.93 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.062 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.614 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -88.73 174.26 8.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.494 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -61.76 -18.67 60.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.265 179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -94.08 23.45 4.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.207 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.65 21.71 50.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.668 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.42 176.49 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.736 0.303 . . . . 0.0 110.617 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.09 116.46 30.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.708 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.614 HD11 ' HB3' ' A' ' 82' ' ' SER . 31.9 mm -90.47 -46.93 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.362 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.631 HD11 ' HE3' ' A' ' 91' ' ' LYS . 1.6 tt -153.6 148.4 26.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 111.796 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.485 ' OD1' HG23 ' A' ' 79' ' ' THR . 56.5 t30 -136.79 108.58 7.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.197 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.631 ' HE3' HD11 ' A' ' 89' ' ' LEU . 46.3 mmtt -121.13 156.6 31.96 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.655 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.37 122.24 17.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.966 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.65 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -118.2 158.97 24.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.018 0.437 . . . . 0.0 111.728 -179.09 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -111.81 107.99 17.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.263 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.934 HD22 HD11 ' A' ' 97' ' ' ILE . 0.5 OUTLIER -94.29 98.46 10.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.095 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -98.02 126.05 43.26 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.995 0.426 . . . . 0.0 110.498 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.934 HD11 HD22 ' A' ' 95' ' ' LEU . 2.3 mp -134.34 133.58 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.91 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.52 169.02 14.89 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.712 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.96 179.857 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.867 0.365 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -106.5 -40.03 5.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 p -60.16 175.84 0.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.68 167.18 32.03 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.578 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.0 m -142.97 147.63 35.48 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.26 0.553 . . . . 0.0 110.939 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.891 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER -139.19 150.51 23.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.812 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -120.89 128.87 53.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.669 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.24 -178.82 22.82 Favored Glycine 0 N--CA 1.46 0.254 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.748 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.448 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -130.11 133.63 46.79 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.146 0.498 . . . . 0.0 111.597 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.41 ' CD1' ' HA ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -52.08 131.7 32.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.179 179.784 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.94 -7.96 80.72 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.74 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.528 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.01 168.33 9.36 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.603 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.91 -174.24 16.93 Favored Glycine 0 C--O 1.228 -0.249 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.502 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.815 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 163.13 136.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.803 0.335 . . . . 0.0 110.386 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -126.25 125.22 42.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.919 0.39 . . . . 0.0 111.436 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.481 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -77.37 122.49 25.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.735 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -103.71 123.05 46.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.177 0.513 . . . . 0.0 111.963 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.938 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -81.78 119.53 75.55 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.145 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.71 130.92 37.27 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.386 2.057 . . . . 0.0 112.98 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 42.79 65.13 0.99 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -141.72 149.13 40.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.79 0.329 . . . . 0.0 110.553 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -145.01 115.24 7.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.967 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.5 ttt -78.19 76.45 4.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.849 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.19 -173.74 2.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.822 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -56.86 -30.79 64.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.03 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -65.4 -26.74 68.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.009 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.602 HD12 ' CG1' ' A' ' 80' ' ' VAL . 43.6 mm -85.58 127.28 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.347 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.411 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -113.02 -42.05 3.62 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.182 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 6.6 tm-20 -128.26 138.78 52.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.881 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.2 t -145.27 124.37 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.295 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.446 ' NH1' ' CE2' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -118.84 139.16 52.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.136 0.493 . . . . 0.0 112.222 -179.285 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.48 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 69.2 m95 -111.49 83.28 1.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -96.54 151.59 19.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.408 0.623 . . . . 0.0 112.351 -178.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.445 ' HD2' ' CE1' ' A' ' 76' ' ' TYR . 6.0 ttp-105 -143.93 116.75 8.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.439 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.92 -114.82 6.09 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.18 -1.009 . . . . 0.0 111.671 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.2 m -118.47 44.25 2.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.754 0.311 . . . . 0.0 110.701 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.9 m -153.29 160.37 42.71 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.287 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.657 HD13 ' OE1' ' A' ' 41' ' ' GLU . 5.5 mt -104.4 147.86 27.07 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.475 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 46.9 t -119.14 -42.06 2.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.581 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -174.2 116.09 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.022 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.657 ' OE1' HD13 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -124.36 159.47 30.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.009 0.433 . . . . 0.0 110.792 179.24 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -126.36 149.89 48.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.884 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -159.42 111.71 2.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.672 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -51.63 -59.62 4.08 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.737 0.78 . . . . 0.0 111.014 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.4 tttp -82.77 47.28 1.18 Allowed 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.837 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.09 -172.68 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 8.2 mtpt -108.59 156.69 38.32 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.772 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -82.36 161.27 17.4 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.919 2.413 . . . . 0.0 112.477 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.517 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 39.1 t80 -127.03 99.48 5.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.931 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 50' ' ' LEU . 11.6 mt -91.98 109.06 20.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.132 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 7.6 ttmt -47.6 -33.44 6.6 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.682 0.277 . . . . 0.0 111.468 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.6 p -174.01 163.53 4.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.925 0.393 . . . . 0.0 111.217 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.71 -6.97 19.08 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.008 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.52 5.56 10.55 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 117.626 0.713 . . . . 0.0 112.003 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -132.78 157.65 44.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.109 0.481 . . . . 0.0 111.434 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -148.59 118.15 6.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.003 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.644 HG23 ' O ' ' A' ' 57' ' ' ILE . 10.1 tt -77.56 98.45 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.086 0.47 . . . . 0.0 111.389 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -51.6 163.29 0.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.031 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.17 -22.39 65.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.592 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.465 ' ND2' ' HB2' ' A' ' 62' ' ' ASP . 2.2 p-10 -96.23 32.87 1.86 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.763 0.316 . . . . 0.0 111.234 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.53 36.55 71.2 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.738 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.465 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -108.84 158.04 18.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 0.0 111.014 179.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.3 tp -99.39 121.8 41.62 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.586 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.43 108.21 18.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.793 0.33 . . . . 0.0 111.141 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.799 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.3 mt -86.95 138.91 18.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.41 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -85.07 -47.12 10.5 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.057 0.456 . . . . 0.0 111.855 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -143.6 111.43 6.06 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.233 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.815 HD21 HG21 ' A' ' 14' ' ' ILE . 5.3 mt -53.28 144.07 17.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.894 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.41 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 5.0 p -141.76 159.97 41.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.923 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.11 -56.23 15.81 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -55.72 -19.48 11.14 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.578 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.594 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -79.22 -14.3 59.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.568 0.223 . . . . 0.0 111.475 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 98.5 p -85.23 128.43 34.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.629 0.252 . . . . 0.0 110.753 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.32 -135.08 4.34 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.542 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.7 m -124.29 130.4 52.44 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.556 0.678 . . . . 0.0 110.714 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.445 ' CE1' ' HD2' ' A' ' 34' ' ' ARG . 16.3 m-85 -107.41 151.6 25.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.979 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.642 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 12.4 m-20 -133.59 124.66 27.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.314 . . . . 0.0 111.593 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.938 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.09 133.54 53.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.283 179.045 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.04 103.39 9.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.671 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.602 ' CG1' HD12 ' A' ' 27' ' ' ILE . 94.9 t -93.7 129.66 43.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.42 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 97.9 m-85 -121.71 154.93 36.24 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.151 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.557 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -89.98 178.3 6.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.588 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.411 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 27.0 p -64.26 -22.97 67.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.068 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -95.74 23.48 6.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.098 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.52 25.87 61.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.524 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.5 152.29 18.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.8 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -74.82 119.9 19.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.718 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.557 HD11 ' HB3' ' A' ' 82' ' ' SER . 32.8 mm -92.79 -67.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.381 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.919 HD21 ' HG3' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -146.06 133.28 20.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.147 0.499 . . . . 0.0 111.85 -179.304 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.22 107.41 14.41 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.919 ' HG3' HD21 ' A' ' 89' ' ' LEU . 25.4 mmtt -117.55 156.61 27.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.428 0.633 . . . . 0.0 112.662 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.642 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -137.98 122.69 18.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.084 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.649 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -119.68 160.76 21.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.079 0.466 . . . . 0.0 111.607 -179.211 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -110.05 116.13 31.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.158 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.891 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -100.07 100.71 11.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.362 -179.441 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -96.72 115.16 26.95 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.096 0.474 . . . . 0.0 110.353 179.277 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.696 HG12 HD22 ' A' ' 68' ' ' LEU . 3.8 mt -116.33 120.14 64.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.838 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.29 119.65 14.79 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.684 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.85 -179.813 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.873 0.368 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.41 -39.43 94.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -59.33 136.67 58.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.942 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.4 -149.28 41.87 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.561 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.5 m -45.99 137.03 6.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.408 0.623 . . . . 0.0 111.466 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.729 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER -130.02 146.63 33.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.484 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.474 ' CE2' ' HD3' ' A' ' 96' ' ' ARG . 82.9 m95 -112.05 127.52 55.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.609 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.18 -178.18 22.27 Favored Glycine 0 N--CA 1.459 0.217 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.887 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.445 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -125.14 133.34 52.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.048 0.451 . . . . 0.0 111.123 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.729 HD12 HG21 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -53.93 133.14 43.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.027 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.69 -6.35 83.72 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.757 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.542 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.42 167.31 10.13 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.994 0.397 . . . . 0.0 110.006 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.586 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.43 -175.69 18.44 Favored Glycine 0 C--O 1.228 -0.264 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.622 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.829 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.1 tp 167.33 136.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.897 0.38 . . . . 0.0 110.726 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.509 ' OD2' HD22 ' A' ' 58' ' ' LEU . 1.3 t70 -121.81 132.11 54.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.187 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.617 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -90.4 108.95 20.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.855 179.359 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -91.71 123.36 35.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.225 0.536 . . . . 0.0 112.209 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.945 HD11 HG11 ' A' ' 78' ' ' VAL . 3.4 mt -80.82 120.07 77.9 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.112 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.78 130.95 37.26 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.301 2.0 . . . . 0.0 112.975 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 42.67 64.96 1.01 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -140.87 149.55 42.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.593 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -146.29 116.35 7.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -78.67 81.64 4.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.947 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.35 -175.14 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -57.57 -32.81 67.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.897 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -63.74 -23.73 67.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.144 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.563 HD12 ' CG1' ' A' ' 80' ' ' VAL . 37.4 mm -81.11 127.84 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.414 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -105.96 -38.36 6.35 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 122.231 -0.293 . . . . 0.0 111.728 -179.319 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 17.8 mt-10 -141.09 152.64 44.93 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.662 0.744 . . . . 0.0 112.448 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -145.68 117.98 2.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.125 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -115.19 133.65 55.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.024 0.44 . . . . 0.0 112.155 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.414 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 68.6 m95 -110.73 83.65 1.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -98.65 146.29 26.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.298 0.57 . . . . 0.0 112.288 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -137.19 116.93 13.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.532 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.05 -115.9 7.58 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.734 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.8 m -117.3 43.73 2.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.833 0.349 . . . . 0.0 110.71 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.5 m -153.6 160.05 42.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.282 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.548 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.6 mt -102.2 147.08 27.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.464 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 48.2 t -118.4 -42.7 2.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.258 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -166.47 111.55 0.8 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.562 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -117.69 119.69 35.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.941 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.705 ' HB2' HD13 ' A' ' 57' ' ' ILE . 51.5 t80 -104.55 157.98 16.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.79 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.405 ' CG ' ' HB2' ' A' ' 46' ' ' MET . 10.4 ttmt -151.75 145.45 25.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.942 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.59 91.55 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.967 0.889 . . . . 0.0 110.705 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 81.66 -47.21 0.21 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.164 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.405 ' HB2' ' CG ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -48.92 144.51 4.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.083 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -57.2 127.29 76.16 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.273 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.49 -167.94 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.721 2.28 . . . . 0.0 112.493 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.548 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 75.6 t80 -139.18 104.02 4.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.319 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.2 mt -98.45 109.33 22.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 10.3 ttmt -44.57 -39.77 5.2 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.774 0.321 . . . . 0.0 111.529 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.4 p -177.83 163.98 1.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 111.122 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.28 -11.46 4.95 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.025 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.413 ' HA ' ' CD ' ' A' ' 66' ' ' LYS . . . -74.29 0.42 14.31 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 117.786 0.793 . . . . 0.0 112.233 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -130.79 156.87 44.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.161 0.505 . . . . 0.0 111.303 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -150.73 117.4 5.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.098 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.705 HD13 ' HB2' ' A' ' 42' ' ' PHE . 12.0 tt -75.72 97.29 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.45 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.509 HD22 ' OD2' ' A' ' 15' ' ' ASP . 0.8 OUTLIER -47.01 168.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.184 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.59 -24.57 65.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.592 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.478 ' ND2' ' HB2' ' A' ' 62' ' ' ASP . 5.8 p-10 -96.83 33.63 1.84 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.737 0.303 . . . . 0.0 111.21 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.65 34.18 69.38 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.56 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.478 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -101.39 165.09 11.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 0.0 111.043 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.41 HD11 HG12 ' A' ' 39' ' ' VAL . 10.5 tp -106.13 120.56 42.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.499 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.26 111.2 23.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.725 0.298 . . . . 0.0 110.991 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.829 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.4 mt -90.92 135.88 25.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.369 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.443 ' HG3' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -80.7 -45.96 16.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.074 0.464 . . . . 0.0 111.991 -179.044 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.443 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -145.8 113.31 6.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.468 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.638 HD22 ' CG1' ' A' ' 97' ' ' ILE . 4.2 mt -53.85 145.57 15.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.513 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.44 ' HA ' HD11 ' A' ' 10' ' ' LEU . 4.7 p -145.67 158.75 43.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.004 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -55.92 14.12 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.417 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.06 -22.81 11.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.411 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.617 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -76.3 -14.58 60.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.248 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.445 ' CB ' HD12 ' A' ' 97' ' ' ILE . 2.8 t -79.39 119.92 23.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.706 0.288 . . . . 0.0 110.521 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.13 -147.27 12.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.144 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.5 m -116.62 130.78 56.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.102 0.451 . . . . 0.0 110.59 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -106.72 129.77 54.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.38 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.708 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 2.0 m-20 -112.85 123.9 51.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.569 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.945 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -105.99 133.92 49.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.031 178.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.37 96.93 5.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.877 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.563 ' CG1' HD12 ' A' ' 27' ' ' ILE . 82.8 t -87.29 127.76 40.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.1 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.489 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 2.5 m-30 -112.81 152.6 28.99 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.298 0.57 . . . . 0.0 111.02 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.857 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -92.72 176.7 6.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.366 179.646 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.427 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 2.1 p -67.4 -18.34 65.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.236 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -89.94 12.13 18.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.422 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.74 25.05 74.95 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.631 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.11 -169.4 1.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.644 0.259 . . . . 0.0 110.595 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 -119.76 99.73 6.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.938 0.399 . . . . 0.0 110.783 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.857 HD11 ' HB3' ' A' ' 82' ' ' SER . 38.5 mm -58.0 -61.31 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.423 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.639 HD21 ' CG ' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -144.14 140.47 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.226 0.536 . . . . 0.0 112.019 -179.032 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -121.65 109.23 14.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.807 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.639 ' CG ' HD21 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -119.38 160.85 21.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.024 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.708 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -139.37 122.65 17.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.159 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.661 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -119.61 161.98 19.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 111.233 -179.466 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.06 146.1 33.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.265 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.729 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -136.4 119.1 16.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.213 -179.533 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.474 ' HD3' ' CE2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -119.87 124.6 46.46 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.318 0.58 . . . . 0.0 111.038 179.215 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.729 HG21 HD12 ' A' ' 10' ' ' LEU . 3.9 mp -103.44 103.9 15.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.784 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.79 125.63 25.42 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.319 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.966 -179.837 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.774 0.321 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 64.23 -79.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.1 p -86.37 99.09 11.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.874 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.89 161.47 54.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.53 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.439 HG23 ' HB2' ' A' ' 94' ' ' ASP . 96.4 m -136.41 118.88 15.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.883 0.373 . . . . 0.0 110.802 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.91 HG23 ' HA ' ' A' ' 95' ' ' LEU . 2.6 m -98.11 178.49 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 121.848 0.832 . . . . 0.0 112.496 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.437 ' CE3' ' HB2' ' A' ' 96' ' ' ARG . 69.5 m95 -147.56 162.26 39.45 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.543 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.25 178.48 44.39 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.494 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -119.8 135.05 55.02 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 120.883 0.373 . . . . 0.0 110.827 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.686 HD11 ' C ' ' A' ' 69' ' ' THR . 1.2 tp -57.11 133.27 54.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.03 -2.84 87.15 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.593 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.776 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -106.56 168.33 9.24 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.776 ' O ' ' CE1' ' A' ' 12' ' ' HIS . . . -82.66 163.47 42.33 Favored Glycine 0 C--O 1.223 -0.556 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.098 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.832 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.5 tp -176.11 137.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.952 0.406 . . . . 0.0 111.183 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.46 ' OD2' HD22 ' A' ' 58' ' ' LEU . 2.6 t70 -116.99 119.74 36.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.079 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.433 ' CD1' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -80.94 114.45 19.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.957 179.589 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -94.1 124.03 37.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.168 0.509 . . . . 0.0 111.925 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.925 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.4 mt -80.4 119.78 77.41 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.023 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.449 ' O ' HD11 ' A' ' 89' ' ' LEU . 32.1 Cg_exo -59.39 130.85 37.64 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.281 1.987 . . . . 0.0 112.931 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 42.7 65.17 0.98 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -141.96 151.14 42.27 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.869 0.366 . . . . 0.0 110.638 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -141.35 117.98 10.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.71 78.4 7.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.009 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.5 p -110.77 -172.88 2.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.25 -30.53 68.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -61.46 -27.28 68.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.016 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.603 HD12 ' CG1' ' A' ' 80' ' ' VAL . 21.0 mm -81.76 127.52 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.451 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.95 -43.64 3.56 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 60.1 tt0 -128.39 116.38 19.68 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.196 -0.601 . . . . 0.0 112.412 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.7 t -116.22 117.12 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.886 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -118.17 133.53 55.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.202 0.525 . . . . 0.0 112.384 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -109.63 84.52 1.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.767 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -95.06 149.94 20.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.382 0.61 . . . . 0.0 112.432 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -139.66 113.47 8.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.408 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.47 -114.77 6.24 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.613 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -117.01 43.62 2.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.77 0.319 . . . . 0.0 110.629 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 66.4 m -153.74 160.08 42.17 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.332 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.557 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.5 mt -101.42 147.12 26.73 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.431 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 51.1 t -118.21 -43.25 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.189 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.4 112.45 0.83 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.294 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.28 120.08 35.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.195 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.771 ' HB2' HD13 ' A' ' 57' ' ' ILE . 14.0 t80 -97.48 152.41 19.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.471 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.422 ' CG ' ' HB2' ' A' ' 46' ' ' MET . 1.0 OUTLIER -150.47 121.78 7.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.863 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.34 95.8 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.975 0.893 . . . . 0.0 111.377 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 81.51 -47.36 0.23 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.844 -1.525 . . . . 0.0 111.119 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.422 ' HB2' ' CG ' ' A' ' 43' ' ' LYS . 3.7 mtt -50.02 156.55 0.75 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.913 0.387 . . . . 0.0 111.097 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -68.42 114.3 20.88 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.482 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -69.18 -173.2 0.6 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.516 2.144 . . . . 0.0 112.218 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.557 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 70.5 t80 -137.46 98.89 3.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.756 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 50' ' ' LEU . 9.5 mt -93.89 113.81 25.9 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 6.5 tptp -36.43 -90.06 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.7 m -118.56 21.45 12.57 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.08 -1.52 55.19 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.125 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.81 3.42 29.56 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 117.546 0.673 . . . . 0.0 111.008 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -124.31 158.05 33.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.782 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -140.95 120.53 13.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.202 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.771 HD13 ' HB2' ' A' ' 42' ' ' PHE . 4.7 tt -76.99 103.33 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.12 0.486 . . . . 0.0 111.375 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.46 HD22 ' OD2' ' A' ' 15' ' ' ASP . 0.7 OUTLIER -54.5 166.58 0.42 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.102 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.3 -23.48 64.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.72 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' A' ' 62' ' ' ASP . 5.7 p-10 -96.53 33.3 1.84 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.734 0.302 . . . . 0.0 111.214 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.97 34.01 64.9 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.632 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.496 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -101.3 173.87 6.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 0.0 111.034 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 tp -114.22 121.07 42.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.57 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.412 ' HB2' HD13 ' A' ' 58' ' ' LEU . 17.2 tttt -107.61 104.07 13.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.823 0.344 . . . . 0.0 111.051 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.832 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -82.27 127.18 39.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.625 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -76.0 -45.65 33.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.065 0.459 . . . . 0.0 111.322 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.11 111.9 4.82 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.235 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.829 HD22 HG12 ' A' ' 97' ' ' ILE . 4.5 mt -56.21 152.01 11.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.12 0.486 . . . . 0.0 111.681 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.686 ' C ' HD11 ' A' ' 10' ' ' LEU . 8.7 p -153.17 163.35 40.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.123 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.635 ' N ' HD11 ' A' ' 10' ' ' LEU . 21.4 mmt85 -51.42 -54.76 23.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.476 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -58.56 -19.22 36.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.321 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.41 -15.8 34.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.37 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.479 ' CB ' HD12 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -82.7 130.83 35.19 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.823 0.344 . . . . 0.0 110.586 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.56 -130.83 3.26 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.325 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 1.3 m -125.82 126.65 44.85 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 117.753 0.776 . . . . 0.0 111.063 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.428 ' CD1' HD21 ' A' ' 16' ' ' LEU . 61.2 m-85 -97.03 149.93 21.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.21 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.648 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 11.5 m-20 -132.94 120.53 21.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.201 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.925 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -107.91 128.54 63.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.174 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.73 97.4 5.83 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.603 ' CG1' HD12 ' A' ' 27' ' ' ILE . 71.2 t -87.01 126.79 40.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.52 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.507 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 97.2 m-85 -118.71 151.56 37.76 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.236 0.541 . . . . 0.0 111.024 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.629 ' CB ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -89.72 173.62 8.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.406 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.3 p -59.95 -29.51 68.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.926 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -77.77 -4.07 44.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.491 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.86 27.2 51.3 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.531 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.17 165.16 11.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 110.79 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.37 115.37 21.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.644 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.629 HD11 ' CB ' ' A' ' 82' ' ' SER . 34.9 mt -91.16 -67.71 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.322 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.724 HD21 ' CG ' ' A' ' 91' ' ' LYS . 4.5 tt -136.41 130.14 32.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.062 0.458 . . . . 0.0 111.71 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -120.71 108.68 14.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.333 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.724 ' CG ' HD21 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -119.61 153.51 35.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.275 0.56 . . . . 0.0 112.337 -178.514 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.648 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.91 121.69 16.48 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.496 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.641 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -120.63 164.85 15.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.243 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.439 ' HB2' HG23 ' A' ' 5' ' ' THR . 1.1 m-20 -124.24 107.24 10.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.66 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.91 ' HA ' HG23 ' A' ' 6' ' ' VAL . 7.2 tt -101.8 113.89 27.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.017 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.437 ' HB2' ' CE3' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -96.77 111.93 23.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.874 0.369 . . . . 0.0 110.479 179.299 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.829 HG12 HD22 ' A' ' 68' ' ' LEU . 5.6 mt -95.33 109.14 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.873 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mt -67.76 125.32 25.87 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.416 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.879 -179.762 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.798 0.332 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -73.61 -44.69 56.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.923 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.55 120.5 39.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.44 166.67 21.98 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.556 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.6 m -147.11 147.68 30.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 110.972 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.881 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -138.72 145.17 28.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.648 -179.469 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -116.49 127.43 54.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.877 0.37 . . . . 0.0 110.737 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.55 177.42 29.48 Favored Glycine 0 C--N 1.329 0.161 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.662 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.408 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -122.18 135.6 54.8 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.913 0.387 . . . . 0.0 110.75 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.725 HD11 ' C ' ' A' ' 69' ' ' THR . 1.1 tp -54.46 130.01 38.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.714 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.85 -9.27 68.33 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.762 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.569 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.6 170.74 7.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 117.002 0.401 . . . . 0.0 109.927 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -79.87 175.2 55.05 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.119 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.856 ' CG2' HD12 ' A' ' 65' ' ' ILE . 2.0 tp 178.13 139.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.691 0.281 . . . . 0.0 110.906 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -116.08 126.21 53.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.94 0.4 . . . . 0.0 111.317 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -86.54 105.57 16.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.806 179.304 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -88.3 123.75 33.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.144 0.497 . . . . 0.0 112.194 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.923 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.3 mt -80.25 120.05 78.34 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.055 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.82 130.98 37.31 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.313 2.008 . . . . 0.0 112.859 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 43.09 65.22 1.0 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -142.0 150.96 42.02 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.801 0.334 . . . . 0.0 110.617 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -140.61 117.68 11.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.98 84.08 7.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.956 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.0 p -119.66 -173.01 2.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -57.45 -30.03 64.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.955 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -63.14 -28.02 69.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.637 HD12 ' CG1' ' A' ' 80' ' ' VAL . 36.4 mm -87.38 127.02 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.44 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.405 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -112.76 -42.37 3.62 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.053 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 34.1 tt0 -124.99 118.74 26.91 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.146 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 42' ' ' PHE . 39.3 t -123.74 112.79 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.262 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -112.62 139.0 48.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.205 0.526 . . . . 0.0 112.071 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.461 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 71.7 m95 -112.39 82.99 1.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.865 178.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -94.69 142.92 26.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.337 0.589 . . . . 0.0 112.286 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 118.23 18.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.418 178.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.97 -113.73 5.01 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.654 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.5 p -119.55 44.82 2.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.738 0.304 . . . . 0.0 110.663 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.8 m -156.46 159.64 38.83 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.887 0.375 . . . . 0.0 111.315 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.52 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 4.8 mt -99.81 147.49 25.43 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.697 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 40.3 t -118.37 -41.14 2.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.481 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -172.97 117.54 0.31 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.679 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -122.53 156.94 33.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 110.617 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 30' ' ' VAL . 63.5 t80 -121.53 134.54 55.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.717 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.37 113.44 14.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.753 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -44.7 95.73 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 122.165 0.983 . . . . 0.0 111.114 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.4 mttt 81.44 -47.12 0.23 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 113.493 -1.685 . . . . 0.0 110.968 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.5 mtt -55.78 150.36 13.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.94 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.34 111.06 3.68 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.152 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -69.71 -166.53 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.466 2.11 . . . . 0.0 112.043 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.52 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 84.9 t80 -136.67 113.7 10.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.869 0.366 . . . . 0.0 111.481 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 50' ' ' LEU . 10.1 mt -108.69 112.64 25.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.98 179.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 24.3 tttm -44.67 -49.22 10.5 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.732 0.301 . . . . 0.0 111.381 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.52 168.69 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.085 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.82 -12.46 1.7 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.445 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.74 0.3 13.44 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 117.847 0.824 . . . . 0.0 112.336 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -136.99 156.89 47.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 111.269 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -150.8 120.46 6.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.232 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.627 HG23 ' O ' ' A' ' 57' ' ' ILE . 4.7 tt -75.59 103.9 3.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.047 0.451 . . . . 0.0 111.368 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.481 HD11 ' HG3' ' A' ' 64' ' ' LYS . 1.6 mp -54.15 169.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.069 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.33 -24.44 64.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.624 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' A' ' 62' ' ' ASP . 5.8 p-10 -96.48 33.22 1.84 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.79 0.329 . . . . 0.0 111.157 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.04 31.0 64.43 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.723 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.512 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 0.3 OUTLIER -97.47 174.03 6.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.886 0.374 . . . . 0.0 111.117 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 11.1 tp -113.7 121.11 43.12 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.53 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HG3' HD11 ' A' ' 58' ' ' LEU . 3.1 tmtp? -106.87 106.32 16.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.755 0.312 . . . . 0.0 111.196 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.856 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.7 mt -86.4 135.41 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.067 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -90.75 -40.72 11.67 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -143.63 109.19 5.13 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.758 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.848 ' HB3' HG21 ' A' ' 97' ' ' ILE . 5.3 mt -58.54 145.89 37.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.129 0.49 . . . . 0.0 111.339 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.725 ' C ' HD11 ' A' ' 10' ' ' LEU . 4.5 p -148.78 158.48 44.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.238 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.681 ' N ' HD11 ' A' ' 10' ' ' LEU . 9.9 mmm-85 -50.5 -57.1 8.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.185 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -54.42 -22.29 12.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.094 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.559 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -81.4 -14.81 56.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.319 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.445 ' HB3' HD12 ' A' ' 97' ' ' ILE . 5.0 p -83.55 138.2 33.5 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.647 0.26 . . . . 0.0 110.845 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.07 -126.02 2.32 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.681 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 m -132.99 129.61 38.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.864 0.832 . . . . 0.0 110.921 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.53 ' CE1' HD12 ' A' ' 95' ' ' LEU . 23.6 m-85 -103.91 151.28 23.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.293 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -132.63 122.42 24.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.371 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.923 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -108.0 127.85 63.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.056 179.288 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.98 97.09 6.03 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.637 ' CG1' HD12 ' A' ' 27' ' ' ILE . 80.7 t -88.16 130.25 38.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.304 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.555 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 96.8 m-85 -124.02 154.45 39.86 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.269 0.556 . . . . 0.0 111.184 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.534 ' CB ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -87.98 175.85 7.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.381 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.405 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 20.3 p -62.65 -22.03 66.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.165 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -96.0 24.97 5.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.191 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.63 26.83 53.82 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.581 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.69 157.84 15.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.816 0.341 . . . . 0.0 110.816 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.12 111.41 14.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.534 HD11 ' CB ' ' A' ' 82' ' ' SER . 34.4 mm -92.98 -49.72 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.33 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.518 HD21 ' CG ' ' A' ' 91' ' ' LYS . 2.6 tt -154.01 149.15 26.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.283 0.563 . . . . 0.0 111.773 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -140.62 108.32 5.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.173 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.518 ' CG ' HD21 ' A' ' 89' ' ' LEU . 7.4 mmpt? -120.52 159.2 25.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.83 121.71 14.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.039 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.647 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -120.91 161.89 20.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.892 0.377 . . . . 0.0 111.695 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.59 125.81 53.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.199 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.881 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -106.31 101.51 10.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.233 -179.44 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.36 108.95 21.78 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.22 0.533 . . . . 0.0 110.412 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.848 HG21 ' HB3' ' A' ' 68' ' ' LEU . 3.6 mt -110.44 113.41 44.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.731 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mt -67.69 121.0 14.98 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.534 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.912 -179.872 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.812 0.339 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -131.31 -65.86 0.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.897 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.3 115.34 3.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.87 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.41 160.65 13.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.495 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.415 HG23 ' HB2' ' A' ' 94' ' ' ASP . 97.3 m -64.58 118.72 9.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 0.0 110.887 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.89 HG23 ' HA ' ' A' ' 95' ' ' LEU . 2.9 m -95.74 178.57 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 CA-C-O 121.78 0.8 . . . . 0.0 112.345 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.433 ' CE3' ' HB2' ' A' ' 96' ' ' ARG . 73.3 m95 -145.42 161.97 38.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.55 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.48 179.16 41.15 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.427 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.413 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -122.63 134.42 54.5 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.976 0.417 . . . . 0.0 111.25 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.686 HD11 ' N ' ' A' ' 70' ' ' ARG . 1.2 tp -58.0 134.09 56.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.692 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.0 -4.11 83.89 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.393 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.614 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.4 OUTLIER -108.99 167.94 9.73 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.614 ' O ' ' CE1' ' A' ' 12' ' ' HIS . . . -78.73 -173.4 43.02 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.659 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.895 HG21 HD21 ' A' ' 68' ' ' LEU . 1.1 tp 164.18 136.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.756 0.312 . . . . 0.0 110.38 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -116.93 118.7 33.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.89 0.376 . . . . 0.0 111.391 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.475 HD21 ' CD1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -81.23 102.93 10.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.849 179.299 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -85.97 124.73 32.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.192 0.52 . . . . 0.0 111.724 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.94 HD11 HG11 ' A' ' 78' ' ' VAL . 3.4 mt -78.42 119.93 79.16 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.154 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -58.26 130.15 36.33 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.37 2.047 . . . . 0.0 113.094 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 42.44 64.61 1.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.518 ' HB2' HD13 ' A' ' 89' ' ' LEU . 9.6 t80 -140.7 149.0 41.64 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.817 0.341 . . . . 0.0 110.585 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -139.42 117.16 11.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.961 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.35 81.14 7.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.868 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.54 -174.53 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.829 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -56.8 -30.78 64.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.961 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.02 -27.85 69.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.565 HD12 ' CG1' ' A' ' 80' ' ' VAL . 33.6 mm -83.67 127.88 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.429 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.73 -44.06 3.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 13.9 tp10 -125.91 134.58 51.53 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.317 -179.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -135.41 108.01 8.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.723 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -105.17 132.03 51.9 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -109.01 82.88 1.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -99.17 157.92 16.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.394 0.616 . . . . 0.0 112.467 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -149.3 113.8 5.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.509 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.46 -117.03 9.4 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.741 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 p -115.0 42.47 2.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.741 0.305 . . . . 0.0 110.705 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.0 m -150.66 160.4 43.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.237 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.541 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 6.2 mt -106.82 147.94 29.11 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.444 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 53.7 t -119.03 -43.76 2.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.235 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.39 113.26 1.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.527 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.528 ' OE2' HD21 ' A' ' 38' ' ' LEU . 2.2 mt-10 -118.51 113.58 21.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.051 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.561 ' HB2' HD13 ' A' ' 57' ' ' ILE . 16.5 t80 -103.82 120.99 42.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.882 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -120.07 132.68 55.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.466 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.9 tpp85 -47.72 -28.43 2.46 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.497 0.665 . . . . 0.0 111.684 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.8 tttm -82.73 41.9 0.75 Allowed 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.906 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 41.58 -164.8 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.501 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm 54.69 69.45 2.08 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.57 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.48 176.56 7.81 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.978 2.452 . . . . 0.0 111.939 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.541 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 69.8 t80 -125.34 99.87 6.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.337 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 50' ' ' LEU . 9.1 mt -96.24 105.66 17.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.931 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 39.8 tttm -43.92 -59.2 2.38 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.586 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.6 p -144.74 162.75 35.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 0.0 111.193 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.08 -8.16 21.67 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.022 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.432 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . . . -78.39 3.41 15.78 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 117.559 0.679 . . . . 0.0 111.952 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -125.5 157.36 37.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.273 0.559 . . . . 0.0 111.743 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -154.55 124.65 6.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.212 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 57' ' ' ILE . 3.0 tt -83.49 106.66 14.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.308 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.66 HD23 HD21 ' A' ' 60' ' ' ASN . 1.2 mp -65.7 172.79 3.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.904 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.3 -44.83 64.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.156 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.66 HD21 HD23 ' A' ' 58' ' ' LEU . 4.7 p30 -57.33 -25.13 58.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.06 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.69 33.42 3.84 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.547 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -113.39 154.61 26.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.841 0.353 . . . . 0.0 110.964 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 tp -84.39 122.05 28.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.459 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -102.99 111.33 23.61 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.831 0.348 . . . . 0.0 111.421 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.865 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.8 mt -97.13 122.64 48.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.114 179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.432 ' HD2' ' HA ' ' A' ' 54' ' ' ALA . 1.6 ptpp? -89.27 -33.76 16.84 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.471 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -140.8 104.82 4.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.601 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.895 HD21 HG21 ' A' ' 14' ' ' ILE . 6.2 mt -63.01 154.43 30.68 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.13 0.49 . . . . 0.0 111.458 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.545 ' C ' HD11 ' A' ' 10' ' ' LEU . 5.1 p -152.35 157.04 40.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.209 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.686 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -50.11 -55.98 12.77 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.363 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -52.63 -24.6 8.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.132 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.01 -15.36 44.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.255 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.403 ' N ' HD12 ' A' ' 97' ' ' ILE . 14.4 p -77.86 126.2 30.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.415 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 154.21 -131.08 3.09 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.447 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 1.3 m -126.03 129.19 48.68 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 117.711 0.756 . . . . 0.0 111.143 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.475 ' CD1' HD21 ' A' ' 16' ' ' LEU . 63.9 m-85 -99.82 148.4 24.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.035 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.651 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 12.8 m-20 -130.05 122.23 27.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.769 0.319 . . . . 0.0 111.356 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.94 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.57 130.55 62.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.274 179.34 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.94 96.72 5.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.818 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.565 ' CG1' HD12 ' A' ' 27' ' ' ILE . 55.0 t -86.56 134.07 28.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.243 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.491 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 81.0 m-85 -127.39 156.69 41.65 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.347 0.594 . . . . 0.0 111.199 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.661 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -90.02 174.96 7.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.448 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.3 -24.94 66.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.15 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -95.9 27.1 3.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.198 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.7 23.61 37.32 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.719 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.61 156.32 18.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.731 0.3 . . . . 0.0 110.823 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.58 118.42 22.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.541 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.661 HD11 ' HB3' ' A' ' 82' ' ' SER . 45.9 mt -102.05 -67.1 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.425 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.569 HD21 ' CG ' ' A' ' 91' ' ' LYS . 5.1 tt -134.18 148.8 50.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.322 0.582 . . . . 0.0 111.875 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.69 109.21 5.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.061 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.569 ' CG ' HD21 ' A' ' 89' ' ' LEU . 58.4 mmtt -122.53 153.33 39.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.651 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -139.85 122.95 16.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.284 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.647 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -122.82 165.28 16.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.267 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.415 ' HB2' HG23 ' A' ' 5' ' ' THR . 0.7 OUTLIER -125.22 106.32 9.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.73 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.89 ' HA ' HG23 ' A' ' 6' ' ' VAL . 7.1 tt -101.16 114.86 29.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.897 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -96.79 108.33 20.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.408 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.748 HG12 HD22 ' A' ' 68' ' ' LEU . 8.6 mt -90.88 108.94 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.776 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.91 120.38 13.5 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.571 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.872 -179.835 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.876 0.369 . . . . 0.0 111.269 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -158.75 169.24 24.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 m -60.47 -175.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.74 160.81 24.66 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.537 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 5.8 m -138.78 154.64 48.52 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.292 0.568 . . . . 0.0 111.067 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.743 HG11 HD12 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -153.61 141.56 13.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.884 -178.604 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -115.73 139.35 50.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.81 0.338 . . . . 0.0 110.957 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.57 176.59 28.21 Favored Glycine 0 C--O 1.228 -0.221 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.972 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.61 135.12 54.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.172 0.486 . . . . 0.0 111.121 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.565 HD12 HG21 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -54.02 130.38 37.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.713 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.11 -8.95 75.64 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.887 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.549 ' NE2' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -106.57 170.97 7.62 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.549 ' O ' ' NE2' ' A' ' 12' ' ' HIS . . . -86.55 174.36 46.56 Favored Glycine 0 C--O 1.224 -0.477 0 C-N-CA 120.705 -0.759 . . . . 0.0 113.468 -178.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.815 ' CG2' HD12 ' A' ' 65' ' ' ILE . 3.3 tp 179.59 144.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.6 0.238 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -120.69 129.94 53.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.951 0.405 . . . . 0.0 111.639 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -91.52 104.08 16.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.713 179.222 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -86.19 123.9 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.188 0.518 . . . . 0.0 111.911 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.934 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.4 mt -79.55 120.19 79.43 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.184 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.25 130.63 36.92 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.26 1.973 . . . . 0.0 113.0 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 43.08 64.78 1.1 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -141.67 150.5 41.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.784 0.326 . . . . 0.0 110.551 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -142.07 117.55 10.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.881 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.97 76.87 6.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.978 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.1 p -105.86 -172.51 2.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -59.08 -31.45 68.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.966 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.01 -26.94 68.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.99 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.552 HD12 ' CG1' ' A' ' 80' ' ' VAL . 22.1 mm -79.01 129.21 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.43 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.418 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.9 OUTLIER -112.68 -44.11 3.37 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.082 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 69.2 tt0 -132.45 116.39 16.73 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.001 -0.68 . . . . 0.0 112.655 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.31 114.69 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -112.17 130.73 55.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.172 0.51 . . . . 0.0 112.36 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -112.73 85.37 2.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.987 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -98.97 148.75 23.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.252 0.548 . . . . 0.0 112.229 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.0 114.69 9.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.609 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.45 -117.73 11.5 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.809 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.5 m -114.64 42.36 2.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.764 0.316 . . . . 0.0 110.665 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.7 m -151.95 160.18 43.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.235 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.542 HD21 ' OE2' ' A' ' 41' ' ' GLU . 5.5 mt -102.94 146.15 28.75 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.463 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 46.9 t -117.59 -42.47 2.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.941 0.401 . . . . 0.0 110.243 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -165.83 112.17 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.492 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.542 ' OE2' HD21 ' A' ' 38' ' ' LEU . 2.2 mt-10 -120.36 112.67 19.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.066 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.43 ' HB2' HD13 ' A' ' 57' ' ' ILE . 22.4 t80 -102.34 158.88 15.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.761 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.412 ' N ' ' CD1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -147.93 174.4 11.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.927 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.427 ' HD3' ' HA ' ' A' ' 44' ' ' ARG . 2.7 tpp180 -99.58 105.7 17.61 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.82 0.819 . . . . 0.0 109.791 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 44' ' ' ARG . 2.3 tmtt? 82.77 -47.95 0.16 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.706 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -56.91 178.18 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.742 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.45 132.52 31.65 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.209 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.412 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 91.7 Cg_endo -84.29 -175.31 2.13 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.767 2.311 . . . . 0.0 112.52 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.536 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 78.7 t80 -138.83 106.17 5.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.415 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 50' ' ' LEU . 7.9 mt -100.95 110.66 22.73 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 36.2 tttt -44.84 -49.14 10.99 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.73 0.3 . . . . 0.0 111.607 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.1 p -169.84 164.98 9.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.956 0.408 . . . . 0.0 111.319 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.77 -12.1 4.78 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.138 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.28 0.93 12.69 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 117.782 0.791 . . . . 0.0 112.083 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -131.94 157.54 43.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.052 0.453 . . . . 0.0 111.09 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -154.09 127.21 8.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.512 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.661 HG23 ' O ' ' A' ' 57' ' ' ILE . 7.1 tt -86.02 101.26 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.178 0.513 . . . . 0.0 111.276 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.633 HD23 HD21 ' A' ' 60' ' ' ASN . 1.2 mp -58.68 171.16 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.957 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.7 -44.64 77.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.185 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.633 HD21 HD23 ' A' ' 58' ' ' LEU . 4.9 p30 -58.2 -25.1 61.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.07 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.75 34.17 3.88 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.568 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -112.96 154.73 25.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.789 0.328 . . . . 0.0 110.968 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.0 tp -82.72 123.13 29.01 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.632 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.413 ' HB2' HD13 ' A' ' 58' ' ' LEU . 1.4 tptt -106.38 110.09 22.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.906 0.384 . . . . 0.0 111.219 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.815 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.9 mt -92.21 121.2 42.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.148 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -81.14 -36.21 30.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.894 0.378 . . . . 0.0 111.798 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -144.25 107.52 4.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.706 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.605 HD22 ' CD1' ' A' ' 97' ' ' ILE . 4.4 mt -59.03 143.73 47.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.058 0.456 . . . . 0.0 111.337 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.448 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 9.2 p -143.33 165.09 28.45 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.856 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.7 mmt85 -50.5 -54.94 18.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.256 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -53.45 -23.87 11.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.41 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -73.5 -13.57 61.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.567 0.222 . . . . 0.0 111.427 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.418 ' HB3' ' CG1' ' A' ' 97' ' ' ILE . 5.0 p -82.78 116.05 21.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.68 0.276 . . . . 0.0 110.647 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.27 -144.93 10.3 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.21 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -120.38 131.02 54.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.145 0.472 . . . . 0.0 110.621 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -103.96 131.99 50.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.411 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.708 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 1.9 m-20 -114.39 123.4 49.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.286 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.934 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -106.11 129.06 59.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.275 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.47 97.66 6.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.552 ' CG1' HD12 ' A' ' 27' ' ' ILE . 77.7 t -88.0 123.23 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.436 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.445 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 93.4 m-85 -113.81 151.15 32.46 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.224 0.535 . . . . 0.0 111.053 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.61 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -90.79 172.87 8.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.545 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 16.9 p -60.81 -19.18 59.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.351 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -94.39 24.67 4.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.218 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.82 23.29 44.4 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.6 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.94 176.11 5.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.783 0.325 . . . . 0.0 110.735 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -98.31 126.47 43.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.676 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.61 HD11 ' HB3' ' A' ' 82' ' ' SER . 51.4 mt -101.24 -61.42 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.416 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.749 HD21 ' CG ' ' A' ' 91' ' ' LYS . 5.0 tt -140.06 129.53 24.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.113 0.483 . . . . 0.0 111.855 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -120.54 108.54 14.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.17 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.749 ' CG ' HD21 ' A' ' 89' ' ' LEU . 26.2 mmtt -121.05 159.69 25.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.352 0.596 . . . . 0.0 112.439 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.708 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -139.83 121.75 15.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.45 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 93' ' ' LEU . 1.4 mp -119.49 165.39 14.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.865 0.364 . . . . 0.0 111.152 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 5' ' ' THR . 0.7 OUTLIER -123.47 134.31 53.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.639 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.743 HD12 HG11 ' A' ' 6' ' ' VAL . 8.5 tt -129.73 132.37 46.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.023 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -109.8 132.29 54.28 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.931 0.396 . . . . 0.0 111.062 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.605 ' CD1' HD22 ' A' ' 68' ' ' LEU . 7.0 mm -101.12 100.9 11.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.615 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.8 mt -74.86 122.81 23.95 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 120.971 0.415 . . . . 0.0 110.479 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.318 -0.848 . . . . 0.0 110.912 -179.829 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.731 0.3 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -107.48 -67.12 0.98 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.87 -166.81 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.821 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.65 -150.24 42.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.397 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 1.8 m -47.07 146.07 1.89 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.252 0.548 . . . . 0.0 111.267 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.815 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -142.01 148.86 20.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.706 -179.187 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -118.53 128.57 54.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.659 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.07 179.66 21.24 Favored Glycine 0 N--CA 1.46 0.296 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.733 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.41 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -124.72 134.7 52.74 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.929 0.395 . . . . 0.0 111.116 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.683 HD11 ' N ' ' A' ' 70' ' ' ARG . 1.0 OUTLIER -52.81 134.57 36.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.158 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.73 -6.44 82.75 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.928 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -105.97 168.66 8.97 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 117.144 0.472 . . . . 0.0 109.988 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.529 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -77.11 163.59 52.27 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.203 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.872 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.6 tp -176.97 138.96 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 122.635 -0.332 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -125.48 133.3 52.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.928 0.394 . . . . 0.0 111.352 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.836 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -87.24 122.4 30.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.563 179.156 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.458 ' O ' HD21 ' A' ' 93' ' ' LEU . 77.4 m-20 -103.59 124.49 48.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.134 0.492 . . . . 0.0 111.687 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.957 HD11 HG11 ' A' ' 78' ' ' VAL . 3.2 mt -80.51 119.46 76.37 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.349 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.26 131.33 38.19 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.357 2.038 . . . . 0.0 113.066 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.15 64.81 1.01 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -139.69 149.32 43.54 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.809 0.337 . . . . 0.0 110.517 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -135.38 117.01 14.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.511 ' SD ' HG21 ' A' ' 30' ' ' VAL . 1.8 tpt -87.53 83.62 7.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.9 p -115.47 -173.13 2.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.849 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -58.61 -31.62 68.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.47 -24.91 67.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.945 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.492 HD12 ' CG1' ' A' ' 80' ' ' VAL . 34.6 mm -79.86 127.89 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.43 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.441 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 1.3 t0 -103.9 -38.37 7.04 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 122.267 -0.27 . . . . 0.0 111.673 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 8.8 mt-10 -141.96 151.81 42.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.722 0.772 . . . . 0.0 112.574 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.511 HG21 ' SD ' ' A' ' 23' ' ' MET . 45.5 t -145.29 106.87 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.955 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -101.53 126.05 48.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.079 0.466 . . . . 0.0 112.232 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -105.16 84.39 2.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.03 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -103.99 156.13 18.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.233 0.539 . . . . 0.0 112.211 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.58 117.73 7.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.734 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.99 -118.12 12.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.826 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.9 t -115.19 42.52 2.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.758 0.313 . . . . 0.0 110.721 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.9 m -149.93 159.94 43.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.136 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.533 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 6.3 mt -105.57 145.69 30.62 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.872 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.407 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 54.2 t -117.04 -43.6 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.086 0.47 . . . . 0.0 110.089 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.91 112.36 0.89 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.713 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -116.5 111.79 20.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.076 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -110.19 115.35 29.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.943 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -120.08 142.7 48.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.472 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -50.76 -24.93 3.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.235 0.54 . . . . 0.0 111.878 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.41 37.88 0.47 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.225 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.4 ttm 40.05 -163.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.63 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.5 mttt 52.47 65.18 6.4 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.65 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -78.66 179.76 6.2 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.548 2.165 . . . . 0.0 112.055 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 64.4 t80 -129.87 98.71 4.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.433 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 50' ' ' LEU . 10.1 mt -95.82 108.68 21.05 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 38.8 tttt -42.19 -37.83 1.57 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.707 0.289 . . . . 0.0 111.7 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.52 165.4 1.36 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 111.07 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.64 -10.49 4.52 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.338 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.65 2.01 10.88 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.748 0.774 . . . . 0.0 112.185 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -132.1 157.59 43.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.092 0.473 . . . . 0.0 111.262 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -155.94 123.87 5.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.421 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.648 HG23 ' O ' ' A' ' 57' ' ' ILE . 6.6 tt -81.25 101.73 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.224 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.676 HD23 HD21 ' A' ' 60' ' ' ASN . 0.8 OUTLIER -58.88 173.35 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.993 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.78 -45.19 65.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.199 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.676 HD21 HD23 ' A' ' 58' ' ' LEU . 4.6 p30 -58.15 -21.88 48.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.67 35.06 4.18 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.611 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -116.1 155.17 28.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.841 0.353 . . . . 0.0 111.036 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 12.1 tp -81.77 122.46 27.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.671 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -104.83 110.26 22.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.752 0.311 . . . . 0.0 111.111 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.872 HD12 ' CG2' ' A' ' 14' ' ' ILE . 3.1 mt -91.38 134.35 30.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.339 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -82.73 -45.94 13.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.015 0.436 . . . . 0.0 111.692 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.77 112.31 5.6 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.249 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.066 HD22 HD12 ' A' ' 97' ' ' ILE . 4.4 mt -51.37 146.49 6.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.166 0.508 . . . . 0.0 111.974 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.581 ' C ' HD11 ' A' ' 10' ' ' LEU . 2.7 p -143.98 155.23 43.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.826 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.683 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -50.11 -56.33 11.33 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.363 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -52.98 -23.8 8.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.162 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.553 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -77.32 -16.17 59.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.303 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.438 ' CB ' HG12 ' A' ' 97' ' ' ILE . 22.1 p -76.95 117.48 18.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.641 0.258 . . . . 0.0 110.711 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.54 -151.33 21.17 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.169 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -110.05 131.34 55.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.783 0.325 . . . . 0.0 110.512 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -105.21 151.72 23.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.266 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.661 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 12.1 m-20 -133.8 125.0 27.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.355 . . . . 0.0 111.434 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.957 HG11 HD11 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -107.47 134.23 49.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.256 179.195 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.39 95.03 4.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.649 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.493 HG12 ' HB ' ' A' ' 88' ' ' ILE . 64.8 t -85.31 130.97 35.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.015 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.538 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 2.7 m-30 -116.87 152.99 33.32 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.31 0.576 . . . . 0.0 110.764 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.507 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -92.48 179.24 5.58 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.884 179.393 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 0.8 OUTLIER -64.78 -23.61 67.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.088 179.619 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -84.69 -5.12 59.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.52 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.56 19.23 55.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.812 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.88 141.82 37.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.749 0.309 . . . . 0.0 110.861 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.39 111.04 2.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.95 0.405 . . . . 0.0 111.014 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.507 HD11 ' HB3' ' A' ' 82' ' ' SER . 26.1 mm -80.14 -40.29 20.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.159 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.913 HD21 ' HG3' ' A' ' 91' ' ' LYS . 4.4 tt -152.82 127.36 9.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.107 0.479 . . . . 0.0 111.885 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -117.35 108.12 15.2 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.913 ' HG3' HD21 ' A' ' 89' ' ' LEU . 15.5 mmtt -119.32 159.4 24.22 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.661 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.73 122.41 17.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.071 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.643 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -119.88 162.15 19.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.015 0.435 . . . . 0.0 111.57 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 5' ' ' THR . 29.0 m-20 -111.25 122.6 48.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.449 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.836 HD12 HD21 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -117.2 101.95 8.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.051 -179.585 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.545 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -94.42 125.18 38.9 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.129 0.49 . . . . 0.0 110.929 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.066 HD12 HD22 ' A' ' 68' ' ' LEU . 2.8 mm -108.72 112.49 40.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.999 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 98' ' ' LEU . 10.1 mt -73.68 123.54 24.26 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.416 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.883 -179.793 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.776 0.322 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.49 149.38 44.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.882 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.5 p -78.78 -76.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.62 158.84 30.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.574 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.1 m -142.74 152.69 42.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.22 0.534 . . . . 0.0 110.92 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.955 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER -142.63 145.47 23.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.866 -179.308 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -115.13 130.09 56.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.802 0.334 . . . . 0.0 110.752 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.57 -179.62 23.74 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.781 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.434 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -129.79 134.43 47.57 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.972 0.415 . . . . 0.0 111.192 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.66 HD11 ' N ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -53.63 135.86 39.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.992 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.88 -8.77 74.64 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.73 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.527 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.61 167.37 10.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.594 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.89 -171.75 11.34 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.472 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.893 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 163.04 136.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.94 0.4 . . . . 0.0 110.531 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -119.33 134.02 55.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.067 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -92.18 105.27 17.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.173 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.42 ' O ' HD21 ' A' ' 93' ' ' LEU . 61.9 m-20 -88.45 122.09 31.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.183 0.516 . . . . 0.0 112.116 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.941 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.3 mt -80.58 119.46 76.34 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.229 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.68 131.76 39.4 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.316 2.011 . . . . 0.0 112.878 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 43.26 65.37 0.98 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -142.75 149.31 38.57 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.791 0.329 . . . . 0.0 110.625 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -142.75 116.95 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.948 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.07 78.82 5.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.2 p -107.37 -173.49 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.31 -34.87 71.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.923 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -59.76 -24.77 64.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.994 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.548 HD12 ' CG1' ' A' ' 80' ' ' VAL . 26.9 mm -78.61 129.08 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.448 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -110.72 -45.11 3.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.024 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 63.6 tt0 -135.36 118.24 16.23 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.786 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 t -110.08 115.08 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.922 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -112.82 132.87 55.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.297 0.57 . . . . 0.0 112.426 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.451 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 70.3 m95 -112.28 86.48 2.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.784 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -100.44 145.67 27.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.272 0.558 . . . . 0.0 112.386 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.8 ttp85 -136.98 118.43 14.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.403 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.95 -114.7 5.98 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.685 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.4 m -119.3 44.69 2.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.763 0.316 . . . . 0.0 110.663 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.8 m -154.78 159.98 40.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.309 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.525 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.7 mt -101.47 146.76 27.2 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.482 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 41.8 t -117.05 -41.25 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.992 0.425 . . . . 0.0 110.494 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -170.42 113.62 0.45 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.676 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.72 149.36 40.87 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.046 0.45 . . . . 0.0 110.422 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.434 ' HA ' ' HB3' ' A' ' 48' ' ' PRO . 55.2 t80 -127.75 158.17 38.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.932 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 28' ' ' ASP . 0.6 OUTLIER -146.49 169.94 17.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.678 179.577 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.409 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -93.47 102.08 14.29 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.757 0.789 . . . . 0.0 109.543 179.263 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 44' ' ' ARG . 29.0 tttt 82.93 -47.42 0.15 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.588 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.2 ttt -55.92 169.83 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.757 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -86.51 134.24 38.41 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.173 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.434 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 93.4 Cg_endo -82.83 -176.07 2.72 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.694 2.263 . . . . 0.0 112.691 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 61.0 t80 -130.62 106.77 8.71 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.156 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.4 mt -99.49 113.89 26.53 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.197 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.482 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 22.6 tttt -46.91 -44.83 20.09 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.71 0.291 . . . . 0.0 111.431 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 p -176.54 165.78 2.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.02 -12.09 3.59 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.159 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.71 0.94 13.58 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.746 0.773 . . . . 0.0 112.133 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -132.93 156.81 46.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.102 0.477 . . . . 0.0 111.195 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -151.23 118.43 5.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.348 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.642 HG23 ' O ' ' A' ' 57' ' ' ILE . 8.8 tt -75.04 99.31 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.064 0.459 . . . . 0.0 111.319 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' A' ' 58' ' ' LEU . 0.7 OUTLIER -49.59 167.02 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.245 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.74 -23.92 65.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.555 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.49 ' ND2' ' HB2' ' A' ' 62' ' ' ASP . 5.7 p-10 -96.59 33.18 1.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.836 0.351 . . . . 0.0 111.183 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.54 34.33 69.07 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.713 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.49 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -103.51 166.4 10.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.876 0.369 . . . . 0.0 111.007 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 10.4 tp -107.24 120.72 42.91 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.515 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -107.38 110.64 22.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 110.875 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.801 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.8 mt -89.56 137.53 21.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.363 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -84.79 -47.11 10.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.974 0.416 . . . . 0.0 112.006 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.35 110.86 5.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.403 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 14' ' ' ILE . 6.7 mt -55.2 150.78 10.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.71 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.596 ' C ' HD11 ' A' ' 10' ' ' LEU . 5.4 p -152.14 158.6 43.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.924 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.66 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -50.53 -56.27 12.37 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.2 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -55.03 -22.41 15.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.129 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.643 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -80.16 -14.41 58.49 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.313 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.3 t -79.59 127.34 32.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.644 0.259 . . . . 0.0 110.581 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.56 -167.85 32.07 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.226 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.55 125.33 36.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.763 0.316 . . . . 0.0 111.487 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -103.32 130.7 50.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.29 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -113.29 126.07 54.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.857 0.36 . . . . 0.0 111.562 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.941 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -108.01 126.14 64.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.027 179.178 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.88 97.91 6.85 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.548 ' CG1' HD12 ' A' ' 27' ' ' ILE . 69.0 t -90.41 124.24 42.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.441 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.404 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 85.1 m-85 -112.93 151.22 30.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.169 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.633 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -90.75 173.8 7.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.551 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.5 p -61.23 -18.46 58.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.385 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -93.01 22.98 4.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.325 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.57 19.52 48.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.656 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.55 -178.73 3.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.703 0.287 . . . . 0.0 110.616 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -101.08 126.3 47.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.778 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.633 HD11 ' HB3' ' A' ' 82' ' ' SER . 33.7 mm -98.95 -54.44 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.417 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.744 HD21 ' CG ' ' A' ' 91' ' ' LYS . 5.3 tt -144.98 126.12 14.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.105 0.479 . . . . 0.0 111.98 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -118.01 107.41 14.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.1 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.744 ' CG ' HD21 ' A' ' 89' ' ' LEU . 8.2 mmpt? -120.17 162.79 18.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.85 120.56 12.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.091 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.639 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -115.11 156.47 25.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.87 0.367 . . . . 0.0 111.531 -179.139 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.02 121.45 43.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.244 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.955 ' HA ' HG12 ' A' ' 6' ' ' VAL . 9.7 tp -108.85 98.59 8.06 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.286 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -96.59 110.73 23.08 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.125 0.488 . . . . 0.0 110.322 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.749 HG21 ' HB3' ' A' ' 68' ' ' LEU . 4.6 mt -104.9 113.16 41.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.895 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 98' ' ' LEU . 8.8 mt -69.0 121.01 15.76 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.549 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.939 -179.84 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.876 0.369 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.02 -39.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.837 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.4 t -58.04 125.32 22.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.923 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.23 -148.81 19.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.552 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -45.2 145.83 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.411 0.624 . . . . 0.0 111.454 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.899 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.6 OUTLIER -137.88 144.56 30.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.619 -179.261 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -112.68 129.56 56.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.799 0.333 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -153.98 177.6 31.34 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.76 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.76 135.62 54.93 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.969 0.414 . . . . 0.0 110.848 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.801 HD11 ' C ' ' A' ' 69' ' ' THR . 1.7 tp -56.92 129.34 41.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.901 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.53 -4.69 76.68 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.502 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.559 ' NE2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.9 168.7 9.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.559 ' O ' ' NE2' ' A' ' 12' ' ' HIS . . . -77.74 160.67 49.02 Favored Glycine 0 C--O 1.224 -0.524 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.083 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.815 HG21 HD21 ' A' ' 68' ' ' LEU . 1.6 tp -176.14 138.06 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.834 0.349 . . . . 0.0 111.237 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -117.92 129.24 55.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.208 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -86.55 106.09 17.29 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.22 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.484 ' O ' HD21 ' A' ' 93' ' ' LEU . 67.5 m-20 -88.72 126.28 35.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.304 0.573 . . . . 0.0 112.008 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.913 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.3 mt -80.79 119.82 77.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.153 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.33 131.26 37.66 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.318 2.012 . . . . 0.0 112.862 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 m120 43.27 65.37 0.99 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.469 ' HB2' HD13 ' A' ' 89' ' ' LEU . 9.3 t80 -142.7 151.3 41.2 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 110.55 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -141.94 114.97 8.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.29 83.27 5.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.14 -174.07 2.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.86 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -56.08 -30.02 61.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.953 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -63.67 -27.87 69.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.999 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.643 HD12 ' CG1' ' A' ' 80' ' ' VAL . 35.1 mm -87.39 127.04 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.399 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -113.03 -42.16 3.6 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.069 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 43.2 tt0 -124.63 118.38 26.38 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.174 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 24.6 t -122.43 115.09 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.152 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -114.59 137.34 52.0 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.2 0.524 . . . . 0.0 112.261 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.446 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 71.9 m95 -112.19 85.58 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.86 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -97.28 142.39 29.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.287 0.565 . . . . 0.0 112.264 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.77 118.55 19.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.424 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.81 -114.22 5.45 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.687 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 m -119.68 44.94 2.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.732 0.301 . . . . 0.0 110.686 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.0 m -155.26 159.68 40.23 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.906 0.384 . . . . 0.0 111.357 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.535 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 4.5 mt -97.82 147.29 24.56 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.7 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 55.2 t -119.13 -43.09 2.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.341 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -172.45 114.39 0.3 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.725 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 1.1 pt-20 -125.05 156.61 37.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.078 0.466 . . . . 0.0 111.005 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -127.54 142.2 51.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.845 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.6 ' HE2' ' HE3' ' A' ' 46' ' ' MET . 1.5 ttpt -146.61 113.19 5.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.697 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -51.65 -59.31 4.43 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.795 0.807 . . . . 0.0 111.114 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -82.5 46.57 1.07 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.908 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.6 ' HE3' ' HE2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 176.85 -172.11 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.816 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -107.55 141.04 22.16 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.755 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.61 155.17 59.45 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.445 2.097 . . . . 0.0 112.48 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.535 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 46.5 t80 -111.61 103.54 11.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.177 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.3 mt -94.79 112.89 24.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.289 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 19.9 tttp -48.07 -46.63 33.82 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.695 0.283 . . . . 0.0 111.23 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -173.41 166.11 4.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 0.0 111.196 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.38 -11.47 3.63 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.376 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.53 -0.09 14.09 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 117.834 0.817 . . . . 0.0 112.236 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -132.84 157.8 44.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.076 0.465 . . . . 0.0 111.073 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -152.07 124.45 8.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.43 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.649 HG23 ' O ' ' A' ' 57' ' ' ILE . 4.7 tt -84.61 103.9 12.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 111.176 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.668 HD23 HD21 ' A' ' 60' ' ' ASN . 1.4 mp -62.73 172.63 1.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.005 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.36 -45.15 63.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.668 HD21 HD23 ' A' ' 58' ' ' LEU . 4.5 p30 -57.43 -22.45 43.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.113 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.01 35.0 4.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.634 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -115.33 155.38 27.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 110.979 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.2 tp -85.48 122.72 30.02 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.798 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -104.84 108.24 19.62 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.736 0.303 . . . . 0.0 111.073 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.794 HD12 ' CG2' ' A' ' 14' ' ' ILE . 4.0 mt -89.35 132.59 33.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.449 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -81.13 -46.06 15.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.953 0.406 . . . . 0.0 111.76 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.16 112.64 5.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.322 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.834 ' HB3' HG21 ' A' ' 97' ' ' ILE . 5.1 mt -54.16 149.62 9.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.166 0.508 . . . . 0.0 111.746 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.801 ' C ' HD11 ' A' ' 10' ' ' LEU . 5.2 p -151.32 158.26 43.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.153 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.612 ' N ' HD11 ' A' ' 10' ' ' LEU . 5.5 mmt180 -50.62 -56.82 10.07 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.173 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.37 -20.76 20.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.315 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.621 ' O ' HD23 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -93.17 17.03 11.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.289 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.48 146.99 36.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.684 0.278 . . . . 0.0 110.756 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.32 -117.71 1.76 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.291 -0.957 . . . . 0.0 112.901 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -138.04 130.3 29.0 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 117.717 0.759 . . . . 0.0 110.848 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -103.98 151.92 22.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.359 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.668 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 11.6 m-20 -132.57 124.15 27.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.192 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.913 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.46 127.3 66.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.223 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.58 97.18 6.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.715 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.643 ' CG1' HD12 ' A' ' 27' ' ' ILE . 73.2 t -88.22 131.78 34.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.269 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.551 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 96.0 m-85 -125.35 154.67 41.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.313 0.577 . . . . 0.0 111.198 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.534 ' CB ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -87.77 175.71 7.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.414 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 2.1 p -62.82 -22.1 66.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.118 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -96.21 24.87 5.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.114 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.92 27.35 56.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.645 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.45 157.14 16.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 0.0 110.866 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.46 111.0 12.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.611 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.534 HD11 ' CB ' ' A' ' 82' ' ' SER . 35.2 mm -93.22 -51.55 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.403 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.469 HD13 ' HB2' ' A' ' 21' ' ' PHE . 2.5 tt -151.02 149.78 29.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.212 0.53 . . . . 0.0 111.697 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.7 108.35 5.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.176 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.466 ' CG ' HD21 ' A' ' 89' ' ' LEU . 4.1 mmpt? -122.06 156.19 34.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.378 0.608 . . . . 0.0 112.516 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.668 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -139.42 123.65 18.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.174 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.655 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -122.51 163.05 20.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 0.0 111.437 -179.344 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.23 133.05 53.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.482 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.899 ' HA ' HG12 ' A' ' 6' ' ' VAL . 8.1 tp -113.36 97.9 6.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.635 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -95.37 108.13 20.31 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.105 0.478 . . . . 0.0 109.98 178.898 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.834 HG21 ' HB3' ' A' ' 68' ' ' LEU . 1.6 mt -106.65 110.51 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.001 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.9 mt -66.68 126.68 29.73 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.289 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.927 -179.749 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.817 0.341 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -103.0 114.64 29.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.23 165.22 2.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.844 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 66.53 -149.29 51.3 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.499 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -45.84 140.72 3.41 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.267 0.556 . . . . 0.0 111.461 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.872 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -133.69 149.53 30.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.775 -179.521 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -118.16 127.16 53.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.59 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.69 177.7 27.68 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.826 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.4 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -123.56 135.55 54.06 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.889 0.376 . . . . 0.0 110.969 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.675 HD11 ' C ' ' A' ' 69' ' ' THR . 0.9 OUTLIER -53.17 134.59 38.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.053 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.55 -5.31 84.96 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.852 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.548 ' NE2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.34 168.68 9.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 117.126 0.463 . . . . 0.0 109.958 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.548 ' O ' ' NE2' ' A' ' 12' ' ' HIS . . . -78.57 162.09 48.85 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.287 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.879 HG21 HD21 ' A' ' 68' ' ' LEU . 1.9 tp -176.54 138.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.764 0.316 . . . . 0.0 111.008 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.667 ' OD2' HD22 ' A' ' 58' ' ' LEU . 8.0 t0 -124.09 128.23 48.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.254 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.428 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -81.93 125.09 30.33 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.157 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -104.09 124.23 48.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.275 0.559 . . . . 0.0 111.914 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.958 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.4 mt -82.1 119.94 76.18 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.417 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.97 131.15 37.88 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.37 2.047 . . . . 0.0 112.96 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.65 65.23 0.96 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -142.18 149.13 39.31 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.643 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -138.75 117.58 12.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.912 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.26 81.87 8.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.0 p -117.47 -173.01 2.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -57.13 -30.43 64.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.69 -24.52 64.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.012 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.557 HD12 ' CG1' ' A' ' 80' ' ' VAL . 37.1 mm -85.01 127.44 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.348 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -111.15 -43.86 3.67 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.172 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 34.6 tt0 -127.77 118.29 23.47 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.125 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 t -119.09 144.33 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.373 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -148.14 132.4 17.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.053 0.454 . . . . 0.0 112.076 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.46 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 54.5 m95 -108.07 89.41 2.99 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -98.36 146.57 25.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.395 0.617 . . . . 0.0 112.481 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.67 116.99 11.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.353 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.1 -114.81 6.14 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.641 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.1 m -119.06 44.66 2.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.807 0.337 . . . . 0.0 110.654 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.5 m -154.27 160.74 41.93 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.294 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.593 HD13 ' OE1' ' A' ' 41' ' ' GLU . 4.1 mt -102.58 148.22 25.82 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.525 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 43.2 t -119.49 -41.31 2.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.746 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -173.05 114.27 0.25 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.904 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.593 ' OE1' HD13 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -128.07 154.71 45.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.183 0.516 . . . . 0.0 110.754 179.311 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -117.86 156.02 29.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.833 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -151.96 119.12 5.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.342 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.414 ' C ' ' H ' ' A' ' 46' ' ' MET . 0.0 OUTLIER -48.67 -25.6 1.86 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.329 0.585 . . . . 0.0 111.547 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -77.47 28.73 0.15 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.124 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.414 ' H ' ' C ' ' A' ' 44' ' ' ARG . 1.4 ttt 52.26 169.9 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.201 0.524 . . . . 0.0 111.68 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt 62.4 78.06 0.31 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.973 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -83.12 -166.92 0.41 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.614 2.209 . . . . 0.0 111.928 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.52 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 83.5 t80 -127.92 111.16 13.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.811 0.338 . . . . 0.0 111.416 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 50' ' ' LEU . 9.2 mt -107.32 112.28 25.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.005 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 8.0 ttmt -46.71 -41.33 14.88 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.673 0.273 . . . . 0.0 111.464 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.2 p -177.03 164.38 2.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.946 0.403 . . . . 0.0 111.231 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.94 -11.95 4.91 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.106 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.86 1.05 13.59 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 117.688 0.744 . . . . 0.0 112.075 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -131.8 157.24 44.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.102 0.477 . . . . 0.0 111.161 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -151.41 119.69 6.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.216 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 57' ' ' ILE . 7.8 tt -76.79 99.52 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.216 0.531 . . . . 0.0 111.237 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.667 HD22 ' OD2' ' A' ' 15' ' ' ASP . 0.7 OUTLIER -53.1 163.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.275 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.58 -21.76 66.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.39 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.61 30.41 2.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.802 0.334 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.26 36.08 67.64 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.892 -0.671 . . . . 0.0 113.02 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -111.67 157.39 20.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 110.963 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.404 HD11 HG12 ' A' ' 39' ' ' VAL . 10.7 tp -93.19 121.25 34.35 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.716 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.584 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -106.77 107.49 18.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.876 0.37 . . . . 0.0 110.948 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.839 HD12 ' CG2' ' A' ' 14' ' ' ILE . 3.4 mt -87.48 136.47 23.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.437 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 tttm -86.04 -45.91 10.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.952 0.406 . . . . 0.0 111.713 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.47 110.96 5.6 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.319 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.879 HD21 HG21 ' A' ' 14' ' ' ILE . 5.5 mt -53.78 152.39 5.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.169 0.509 . . . . 0.0 111.855 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.675 ' C ' HD11 ' A' ' 10' ' ' LEU . 6.0 p -152.92 159.36 42.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.194 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.673 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -51.1 -56.94 10.15 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.078 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -55.28 -20.94 12.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.735 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -81.38 -14.8 56.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.425 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.407 ' HB3' HD12 ' A' ' 97' ' ' ILE . 5.6 p -81.99 137.88 35.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.58 0.229 . . . . 0.0 110.863 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.63 -124.62 2.04 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.835 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -136.92 133.43 35.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 117.9 0.85 . . . . 0.0 110.595 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.541 ' CE1' HD12 ' A' ' 95' ' ' LEU . 29.3 m-85 -108.69 135.55 49.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.44 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.726 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 17.2 m-20 -115.44 121.93 44.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.162 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.958 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -104.58 130.94 54.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.304 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.97 104.23 10.69 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.557 ' CG1' HD12 ' A' ' 27' ' ' ILE . 89.7 t -95.91 125.44 48.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.7 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.553 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 77.9 m-85 -119.31 147.54 44.19 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.28 0.562 . . . . 0.0 111.058 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.551 ' OG ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -88.85 178.75 6.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.491 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.427 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -64.06 -18.65 64.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.208 179.628 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -94.73 20.88 8.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.234 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.85 30.05 56.08 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.756 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.56 153.66 20.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.344 . . . . 0.0 110.901 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.21 106.04 6.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.707 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.551 HD11 ' OG ' ' A' ' 82' ' ' SER . 28.4 mm -78.23 -64.68 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.404 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.917 HD21 ' HG3' ' A' ' 91' ' ' LYS . 3.0 tt -145.1 133.26 21.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.155 0.502 . . . . 0.0 111.814 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.2 108.33 14.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.168 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.917 ' HG3' HD21 ' A' ' 89' ' ' LEU . 7.9 mmpt? -121.2 158.08 28.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.726 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.39 122.43 17.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.238 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -118.45 160.77 21.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.963 0.411 . . . . 0.0 111.421 -179.39 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -106.79 131.82 53.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.383 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.872 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -117.39 99.16 6.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.319 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -94.84 111.92 23.67 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.188 0.518 . . . . 0.0 110.524 179.238 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.782 HG21 ' HB3' ' A' ' 68' ' ' LEU . 4.0 mt -110.67 114.18 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.753 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mt -68.08 119.49 12.77 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.652 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.938 -179.842 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.942 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.486 0 CA-C-O 120.657 0.265 . . . . 0.0 110.432 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -117.68 131.46 56.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.895 0.378 . . . . 0.0 110.92 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.96 -178.04 19.36 Favored Glycine 0 C--O 1.229 -0.163 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.562 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.429 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.23 134.09 48.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.995 0.426 . . . . 0.0 111.178 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.648 HD11 ' C ' ' A' ' 69' ' ' THR . 1.3 tp -56.62 130.88 47.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.837 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.89 -7.18 81.55 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.507 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.531 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.88 167.64 9.84 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.604 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.68 -172.69 12.23 Favored Glycine 0 C--O 1.226 -0.366 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.607 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.833 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.0 OUTLIER 163.29 136.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.432 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -120.83 122.13 39.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.545 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.773 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -79.07 103.47 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.788 179.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.44 ' O ' HD21 ' A' ' 93' ' ' LEU . 68.7 m-20 -87.74 122.25 31.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.226 0.536 . . . . 0.0 112.186 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.935 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -79.9 119.91 78.2 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.158 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.11 131.04 36.95 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.272 1.982 . . . . 0.0 112.829 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.4 m120 43.56 65.28 1.02 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -142.71 149.4 38.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.766 0.317 . . . . 0.0 110.576 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -142.88 104.49 4.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.905 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.78 75.2 0.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.83 -173.53 2.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.76 -31.07 62.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.017 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -64.12 -26.64 68.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.966 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.641 HD12 ' CG1' ' A' ' 80' ' ' VAL . 27.4 mm -86.04 127.06 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.437 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.408 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -112.32 -42.72 3.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.081 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.541 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 36.0 tt0 -126.46 117.28 22.58 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.433 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.9 t -116.88 107.62 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.149 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -105.44 134.76 48.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.233 0.539 . . . . 0.0 112.034 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.483 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 69.0 m95 -112.39 88.1 2.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.209 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -102.11 146.35 28.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.253 0.549 . . . . 0.0 112.295 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.5 116.22 12.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.527 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.14 -116.34 8.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.745 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 p -116.5 43.4 2.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.768 0.318 . . . . 0.0 110.642 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.2 m -152.86 159.76 43.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.271 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.54 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.6 mt -102.43 148.56 25.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.808 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.415 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 54.7 t -119.57 -43.53 2.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.256 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -167.2 113.23 0.76 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.547 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -120.61 113.54 20.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.226 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.517 ' HB2' HD13 ' A' ' 57' ' ' ILE . 13.3 t80 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.742 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 0 N--CA 1.463 -0.288 0 CA-C-O 120.557 0.149 . . . . 0.0 112.021 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.54 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 70.1 t80 -125.71 101.93 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.688 0.28 . . . . 0.0 111.51 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.7 mt -98.08 110.99 23.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.423 . . . . 0.0 109.879 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 51.7 tptt -43.83 -39.5 3.89 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.82 0.343 . . . . 0.0 111.365 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.05 165.97 0.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.943 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.84 -10.56 2.37 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.371 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.88 2.15 10.97 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 117.819 0.809 . . . . 0.0 112.343 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -134.05 156.93 47.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.153 0.502 . . . . 0.0 111.261 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -152.35 118.54 5.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.191 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 57' ' ' ILE . 6.6 tt -73.96 101.62 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.122 0.487 . . . . 0.0 111.388 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.556 HD23 HD21 ' A' ' 60' ' ' ASN . 0.7 OUTLIER -50.6 169.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.177 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.8 -25.06 65.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.581 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.556 HD21 HD23 ' A' ' 58' ' ' LEU . 5.8 p30 -97.06 33.25 1.96 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.753 0.311 . . . . 0.0 111.122 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.55 30.51 65.39 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.672 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.99 170.47 9.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 111.096 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 10.0 tp -110.08 119.24 38.65 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.469 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.453 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.5 OUTLIER -106.73 110.94 23.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.742 0.306 . . . . 0.0 110.746 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.833 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -89.42 138.53 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.468 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -84.26 -49.17 9.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.009 0.433 . . . . 0.0 111.875 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.26 110.65 5.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.494 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.035 HD22 HD12 ' A' ' 97' ' ' ILE . 5.1 mt -54.09 147.9 11.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.273 0.559 . . . . 0.0 111.779 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.648 ' C ' HD11 ' A' ' 10' ' ' LEU . 12.0 p -152.3 169.41 22.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.485 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.4 ' N ' HD11 ' A' ' 10' ' ' LEU . 7.0 mmm180 -51.33 -52.89 41.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.477 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -56.06 -21.65 23.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.597 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.12 -14.87 52.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.549 0.214 . . . . 0.0 111.498 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -82.82 117.84 22.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.678 0.275 . . . . 0.0 110.601 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.95 -166.26 33.43 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.17 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.44 126.39 39.68 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 122.507 0.323 . . . . 0.0 111.266 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -102.95 148.41 25.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.358 -0.383 . . . . 0.0 109.982 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -129.67 126.17 37.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 0.0 111.707 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.935 HG11 HD11 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -111.99 132.67 59.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.025 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.03 96.85 5.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.588 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.641 ' CG1' HD12 ' A' ' 27' ' ' ILE . 76.0 t -85.58 128.61 39.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.301 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.541 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.5 m-85 -119.25 153.02 35.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.068 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.658 ' OG ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -88.25 175.42 7.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.355 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.1 p -62.69 -28.4 69.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.994 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -77.62 -4.49 46.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.427 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.6 27.91 45.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.6 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.33 165.5 11.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.867 0.365 . . . . 0.0 110.764 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.53 127.08 31.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.592 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.658 HD11 ' OG ' ' A' ' 82' ' ' SER . 33.0 mm -104.12 -67.31 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.372 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.918 HD21 ' HG3' ' A' ' 91' ' ' LYS . 3.2 tt -137.37 127.17 25.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.132 0.492 . . . . 0.0 111.799 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -115.75 106.69 14.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.199 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.918 ' HG3' HD21 ' A' ' 89' ' ' LEU . 5.7 mmpt? -117.19 161.96 18.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.372 0.606 . . . . 0.0 112.526 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.95 122.07 12.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.993 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -120.25 156.22 31.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.937 0.399 . . . . 0.0 111.679 -179.045 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.78 110.72 22.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.17 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.942 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -101.73 98.2 8.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.286 -179.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.44 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -92.78 121.83 34.56 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 110.743 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.035 HD12 HD22 ' A' ' 68' ' ' LEU . 2.9 mm -107.24 116.38 50.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.991 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.3 mt . . . . . 0 N--CA 1.439 -0.979 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.467 179.044 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.893 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 120.8 0.333 . . . . 0.0 110.737 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.487 ' CD2' ' HD3' ' A' ' 96' ' ' ARG . 79.1 m95 -110.85 129.65 55.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.689 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.41 -179.9 26.58 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.062 -1.066 . . . . 0.0 112.969 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.426 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.15 134.55 49.1 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.95 0.405 . . . . 0.0 110.962 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.733 HD11 ' C ' ' A' ' 69' ' ' THR . 1.4 tp -55.81 133.27 51.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.41 -5.72 84.4 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.47 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.523 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -110.61 168.71 9.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.594 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -72.3 -169.4 12.76 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.5 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.937 HG21 HD21 ' A' ' 68' ' ' LEU . 0.9 OUTLIER 160.36 136.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 122.647 0.379 . . . . 0.0 110.347 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.563 ' OD2' HD22 ' A' ' 58' ' ' LEU . 17.5 t70 -118.71 130.1 55.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.949 0.404 . . . . 0.0 111.299 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -88.94 106.45 18.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.765 179.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -88.85 123.86 33.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.165 0.507 . . . . 0.0 111.867 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.93 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.4 mt -79.89 119.86 78.05 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.284 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.93 131.3 38.75 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.325 2.017 . . . . 0.0 112.856 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 43.04 65.42 0.96 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -142.65 149.31 38.73 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.579 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -139.26 117.46 11.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -80.24 80.98 6.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.38 -174.23 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.843 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.23 -30.86 62.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.991 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -62.19 -27.86 69.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.962 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.639 HD12 ' CG1' ' A' ' 80' ' ' VAL . 35.1 mm -88.21 127.21 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.369 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -113.13 -42.27 3.57 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.053 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.543 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 45.9 tt0 -123.94 115.91 22.03 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.365 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.41 112.79 42.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.829 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -111.01 130.6 55.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.024 0.44 . . . . 0.0 112.149 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -112.03 84.06 1.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.934 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -100.73 153.77 19.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.338 0.59 . . . . 0.0 112.297 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.34 116.14 8.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.676 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.24 -117.76 11.43 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.207 -0.997 . . . . 0.0 111.88 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.07 42.61 2.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.818 0.342 . . . . 0.0 110.738 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.1 m -151.14 160.26 43.97 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.155 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.633 HD21 ' OE2' ' A' ' 41' ' ' GLU . 6.0 mt -104.97 146.08 29.53 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.448 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 52.8 t -117.1 -42.94 3.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.983 0.42 . . . . 0.0 110.227 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.76 111.86 0.89 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.519 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.633 ' OE2' HD21 ' A' ' 38' ' ' LEU . 2.4 mt-10 -120.77 117.02 26.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.203 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 23.8 t80 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.648 179.867 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 N--CA 1.463 -0.308 0 CA-C-O 120.878 0.283 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.528 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 58.9 t80 -131.39 103.47 6.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.202 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.3 mt -97.6 111.87 23.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.081 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 33.6 tttm -45.2 -42.64 9.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.745 0.307 . . . . 0.0 111.527 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.8 p -176.63 165.79 2.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.888 0.375 . . . . 0.0 111.154 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.14 -11.34 4.62 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.158 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.17 2.19 11.47 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 117.707 0.753 . . . . 0.0 112.098 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -133.15 157.16 46.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.074 0.464 . . . . 0.0 111.184 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -153.92 120.18 5.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.331 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.641 HG23 ' O ' ' A' ' 57' ' ' ILE . 7.9 tt -74.93 99.94 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 0.0 111.282 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.563 HD22 ' OD2' ' A' ' 15' ' ' ASP . 0.7 OUTLIER -51.68 163.39 0.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.209 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.88 -22.0 65.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.458 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -96.53 31.91 2.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.761 0.315 . . . . 0.0 111.096 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.66 35.65 68.18 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.901 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.06 157.19 21.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.836 0.35 . . . . 0.0 111.033 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.95 123.25 36.07 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.782 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.524 ' HB2' HD13 ' A' ' 58' ' ' LEU . 2.1 ttpt -108.24 108.57 19.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.693 0.283 . . . . 0.0 110.919 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.859 HD12 ' CG2' ' A' ' 14' ' ' ILE . 3.2 mt -88.1 137.47 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.404 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -87.82 -45.98 9.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.974 0.416 . . . . 0.0 111.829 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.53 109.21 5.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.481 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.937 HD21 HG21 ' A' ' 14' ' ' ILE . 5.7 mt -57.37 152.5 14.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.178 0.514 . . . . 0.0 111.564 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.733 ' C ' HD11 ' A' ' 10' ' ' LEU . 7.5 p -154.11 161.35 41.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.136 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.583 ' N ' HD11 ' A' ' 10' ' ' LEU . 26.2 mmm180 -50.62 -56.18 12.98 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.247 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -54.85 -22.19 13.79 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.465 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.697 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -81.39 -15.09 56.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.307 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.8 p -83.13 132.19 35.1 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.72 0.295 . . . . 0.0 110.733 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.45 -131.34 3.25 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.344 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -128.81 130.48 47.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.722 0.761 . . . . 0.0 110.627 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.484 ' CE1' HD12 ' A' ' 95' ' ' LEU . 25.7 m-85 -105.08 148.51 26.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.219 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.662 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 13.6 m-20 -130.73 122.35 27.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.767 0.318 . . . . 0.0 111.374 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.93 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -105.75 129.04 59.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.232 179.267 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.6 97.8 6.34 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.655 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.639 ' CG1' HD12 ' A' ' 27' ' ' ILE . 87.2 t -89.36 129.92 39.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.335 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.543 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 96.9 m-85 -123.87 154.01 40.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.403 0.62 . . . . 0.0 111.188 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.533 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -87.79 175.31 7.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.352 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 2.1 p -62.13 -21.69 65.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.115 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -96.27 25.6 4.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.161 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.95 27.72 51.51 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.69 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.15 156.84 16.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.319 . . . . 0.0 110.866 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -77.38 110.26 11.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.783 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.533 HD11 ' HB3' ' A' ' 82' ' ' SER . 33.3 mm -91.46 -48.33 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.293 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.483 HD21 ' CG ' ' A' ' 91' ' ' LYS . 2.6 tt -154.57 149.85 27.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.277 0.56 . . . . 0.0 111.709 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -141.11 108.58 5.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.289 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.483 ' CG ' HD21 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -121.59 157.33 30.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.416 0.627 . . . . 0.0 112.598 -178.254 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.662 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -140.0 124.59 18.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.126 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.644 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -122.34 164.82 17.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.036 0.446 . . . . 0.0 111.674 -179.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -111.94 124.21 51.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.239 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.893 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -108.84 113.61 26.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.419 -179.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.487 ' HD3' ' CD2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -113.21 117.13 31.02 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.193 0.52 . . . . 0.0 110.447 178.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.918 HG21 ' HB3' ' A' ' 68' ' ' LEU . 1.2 mt -108.61 110.28 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.924 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.5 mt . . . . . 0 N--CA 1.439 -0.979 0 CA-C-O 121.077 0.465 . . . . 0.0 110.219 178.906 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.939 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 120.751 0.31 . . . . 0.0 110.724 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -120.27 130.16 54.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.56 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.735 ' C ' HG23 ' A' ' 97' ' ' ILE . . . -148.9 -179.02 24.46 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.904 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.527 ' N ' HG23 ' A' ' 97' ' ' ILE . . . -132.09 134.85 45.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.071 0.462 . . . . 0.0 111.226 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.649 HD11 ' N ' ' A' ' 70' ' ' ARG . 0.7 OUTLIER -52.84 136.22 34.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.031 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.2 -9.6 72.15 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.702 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.527 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.44 168.35 9.3 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.601 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -71.95 -170.94 14.65 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.424 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.893 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 162.03 136.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.815 0.34 . . . . 0.0 110.43 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.411 ' OD2' HD22 ' A' ' 58' ' ' LEU . 65.7 t0 -123.72 130.43 52.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.402 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.426 HD11 ' HG ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -84.27 135.73 34.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.692 179.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.479 ' O ' HD21 ' A' ' 93' ' ' LEU . 73.5 m-20 -116.39 122.02 43.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.275 0.559 . . . . 0.0 111.813 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.925 HD11 HG11 ' A' ' 78' ' ' VAL . 3.2 mt -81.46 119.6 76.02 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.245 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.65 130.87 37.19 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.364 2.043 . . . . 0.0 112.999 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.0 m120 42.78 65.07 1.0 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -141.43 149.3 40.83 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.772 0.32 . . . . 0.0 110.559 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -137.91 117.43 12.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.939 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.564 ' SD ' HG21 ' A' ' 30' ' ' VAL . 1.7 tpt -79.57 75.39 6.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.972 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.7 p -107.44 -173.16 2.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.99 -32.34 70.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -59.24 -27.04 65.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.98 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.535 HD12 ' CG1' ' A' ' 80' ' ' VAL . 19.2 mm -78.81 128.1 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.492 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.483 ' OD1' HG22 ' A' ' 83' ' ' THR . 0.4 OUTLIER -111.3 -44.32 3.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.14 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 73.3 tt0 -130.31 116.32 18.18 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.172 -0.611 . . . . 0.0 112.537 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.564 HG21 ' SD ' ' A' ' 23' ' ' MET . 2.8 t -112.42 111.24 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.743 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -108.18 130.31 55.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.178 0.513 . . . . 0.0 112.239 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -112.68 84.65 2.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.9 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.35 154.16 19.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.316 0.579 . . . . 0.0 112.247 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.424 ' HD3' ' CZ ' ' A' ' 76' ' ' TYR . 10.3 ttp-105 -143.96 118.32 9.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.602 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.01 -117.64 10.9 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.829 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.1 m -115.99 43.02 2.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.743 0.306 . . . . 0.0 110.739 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.7 m -151.14 160.06 44.09 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.171 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.537 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 6.0 mt -103.73 145.66 29.76 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.402 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 55.7 t -117.5 -43.42 3.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.153 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -166.06 111.31 0.84 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.752 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -117.66 112.42 20.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.042 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.407 ' HA ' ' HB3' ' A' ' 48' ' ' PRO . 21.1 t80 . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.85 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.407 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 97.9 Cg_endo . . . . . 0 N--CA 1.463 -0.29 0 CA-C-O 120.898 0.291 . . . . 0.0 112.607 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.537 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 71.1 t80 -137.49 105.46 5.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.352 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.1 mt -99.73 112.26 24.52 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.402 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 78.0 tttt -44.53 -45.87 9.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.725 0.298 . . . . 0.0 111.368 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.87 166.69 2.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.94 0.4 . . . . 0.0 111.112 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.77 -11.61 2.13 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.401 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.49 2.01 10.58 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 117.79 0.795 . . . . 0.0 112.296 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -135.46 157.16 47.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.084 0.468 . . . . 0.0 111.284 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -153.32 122.06 6.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.249 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 57' ' ' ILE . 6.4 tt -76.0 101.52 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.152 0.501 . . . . 0.0 111.213 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.666 HD13 ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -54.35 160.35 1.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.138 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.19 -21.97 66.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.404 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -96.13 32.81 1.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.052 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.71 34.37 56.25 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.778 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.26 155.3 22.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.866 0.365 . . . . 0.0 111.028 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 tp -92.95 122.71 35.59 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.821 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.666 ' HB2' HD13 ' A' ' 58' ' ' LEU . 4.4 tmtt? -108.04 110.06 21.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.71 0.29 . . . . 0.0 110.863 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.84 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.8 mt -89.18 138.79 18.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.408 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -86.69 -47.67 8.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.008 0.432 . . . . 0.0 111.91 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -142.73 110.73 5.96 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.335 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 14' ' ' ILE . 7.2 mt -55.65 150.77 11.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.308 0.575 . . . . 0.0 111.795 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.648 ' C ' HD11 ' A' ' 10' ' ' LEU . 6.8 p -153.36 161.42 42.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.813 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.649 ' N ' HD11 ' A' ' 10' ' ' LEU . 1.5 ptp180 -50.91 -54.84 20.64 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.429 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -57.43 -20.64 31.53 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.459 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.693 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -82.76 -15.53 51.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.389 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.8 t -82.78 130.69 35.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.582 0.23 . . . . 0.0 110.446 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.51 -166.25 29.63 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.172 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.7 126.4 36.77 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 122.522 0.329 . . . . 0.0 111.538 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.424 ' CZ ' ' HD3' ' A' ' 34' ' ' ARG . 18.9 m-85 -102.93 151.83 22.01 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -131.52 125.77 33.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.754 0.312 . . . . 0.0 111.492 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.925 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -110.1 130.8 62.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.211 179.155 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.419 HG23 ' OD1' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -118.02 98.46 6.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.512 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.535 ' CG1' HD12 ' A' ' 27' ' ' ILE . 93.5 t -91.46 125.73 44.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.748 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.459 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.5 m-85 -118.39 152.79 35.18 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.91 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.658 ' HA ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -90.67 172.32 8.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.567 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.483 HG22 ' OD1' ' A' ' 28' ' ' ASP . 16.9 p -60.04 -19.46 52.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.377 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -93.97 25.27 3.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.233 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.59 20.95 40.63 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.787 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.62 166.08 11.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.703 0.287 . . . . 0.0 110.696 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -90.89 120.19 31.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.731 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' A' ' 82' ' ' SER . 38.3 mt -90.71 -58.87 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.498 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.811 HD11 ' HE2' ' A' ' 91' ' ' LYS . 2.7 tt -147.83 133.68 19.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.117 0.484 . . . . 0.0 111.879 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.419 ' OD1' HG23 ' A' ' 79' ' ' THR . 0.1 OUTLIER -121.23 109.61 15.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.923 178.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.811 ' HE2' HD11 ' A' ' 89' ' ' LEU . 31.5 mmtm -121.5 162.66 20.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.01 121.95 14.52 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.047 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.642 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -113.76 164.71 13.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.03 0.443 . . . . 0.0 111.737 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -114.73 111.82 21.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.271 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.939 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -99.22 99.38 10.34 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.245 -179.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.73 120.47 40.14 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.004 0.431 . . . . 0.0 110.455 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.759 HG12 HD22 ' A' ' 68' ' ' LEU . 1.7 mt -128.42 129.13 68.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.794 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.7 mt . . . . . 0 N--CA 1.436 -1.134 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.71 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.812 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.449 -0.521 0 CA-C-O 120.708 0.289 . . . . 0.0 110.717 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -115.89 127.91 55.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.525 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.75 -178.8 21.52 Favored Glycine 0 N--CA 1.459 0.171 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.705 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.429 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.96 134.68 48.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.069 0.461 . . . . 0.0 111.287 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.712 HD11 ' C ' ' A' ' 69' ' ' THR . 1.0 OUTLIER -55.62 134.82 51.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.741 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.66 -8.58 77.02 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.456 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.53 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -106.95 167.16 10.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.614 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.41 -173.85 14.06 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.551 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.814 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 161.24 136.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 122.579 0.352 . . . . 0.0 110.367 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.546 ' OD2' HD22 ' A' ' 58' ' ' LEU . 7.4 t0 -124.85 123.78 40.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.955 0.407 . . . . 0.0 111.525 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.726 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -79.07 112.19 16.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.744 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -93.76 124.89 38.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.191 0.52 . . . . 0.0 111.884 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.937 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -81.64 120.04 76.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.252 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.01 131.12 37.63 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.278 1.985 . . . . 0.0 112.901 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.9 m120 43.12 65.16 1.01 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -142.14 149.37 39.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.758 0.313 . . . . 0.0 110.607 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -138.83 117.41 12.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.407 ' SD ' HG21 ' A' ' 30' ' ' VAL . 4.1 tpt -81.17 76.22 8.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 46.8 p -111.43 -173.03 2.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -57.8 -30.52 65.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.966 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -62.1 -28.12 69.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.641 HD12 ' CG1' ' A' ' 80' ' ' VAL . 33.6 mm -87.74 126.8 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.383 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.73 -41.92 3.71 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 61.3 tt0 -125.84 118.32 25.24 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.28 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 30.9 t -121.32 117.69 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.019 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.449 ' NH1' ' CE2' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -115.81 136.94 52.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.266 0.555 . . . . 0.0 112.223 -178.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.478 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 74.8 m95 -112.12 87.38 2.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.702 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -101.05 149.91 23.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.355 0.598 . . . . 0.0 112.283 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.7 ttp85 -142.13 117.59 10.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.462 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.81 -115.65 7.13 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.737 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 t -118.59 44.35 2.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.786 0.327 . . . . 0.0 110.683 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.3 m -151.94 160.39 43.51 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.328 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.607 HD22 ' OE1' ' A' ' 41' ' ' GLU . 5.5 mt -103.25 146.89 27.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.479 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 56.1 t -119.01 -43.52 2.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.959 0.409 . . . . 0.0 110.476 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -174.73 114.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.045 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.607 ' OE1' HD22 ' A' ' 38' ' ' LEU . 1.1 pt-20 -128.35 156.04 43.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.009 0.433 . . . . 0.0 110.947 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 57.0 t80 . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.871 -179.723 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 C--O 1.231 0.173 0 CA-C-O 120.923 0.301 . . . . 0.0 112.585 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.521 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 33.8 t80 -115.86 101.85 9.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.34 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 50' ' ' LEU . 11.2 mt -91.29 116.22 28.66 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.479 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 12.1 tptm -38.88 -90.33 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.729 0.641 . . . . 0.0 112.729 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 m -117.41 22.68 12.28 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.76 -0.03 52.77 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.089 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.32 5.33 27.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 117.53 0.665 . . . . 0.0 111.02 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -126.24 158.22 36.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.024 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -138.71 119.55 14.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.147 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.649 HG23 ' O ' ' A' ' 57' ' ' ILE . 7.4 tt -78.13 99.67 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.182 0.515 . . . . 0.0 111.064 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.546 HD22 ' OD2' ' A' ' 15' ' ' ASP . 0.5 OUTLIER -55.47 153.14 7.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.279 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.32 -19.79 56.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.475 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.24 31.94 2.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.861 0.363 . . . . 0.0 111.043 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.37 36.35 57.64 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.847 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -112.97 157.88 20.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.023 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 12.0 tp -95.2 122.49 37.93 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.125 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.507 ' HB2' HD13 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -110.26 104.71 13.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.715 0.293 . . . . 0.0 110.696 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.806 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -81.02 134.59 26.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.774 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -78.28 -49.06 14.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.09 0.471 . . . . 0.0 111.513 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.53 112.99 5.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.134 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.814 HD21 HG21 ' A' ' 14' ' ' ILE . 5.8 mt -52.73 148.37 7.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.261 0.553 . . . . 0.0 111.873 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.712 ' C ' HD11 ' A' ' 10' ' ' LEU . 7.1 p -152.13 163.1 40.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.78 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.579 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -50.81 -55.22 17.91 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.291 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -52.66 -22.95 5.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.614 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -82.99 -13.87 55.13 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.571 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.7 t -83.45 119.96 25.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.672 0.272 . . . . 0.0 110.582 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.46 -139.06 5.85 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.467 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 m -120.32 130.86 54.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 117.382 0.591 . . . . 0.0 110.648 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -106.43 151.27 25.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.386 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.652 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 4.0 m-20 -134.47 121.81 21.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.332 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.937 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -106.8 133.46 51.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.24 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.28 103.6 9.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.549 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.641 ' CG1' HD12 ' A' ' 27' ' ' ILE . 91.1 t -93.81 129.28 44.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.689 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.564 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.8 m-85 -121.44 153.64 37.61 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.998 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.714 ' OG ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -87.99 176.45 7.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.336 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.0 p -64.63 -28.67 69.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.979 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -77.3 -4.53 45.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.421 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.62 27.33 43.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.536 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.6 165.68 11.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 110.783 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.98 134.13 38.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.568 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.714 HD11 ' OG ' ' A' ' 82' ' ' SER . 37.8 mm -111.52 -66.64 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.397 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.914 HD21 ' HG3' ' A' ' 91' ' ' LYS . 3.5 tt -141.09 128.76 21.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.1 0.476 . . . . 0.0 111.845 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.47 107.22 14.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.177 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.914 ' HG3' HD21 ' A' ' 89' ' ' LEU . 16.0 mmtt -118.1 158.57 24.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.389 0.614 . . . . 0.0 112.536 -178.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.652 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -140.63 125.79 18.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.152 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.646 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -125.32 161.53 26.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.047 0.451 . . . . 0.0 111.65 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -110.32 116.85 32.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.228 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.812 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -104.8 103.76 13.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.308 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.46 115.26 28.88 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 110.692 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.736 HG12 HD22 ' A' ' 68' ' ' LEU . 3.1 mt -106.4 111.79 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.557 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.8 mt . . . . . 0 N--CA 1.437 -1.114 0 CA-C-O 121.246 0.546 . . . . 0.0 110.734 179.692 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.943 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.51 0 CA-C-O 120.64 0.257 . . . . 0.0 110.642 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -118.84 131.15 56.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.29 -178.53 19.19 Favored Glycine 0 N--CA 1.459 0.21 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.508 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.444 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -126.48 133.25 51.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.048 0.452 . . . . 0.0 111.313 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.421 ' CD1' ' HA ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -55.6 131.06 45.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.874 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.51 -6.42 83.22 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.452 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.524 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.05 167.66 9.84 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.596 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.4 -172.93 11.85 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.597 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.836 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.0 OUTLIER 163.31 136.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.773 0.32 . . . . 0.0 110.354 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.467 ' OD2' HD22 ' A' ' 58' ' ' LEU . 2.1 t70 -121.75 122.47 39.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.936 0.398 . . . . 0.0 111.476 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.741 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -77.96 108.82 11.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.773 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -93.3 123.11 36.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.176 0.513 . . . . 0.0 111.967 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.978 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -79.37 119.47 77.12 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.262 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.54 131.21 36.94 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.393 2.062 . . . . 0.0 112.976 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 43.27 64.74 1.13 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -140.21 149.07 42.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.834 0.35 . . . . 0.0 110.497 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -132.9 116.72 16.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.1 90.01 7.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.8 p -125.84 -173.04 2.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.937 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.27 -30.53 64.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.941 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.712 ' O ' HG23 ' A' ' 83' ' ' THR . 2.0 t70 -62.07 -25.59 67.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.992 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.484 HD12 ' CG1' ' A' ' 80' ' ' VAL . 33.8 mm -79.34 128.47 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.509 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.2 -38.82 7.52 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.234 -0.291 . . . . 0.0 111.325 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 12.7 mt-10 -142.6 153.75 43.78 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-O 121.581 0.705 . . . . 0.0 112.355 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.8 t -148.26 116.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.162 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -112.24 134.1 53.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.071 0.462 . . . . 0.0 112.05 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.46 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 73.3 m95 -112.33 85.07 2.08 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -102.47 148.17 25.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.3 0.571 . . . . 0.0 112.22 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.04 118.75 13.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.557 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.91 -116.37 8.17 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.773 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.9 m -117.66 43.88 2.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.769 0.319 . . . . 0.0 110.71 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.7 m -152.88 160.0 43.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.265 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.536 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.8 mt -102.79 147.19 27.17 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.798 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 50.0 t -118.47 -42.92 2.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.285 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -167.47 112.17 0.7 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.597 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -118.51 119.32 34.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.969 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.708 ' HB2' HD13 ' A' ' 57' ' ' ILE . 49.1 t80 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.705 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo . . . . . 0 N--CA 1.463 -0.284 0 CA-C-O 120.897 0.29 . . . . 0.0 112.567 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.536 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 68.7 t80 -136.82 104.24 5.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.284 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.1 mt -98.01 110.78 23.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.02 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 28.8 tttm -45.29 -40.58 7.8 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.77 0.319 . . . . 0.0 111.533 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 p -178.21 164.61 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 111.205 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.75 -11.73 4.42 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.166 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.83 1.6 12.21 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 117.593 0.697 . . . . 0.0 112.155 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -131.99 156.97 45.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.184 0.516 . . . . 0.0 111.262 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -151.82 117.24 5.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.196 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.708 HD13 ' HB2' ' A' ' 42' ' ' PHE . 9.2 tt -73.83 99.48 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.321 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.623 HD23 HD21 ' A' ' 60' ' ' ASN . 0.7 OUTLIER -51.12 166.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.163 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.9 -23.96 65.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.637 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.623 HD21 HD23 ' A' ' 58' ' ' LEU . 6.1 p30 -96.76 33.33 1.88 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.796 0.331 . . . . 0.0 111.16 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.75 33.9 69.12 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.621 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.08 165.79 10.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.868 0.366 . . . . 0.0 111.012 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 10.3 tp -107.0 119.71 40.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.518 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HB2' HD13 ' A' ' 58' ' ' LEU . 1.5 ttpt -105.75 111.25 23.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.309 . . . . 0.0 110.996 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.836 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.7 mt -90.93 138.22 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.449 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -84.16 -48.19 10.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.066 0.46 . . . . 0.0 111.896 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.11 111.35 5.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.312 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.045 HD22 HD12 ' A' ' 97' ' ' ILE . 4.9 mt -53.61 147.22 11.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.22 0.533 . . . . 0.0 111.736 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.421 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 5.3 p -147.59 160.88 42.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.852 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.74 -56.43 12.04 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.093 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.6 -22.7 9.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.428 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.688 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -80.54 -15.24 57.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.627 0.251 . . . . 0.0 111.308 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.415 ' CB ' HG12 ' A' ' 97' ' ' ILE . 2.4 t -81.58 120.79 25.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.591 0.234 . . . . 0.0 110.578 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.98 -144.43 9.88 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.373 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.9 m -115.65 130.62 56.93 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.056 0.428 . . . . 0.0 110.663 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -108.26 133.23 52.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.24 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.724 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 17.4 m-20 -114.98 124.37 51.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.458 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.978 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -107.02 133.52 51.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.192 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.36 96.37 5.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.695 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.492 HG12 ' HB ' ' A' ' 88' ' ' ILE . 70.9 t -86.74 126.9 40.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.234 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.517 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 2.6 m-30 -112.8 151.33 30.48 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.346 0.593 . . . . 0.0 110.612 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.73 ' HA ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -93.42 178.99 5.53 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.199 179.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 26' ' ' ASP . 73.5 p -68.51 -23.51 64.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.044 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -75.91 -5.22 45.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.592 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.29 24.57 47.08 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.666 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.64 -170.59 1.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.757 0.313 . . . . 0.0 110.683 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -105.31 115.62 30.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.971 0.415 . . . . 0.0 110.811 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.73 HD11 ' HA ' ' A' ' 82' ' ' SER . 74.4 mt -78.89 -51.66 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.343 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.688 HD21 ' HG3' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -151.83 136.25 16.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.204 0.526 . . . . 0.0 111.9 -179.246 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.4 106.98 13.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.884 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.688 ' HG3' HD21 ' A' ' 89' ' ' LEU . 7.4 mmpt? -116.48 156.97 25.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.724 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.14 122.45 18.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.132 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -117.98 159.41 23.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.896 0.379 . . . . 0.0 111.538 -179.239 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -109.16 110.76 22.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.381 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.943 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -102.27 100.2 10.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.071 -179.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.527 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.5 OUTLIER -95.16 123.43 38.66 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.071 0.462 . . . . 0.0 110.89 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.045 HD12 HD22 ' A' ' 68' ' ' LEU . 2.9 mm -107.81 117.47 53.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.999 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 N--CA 1.439 -0.988 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.422 179.205 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.975 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.439 0 CA-C-O 120.648 0.261 . . . . 0.0 110.855 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -121.89 136.39 54.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.033 0.444 . . . . 0.0 111.255 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.485 ' C ' HG23 ' A' ' 97' ' ' ILE . . . -151.45 178.68 28.65 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.303 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.442 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.03 133.8 49.15 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.049 0.452 . . . . 0.0 111.221 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.644 HD11 ' C ' ' A' ' 69' ' ' THR . 1.2 tp -53.51 134.88 40.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.65 -10.94 71.81 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.632 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.524 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -106.66 168.0 9.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.598 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -72.02 -169.61 12.37 Favored Glycine 0 C--O 1.227 -0.315 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.491 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.834 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.0 OUTLIER 163.79 136.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.963 0.411 . . . . 0.0 110.632 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -117.97 130.1 56.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.043 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -91.5 102.99 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -88.68 123.5 33.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.174 0.511 . . . . 0.0 112.3 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.947 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -79.2 119.96 78.95 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.022 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.03 131.04 37.15 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.262 1.975 . . . . 0.0 112.903 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 43.38 65.09 1.04 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -142.03 150.9 41.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.79 0.328 . . . . 0.0 110.595 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -139.44 117.75 12.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -82.78 78.37 9.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.7 p -112.51 -173.02 2.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -57.9 -30.66 66.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.967 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.49 -27.74 68.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.971 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.611 HD12 ' CG1' ' A' ' 80' ' ' VAL . 31.4 mm -84.38 127.62 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.447 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.5 OUTLIER -111.63 -44.08 3.55 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.247 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 45.8 tp10 -123.69 121.27 35.07 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.187 -0.605 . . . . 0.0 112.117 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.82 114.25 42.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.904 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -112.85 132.38 55.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.133 0.492 . . . . 0.0 112.289 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.413 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 71.7 m95 -113.3 87.77 2.68 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -101.7 148.13 25.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.313 0.578 . . . . 0.0 112.478 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -139.26 116.46 11.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.522 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.07 -116.52 8.46 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.729 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.5 t -117.39 43.87 2.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.866 0.365 . . . . 0.0 110.651 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.0 m -152.27 160.38 43.36 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.224 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.533 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.8 mt -101.7 146.5 27.65 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.464 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 52.9 t -118.52 -43.02 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.97 0.414 . . . . 0.0 110.199 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -166.6 110.17 0.75 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.579 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.44 121.76 40.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.79 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 39.3 t80 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.041 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 N--CA 1.465 -0.181 0 CA-C-O 120.937 0.307 . . . . 0.0 112.709 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 48.9 t80 -113.21 100.73 8.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.131 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 50' ' ' LEU . 9.7 mt -94.08 111.15 22.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.069 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 36.3 tttt -45.99 -36.73 5.84 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.702 0.287 . . . . 0.0 111.452 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.0 p -178.74 164.29 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 111.222 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.74 -10.2 6.08 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.142 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.63 2.72 11.16 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.651 0.726 . . . . 0.0 112.188 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -132.08 156.89 45.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.107 0.48 . . . . 0.0 111.239 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -151.5 116.33 5.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.367 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.646 HG23 ' O ' ' A' ' 57' ' ' ILE . 9.7 tt -73.98 99.22 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.105 0.479 . . . . 0.0 111.295 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.656 HD23 HD21 ' A' ' 60' ' ' ASN . 0.7 OUTLIER -49.19 165.75 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.154 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.46 -23.67 65.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.566 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.656 HD21 HD23 ' A' ' 58' ' ' LEU . 6.3 p30 -96.21 33.11 1.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.188 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.02 34.71 73.41 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.604 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.31 171.16 7.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.899 0.38 . . . . 0.0 110.874 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 11.6 tp -112.81 122.35 47.39 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.499 ' HB2' HD13 ' A' ' 58' ' ' LEU . 16.1 tttt -109.04 108.88 19.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.683 0.278 . . . . 0.0 110.947 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.834 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -87.2 141.0 14.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.413 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -85.76 -50.86 6.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.025 0.441 . . . . 0.0 112.1 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.65 110.84 6.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.5 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.69 HD21 HG21 ' A' ' 14' ' ' ILE . 5.4 mt -53.83 147.58 11.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.643 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.644 ' C ' HD11 ' A' ' 10' ' ' LEU . 6.1 p -152.7 161.3 42.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.786 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.528 ' N ' HD11 ' A' ' 10' ' ' LEU . 13.3 mmm-85 -50.48 -56.12 12.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.331 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -57.6 -20.28 31.53 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.629 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.596 ' OD1' HD13 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -84.31 -15.75 45.47 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.533 0.206 . . . . 0.0 111.425 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 t -82.7 133.36 35.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.603 0.24 . . . . 0.0 110.483 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.07 -166.97 30.02 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.134 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.06 126.63 35.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.896 0.379 . . . . 0.0 111.435 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -106.84 128.2 54.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.33 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -112.07 129.16 56.31 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.853 0.359 . . . . 0.0 111.657 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.947 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -112.08 130.59 65.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.98 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.65 98.9 6.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.8 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.611 ' CG1' HD12 ' A' ' 27' ' ' ILE . 82.0 t -92.02 128.71 43.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.462 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.532 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.3 m-85 -124.02 153.45 41.3 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.291 0.567 . . . . 0.0 111.108 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.631 ' CA ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -88.93 174.81 7.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.408 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.1 p -61.07 -22.34 64.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.169 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.83 26.46 4.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.168 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.74 25.77 37.53 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.691 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.24 155.59 16.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.778 0.323 . . . . 0.0 110.889 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.53 116.35 18.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.649 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.631 HD11 ' CA ' ' A' ' 82' ' ' SER . 36.2 mt -93.95 -69.3 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.339 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.906 HD21 ' HG3' ' A' ' 91' ' ' LYS . 2.6 tt -142.34 126.78 17.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.152 0.501 . . . . 0.0 111.903 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.3 106.95 14.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.906 ' HG3' HD21 ' A' ' 89' ' ' LEU . 5.7 mmpt? -118.15 162.49 18.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.464 0.65 . . . . 0.0 112.702 -178.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.6 119.96 10.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.067 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -114.45 157.83 22.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.836 0.351 . . . . 0.0 111.407 -179.235 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -107.09 115.23 29.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.361 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.975 ' HA ' HG12 ' A' ' 6' ' ' VAL . 38.3 tp -101.11 98.14 8.6 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.958 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.802 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -101.1 123.37 45.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.031 0.443 . . . . 0.0 110.599 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.823 HD11 ' HG ' ' A' ' 95' ' ' LEU . 1.9 mm -122.61 126.65 74.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.065 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 98' ' ' LEU . 12.7 mt . . . . . 0 N--CA 1.435 -1.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.564 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.93 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 120.735 0.303 . . . . 0.0 111.094 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -119.98 130.45 54.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.562 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.43 -178.07 18.92 Favored Glycine 0 N--CA 1.459 0.196 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.502 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.426 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -130.12 133.99 47.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.07 0.462 . . . . 0.0 111.551 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.431 ' CD1' ' HA ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -54.0 131.84 41.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.798 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.36 -10.65 74.3 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.58 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -107.07 168.97 8.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.6 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -73.52 -168.94 16.14 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.576 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.913 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 161.7 137.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 122.675 0.39 . . . . 0.0 110.062 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.8 124.33 44.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.935 0.397 . . . . 0.0 111.812 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.718 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -82.02 105.98 13.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.482 178.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.408 ' O ' HD21 ' A' ' 93' ' ' LEU . 69.8 m-20 -90.83 123.07 34.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.287 0.565 . . . . 0.0 112.304 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.949 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -80.38 120.35 79.13 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.176 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.27 130.71 37.27 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.32 2.013 . . . . 0.0 112.938 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 42.8 65.05 1.0 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -141.96 149.04 39.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.787 0.327 . . . . 0.0 110.501 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -141.7 117.15 10.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.941 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.38 80.44 3.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.01 -175.65 2.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.18 -33.09 68.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.912 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.79 -26.8 66.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.586 HD12 ' CG1' ' A' ' 80' ' ' VAL . 22.6 mm -79.41 128.32 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.405 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.9 OUTLIER -111.36 -44.44 3.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -179.089 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 42.6 tt0 -130.43 116.88 18.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.572 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -112.48 113.0 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.794 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -111.56 132.48 54.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.12 0.485 . . . . 0.0 112.206 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.431 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 70.3 m95 -113.31 86.53 2.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.954 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -102.62 148.1 25.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.316 0.579 . . . . 0.0 112.295 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.52 117.59 11.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.51 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.96 -116.62 8.53 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.768 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 t -117.28 43.76 2.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.76 0.315 . . . . 0.0 110.672 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.0 m -152.33 159.95 43.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.238 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.539 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.8 mt -103.11 146.83 27.8 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.465 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 51.3 t -118.45 -43.1 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.164 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -166.64 111.57 0.78 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.551 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -118.56 114.77 23.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.567 ' HB2' HD13 ' A' ' 57' ' ' ILE . 25.4 t80 . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.859 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.442 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 89.8 Cg_endo . . . . . 0 N--CA 1.461 -0.384 0 CA-C-O 120.865 0.277 . . . . 0.0 112.547 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.539 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 73.3 t80 -137.11 104.36 5.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.338 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 50' ' ' LEU . 7.9 mt -98.57 111.18 23.63 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 12.8 tptm -44.38 -54.58 5.73 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.807 0.336 . . . . 0.0 111.484 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.0 165.07 22.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.146 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.16 -11.69 3.49 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.112 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.41 2.24 11.91 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 117.674 0.737 . . . . 0.0 112.163 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -131.99 156.48 46.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.124 0.488 . . . . 0.0 111.392 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -152.57 119.59 5.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.252 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.644 HG23 ' O ' ' A' ' 57' ' ' ILE . 8.1 tt -75.0 100.26 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.112 0.482 . . . . 0.0 111.325 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.596 HD23 HD21 ' A' ' 60' ' ' ASN . 0.7 OUTLIER -50.63 167.57 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.169 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.74 -24.54 65.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.651 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.596 HD21 HD23 ' A' ' 58' ' ' LEU . 6.1 p30 -96.57 33.12 1.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.736 0.303 . . . . 0.0 111.18 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.8 33.37 67.84 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.563 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.38 165.39 11.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 111.049 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 tp -105.14 121.46 43.86 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.47 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.445 ' HB2' HD13 ' A' ' 58' ' ' LEU . 2.1 tmtp? -107.91 110.18 21.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 111.13 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.851 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -90.38 138.24 19.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.063 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -93.3 -41.64 9.76 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.2 106.93 5.36 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.582 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.913 HD21 HG21 ' A' ' 14' ' ' ILE . 7.8 mt -57.35 143.73 38.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.13 0.491 . . . . 0.0 111.461 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.431 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 5.1 p -144.36 159.53 42.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.037 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.32 -56.46 12.93 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.022 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -54.25 -21.83 10.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.429 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.623 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -79.39 -14.44 58.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.3 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.4 t -80.57 129.11 34.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.65 0.262 . . . . 0.0 110.475 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.01 -165.06 30.18 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.12 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -93.98 126.65 39.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.702 0.287 . . . . 0.0 111.349 -179.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -104.44 130.86 52.31 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.129 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -112.84 125.8 54.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.881 0.372 . . . . 0.0 111.603 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.949 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.26 130.04 62.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.12 179.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.12 98.44 6.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.597 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.586 ' CG1' HD12 ' A' ' 27' ' ' ILE . 91.9 t -91.71 123.34 43.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.583 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.446 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 99.0 m-85 -116.33 152.68 33.39 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.172 0.511 . . . . 0.0 111.135 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.638 ' CA ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -90.5 172.96 8.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.526 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.403 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 7.5 p -57.1 -22.63 41.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.234 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -96.02 26.42 4.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.147 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.87 25.52 30.53 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.718 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.4 156.65 16.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.832 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -79.01 107.52 11.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.695 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.638 HD11 ' CA ' ' A' ' 82' ' ' SER . 38.6 mt -82.2 -70.71 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.347 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.799 HD21 ' HG3' ' A' ' 91' ' ' LYS . 1.5 tt -141.43 128.18 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.112 0.482 . . . . 0.0 111.892 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.85 106.57 14.33 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.799 ' HG3' HD21 ' A' ' 89' ' ' LEU . 5.2 mmtt -117.36 162.45 17.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.446 0.641 . . . . 0.0 112.631 -178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.87 120.88 10.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.162 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.642 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -116.78 161.12 19.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.81 0.338 . . . . 0.0 111.403 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.81 112.22 24.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.201 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.93 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -102.26 101.84 12.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.279 -179.485 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.31 119.81 37.63 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.06 0.457 . . . . 0.0 110.67 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.77 HG21 ' HB3' ' A' ' 68' ' ' LEU . 3.8 mt -112.79 118.24 57.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.732 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 98' ' ' LEU . 8.8 mt . . . . . 0 N--CA 1.443 -0.781 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.683 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.85 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.515 0 CA-C-O 120.798 0.332 . . . . 0.0 110.773 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -114.71 126.14 54.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.437 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.17 -179.62 22.49 Favored Glycine 0 N--CA 1.459 0.197 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.76 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.436 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -130.26 134.85 47.53 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.05 0.452 . . . . 0.0 111.353 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.675 HD11 ' C ' ' A' ' 69' ' ' THR . 0.8 OUTLIER -53.07 136.3 35.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.006 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.33 -8.34 74.74 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.668 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.534 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.12 167.8 9.75 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.612 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -71.23 -173.86 17.23 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.565 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.819 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 162.19 136.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 122.493 0.317 . . . . 0.0 110.401 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -122.86 128.18 50.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.964 0.412 . . . . 0.0 111.489 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -85.14 106.6 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.858 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -89.22 124.45 34.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.152 0.501 . . . . 0.0 111.911 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.967 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -79.97 119.62 77.23 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.138 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.16 131.38 38.69 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.367 2.045 . . . . 0.0 112.945 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m120 42.81 65.03 1.01 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.416 ' HB2' HD13 ' A' ' 89' ' ' LEU . 8.9 t80 -141.6 149.29 40.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.817 0.342 . . . . 0.0 110.56 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -143.87 116.43 8.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.02 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.0 ttt -80.68 77.69 7.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.15 -174.44 2.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.2 -30.73 62.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.08 -24.74 65.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.02 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.538 HD12 ' CG1' ' A' ' 80' ' ' VAL . 45.2 mm -85.52 126.54 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.457 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.415 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -111.59 -42.65 3.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 122.142 -0.349 . . . . 0.0 111.742 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.493 ' OE1' ' HB2' ' A' ' 81' ' ' TYR . 6.7 mp0 -117.57 158.75 24.05 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.001 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.6 t -154.28 108.7 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.884 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.457 ' NH1' ' CE2' ' A' ' 81' ' ' TYR . 0.6 OUTLIER -111.15 129.82 55.82 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -110.62 86.11 2.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.848 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -103.13 153.66 20.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.342 0.591 . . . . 0.0 112.303 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -145.48 116.24 7.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.503 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.08 -117.67 11.04 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.75 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 m -115.59 42.85 2.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.785 0.326 . . . . 0.0 110.659 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.4 m -150.59 160.62 43.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.145 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.722 HD21 ' OE2' ' A' ' 41' ' ' GLU . 5.7 mt -106.68 147.89 29.03 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.447 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 55.6 t -119.45 -44.16 2.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.255 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.34 112.55 1.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.43 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.722 ' OE2' HD21 ' A' ' 38' ' ' LEU . 2.2 mt-10 -119.48 114.62 22.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.081 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.788 ' HB2' HD13 ' A' ' 57' ' ' ILE . 26.0 t80 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.888 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo . . . . . 0 N--CA 1.464 -0.221 0 CA-C-O 120.664 0.193 . . . . 0.0 111.945 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.553 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 73.7 t80 -133.1 98.51 4.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.575 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 50' ' ' LEU . 10.7 mt -95.24 112.78 24.44 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.447 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 19.3 tttm -34.82 -89.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.1 t -118.76 23.45 11.45 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.24 0.18 51.25 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.973 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.32 6.29 26.92 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 117.534 0.667 . . . . 0.0 111.012 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -126.57 158.37 36.41 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.975 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -140.27 118.66 12.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.203 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.788 HD13 ' HB2' ' A' ' 42' ' ' PHE . 6.4 tt -76.09 101.79 2.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.214 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.555 HD13 ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -53.28 163.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.098 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.64 -21.79 64.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.72 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -97.88 33.31 2.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.779 0.323 . . . . 0.0 111.103 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.89 36.43 80.24 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.738 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.49 166.86 10.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 0.0 110.92 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 11.9 tp -107.71 121.41 44.65 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.893 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.555 ' HB2' HD13 ' A' ' 58' ' ' LEU . 4.3 tmtt? -109.15 103.87 12.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.735 0.302 . . . . 0.0 110.814 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.776 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.7 mt -79.91 134.54 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.533 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -79.47 -48.46 13.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.025 0.441 . . . . 0.0 111.675 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.31 113.29 5.79 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.243 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.819 HD21 HG21 ' A' ' 14' ' ' ILE . 5.7 mt -53.5 149.04 8.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 111.716 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.675 ' C ' HD11 ' A' ' 10' ' ' LEU . 6.1 p -151.94 160.45 43.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.03 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.656 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -51.28 -56.53 12.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.075 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -55.26 -20.82 12.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.346 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.657 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -81.33 -15.39 55.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.413 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.4 t -79.03 128.96 33.93 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.608 0.242 . . . . 0.0 110.576 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.46 -167.33 30.27 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.331 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.76 125.77 36.6 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.529 -0.336 . . . . 0.0 111.418 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -101.45 149.2 24.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.177 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -131.28 123.13 27.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.694 0.283 . . . . 0.0 111.567 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.967 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -108.65 128.81 64.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.036 179.159 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.13 97.9 6.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.64 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.538 ' CG1' HD12 ' A' ' 27' ' ' ILE . 82.0 t -86.25 137.97 19.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.139 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.493 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 84.2 m-85 -132.16 153.56 50.4 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.58 0.705 . . . . 0.0 111.602 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.585 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -87.64 -179.62 6.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.43 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.415 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 41.7 p -65.81 -35.5 80.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.942 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -77.91 -3.67 42.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.434 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.37 24.68 42.47 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.533 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.4 160.06 14.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.346 . . . . 0.0 110.699 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 106.71 11.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.682 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.585 HD11 ' HB3' ' A' ' 82' ' ' SER . 40.2 mm -87.35 -43.67 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.304 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.608 HD11 ' HE2' ' A' ' 91' ' ' LYS . 3.1 tt -157.69 149.97 22.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.218 0.533 . . . . 0.0 111.822 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.92 109.9 5.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.003 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.608 ' HE2' HD11 ' A' ' 89' ' ' LEU . 20.7 mmtm -121.63 162.24 21.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.482 0.658 . . . . 0.0 112.77 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.16 121.95 11.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.9 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.646 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -120.17 163.2 18.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 0.0 111.688 -179.189 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -111.13 114.27 27.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.369 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.85 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -100.94 103.71 14.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.396 -179.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.46 113.22 25.82 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.08 0.467 . . . . 0.0 110.551 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.691 HG21 ' HB3' ' A' ' 68' ' ' LEU . 3.7 mt -109.34 115.05 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.523 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 N--CA 1.438 -1.062 0 CA-C-O 121.24 0.543 . . . . 0.0 110.761 179.698 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.793 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.447 -0.623 0 CA-C-O 120.717 0.294 . . . . 0.0 110.393 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -122.77 128.49 50.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.826 0.346 . . . . 0.0 111.005 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.7 178.51 24.31 Favored Glycine 0 N--CA 1.459 0.233 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.454 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.411 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -125.34 135.11 52.11 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.941 0.4 . . . . 0.0 111.106 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.834 HD12 HG21 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -52.7 132.41 36.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.792 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.66 -12.45 69.45 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.83 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.512 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -104.74 169.78 8.26 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.219 0.509 . . . . 0.0 110.016 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.512 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -79.68 168.78 52.87 Favored Glycine 0 C--O 1.224 -0.515 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.25 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.869 ' CG2' HD12 ' A' ' 65' ' ' ILE . 2.2 tp -179.09 140.26 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.696 0.284 . . . . 0.0 110.765 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -124.08 131.52 53.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.031 0.443 . . . . 0.0 111.647 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.833 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -88.09 113.68 23.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.586 179.135 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -97.83 125.63 42.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.193 0.521 . . . . 0.0 111.931 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.947 HD11 HG11 ' A' ' 78' ' ' VAL . 3.2 mt -81.62 119.95 76.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.299 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.23 131.0 36.52 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.355 2.037 . . . . 0.0 112.865 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.6 m120 43.42 65.14 1.04 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -142.3 149.3 39.33 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.804 0.335 . . . . 0.0 110.531 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -138.65 117.46 12.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.931 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -80.87 82.41 6.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.78 -174.27 2.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.765 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -56.82 -30.94 64.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.954 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -60.98 -28.01 68.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.596 HD12 ' CG1' ' A' ' 80' ' ' VAL . 23.4 mm -81.57 127.75 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.444 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.55 -44.16 3.55 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 122.214 -0.304 . . . . 0.0 111.736 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 72.6 tt0 -127.43 116.23 20.13 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.217 -0.593 . . . . 0.0 112.31 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 t -113.2 114.28 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.974 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -113.08 132.12 55.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.084 0.469 . . . . 0.0 112.192 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.402 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 70.2 m95 -113.18 83.26 1.8 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -99.17 150.9 21.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.299 0.571 . . . . 0.0 112.274 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.47 116.01 9.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.62 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.29 -117.36 10.29 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.76 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.25 42.77 2.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.837 0.351 . . . . 0.0 110.759 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.2 m -152.0 160.03 43.58 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.215 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.56 HD21 ' OE2' ' A' ' 41' ' ' GLU . 5.8 mt -104.09 146.94 28.01 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.452 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 52.0 t -117.89 -42.83 2.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.293 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -166.21 113.11 0.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.455 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.56 ' OE2' HD21 ' A' ' 38' ' ' LEU . 2.4 mt-10 -120.53 116.32 25.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.094 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.46 ' HB2' HD13 ' A' ' 57' ' ' ILE . 32.1 t80 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.666 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.415 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 87.1 Cg_endo . . . . . 0 N--CA 1.463 -0.276 0 CA-C-O 120.862 0.276 . . . . 0.0 112.467 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.531 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 69.4 t80 -135.03 104.64 6.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.343 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.1 mt -99.27 111.09 23.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.0 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 55.6 tttm -44.94 -42.46 8.16 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.579 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.0 p -176.66 164.96 2.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.966 0.412 . . . . 0.0 111.213 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.36 -12.37 4.36 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.732 -0.746 . . . . 0.0 113.118 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.44 1.06 12.69 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 117.75 0.775 . . . . 0.0 112.182 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -131.1 157.38 43.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.11 0.481 . . . . 0.0 111.214 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -153.95 125.24 7.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.513 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.665 HG23 ' O ' ' A' ' 57' ' ' ILE . 6.9 tt -84.04 101.53 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.657 HD23 HD21 ' A' ' 60' ' ' ASN . 1.2 mp -61.32 166.97 3.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.991 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.04 -45.58 80.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.205 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.657 HD21 HD23 ' A' ' 58' ' ' LEU . 3.5 p30 -56.32 -22.88 33.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.137 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.85 35.05 4.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.59 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -116.03 154.48 29.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.878 0.371 . . . . 0.0 110.924 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 12.7 tp -83.46 122.94 29.19 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.463 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -104.46 109.79 21.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.701 0.286 . . . . 0.0 111.38 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.869 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.8 mt -93.29 127.34 45.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.939 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 ttpp -85.63 -36.31 20.41 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -147.16 110.23 4.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.812 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.078 HD22 HD12 ' A' ' 97' ' ' ILE . 4.9 mt -56.62 144.88 30.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.056 0.455 . . . . 0.0 111.469 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.677 ' C ' HD11 ' A' ' 10' ' ' LEU . 7.5 p -149.25 163.79 36.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.843 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.582 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -50.84 -55.52 16.55 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.223 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -52.9 -23.01 6.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.539 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.646 ' OD1' HD13 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -79.53 -14.01 59.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.472 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.436 ' CB ' HG12 ' A' ' 97' ' ' ILE . 2.6 t -81.15 124.74 29.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.685 0.279 . . . . 0.0 110.707 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.1 -166.87 29.47 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.296 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.94 130.34 38.55 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.56 0.344 . . . . 0.0 111.139 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -106.21 148.65 27.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.063 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 14.7 m-20 -132.42 127.2 34.85 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.834 0.35 . . . . 0.0 111.641 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.947 HG11 HD11 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -109.76 131.13 61.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.202 179.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.0 98.61 6.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.476 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.596 ' CG1' HD12 ' A' ' 27' ' ' ILE . 93.5 t -92.05 123.29 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.65 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.496 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 99.3 m-85 -117.17 152.11 35.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.271 0.558 . . . . 0.0 111.027 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.646 ' CA ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -89.96 173.64 8.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.532 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.8 p -57.38 -24.31 54.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.191 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -96.01 27.5 3.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.169 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.78 25.13 28.59 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.686 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.04 144.26 25.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.799 0.333 . . . . 0.0 110.818 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.78 107.04 3.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.643 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.646 HD11 ' CA ' ' A' ' 82' ' ' SER . 40.0 mt -80.97 -69.9 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.373 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.915 HD21 ' HG3' ' A' ' 91' ' ' LYS . 1.9 tt -141.68 129.76 22.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.192 0.52 . . . . 0.0 111.87 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.28 107.23 14.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.472 -0.786 . . . . 0.0 108.897 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.915 ' HG3' HD21 ' A' ' 89' ' ' LEU . 5.0 mmpt? -117.84 158.71 24.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.43 0.633 . . . . 0.0 112.676 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.655 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.19 122.33 18.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.146 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.653 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -120.63 162.98 18.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.984 0.421 . . . . 0.0 111.519 -179.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.92 136.85 48.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.335 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.833 HD12 HD21 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -131.78 100.8 5.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.273 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 1.1 mmm180 -92.81 124.04 36.52 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.038 0.446 . . . . 0.0 110.945 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.078 HD12 HD22 ' A' ' 68' ' ' LEU . 4.4 mm -106.46 103.73 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.841 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 mt . . . . . 0 N--CA 1.441 -0.902 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.598 179.353 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.903 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 120.729 0.299 . . . . 0.0 110.62 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -121.38 131.33 54.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.926 0.393 . . . . 0.0 110.697 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.786 ' C ' HG23 ' A' ' 97' ' ' ILE . . . -149.69 -179.71 25.75 Favored Glycine 0 N--CA 1.459 0.226 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.812 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.562 ' N ' HG23 ' A' ' 97' ' ' ILE . . . -126.49 135.34 51.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.938 0.399 . . . . 0.0 110.735 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.732 HD11 ' C ' ' A' ' 69' ' ' THR . 1.2 tp -55.49 130.32 42.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.003 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.49 -6.96 77.97 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.656 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.534 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -106.28 169.18 8.66 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 117.122 0.461 . . . . 0.0 109.941 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.534 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -76.77 166.63 54.17 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.139 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.832 HG21 HD21 ' A' ' 68' ' ' LEU . 1.6 tp -177.56 138.34 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 0.0 110.986 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.493 ' OD2' HD22 ' A' ' 58' ' ' LEU . 3.1 t70 -120.6 120.48 35.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.44 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.722 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -77.44 105.08 8.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.767 179.299 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.456 ' O ' HD21 ' A' ' 93' ' ' LEU . 54.0 m-20 -88.93 124.84 34.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.228 0.537 . . . . 0.0 112.152 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.924 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -81.8 119.96 76.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.118 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.93 131.8 39.02 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.221 1.947 . . . . 0.0 112.877 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 43.61 65.45 0.99 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -143.28 149.44 37.86 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.742 0.306 . . . . 0.0 110.549 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -141.08 117.14 10.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.958 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.82 79.91 6.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.31 -173.74 2.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.64 -30.46 61.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.0 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -62.56 -28.83 70.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.626 HD12 ' CG1' ' A' ' 80' ' ' VAL . 23.2 mm -86.05 127.16 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.476 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.408 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -112.82 -42.78 3.53 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.091 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 37.9 tt0 -127.67 118.22 23.44 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.155 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.81 118.52 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.21 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -117.43 135.83 53.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.271 0.558 . . . . 0.0 112.17 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.487 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 69.9 m95 -111.13 88.24 2.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.971 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -98.7 141.8 31.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.364 0.602 . . . . 0.0 112.267 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -132.12 114.92 15.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.396 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.26 -114.02 5.41 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.64 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.2 t -118.38 44.28 2.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.731 0.3 . . . . 0.0 110.652 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.1 m -154.95 159.56 40.49 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.906 0.384 . . . . 0.0 111.332 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.534 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 4.6 mt -99.18 148.17 24.37 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.804 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.481 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 48.4 t -119.32 -42.26 2.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.444 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -173.5 114.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.724 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -124.73 156.55 37.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.092 0.472 . . . . 0.0 110.907 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 47.7 t80 . . . . . 0 N--CA 1.45 -0.463 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.753 -179.76 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.909 0.295 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.534 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 43.6 t80 -112.7 103.09 11.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.158 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 50' ' ' LEU . 7.9 mt -93.53 113.36 25.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.2 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.481 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 31.0 tttt -47.94 -45.39 30.99 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.745 0.307 . . . . 0.0 111.365 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.1 p -175.27 165.13 3.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.91 0.386 . . . . 0.0 111.191 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.92 -12.43 3.73 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.214 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.02 -1.48 17.35 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.727 0.763 . . . . 0.0 112.063 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -131.38 157.03 44.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.063 0.458 . . . . 0.0 111.206 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -151.3 119.18 6.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.134 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' ' 57' ' ' ILE . 4.2 tt -74.5 103.89 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.115 0.483 . . . . 0.0 111.223 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.639 HD13 ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -51.77 173.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.313 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.5 -26.81 67.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.346 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -96.13 32.4 1.95 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.048 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.08 26.3 58.24 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.58 173.54 8.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 111.04 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.468 HD11 HG12 ' A' ' 39' ' ' VAL . 8.5 tp -109.93 118.35 36.21 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.633 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.639 ' HB2' HD13 ' A' ' 58' ' ' LEU . 12.8 tttp -106.63 108.71 20.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.83 0.347 . . . . 0.0 110.957 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.831 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.4 mt -87.65 135.77 24.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.435 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -82.62 -46.37 13.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.038 0.447 . . . . 0.0 111.831 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.72 112.04 5.78 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.132 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.875 HD22 HG12 ' A' ' 97' ' ' ILE . 6.1 mt -53.76 151.03 6.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.289 0.566 . . . . 0.0 111.865 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.732 ' C ' HD11 ' A' ' 10' ' ' LEU . 7.1 p -154.3 162.42 41.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.815 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.59 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -50.78 -56.4 12.27 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.037 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -57.02 -20.86 26.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.327 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.632 ' OD1' HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -87.06 -14.89 40.18 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.426 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.3 t -90.96 129.62 36.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.649 0.261 . . . . 0.0 110.609 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 154.08 -130.66 2.98 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.588 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 m -123.11 128.73 50.5 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 117.814 0.807 . . . . 0.0 110.931 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -109.06 149.09 29.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.235 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 12.9 m-20 -131.26 125.57 33.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.849 0.356 . . . . 0.0 111.582 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.924 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.98 131.58 60.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.038 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.637 HG23 ' ND2' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -119.95 96.35 5.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.599 178.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.626 ' CG1' HD12 ' A' ' 27' ' ' ILE . 74.1 t -85.75 128.06 39.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.468 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.547 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 83.0 m-85 -117.61 151.56 36.93 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.062 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.614 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -88.73 174.26 8.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.494 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -61.76 -18.67 60.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.265 179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -94.08 23.45 4.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.207 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.65 21.71 50.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.668 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.42 176.49 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.736 0.303 . . . . 0.0 110.617 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.09 116.46 30.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.708 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.614 HD11 ' HB3' ' A' ' 82' ' ' SER . 31.9 mm -90.47 -46.93 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.362 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.631 HD11 ' HE3' ' A' ' 91' ' ' LYS . 1.6 tt -153.6 148.4 26.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 111.796 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.637 ' ND2' HG23 ' A' ' 79' ' ' THR . 10.6 t-20 -136.79 108.58 7.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.197 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.631 ' HE3' HD11 ' A' ' 89' ' ' LEU . 46.3 mmtt -121.13 156.6 31.96 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.655 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.37 122.24 17.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.966 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.65 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -118.2 158.97 24.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.018 0.437 . . . . 0.0 111.728 -179.09 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -111.81 107.99 17.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.263 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.934 HD22 HD11 ' A' ' 97' ' ' ILE . 0.5 OUTLIER -94.29 98.46 10.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.095 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -98.02 126.05 43.26 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.995 0.426 . . . . 0.0 110.498 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.934 HD11 HD22 ' A' ' 95' ' ' LEU . 2.3 mp -134.34 133.58 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.91 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 N--CA 1.436 -1.128 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.712 179.689 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.891 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 120.766 0.317 . . . . 0.0 110.812 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -120.89 128.87 53.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.669 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.24 -178.82 22.82 Favored Glycine 0 N--CA 1.46 0.254 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.748 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.448 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -130.11 133.63 46.79 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.146 0.498 . . . . 0.0 111.597 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.41 ' CD1' ' HA ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -52.08 131.7 32.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.179 179.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.94 -7.96 80.72 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.74 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.528 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.01 168.33 9.36 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.603 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.91 -174.24 16.93 Favored Glycine 0 C--O 1.228 -0.249 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.502 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.815 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 163.13 136.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.803 0.335 . . . . 0.0 110.386 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -126.25 125.22 42.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.919 0.39 . . . . 0.0 111.436 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.481 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -77.37 122.49 25.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.735 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -103.71 123.05 46.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.177 0.513 . . . . 0.0 111.963 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.938 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -81.78 119.53 75.55 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.145 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.71 130.92 37.27 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.386 2.057 . . . . 0.0 112.98 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 42.79 65.13 0.99 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -141.72 149.13 40.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.79 0.329 . . . . 0.0 110.553 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -145.01 115.24 7.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.967 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.5 ttt -78.19 76.45 4.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.849 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.19 -173.74 2.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.822 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -56.86 -30.79 64.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.03 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -65.4 -26.74 68.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.009 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.602 HD12 ' CG1' ' A' ' 80' ' ' VAL . 43.6 mm -85.58 127.28 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.347 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.411 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -113.02 -42.05 3.62 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.182 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 6.6 tm-20 -128.26 138.78 52.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.881 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.2 t -145.27 124.37 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.295 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.446 ' NH1' ' CE2' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -118.84 139.16 52.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.136 0.493 . . . . 0.0 112.222 -179.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.48 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 69.2 m95 -111.49 83.28 1.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -96.54 151.59 19.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.408 0.623 . . . . 0.0 112.351 -178.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.445 ' HD2' ' CE1' ' A' ' 76' ' ' TYR . 6.0 ttp-105 -143.93 116.75 8.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.439 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.92 -114.82 6.09 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.18 -1.009 . . . . 0.0 111.671 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.2 m -118.47 44.25 2.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.754 0.311 . . . . 0.0 110.701 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.9 m -153.29 160.37 42.71 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.287 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.657 HD13 ' OE1' ' A' ' 41' ' ' GLU . 5.5 mt -104.4 147.86 27.07 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.475 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 46.9 t -119.14 -42.06 2.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.581 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -174.2 116.09 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.022 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.657 ' OE1' HD13 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -124.36 159.47 30.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.009 0.433 . . . . 0.0 110.792 179.24 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.1 t80 . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.884 -179.645 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.46 -0.456 0 CA-C-O 120.974 0.322 . . . . 0.0 112.477 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.517 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 39.1 t80 -127.03 99.48 5.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.931 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 50' ' ' LEU . 11.6 mt -91.98 109.06 20.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.132 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 7.6 ttmt -47.6 -33.44 6.6 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.682 0.277 . . . . 0.0 111.468 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.6 p -174.01 163.53 4.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.925 0.393 . . . . 0.0 111.217 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.71 -6.97 19.08 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.008 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.52 5.56 10.55 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 117.626 0.713 . . . . 0.0 112.003 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -132.78 157.65 44.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.109 0.481 . . . . 0.0 111.434 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -148.59 118.15 6.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.003 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.644 HG23 ' O ' ' A' ' 57' ' ' ILE . 10.1 tt -77.56 98.45 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.086 0.47 . . . . 0.0 111.389 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -51.6 163.29 0.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.031 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.17 -22.39 65.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.592 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -96.23 32.87 1.86 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.763 0.316 . . . . 0.0 111.234 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.53 36.55 71.2 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.738 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.84 158.04 18.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 0.0 111.014 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.3 tp -99.39 121.8 41.62 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.586 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.43 108.21 18.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.793 0.33 . . . . 0.0 111.141 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.799 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.3 mt -86.95 138.91 18.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.41 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -85.07 -47.12 10.5 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.057 0.456 . . . . 0.0 111.855 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -143.6 111.43 6.06 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.233 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.815 HD21 HG21 ' A' ' 14' ' ' ILE . 5.3 mt -53.28 144.07 17.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.894 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.41 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 5.0 p -141.76 159.97 41.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.923 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.11 -56.23 15.81 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -55.72 -19.48 11.14 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.578 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.594 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -79.22 -14.3 59.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.568 0.223 . . . . 0.0 111.475 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 98.5 p -85.23 128.43 34.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.629 0.252 . . . . 0.0 110.753 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.32 -135.08 4.34 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.542 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.7 m -124.29 130.4 52.44 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.556 0.678 . . . . 0.0 110.714 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.445 ' CE1' ' HD2' ' A' ' 34' ' ' ARG . 16.3 m-85 -107.41 151.6 25.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.979 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.642 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 12.4 m-20 -133.59 124.66 27.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.314 . . . . 0.0 111.593 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.938 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.09 133.54 53.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.283 179.045 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.04 103.39 9.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.671 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.602 ' CG1' HD12 ' A' ' 27' ' ' ILE . 94.9 t -93.7 129.66 43.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.42 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 97.9 m-85 -121.71 154.93 36.24 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.151 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.557 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -89.98 178.3 6.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.588 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.411 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 27.0 p -64.26 -22.97 67.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.068 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -95.74 23.48 6.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.098 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.52 25.87 61.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.524 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.5 152.29 18.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.8 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -74.82 119.9 19.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.718 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.557 HD11 ' HB3' ' A' ' 82' ' ' SER . 32.8 mm -92.79 -67.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.381 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.919 HD21 ' HG3' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -146.06 133.28 20.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.147 0.499 . . . . 0.0 111.85 -179.304 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.22 107.41 14.41 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.919 ' HG3' HD21 ' A' ' 89' ' ' LEU . 25.4 mmtt -117.55 156.61 27.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.428 0.633 . . . . 0.0 112.662 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.642 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -137.98 122.69 18.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.084 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.649 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -119.68 160.76 21.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.079 0.466 . . . . 0.0 111.607 -179.211 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -110.05 116.13 31.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.158 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.891 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -100.07 100.71 11.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.362 -179.441 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -96.72 115.16 26.95 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.096 0.474 . . . . 0.0 110.353 179.277 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.696 HG12 HD22 ' A' ' 68' ' ' LEU . 3.8 mt -116.33 120.14 64.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.838 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.3 mt . . . . . 0 N--CA 1.441 -0.877 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.684 179.33 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.729 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 120.792 0.33 . . . . 0.0 110.484 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.474 ' CE2' ' HD3' ' A' ' 96' ' ' ARG . 82.9 m95 -112.05 127.52 55.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.609 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.18 -178.18 22.27 Favored Glycine 0 N--CA 1.459 0.217 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.887 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.445 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -125.14 133.34 52.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.048 0.451 . . . . 0.0 111.123 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.729 HD12 HG21 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -53.93 133.14 43.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.027 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.69 -6.35 83.72 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.757 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.542 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.42 167.31 10.13 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.994 0.397 . . . . 0.0 110.006 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.586 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.43 -175.69 18.44 Favored Glycine 0 C--O 1.228 -0.264 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.622 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.829 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.1 tp 167.33 136.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.897 0.38 . . . . 0.0 110.726 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.509 ' OD2' HD22 ' A' ' 58' ' ' LEU . 1.3 t70 -121.81 132.11 54.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.187 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.617 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -90.4 108.95 20.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.855 179.359 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -91.71 123.36 35.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.225 0.536 . . . . 0.0 112.209 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.945 HD11 HG11 ' A' ' 78' ' ' VAL . 3.4 mt -80.82 120.07 77.9 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.112 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.78 130.95 37.26 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.301 2.0 . . . . 0.0 112.975 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 42.67 64.96 1.01 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -140.87 149.55 42.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.593 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -146.29 116.35 7.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -78.67 81.64 4.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.947 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.35 -175.14 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -57.57 -32.81 67.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.897 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -63.74 -23.73 67.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.144 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.563 HD12 ' CG1' ' A' ' 80' ' ' VAL . 37.4 mm -81.11 127.84 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.414 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -105.96 -38.36 6.35 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 122.231 -0.293 . . . . 0.0 111.728 -179.319 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 17.8 mt-10 -141.09 152.64 44.93 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.662 0.744 . . . . 0.0 112.448 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -145.68 117.98 2.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.125 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -115.19 133.65 55.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.024 0.44 . . . . 0.0 112.155 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.414 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 68.6 m95 -110.73 83.65 1.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -98.65 146.29 26.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.298 0.57 . . . . 0.0 112.288 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -137.19 116.93 13.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.532 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.05 -115.9 7.58 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.734 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.8 m -117.3 43.73 2.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.833 0.349 . . . . 0.0 110.71 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.5 m -153.6 160.05 42.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.282 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.548 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.6 mt -102.2 147.08 27.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.464 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 48.2 t -118.4 -42.7 2.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.258 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -166.47 111.55 0.8 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.562 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -117.69 119.69 35.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.941 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.705 ' HB2' HD13 ' A' ' 57' ' ' ILE . 51.5 t80 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.79 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo . . . . . 0 N--CA 1.463 -0.31 0 CA-C-O 120.947 0.311 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.548 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 75.6 t80 -139.18 104.02 4.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.319 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.2 mt -98.45 109.33 22.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 10.3 ttmt -44.57 -39.77 5.2 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.774 0.321 . . . . 0.0 111.529 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.4 p -177.83 163.98 1.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 111.122 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.28 -11.46 4.95 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.025 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.413 ' HA ' ' CD ' ' A' ' 66' ' ' LYS . . . -74.29 0.42 14.31 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 117.786 0.793 . . . . 0.0 112.233 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -130.79 156.87 44.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.161 0.505 . . . . 0.0 111.303 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -150.73 117.4 5.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.098 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.705 HD13 ' HB2' ' A' ' 42' ' ' PHE . 12.0 tt -75.72 97.29 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.45 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.609 HD23 HD21 ' A' ' 60' ' ' ASN . 0.8 OUTLIER -47.01 168.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.184 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.59 -24.57 65.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.592 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.609 HD21 HD23 ' A' ' 58' ' ' LEU . 5.8 p30 -96.83 33.63 1.84 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.737 0.303 . . . . 0.0 111.21 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.65 34.18 69.38 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.56 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.39 165.09 11.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 0.0 111.043 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.41 HD11 HG12 ' A' ' 39' ' ' VAL . 10.5 tp -106.13 120.56 42.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.499 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.26 111.2 23.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.725 0.298 . . . . 0.0 110.991 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.829 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.4 mt -90.92 135.88 25.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.369 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.443 ' HG3' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -80.7 -45.96 16.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.074 0.464 . . . . 0.0 111.991 -179.044 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.443 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -145.8 113.31 6.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.468 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.638 HD22 ' CG1' ' A' ' 97' ' ' ILE . 4.2 mt -53.85 145.57 15.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.513 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.44 ' HA ' HD11 ' A' ' 10' ' ' LEU . 4.7 p -145.67 158.75 43.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.004 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -55.92 14.12 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.417 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.06 -22.81 11.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.411 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.617 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -76.3 -14.58 60.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.248 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.445 ' CB ' HD12 ' A' ' 97' ' ' ILE . 2.8 t -79.39 119.92 23.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.706 0.288 . . . . 0.0 110.521 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.13 -147.27 12.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.144 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.5 m -116.62 130.78 56.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.102 0.451 . . . . 0.0 110.59 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -106.72 129.77 54.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.38 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.708 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 2.0 m-20 -112.85 123.9 51.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.569 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.945 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -105.99 133.92 49.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.031 178.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.426 HG23 ' ND2' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -120.37 96.93 5.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.877 178.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.563 ' CG1' HD12 ' A' ' 27' ' ' ILE . 82.8 t -87.29 127.76 40.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.1 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.489 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 2.5 m-30 -112.81 152.6 28.99 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.298 0.57 . . . . 0.0 111.02 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.857 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -92.72 176.7 6.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.366 179.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.427 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 2.1 p -67.4 -18.34 65.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.236 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -89.94 12.13 18.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.422 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.74 25.05 74.95 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.631 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.11 -169.4 1.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.644 0.259 . . . . 0.0 110.595 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 -119.76 99.73 6.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.938 0.399 . . . . 0.0 110.783 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.857 HD11 ' HB3' ' A' ' 82' ' ' SER . 38.5 mm -58.0 -61.31 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.423 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.639 HD21 ' CG ' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -144.14 140.47 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.226 0.536 . . . . 0.0 112.019 -179.032 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.426 ' ND2' HG23 ' A' ' 79' ' ' THR . 17.0 t-20 -121.65 109.23 14.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.807 178.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.639 ' CG ' HD21 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -119.38 160.85 21.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.708 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -139.37 122.65 17.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.159 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.661 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -119.61 161.98 19.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 111.233 -179.466 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.06 146.1 33.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.265 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.729 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -136.4 119.1 16.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.213 -179.533 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.474 ' HD3' ' CE2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -119.87 124.6 46.46 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.318 0.58 . . . . 0.0 111.038 179.215 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.729 HG21 HD12 ' A' ' 10' ' ' LEU . 3.9 mp -103.44 103.9 15.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.784 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.3 mt . . . . . 0 N--CA 1.44 -0.955 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.319 179.051 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.91 HG23 ' HA ' ' A' ' 95' ' ' LEU . 2.6 m . . . . . 0 N--CA 1.433 -1.304 0 CA-C-O 121.848 0.832 . . . . 0.0 112.496 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.437 ' CE3' ' HB2' ' A' ' 96' ' ' ARG . 69.5 m95 -147.56 162.26 39.45 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.543 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.25 178.48 44.39 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.494 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -119.8 135.05 55.02 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 120.883 0.373 . . . . 0.0 110.827 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.686 HD11 ' C ' ' A' ' 69' ' ' THR . 1.2 tp -57.11 133.27 54.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.03 -2.84 87.15 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.593 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.576 ' NE2' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -106.56 168.33 9.24 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.576 ' O ' ' NE2' ' A' ' 12' ' ' HIS . . . -82.66 163.47 42.33 Favored Glycine 0 C--O 1.223 -0.556 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.098 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.832 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.5 tp -176.11 137.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.952 0.406 . . . . 0.0 111.183 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.46 ' OD2' HD22 ' A' ' 58' ' ' LEU . 2.6 t70 -116.99 119.74 36.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.079 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.433 ' CD1' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -80.94 114.45 19.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.957 179.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -94.1 124.03 37.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.168 0.509 . . . . 0.0 111.925 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.925 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.4 mt -80.4 119.78 77.41 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.023 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.449 ' O ' HD11 ' A' ' 89' ' ' LEU . 32.1 Cg_exo -59.39 130.85 37.64 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.281 1.987 . . . . 0.0 112.931 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 42.7 65.17 0.98 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -141.96 151.14 42.27 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.869 0.366 . . . . 0.0 110.638 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -141.35 117.98 10.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.71 78.4 7.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.009 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.5 p -110.77 -172.88 2.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.25 -30.53 68.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -61.46 -27.28 68.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.016 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.603 HD12 ' CG1' ' A' ' 80' ' ' VAL . 21.0 mm -81.76 127.52 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.451 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.95 -43.64 3.56 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 60.1 tt0 -128.39 116.38 19.68 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.196 -0.601 . . . . 0.0 112.412 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.7 t -116.22 117.12 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.886 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -118.17 133.53 55.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.202 0.525 . . . . 0.0 112.384 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -109.63 84.52 1.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.767 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -95.06 149.94 20.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.382 0.61 . . . . 0.0 112.432 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -139.66 113.47 8.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.408 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.47 -114.77 6.24 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.613 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -117.01 43.62 2.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.77 0.319 . . . . 0.0 110.629 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 66.4 m -153.74 160.08 42.17 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.332 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.557 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.5 mt -101.42 147.12 26.73 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.431 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 51.1 t -118.21 -43.25 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.189 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.4 112.45 0.83 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.294 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.28 120.08 35.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.195 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.771 ' HB2' HD13 ' A' ' 57' ' ' ILE . 14.0 t80 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.471 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.69 0.204 . . . . 0.0 112.218 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.557 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 70.5 t80 -137.46 98.89 3.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.756 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 50' ' ' LEU . 9.5 mt -93.89 113.81 25.9 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 6.5 tptp -36.43 -90.06 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.7 m -118.56 21.45 12.57 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.08 -1.52 55.19 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.125 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.81 3.42 29.56 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 117.546 0.673 . . . . 0.0 111.008 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -124.31 158.05 33.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.782 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -140.95 120.53 13.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.202 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.771 HD13 ' HB2' ' A' ' 42' ' ' PHE . 4.7 tt -76.99 103.33 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.12 0.486 . . . . 0.0 111.375 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.624 HD23 HD21 ' A' ' 60' ' ' ASN . 0.7 OUTLIER -54.5 166.58 0.42 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.102 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.3 -23.48 64.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.72 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.624 HD21 HD23 ' A' ' 58' ' ' LEU . 6.0 p30 -96.53 33.3 1.84 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.734 0.302 . . . . 0.0 111.214 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.97 34.01 64.9 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.632 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.3 173.87 6.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 0.0 111.034 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 tp -114.22 121.07 42.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.57 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.412 ' HB2' HD13 ' A' ' 58' ' ' LEU . 17.2 tttt -107.61 104.07 13.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.823 0.344 . . . . 0.0 111.051 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.832 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -82.27 127.18 39.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.625 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -76.0 -45.65 33.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.065 0.459 . . . . 0.0 111.322 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.11 111.9 4.82 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.235 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.829 HD22 HG12 ' A' ' 97' ' ' ILE . 4.5 mt -56.21 152.01 11.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.12 0.486 . . . . 0.0 111.681 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.686 ' C ' HD11 ' A' ' 10' ' ' LEU . 8.7 p -153.17 163.35 40.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.123 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.635 ' N ' HD11 ' A' ' 10' ' ' LEU . 21.4 mmt85 -51.42 -54.76 23.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.476 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -58.56 -19.22 36.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.321 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.41 -15.8 34.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.37 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.479 ' CB ' HD12 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -82.7 130.83 35.19 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.823 0.344 . . . . 0.0 110.586 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.56 -130.83 3.26 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.325 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 1.3 m -125.82 126.65 44.85 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 117.753 0.776 . . . . 0.0 111.063 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.428 ' CD1' HD21 ' A' ' 16' ' ' LEU . 61.2 m-85 -97.03 149.93 21.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.21 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.648 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 11.5 m-20 -132.94 120.53 21.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.201 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.925 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -107.91 128.54 63.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.174 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.73 97.4 5.83 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.603 ' CG1' HD12 ' A' ' 27' ' ' ILE . 71.2 t -87.01 126.79 40.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.52 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.507 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 97.2 m-85 -118.71 151.56 37.76 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.236 0.541 . . . . 0.0 111.024 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.629 ' CB ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -89.72 173.62 8.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.406 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.3 p -59.95 -29.51 68.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.926 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -77.77 -4.07 44.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.491 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.86 27.2 51.3 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.531 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.17 165.16 11.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 110.79 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.37 115.37 21.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.644 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.629 HD11 ' CB ' ' A' ' 82' ' ' SER . 34.9 mt -91.16 -67.71 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.322 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.724 HD21 ' CG ' ' A' ' 91' ' ' LYS . 4.5 tt -136.41 130.14 32.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.062 0.458 . . . . 0.0 111.71 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -120.71 108.68 14.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.333 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.724 ' CG ' HD21 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -119.61 153.51 35.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.275 0.56 . . . . 0.0 112.337 -178.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.648 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.91 121.69 16.48 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.496 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.641 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -120.63 164.85 15.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.243 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.24 107.24 10.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.66 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.91 ' HA ' HG23 ' A' ' 6' ' ' VAL . 7.2 tt -101.8 113.89 27.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.017 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.437 ' HB2' ' CE3' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -96.77 111.93 23.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.874 0.369 . . . . 0.0 110.479 179.299 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.829 HG12 HD22 ' A' ' 68' ' ' LEU . 5.6 mt -95.33 109.14 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.873 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mt . . . . . 0 N--CA 1.439 -1.002 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.416 178.889 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.881 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 120.713 0.292 . . . . 0.0 110.648 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -116.49 127.43 54.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.877 0.37 . . . . 0.0 110.737 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.55 177.42 29.48 Favored Glycine 0 C--N 1.329 0.161 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.662 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.408 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -122.18 135.6 54.8 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.913 0.387 . . . . 0.0 110.75 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.725 HD11 ' C ' ' A' ' 69' ' ' THR . 1.1 tp -54.46 130.01 38.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.714 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.85 -9.27 68.33 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.762 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.569 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.6 170.74 7.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 117.002 0.401 . . . . 0.0 109.927 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -79.87 175.2 55.05 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.119 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.856 ' CG2' HD12 ' A' ' 65' ' ' ILE . 2.0 tp 178.13 139.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.691 0.281 . . . . 0.0 110.906 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -116.08 126.21 53.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.94 0.4 . . . . 0.0 111.317 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -86.54 105.57 16.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.806 179.304 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -88.3 123.75 33.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.144 0.497 . . . . 0.0 112.194 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.923 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.3 mt -80.25 120.05 78.34 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.055 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.82 130.98 37.31 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.313 2.008 . . . . 0.0 112.859 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 43.09 65.22 1.0 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -142.0 150.96 42.02 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.801 0.334 . . . . 0.0 110.617 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -140.61 117.68 11.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.98 84.08 7.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.956 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.0 p -119.66 -173.01 2.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -57.45 -30.03 64.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.955 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -63.14 -28.02 69.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.637 HD12 ' CG1' ' A' ' 80' ' ' VAL . 36.4 mm -87.38 127.02 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.44 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.405 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -112.76 -42.37 3.62 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.053 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 34.1 tt0 -124.99 118.74 26.91 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.146 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 42' ' ' PHE . 39.3 t -123.74 112.79 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.262 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -112.62 139.0 48.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.205 0.526 . . . . 0.0 112.071 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.461 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 71.7 m95 -112.39 82.99 1.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.865 178.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -94.69 142.92 26.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.337 0.589 . . . . 0.0 112.286 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 118.23 18.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.418 178.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.97 -113.73 5.01 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.654 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.5 p -119.55 44.82 2.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.738 0.304 . . . . 0.0 110.663 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.8 m -156.46 159.64 38.83 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.887 0.375 . . . . 0.0 111.315 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.52 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 4.8 mt -99.81 147.49 25.43 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.697 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 40.3 t -118.37 -41.14 2.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.481 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -172.97 117.54 0.31 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.679 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -122.53 156.94 33.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 110.617 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 30' ' ' VAL . 63.5 t80 . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.717 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo . . . . . 0 CA--C 1.527 0.148 0 CA-C-O 120.666 0.194 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.52 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 84.9 t80 -136.67 113.7 10.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.869 0.366 . . . . 0.0 111.481 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 50' ' ' LEU . 10.1 mt -108.69 112.64 25.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.98 179.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 24.3 tttm -44.67 -49.22 10.5 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.732 0.301 . . . . 0.0 111.381 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.52 168.69 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.085 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.82 -12.46 1.7 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.445 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.74 0.3 13.44 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 117.847 0.824 . . . . 0.0 112.336 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -136.99 156.89 47.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 111.269 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -150.8 120.46 6.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.232 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.627 HG23 ' O ' ' A' ' 57' ' ' ILE . 4.7 tt -75.59 103.9 3.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.047 0.451 . . . . 0.0 111.368 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.522 HD23 HD21 ' A' ' 60' ' ' ASN . 1.6 mp -54.15 169.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.069 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.33 -24.44 64.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.624 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.522 HD21 HD23 ' A' ' 58' ' ' LEU . 5.8 p30 -96.48 33.22 1.84 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.79 0.329 . . . . 0.0 111.157 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.04 31.0 64.43 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.723 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.47 174.03 6.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.886 0.374 . . . . 0.0 111.117 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 11.1 tp -113.7 121.11 43.12 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.53 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HG3' HD11 ' A' ' 58' ' ' LEU . 3.1 tmtp? -106.87 106.32 16.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.755 0.312 . . . . 0.0 111.196 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.856 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.7 mt -86.4 135.41 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.067 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -90.75 -40.72 11.67 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -143.63 109.19 5.13 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.758 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.848 ' HB3' HG21 ' A' ' 97' ' ' ILE . 5.3 mt -58.54 145.89 37.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.129 0.49 . . . . 0.0 111.339 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.725 ' C ' HD11 ' A' ' 10' ' ' LEU . 4.5 p -148.78 158.48 44.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.238 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.681 ' N ' HD11 ' A' ' 10' ' ' LEU . 9.9 mmm-85 -50.5 -57.1 8.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.185 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -54.42 -22.29 12.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.094 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.559 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -81.4 -14.81 56.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.319 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.445 ' HB3' HD12 ' A' ' 97' ' ' ILE . 5.0 p -83.55 138.2 33.5 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.647 0.26 . . . . 0.0 110.845 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.07 -126.02 2.32 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.681 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 m -132.99 129.61 38.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.864 0.832 . . . . 0.0 110.921 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.53 ' CE1' HD12 ' A' ' 95' ' ' LEU . 23.6 m-85 -103.91 151.28 23.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.293 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -132.63 122.42 24.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.371 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.923 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -108.0 127.85 63.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.056 179.288 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.98 97.09 6.03 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.637 ' CG1' HD12 ' A' ' 27' ' ' ILE . 80.7 t -88.16 130.25 38.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.304 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.555 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 96.8 m-85 -124.02 154.45 39.86 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.269 0.556 . . . . 0.0 111.184 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.534 ' CB ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -87.98 175.85 7.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.381 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.405 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 20.3 p -62.65 -22.03 66.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.165 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -96.0 24.97 5.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.191 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.63 26.83 53.82 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.581 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.69 157.84 15.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.816 0.341 . . . . 0.0 110.816 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.12 111.41 14.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.534 HD11 ' CB ' ' A' ' 82' ' ' SER . 34.4 mm -92.98 -49.72 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.33 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.518 HD21 ' CG ' ' A' ' 91' ' ' LYS . 2.6 tt -154.01 149.15 26.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.283 0.563 . . . . 0.0 111.773 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -140.62 108.32 5.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.173 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.518 ' CG ' HD21 ' A' ' 89' ' ' LEU . 7.4 mmpt? -120.52 159.2 25.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.83 121.71 14.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.039 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.647 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -120.91 161.89 20.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.892 0.377 . . . . 0.0 111.695 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.59 125.81 53.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.199 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.881 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -106.31 101.51 10.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.233 -179.44 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.36 108.95 21.78 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.22 0.533 . . . . 0.0 110.412 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.848 HG21 ' HB3' ' A' ' 68' ' ' LEU . 3.6 mt -110.44 113.41 44.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.731 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mt . . . . . 0 N--CA 1.442 -0.859 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.534 179.323 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.89 HG23 ' HA ' ' A' ' 95' ' ' LEU . 2.9 m . . . . . 0 N--CA 1.432 -1.359 0 CA-C-O 121.78 0.8 . . . . 0.0 112.345 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.433 ' CE3' ' HB2' ' A' ' 96' ' ' ARG . 73.3 m95 -145.42 161.97 38.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.55 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.48 179.16 41.15 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.427 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.413 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -122.63 134.42 54.5 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.976 0.417 . . . . 0.0 111.25 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.686 HD11 ' N ' ' A' ' 70' ' ' ARG . 1.2 tp -58.0 134.09 56.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.692 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.0 -4.11 83.89 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.393 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.614 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.4 OUTLIER -108.99 167.94 9.73 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.614 ' O ' ' CE1' ' A' ' 12' ' ' HIS . . . -78.73 -173.4 43.02 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.659 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.895 HG21 HD21 ' A' ' 68' ' ' LEU . 1.1 tp 164.18 136.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.756 0.312 . . . . 0.0 110.38 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -116.93 118.7 33.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.89 0.376 . . . . 0.0 111.391 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.475 HD21 ' CD1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -81.23 102.93 10.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.849 179.299 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -85.97 124.73 32.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.192 0.52 . . . . 0.0 111.724 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.94 HD11 HG11 ' A' ' 78' ' ' VAL . 3.4 mt -78.42 119.93 79.16 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.154 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -58.26 130.15 36.33 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.37 2.047 . . . . 0.0 113.094 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 42.44 64.61 1.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.518 ' HB2' HD13 ' A' ' 89' ' ' LEU . 9.6 t80 -140.7 149.0 41.64 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.817 0.341 . . . . 0.0 110.585 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -139.42 117.16 11.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.961 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.35 81.14 7.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.868 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.54 -174.53 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.829 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -56.8 -30.78 64.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.961 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.02 -27.85 69.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.565 HD12 ' CG1' ' A' ' 80' ' ' VAL . 33.6 mm -83.67 127.88 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.429 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.73 -44.06 3.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 13.9 tp10 -125.91 134.58 51.53 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.317 -179.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -135.41 108.01 8.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.723 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -105.17 132.03 51.9 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -109.01 82.88 1.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -99.17 157.92 16.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.394 0.616 . . . . 0.0 112.467 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -149.3 113.8 5.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.509 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.46 -117.03 9.4 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.741 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 p -115.0 42.47 2.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.741 0.305 . . . . 0.0 110.705 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.0 m -150.66 160.4 43.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.237 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.541 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 6.2 mt -106.82 147.94 29.11 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.444 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 53.7 t -119.03 -43.76 2.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.235 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.39 113.26 1.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.527 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.528 ' OE2' HD21 ' A' ' 38' ' ' LEU . 2.2 mt-10 -118.51 113.58 21.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.051 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.561 ' HB2' HD13 ' A' ' 57' ' ' ILE . 16.5 t80 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.882 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.46 -0.482 0 CA-C-O 120.629 0.179 . . . . 0.0 111.939 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.541 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 69.8 t80 -125.34 99.87 6.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.337 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 50' ' ' LEU . 9.1 mt -96.24 105.66 17.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.931 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 39.8 tttm -43.92 -59.2 2.38 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.586 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.6 p -144.74 162.75 35.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 0.0 111.193 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.08 -8.16 21.67 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.022 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.432 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . . . -78.39 3.41 15.78 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 117.559 0.679 . . . . 0.0 111.952 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -125.5 157.36 37.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.273 0.559 . . . . 0.0 111.743 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -154.55 124.65 6.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.212 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 57' ' ' ILE . 3.0 tt -83.49 106.66 14.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.308 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.66 HD23 HD21 ' A' ' 60' ' ' ASN . 1.2 mp -65.7 172.79 3.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.904 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.3 -44.83 64.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.156 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.66 HD21 HD23 ' A' ' 58' ' ' LEU . 4.7 p30 -57.33 -25.13 58.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.06 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.69 33.42 3.84 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.547 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -113.39 154.61 26.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.841 0.353 . . . . 0.0 110.964 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 tp -84.39 122.05 28.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.459 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -102.99 111.33 23.61 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.831 0.348 . . . . 0.0 111.421 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.865 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.8 mt -97.13 122.64 48.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.114 179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.432 ' HD2' ' HA ' ' A' ' 54' ' ' ALA . 1.6 ptpp? -89.27 -33.76 16.84 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.471 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -140.8 104.82 4.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.601 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.895 HD21 HG21 ' A' ' 14' ' ' ILE . 6.2 mt -63.01 154.43 30.68 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.13 0.49 . . . . 0.0 111.458 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.545 ' C ' HD11 ' A' ' 10' ' ' LEU . 5.1 p -152.35 157.04 40.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.209 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.686 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -50.11 -55.98 12.77 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.363 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -52.63 -24.6 8.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.132 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.01 -15.36 44.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.255 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.403 ' N ' HD12 ' A' ' 97' ' ' ILE . 14.4 p -77.86 126.2 30.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.415 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 154.21 -131.08 3.09 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.447 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 1.3 m -126.03 129.19 48.68 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 117.711 0.756 . . . . 0.0 111.143 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.475 ' CD1' HD21 ' A' ' 16' ' ' LEU . 63.9 m-85 -99.82 148.4 24.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.035 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.651 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 12.8 m-20 -130.05 122.23 27.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.769 0.319 . . . . 0.0 111.356 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.94 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.57 130.55 62.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.274 179.34 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.94 96.72 5.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.818 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.565 ' CG1' HD12 ' A' ' 27' ' ' ILE . 55.0 t -86.56 134.07 28.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.243 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.491 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 81.0 m-85 -127.39 156.69 41.65 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.347 0.594 . . . . 0.0 111.199 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.661 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -90.02 174.96 7.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.448 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.3 -24.94 66.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.15 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -95.9 27.1 3.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.198 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.7 23.61 37.32 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.719 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.61 156.32 18.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.731 0.3 . . . . 0.0 110.823 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.58 118.42 22.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.541 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.661 HD11 ' HB3' ' A' ' 82' ' ' SER . 45.9 mt -102.05 -67.1 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.425 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.569 HD21 ' CG ' ' A' ' 91' ' ' LYS . 5.1 tt -134.18 148.8 50.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.322 0.582 . . . . 0.0 111.875 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.69 109.21 5.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.061 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.569 ' CG ' HD21 ' A' ' 89' ' ' LEU . 58.4 mmtt -122.53 153.33 39.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.651 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -139.85 122.95 16.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.284 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.647 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -122.82 165.28 16.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.267 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -125.22 106.32 9.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.73 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.89 ' HA ' HG23 ' A' ' 6' ' ' VAL . 7.1 tt -101.16 114.86 29.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.897 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -96.79 108.33 20.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.408 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.748 HG12 HD22 ' A' ' 68' ' ' LEU . 8.6 mt -90.88 108.94 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.776 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mt . . . . . 0 N--CA 1.442 -0.872 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.571 179.254 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.743 HG11 HD12 ' A' ' 95' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.447 -0.593 0 CA-C-O 120.623 0.249 . . . . 0.0 110.884 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -115.73 139.35 50.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.81 0.338 . . . . 0.0 110.957 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.57 176.59 28.21 Favored Glycine 0 C--O 1.228 -0.221 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.972 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.61 135.12 54.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.172 0.486 . . . . 0.0 111.121 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.565 HD12 HG21 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -54.02 130.38 37.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.713 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.11 -8.95 75.64 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.887 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.549 ' NE2' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -106.57 170.97 7.62 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.549 ' O ' ' NE2' ' A' ' 12' ' ' HIS . . . -86.55 174.36 46.56 Favored Glycine 0 C--O 1.224 -0.477 0 C-N-CA 120.705 -0.759 . . . . 0.0 113.468 -178.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.815 ' CG2' HD12 ' A' ' 65' ' ' ILE . 3.3 tp 179.59 144.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.6 0.238 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -120.69 129.94 53.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.951 0.405 . . . . 0.0 111.639 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -91.52 104.08 16.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.713 179.222 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -86.19 123.9 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.188 0.518 . . . . 0.0 111.911 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.934 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.4 mt -79.55 120.19 79.43 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.184 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.25 130.63 36.92 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.26 1.973 . . . . 0.0 113.0 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 43.08 64.78 1.1 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -141.67 150.5 41.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.784 0.326 . . . . 0.0 110.551 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -142.07 117.55 10.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.881 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.97 76.87 6.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.978 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.1 p -105.86 -172.51 2.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -59.08 -31.45 68.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.966 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.01 -26.94 68.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.99 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.552 HD12 ' CG1' ' A' ' 80' ' ' VAL . 22.1 mm -79.01 129.21 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.43 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.418 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.9 OUTLIER -112.68 -44.11 3.37 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.082 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 69.2 tt0 -132.45 116.39 16.73 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.001 -0.68 . . . . 0.0 112.655 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.31 114.69 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -112.17 130.73 55.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.172 0.51 . . . . 0.0 112.36 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -112.73 85.37 2.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.987 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -98.97 148.75 23.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.252 0.548 . . . . 0.0 112.229 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.0 114.69 9.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.609 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.45 -117.73 11.5 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.809 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.5 m -114.64 42.36 2.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.764 0.316 . . . . 0.0 110.665 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.7 m -151.95 160.18 43.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.235 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.542 HD21 ' OE2' ' A' ' 41' ' ' GLU . 5.5 mt -102.94 146.15 28.75 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.463 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 46.9 t -117.59 -42.47 2.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.941 0.401 . . . . 0.0 110.243 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -165.83 112.17 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.492 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.542 ' OE2' HD21 ' A' ' 38' ' ' LEU . 2.2 mt-10 -120.36 112.67 19.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.066 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.43 ' HB2' HD13 ' A' ' 57' ' ' ILE . 22.4 t80 . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.761 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.412 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 91.7 Cg_endo . . . . . 0 N--CA 1.462 -0.357 0 CA-C-O 120.815 0.256 . . . . 0.0 112.52 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.536 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 78.7 t80 -138.83 106.17 5.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.415 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 50' ' ' LEU . 7.9 mt -100.95 110.66 22.73 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 36.2 tttt -44.84 -49.14 10.99 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.73 0.3 . . . . 0.0 111.607 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.1 p -169.84 164.98 9.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.956 0.408 . . . . 0.0 111.319 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.77 -12.1 4.78 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.138 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.28 0.93 12.69 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 117.782 0.791 . . . . 0.0 112.083 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -131.94 157.54 43.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.052 0.453 . . . . 0.0 111.09 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -154.09 127.21 8.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.512 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.661 HG23 ' O ' ' A' ' 57' ' ' ILE . 7.1 tt -86.02 101.26 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.178 0.513 . . . . 0.0 111.276 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.633 HD23 HD21 ' A' ' 60' ' ' ASN . 1.2 mp -58.68 171.16 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.957 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.7 -44.64 77.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.185 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.633 HD21 HD23 ' A' ' 58' ' ' LEU . 4.9 p30 -58.2 -25.1 61.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.07 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.75 34.17 3.88 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.568 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -112.96 154.73 25.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.789 0.328 . . . . 0.0 110.968 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.0 tp -82.72 123.13 29.01 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.632 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.413 ' HB2' HD13 ' A' ' 58' ' ' LEU . 1.4 tptt -106.38 110.09 22.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.906 0.384 . . . . 0.0 111.219 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.815 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.9 mt -92.21 121.2 42.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.148 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -81.14 -36.21 30.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.894 0.378 . . . . 0.0 111.798 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -144.25 107.52 4.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.706 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.605 HD22 ' CD1' ' A' ' 97' ' ' ILE . 4.4 mt -59.03 143.73 47.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.058 0.456 . . . . 0.0 111.337 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.448 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 9.2 p -143.33 165.09 28.45 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.856 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.7 mmt85 -50.5 -54.94 18.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.256 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -53.45 -23.87 11.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.41 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -73.5 -13.57 61.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.567 0.222 . . . . 0.0 111.427 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.418 ' HB3' ' CG1' ' A' ' 97' ' ' ILE . 5.0 p -82.78 116.05 21.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.68 0.276 . . . . 0.0 110.647 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.27 -144.93 10.3 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.21 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -120.38 131.02 54.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.145 0.472 . . . . 0.0 110.621 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -103.96 131.99 50.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.411 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.708 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 1.9 m-20 -114.39 123.4 49.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.286 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.934 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -106.11 129.06 59.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.275 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.47 97.66 6.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.552 ' CG1' HD12 ' A' ' 27' ' ' ILE . 77.7 t -88.0 123.23 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.436 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.445 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 93.4 m-85 -113.81 151.15 32.46 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.224 0.535 . . . . 0.0 111.053 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.61 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -90.79 172.87 8.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.545 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 16.9 p -60.81 -19.18 59.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.351 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -94.39 24.67 4.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.218 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.82 23.29 44.4 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.6 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.94 176.11 5.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.783 0.325 . . . . 0.0 110.735 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -98.31 126.47 43.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.676 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.61 HD11 ' HB3' ' A' ' 82' ' ' SER . 51.4 mt -101.24 -61.42 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.416 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.749 HD21 ' CG ' ' A' ' 91' ' ' LYS . 5.0 tt -140.06 129.53 24.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.113 0.483 . . . . 0.0 111.855 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -120.54 108.54 14.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.17 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.749 ' CG ' HD21 ' A' ' 89' ' ' LEU . 26.2 mmtt -121.05 159.69 25.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.352 0.596 . . . . 0.0 112.439 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.708 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -139.83 121.75 15.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.45 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 93' ' ' LEU . 1.4 mp -119.49 165.39 14.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.865 0.364 . . . . 0.0 111.152 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -123.47 134.31 53.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.639 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.743 HD12 HG11 ' A' ' 6' ' ' VAL . 8.5 tt -129.73 132.37 46.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.023 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -109.8 132.29 54.28 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.931 0.396 . . . . 0.0 111.062 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.605 ' CD1' HD22 ' A' ' 68' ' ' LEU . 7.0 mm -101.12 100.9 11.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.615 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.8 mt . . . . . 0 N--CA 1.44 -0.927 0 CA-C-O 120.971 0.415 . . . . 0.0 110.479 179.348 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.815 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.531 0 CA-C-O 120.698 0.285 . . . . 0.0 110.706 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -118.53 128.57 54.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.659 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.07 179.66 21.24 Favored Glycine 0 N--CA 1.46 0.296 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.733 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.41 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -124.72 134.7 52.74 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.929 0.395 . . . . 0.0 111.116 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.683 HD11 ' N ' ' A' ' 70' ' ' ARG . 1.0 OUTLIER -52.81 134.57 36.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.158 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.73 -6.44 82.75 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.928 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -105.97 168.66 8.97 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 117.144 0.472 . . . . 0.0 109.988 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.529 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -77.11 163.59 52.27 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.203 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.872 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.6 tp -176.97 138.96 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 122.635 -0.332 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -125.48 133.3 52.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.928 0.394 . . . . 0.0 111.352 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.836 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -87.24 122.4 30.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.563 179.156 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.458 ' O ' HD21 ' A' ' 93' ' ' LEU . 77.4 m-20 -103.59 124.49 48.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.134 0.492 . . . . 0.0 111.687 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.957 HD11 HG11 ' A' ' 78' ' ' VAL . 3.2 mt -80.51 119.46 76.37 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.349 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.26 131.33 38.19 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.357 2.038 . . . . 0.0 113.066 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.15 64.81 1.01 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -139.69 149.32 43.54 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.809 0.337 . . . . 0.0 110.517 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -135.38 117.01 14.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.511 ' SD ' HG21 ' A' ' 30' ' ' VAL . 1.8 tpt -87.53 83.62 7.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.9 p -115.47 -173.13 2.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.849 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -58.61 -31.62 68.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.47 -24.91 67.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.945 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.492 HD12 ' CG1' ' A' ' 80' ' ' VAL . 34.6 mm -79.86 127.89 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.43 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.441 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 1.3 t0 -103.9 -38.37 7.04 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 122.267 -0.27 . . . . 0.0 111.673 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 8.8 mt-10 -141.96 151.81 42.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.722 0.772 . . . . 0.0 112.574 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.511 HG21 ' SD ' ' A' ' 23' ' ' MET . 45.5 t -145.29 106.87 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.955 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -101.53 126.05 48.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.079 0.466 . . . . 0.0 112.232 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -105.16 84.39 2.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.03 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -103.99 156.13 18.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.233 0.539 . . . . 0.0 112.211 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.58 117.73 7.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.734 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.99 -118.12 12.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.826 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.9 t -115.19 42.52 2.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.758 0.313 . . . . 0.0 110.721 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.9 m -149.93 159.94 43.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.136 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.533 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 6.3 mt -105.57 145.69 30.62 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.872 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.407 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 54.2 t -117.04 -43.6 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.086 0.47 . . . . 0.0 110.089 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.91 112.36 0.89 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.713 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -116.5 111.79 20.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.076 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.6 t80 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.943 -179.984 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo . . . . . 0 N--CA 1.464 -0.214 0 CA-C-O 120.671 0.196 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 64.4 t80 -129.87 98.71 4.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.433 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 50' ' ' LEU . 10.1 mt -95.82 108.68 21.05 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 38.8 tttt -42.19 -37.83 1.57 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.707 0.289 . . . . 0.0 111.7 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.52 165.4 1.36 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 111.07 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.64 -10.49 4.52 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.338 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.65 2.01 10.88 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.748 0.774 . . . . 0.0 112.185 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -132.1 157.59 43.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.092 0.473 . . . . 0.0 111.262 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -155.94 123.87 5.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.421 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.648 HG23 ' O ' ' A' ' 57' ' ' ILE . 6.6 tt -81.25 101.73 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.224 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.676 HD23 HD21 ' A' ' 60' ' ' ASN . 0.8 OUTLIER -58.88 173.35 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.993 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.78 -45.19 65.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.199 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.676 HD21 HD23 ' A' ' 58' ' ' LEU . 4.6 p30 -58.15 -21.88 48.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.67 35.06 4.18 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.611 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -116.1 155.17 28.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.841 0.353 . . . . 0.0 111.036 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 12.1 tp -81.77 122.46 27.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.671 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -104.83 110.26 22.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.752 0.311 . . . . 0.0 111.111 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.872 HD12 ' CG2' ' A' ' 14' ' ' ILE . 3.1 mt -91.38 134.35 30.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.339 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -82.73 -45.94 13.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.015 0.436 . . . . 0.0 111.692 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.77 112.31 5.6 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.249 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.066 HD22 HD12 ' A' ' 97' ' ' ILE . 4.4 mt -51.37 146.49 6.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.166 0.508 . . . . 0.0 111.974 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.581 ' C ' HD11 ' A' ' 10' ' ' LEU . 2.7 p -143.98 155.23 43.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.826 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.683 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -50.11 -56.33 11.33 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.363 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -52.98 -23.8 8.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.162 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.553 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -77.32 -16.17 59.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.303 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.438 ' CB ' HG12 ' A' ' 97' ' ' ILE . 22.1 p -76.95 117.48 18.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.641 0.258 . . . . 0.0 110.711 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.54 -151.33 21.17 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.169 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -110.05 131.34 55.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.783 0.325 . . . . 0.0 110.512 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -105.21 151.72 23.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.266 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.661 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 12.1 m-20 -133.8 125.0 27.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.355 . . . . 0.0 111.434 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.957 HG11 HD11 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -107.47 134.23 49.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.256 179.195 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.39 95.03 4.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.649 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.493 HG12 ' HB ' ' A' ' 88' ' ' ILE . 64.8 t -85.31 130.97 35.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.015 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.538 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 2.7 m-30 -116.87 152.99 33.32 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.31 0.576 . . . . 0.0 110.764 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.507 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -92.48 179.24 5.58 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.884 179.393 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 0.8 OUTLIER -64.78 -23.61 67.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.088 179.619 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -84.69 -5.12 59.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.52 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.56 19.23 55.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.812 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.88 141.82 37.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.749 0.309 . . . . 0.0 110.861 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.39 111.04 2.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.95 0.405 . . . . 0.0 111.014 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.507 HD11 ' HB3' ' A' ' 82' ' ' SER . 26.1 mm -80.14 -40.29 20.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.159 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.913 HD21 ' HG3' ' A' ' 91' ' ' LYS . 4.4 tt -152.82 127.36 9.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.107 0.479 . . . . 0.0 111.885 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -117.35 108.12 15.2 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.913 ' HG3' HD21 ' A' ' 89' ' ' LEU . 15.5 mmtt -119.32 159.4 24.22 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.661 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.73 122.41 17.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.071 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.643 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -119.88 162.15 19.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.015 0.435 . . . . 0.0 111.57 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -111.25 122.6 48.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.449 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.836 HD12 HD21 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -117.2 101.95 8.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.051 -179.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.545 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -94.42 125.18 38.9 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.129 0.49 . . . . 0.0 110.929 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.066 HD12 HD22 ' A' ' 68' ' ' LEU . 2.8 mm -108.72 112.49 40.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.999 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 98' ' ' LEU . 10.1 mt . . . . . 0 N--CA 1.439 -0.99 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.416 179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.955 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.48 0 CA-C-O 120.702 0.287 . . . . 0.0 110.866 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -115.13 130.09 56.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.802 0.334 . . . . 0.0 110.752 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.57 -179.62 23.74 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.781 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.434 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -129.79 134.43 47.57 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.972 0.415 . . . . 0.0 111.192 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.66 HD11 ' N ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -53.63 135.86 39.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.992 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.88 -8.77 74.64 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.73 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.527 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.61 167.37 10.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.594 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.89 -171.75 11.34 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.472 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.893 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 163.04 136.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.94 0.4 . . . . 0.0 110.531 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -119.33 134.02 55.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.067 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -92.18 105.27 17.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.173 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.42 ' O ' HD21 ' A' ' 93' ' ' LEU . 61.9 m-20 -88.45 122.09 31.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.183 0.516 . . . . 0.0 112.116 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.941 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.3 mt -80.58 119.46 76.34 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.229 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.68 131.76 39.4 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.316 2.011 . . . . 0.0 112.878 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 43.26 65.37 0.98 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -142.75 149.31 38.57 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.791 0.329 . . . . 0.0 110.625 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -142.75 116.95 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.948 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.07 78.82 5.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.2 p -107.37 -173.49 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.31 -34.87 71.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.923 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -59.76 -24.77 64.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.994 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.548 HD12 ' CG1' ' A' ' 80' ' ' VAL . 26.9 mm -78.61 129.08 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.448 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.72 -45.11 3.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 63.6 tt0 -135.36 118.24 16.23 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.786 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 t -110.08 115.08 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.922 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -112.82 132.87 55.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.297 0.57 . . . . 0.0 112.426 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.451 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 70.3 m95 -112.28 86.48 2.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.784 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -100.44 145.67 27.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.272 0.558 . . . . 0.0 112.386 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.8 ttp85 -136.98 118.43 14.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.403 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.95 -114.7 5.98 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.685 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.4 m -119.3 44.69 2.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.763 0.316 . . . . 0.0 110.663 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.8 m -154.78 159.98 40.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.309 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.525 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.7 mt -101.47 146.76 27.2 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.482 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 41.8 t -117.05 -41.25 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.992 0.425 . . . . 0.0 110.494 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -170.42 113.62 0.45 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.676 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.72 149.36 40.87 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.046 0.45 . . . . 0.0 110.422 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.434 ' HA ' ' HB3' ' A' ' 48' ' ' PRO . 55.2 t80 . . . . . 0 C--N 1.321 -0.663 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.932 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.434 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 93.4 Cg_endo . . . . . 0 N--CA 1.462 -0.373 0 CA-C-O 120.825 0.26 . . . . 0.0 112.691 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 61.0 t80 -130.62 106.77 8.71 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.156 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.4 mt -99.49 113.89 26.53 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.197 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.482 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 22.6 tttt -46.91 -44.83 20.09 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.71 0.291 . . . . 0.0 111.431 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 p -176.54 165.78 2.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.02 -12.09 3.59 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.159 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.71 0.94 13.58 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.746 0.773 . . . . 0.0 112.133 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -132.93 156.81 46.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.102 0.477 . . . . 0.0 111.195 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -151.23 118.43 5.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.348 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.642 HG23 ' O ' ' A' ' 57' ' ' ILE . 8.8 tt -75.04 99.31 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.064 0.459 . . . . 0.0 111.319 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.633 HD23 HD21 ' A' ' 60' ' ' ASN . 0.7 OUTLIER -49.59 167.02 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.245 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.74 -23.92 65.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.555 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.633 HD21 HD23 ' A' ' 58' ' ' LEU . 5.9 p30 -96.59 33.18 1.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.836 0.351 . . . . 0.0 111.183 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.54 34.33 69.07 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.713 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.51 166.4 10.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.876 0.369 . . . . 0.0 111.007 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 10.4 tp -107.24 120.72 42.91 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.515 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -107.38 110.64 22.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 110.875 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.801 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.8 mt -89.56 137.53 21.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.363 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -84.79 -47.11 10.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.974 0.416 . . . . 0.0 112.006 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.35 110.86 5.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.403 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 14' ' ' ILE . 6.7 mt -55.2 150.78 10.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.71 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.596 ' C ' HD11 ' A' ' 10' ' ' LEU . 5.4 p -152.14 158.6 43.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.924 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.66 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -50.53 -56.27 12.37 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.2 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -55.03 -22.41 15.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.129 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.643 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -80.16 -14.41 58.49 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.313 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.3 t -79.59 127.34 32.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.644 0.259 . . . . 0.0 110.581 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.56 -167.85 32.07 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.226 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.55 125.33 36.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.763 0.316 . . . . 0.0 111.487 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -103.32 130.7 50.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.29 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -113.29 126.07 54.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.857 0.36 . . . . 0.0 111.562 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.941 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -108.01 126.14 64.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.027 179.178 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.88 97.91 6.85 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.548 ' CG1' HD12 ' A' ' 27' ' ' ILE . 69.0 t -90.41 124.24 42.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.441 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.404 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 85.1 m-85 -112.93 151.22 30.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.169 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.633 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -90.75 173.8 7.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.551 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.5 p -61.23 -18.46 58.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.385 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -93.01 22.98 4.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.325 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.57 19.52 48.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.656 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.55 -178.73 3.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.703 0.287 . . . . 0.0 110.616 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -101.08 126.3 47.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.778 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.633 HD11 ' HB3' ' A' ' 82' ' ' SER . 33.7 mm -98.95 -54.44 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.417 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.744 HD21 ' CG ' ' A' ' 91' ' ' LYS . 5.3 tt -144.98 126.12 14.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.105 0.479 . . . . 0.0 111.98 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -118.01 107.41 14.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.1 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.744 ' CG ' HD21 ' A' ' 89' ' ' LEU . 8.2 mmpt? -120.17 162.79 18.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.85 120.56 12.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.091 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.639 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -115.11 156.47 25.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.87 0.367 . . . . 0.0 111.531 -179.139 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.02 121.45 43.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.244 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.955 ' HA ' HG12 ' A' ' 6' ' ' VAL . 9.7 tp -108.85 98.59 8.06 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.286 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -96.59 110.73 23.08 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.125 0.488 . . . . 0.0 110.322 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.749 HG21 ' HB3' ' A' ' 68' ' ' LEU . 4.6 mt -104.9 113.16 41.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.895 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 98' ' ' LEU . 8.8 mt . . . . . 0 N--CA 1.442 -0.863 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.549 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.899 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 120.639 0.257 . . . . 0.0 110.619 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -112.68 129.56 56.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.799 0.333 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -153.98 177.6 31.34 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.76 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.76 135.62 54.93 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.969 0.414 . . . . 0.0 110.848 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.801 HD11 ' C ' ' A' ' 69' ' ' THR . 1.7 tp -56.92 129.34 41.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.901 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.53 -4.69 76.68 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.502 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.559 ' NE2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.9 168.7 9.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.559 ' O ' ' NE2' ' A' ' 12' ' ' HIS . . . -77.74 160.67 49.02 Favored Glycine 0 C--O 1.224 -0.524 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.083 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.815 HG21 HD21 ' A' ' 68' ' ' LEU . 1.6 tp -176.14 138.06 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.834 0.349 . . . . 0.0 111.237 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -117.92 129.24 55.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.208 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -86.55 106.09 17.29 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.22 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.484 ' O ' HD21 ' A' ' 93' ' ' LEU . 67.5 m-20 -88.72 126.28 35.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.304 0.573 . . . . 0.0 112.008 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.913 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.3 mt -80.79 119.82 77.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.153 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.33 131.26 37.66 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.318 2.012 . . . . 0.0 112.862 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 m120 43.27 65.37 0.99 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.469 ' HB2' HD13 ' A' ' 89' ' ' LEU . 9.3 t80 -142.7 151.3 41.2 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 110.55 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -141.94 114.97 8.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.29 83.27 5.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.14 -174.07 2.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.86 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -56.08 -30.02 61.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.953 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -63.67 -27.87 69.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.999 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.643 HD12 ' CG1' ' A' ' 80' ' ' VAL . 35.1 mm -87.39 127.04 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.399 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -113.03 -42.16 3.6 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.069 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 43.2 tt0 -124.63 118.38 26.38 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.174 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 24.6 t -122.43 115.09 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.152 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -114.59 137.34 52.0 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.2 0.524 . . . . 0.0 112.261 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.446 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 71.9 m95 -112.19 85.58 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.86 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -97.28 142.39 29.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.287 0.565 . . . . 0.0 112.264 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.77 118.55 19.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.424 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.81 -114.22 5.45 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.687 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 m -119.68 44.94 2.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.732 0.301 . . . . 0.0 110.686 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.0 m -155.26 159.68 40.23 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.906 0.384 . . . . 0.0 111.357 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.535 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 4.5 mt -97.82 147.29 24.56 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.7 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 55.2 t -119.13 -43.09 2.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.341 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -172.45 114.39 0.3 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.725 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 1.1 pt-20 -125.05 156.61 37.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.078 0.466 . . . . 0.0 111.005 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 40.4 t80 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.845 -179.873 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.231 0.139 0 CA-C-O 120.847 0.27 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.535 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 46.5 t80 -111.61 103.54 11.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.177 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.3 mt -94.79 112.89 24.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.289 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 19.9 tttp -48.07 -46.63 33.82 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.695 0.283 . . . . 0.0 111.23 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -173.41 166.11 4.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 0.0 111.196 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.38 -11.47 3.63 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.376 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.53 -0.09 14.09 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 117.834 0.817 . . . . 0.0 112.236 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -132.84 157.8 44.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.076 0.465 . . . . 0.0 111.073 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -152.07 124.45 8.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.43 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.649 HG23 ' O ' ' A' ' 57' ' ' ILE . 4.7 tt -84.61 103.9 12.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 111.176 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.668 HD23 HD21 ' A' ' 60' ' ' ASN . 1.4 mp -62.73 172.63 1.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.005 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.36 -45.15 63.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.668 HD21 HD23 ' A' ' 58' ' ' LEU . 4.5 p30 -57.43 -22.45 43.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.113 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.01 35.0 4.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.634 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -115.33 155.38 27.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 110.979 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.2 tp -85.48 122.72 30.02 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.798 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -104.84 108.24 19.62 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.736 0.303 . . . . 0.0 111.073 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.794 HD12 ' CG2' ' A' ' 14' ' ' ILE . 4.0 mt -89.35 132.59 33.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.449 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -81.13 -46.06 15.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.953 0.406 . . . . 0.0 111.76 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -147.16 112.64 5.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.322 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.834 ' HB3' HG21 ' A' ' 97' ' ' ILE . 5.1 mt -54.16 149.62 9.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.166 0.508 . . . . 0.0 111.746 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.801 ' C ' HD11 ' A' ' 10' ' ' LEU . 5.2 p -151.32 158.26 43.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.153 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.612 ' N ' HD11 ' A' ' 10' ' ' LEU . 5.5 mmt180 -50.62 -56.82 10.07 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.173 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.37 -20.76 20.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.315 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.621 ' O ' HD23 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -93.17 17.03 11.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.289 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.48 146.99 36.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.684 0.278 . . . . 0.0 110.756 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.32 -117.71 1.76 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.291 -0.957 . . . . 0.0 112.901 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -138.04 130.3 29.0 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 117.717 0.759 . . . . 0.0 110.848 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -103.98 151.92 22.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.359 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.668 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 11.6 m-20 -132.57 124.15 27.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.192 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.913 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.46 127.3 66.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.223 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.58 97.18 6.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.715 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.643 ' CG1' HD12 ' A' ' 27' ' ' ILE . 73.2 t -88.22 131.78 34.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.269 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.551 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 96.0 m-85 -125.35 154.67 41.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.313 0.577 . . . . 0.0 111.198 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.534 ' CB ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -87.77 175.71 7.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.414 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 2.1 p -62.82 -22.1 66.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.118 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -96.21 24.87 5.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.114 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.92 27.35 56.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.645 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.45 157.14 16.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 0.0 110.866 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.46 111.0 12.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.611 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.534 HD11 ' CB ' ' A' ' 82' ' ' SER . 35.2 mm -93.22 -51.55 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.403 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.469 HD13 ' HB2' ' A' ' 21' ' ' PHE . 2.5 tt -151.02 149.78 29.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.212 0.53 . . . . 0.0 111.697 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.7 108.35 5.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.176 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.466 ' CG ' HD21 ' A' ' 89' ' ' LEU . 4.1 mmpt? -122.06 156.19 34.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.378 0.608 . . . . 0.0 112.516 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.668 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -139.42 123.65 18.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.174 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.655 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -122.51 163.05 20.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 0.0 111.437 -179.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.23 133.05 53.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.482 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.899 ' HA ' HG12 ' A' ' 6' ' ' VAL . 8.1 tp -113.36 97.9 6.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.635 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -95.37 108.13 20.31 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.105 0.478 . . . . 0.0 109.98 178.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.834 HG21 ' HB3' ' A' ' 68' ' ' LEU . 1.6 mt -106.65 110.51 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.001 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.9 mt . . . . . 0 N--CA 1.439 -1.001 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.289 179.074 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.872 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.519 0 CA-C-O 120.719 0.295 . . . . 0.0 110.775 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -118.16 127.16 53.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.59 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.69 177.7 27.68 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.826 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.4 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -123.56 135.55 54.06 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.889 0.376 . . . . 0.0 110.969 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.675 HD11 ' C ' ' A' ' 69' ' ' THR . 0.9 OUTLIER -53.17 134.59 38.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.053 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.55 -5.31 84.96 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.852 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.548 ' NE2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.34 168.68 9.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 117.126 0.463 . . . . 0.0 109.958 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.548 ' O ' ' NE2' ' A' ' 12' ' ' HIS . . . -78.57 162.09 48.85 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.287 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.879 HG21 HD21 ' A' ' 68' ' ' LEU . 1.9 tp -176.54 138.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.764 0.316 . . . . 0.0 111.008 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.667 ' OD2' HD22 ' A' ' 58' ' ' LEU . 8.0 t0 -124.09 128.23 48.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.254 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.428 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -81.93 125.09 30.33 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.157 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -104.09 124.23 48.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.275 0.559 . . . . 0.0 111.914 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.958 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.4 mt -82.1 119.94 76.18 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.417 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.97 131.15 37.88 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.37 2.047 . . . . 0.0 112.96 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.65 65.23 0.96 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -142.18 149.13 39.31 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.643 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -138.75 117.58 12.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.912 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.26 81.87 8.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.0 p -117.47 -173.01 2.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -57.13 -30.43 64.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.69 -24.52 64.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.012 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.557 HD12 ' CG1' ' A' ' 80' ' ' VAL . 37.1 mm -85.01 127.44 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.348 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -111.15 -43.86 3.67 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.172 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 34.6 tt0 -127.77 118.29 23.47 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.125 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 t -119.09 144.33 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.373 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -148.14 132.4 17.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.053 0.454 . . . . 0.0 112.076 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.46 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 54.5 m95 -108.07 89.41 2.99 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -98.36 146.57 25.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.395 0.617 . . . . 0.0 112.481 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.67 116.99 11.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.353 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.1 -114.81 6.14 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.641 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.1 m -119.06 44.66 2.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.807 0.337 . . . . 0.0 110.654 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.5 m -154.27 160.74 41.93 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.294 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.593 HD13 ' OE1' ' A' ' 41' ' ' GLU . 4.1 mt -102.58 148.22 25.82 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.525 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 43.2 t -119.49 -41.31 2.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.746 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -173.05 114.27 0.25 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.904 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.593 ' OE1' HD13 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -128.07 154.71 45.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.183 0.516 . . . . 0.0 110.754 179.311 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 73.4 t80 . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.833 -179.931 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo . . . . . 0 N--CA 1.461 -0.429 0 CA-C-O 120.488 0.12 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.52 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 83.5 t80 -127.92 111.16 13.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.811 0.338 . . . . 0.0 111.416 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 50' ' ' LEU . 9.2 mt -107.32 112.28 25.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.005 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 8.0 ttmt -46.71 -41.33 14.88 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.673 0.273 . . . . 0.0 111.464 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.2 p -177.03 164.38 2.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.946 0.403 . . . . 0.0 111.231 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.94 -11.95 4.91 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.106 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.86 1.05 13.59 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 117.688 0.744 . . . . 0.0 112.075 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -131.8 157.24 44.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.102 0.477 . . . . 0.0 111.161 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -151.41 119.69 6.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.216 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 57' ' ' ILE . 7.8 tt -76.79 99.52 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.216 0.531 . . . . 0.0 111.237 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.667 HD22 ' OD2' ' A' ' 15' ' ' ASP . 0.7 OUTLIER -53.1 163.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.275 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.58 -21.76 66.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.39 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.61 30.41 2.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.802 0.334 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.26 36.08 67.64 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.892 -0.671 . . . . 0.0 113.02 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -111.67 157.39 20.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 110.963 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.404 HD11 HG12 ' A' ' 39' ' ' VAL . 10.7 tp -93.19 121.25 34.35 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.716 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.584 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -106.77 107.49 18.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.876 0.37 . . . . 0.0 110.948 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.839 HD12 ' CG2' ' A' ' 14' ' ' ILE . 3.4 mt -87.48 136.47 23.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.437 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 tttm -86.04 -45.91 10.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.952 0.406 . . . . 0.0 111.713 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.47 110.96 5.6 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.319 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.879 HD21 HG21 ' A' ' 14' ' ' ILE . 5.5 mt -53.78 152.39 5.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.169 0.509 . . . . 0.0 111.855 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.675 ' C ' HD11 ' A' ' 10' ' ' LEU . 6.0 p -152.92 159.36 42.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.194 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.673 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -51.1 -56.94 10.15 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.078 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -55.28 -20.94 12.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.735 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -81.38 -14.8 56.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.425 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.407 ' HB3' HD12 ' A' ' 97' ' ' ILE . 5.6 p -81.99 137.88 35.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.58 0.229 . . . . 0.0 110.863 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.63 -124.62 2.04 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.835 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -136.92 133.43 35.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 117.9 0.85 . . . . 0.0 110.595 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.541 ' CE1' HD12 ' A' ' 95' ' ' LEU . 29.3 m-85 -108.69 135.55 49.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.44 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.726 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 17.2 m-20 -115.44 121.93 44.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.162 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.958 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -104.58 130.94 54.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.304 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.97 104.23 10.69 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.557 ' CG1' HD12 ' A' ' 27' ' ' ILE . 89.7 t -95.91 125.44 48.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.7 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.553 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 77.9 m-85 -119.31 147.54 44.19 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.28 0.562 . . . . 0.0 111.058 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.551 ' OG ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -88.85 178.75 6.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.491 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.427 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -64.06 -18.65 64.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.208 179.628 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -94.73 20.88 8.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.234 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.85 30.05 56.08 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.756 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.56 153.66 20.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.344 . . . . 0.0 110.901 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.21 106.04 6.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.707 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.551 HD11 ' OG ' ' A' ' 82' ' ' SER . 28.4 mm -78.23 -64.68 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.404 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.917 HD21 ' HG3' ' A' ' 91' ' ' LYS . 3.0 tt -145.1 133.26 21.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.155 0.502 . . . . 0.0 111.814 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.2 108.33 14.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.168 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.917 ' HG3' HD21 ' A' ' 89' ' ' LEU . 7.9 mmpt? -121.2 158.08 28.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.726 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.39 122.43 17.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.238 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -118.45 160.77 21.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.963 0.411 . . . . 0.0 111.421 -179.39 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -106.79 131.82 53.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.383 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.872 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -117.39 99.16 6.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.319 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -94.84 111.92 23.67 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.188 0.518 . . . . 0.0 110.524 179.238 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.782 HG21 ' HB3' ' A' ' 68' ' ' LEU . 4.0 mt -110.67 114.18 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.753 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mt . . . . . 0 N--CA 1.442 -0.861 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.652 179.308 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.763 0.316 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -100.03 78.94 2.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.85 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -83.03 -74.94 0.34 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.901 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.58 159.5 9.04 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.481 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -139.93 154.9 47.34 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.317 0.58 . . . . 0.0 111.028 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.942 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -148.04 149.32 15.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.432 -179.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -117.68 131.46 56.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.895 0.378 . . . . 0.0 110.92 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.96 -178.04 19.36 Favored Glycine 0 C--O 1.229 -0.163 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.562 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.429 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.23 134.09 48.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.995 0.426 . . . . 0.0 111.178 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.648 HD11 ' C ' ' A' ' 69' ' ' THR . 1.3 tp -56.62 130.88 47.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.837 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.89 -7.18 81.55 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.507 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.531 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.88 167.64 9.84 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.604 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.68 -172.69 12.23 Favored Glycine 0 C--O 1.226 -0.366 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.607 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.833 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.0 OUTLIER 163.29 136.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.432 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -120.83 122.13 39.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.545 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.773 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -79.07 103.47 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.788 179.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.44 ' O ' HD21 ' A' ' 93' ' ' LEU . 68.7 m-20 -87.74 122.25 31.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.226 0.536 . . . . 0.0 112.186 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.935 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -79.9 119.91 78.2 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.158 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.11 131.04 36.95 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.272 1.982 . . . . 0.0 112.829 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.4 m120 43.56 65.28 1.02 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -142.71 149.4 38.76 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.766 0.317 . . . . 0.0 110.576 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -142.88 104.49 4.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.905 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.78 75.2 0.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.83 -173.53 2.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -55.76 -31.07 62.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.017 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -64.12 -26.64 68.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.966 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.641 HD12 ' CG1' ' A' ' 80' ' ' VAL . 27.4 mm -86.04 127.06 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.437 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.408 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -112.32 -42.72 3.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.081 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.541 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 36.0 tt0 -126.46 117.28 22.58 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.433 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.9 t -116.88 107.62 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.149 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.4 ptp180 -105.44 134.76 48.02 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.233 0.539 . . . . 0.0 112.034 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.483 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 69.0 m95 -112.39 88.1 2.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.209 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -102.11 146.35 28.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.253 0.549 . . . . 0.0 112.295 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.5 116.22 12.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.527 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.14 -116.34 8.24 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.745 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 p -116.5 43.4 2.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.768 0.318 . . . . 0.0 110.642 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.2 m -152.86 159.76 43.04 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.271 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.54 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.6 mt -102.43 148.56 25.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.808 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.415 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 54.7 t -119.57 -43.53 2.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.256 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -167.2 113.23 0.76 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.547 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -120.61 113.54 20.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.226 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.517 ' HB2' HD13 ' A' ' 57' ' ' ILE . 13.3 t80 -102.83 123.61 46.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.742 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -119.74 133.7 55.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.289 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -47.83 -28.9 2.82 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.409 0.623 . . . . 0.0 111.423 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -82.44 39.4 0.6 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.862 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 41.91 -166.19 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.666 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm 55.04 63.62 6.63 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.698 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.06 -178.35 4.45 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.572 2.181 . . . . 0.0 112.021 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.54 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 70.1 t80 -125.71 101.93 7.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.688 0.28 . . . . 0.0 111.51 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.7 mt -98.08 110.99 23.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.268 -0.423 . . . . 0.0 109.879 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 51.7 tptt -43.83 -39.5 3.89 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.82 0.343 . . . . 0.0 111.365 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.05 165.97 0.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.943 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.84 -10.56 2.37 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.371 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.88 2.15 10.97 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 117.819 0.809 . . . . 0.0 112.343 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -134.05 156.93 47.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.153 0.502 . . . . 0.0 111.261 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -152.35 118.54 5.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.191 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 57' ' ' ILE . 6.6 tt -73.96 101.62 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.122 0.487 . . . . 0.0 111.388 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.556 HD23 HD21 ' A' ' 60' ' ' ASN . 0.7 OUTLIER -50.6 169.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.177 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.8 -25.06 65.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.581 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.556 HD21 HD23 ' A' ' 58' ' ' LEU . 5.8 p30 -97.06 33.25 1.96 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.753 0.311 . . . . 0.0 111.122 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.55 30.51 65.39 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.672 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.99 170.47 9.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 0.0 111.096 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 10.0 tp -110.08 119.24 38.65 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.469 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.453 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.5 OUTLIER -106.73 110.94 23.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.742 0.306 . . . . 0.0 110.746 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.833 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -89.42 138.53 19.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.468 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -84.26 -49.17 9.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.009 0.433 . . . . 0.0 111.875 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.26 110.65 5.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.494 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.035 HD22 HD12 ' A' ' 97' ' ' ILE . 5.1 mt -54.09 147.9 11.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.273 0.559 . . . . 0.0 111.779 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.648 ' C ' HD11 ' A' ' 10' ' ' LEU . 12.0 p -152.3 169.41 22.57 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.485 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.4 ' N ' HD11 ' A' ' 10' ' ' LEU . 7.0 mmm180 -51.33 -52.89 41.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.477 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -56.06 -21.65 23.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.597 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.12 -14.87 52.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.549 0.214 . . . . 0.0 111.498 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -82.82 117.84 22.99 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.678 0.275 . . . . 0.0 110.601 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.95 -166.26 33.43 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.604 -0.807 . . . . 0.0 112.17 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.44 126.39 39.68 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 122.507 0.323 . . . . 0.0 111.266 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -102.95 148.41 25.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.358 -0.383 . . . . 0.0 109.982 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -129.67 126.17 37.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 0.0 111.707 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.935 HG11 HD11 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -111.99 132.67 59.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.025 179.009 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.03 96.85 5.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.588 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.641 ' CG1' HD12 ' A' ' 27' ' ' ILE . 76.0 t -85.58 128.61 39.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.301 -178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.541 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.5 m-85 -119.25 153.02 35.66 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.068 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.658 ' OG ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -88.25 175.42 7.69 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.355 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.1 p -62.69 -28.4 69.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.994 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -77.62 -4.49 46.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.427 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 81.6 27.91 45.32 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.6 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.33 165.5 11.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.867 0.365 . . . . 0.0 110.764 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.53 127.08 31.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.592 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.658 HD11 ' OG ' ' A' ' 82' ' ' SER . 33.0 mm -104.12 -67.31 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.372 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.918 HD21 ' HG3' ' A' ' 91' ' ' LYS . 3.2 tt -137.37 127.17 25.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.132 0.492 . . . . 0.0 111.799 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -115.75 106.69 14.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.199 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.918 ' HG3' HD21 ' A' ' 89' ' ' LEU . 5.7 mmpt? -117.19 161.96 18.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.372 0.606 . . . . 0.0 112.526 -178.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.95 122.07 12.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.993 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -120.25 156.22 31.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.937 0.399 . . . . 0.0 111.679 -179.045 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.78 110.72 22.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.17 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.942 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -101.73 98.2 8.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.286 -179.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.44 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -92.78 121.83 34.56 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.135 0.493 . . . . 0.0 110.743 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.035 HD12 HD22 ' A' ' 68' ' ' LEU . 2.9 mm -107.24 116.38 50.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.991 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.3 mt -74.17 124.23 25.96 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.467 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.875 -179.781 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 9.0 mtt180 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.87 0.367 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.27 92.21 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.883 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -74.16 -69.0 0.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.947 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.9 160.69 24.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.524 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.4 m -144.79 148.95 34.66 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.249 0.547 . . . . 0.0 110.919 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.893 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -140.64 142.88 29.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.737 -179.499 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.487 ' CD2' ' HD3' ' A' ' 96' ' ' ARG . 79.1 m95 -110.85 129.65 55.8 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.689 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.41 -179.9 26.58 Favored Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.062 -1.066 . . . . 0.0 112.969 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.426 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.15 134.55 49.1 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.95 0.405 . . . . 0.0 110.962 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.733 HD11 ' C ' ' A' ' 69' ' ' THR . 1.4 tp -55.81 133.27 51.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.41 -5.72 84.4 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.47 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.523 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -110.61 168.71 9.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.594 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -72.3 -169.4 12.76 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.5 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.937 HG21 HD21 ' A' ' 68' ' ' LEU . 0.9 OUTLIER 160.36 136.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 122.647 0.379 . . . . 0.0 110.347 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.563 ' OD2' HD22 ' A' ' 58' ' ' LEU . 17.5 t70 -118.71 130.1 55.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.949 0.404 . . . . 0.0 111.299 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.422 HD12 ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -88.94 106.45 18.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.765 179.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -88.85 123.86 33.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.165 0.507 . . . . 0.0 111.867 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.93 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.4 mt -79.89 119.86 78.05 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.284 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.93 131.3 38.75 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.325 2.017 . . . . 0.0 112.856 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 43.04 65.42 0.96 Allowed 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -142.65 149.31 38.73 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.579 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -139.26 117.46 11.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.949 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -80.24 80.98 6.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.38 -174.23 2.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.843 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.23 -30.86 62.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.991 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -62.19 -27.86 69.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.962 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.639 HD12 ' CG1' ' A' ' 80' ' ' VAL . 35.1 mm -88.21 127.21 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.369 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -113.13 -42.27 3.57 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.053 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.543 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 45.9 tt0 -123.94 115.91 22.03 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.09 -0.644 . . . . 0.0 112.365 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 t -112.41 112.79 42.0 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.829 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -111.01 130.6 55.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.024 0.44 . . . . 0.0 112.149 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -112.03 84.06 1.9 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.934 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -100.73 153.77 19.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.338 0.59 . . . . 0.0 112.297 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.34 116.14 8.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.676 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.24 -117.76 11.43 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.207 -0.997 . . . . 0.0 111.88 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -115.07 42.61 2.16 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.818 0.342 . . . . 0.0 110.738 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.1 m -151.14 160.26 43.97 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.155 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.633 HD21 ' OE2' ' A' ' 41' ' ' GLU . 6.0 mt -104.97 146.08 29.53 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.448 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 52.8 t -117.1 -42.94 3.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.983 0.42 . . . . 0.0 110.227 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.76 111.86 0.89 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.519 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.633 ' OE2' HD21 ' A' ' 38' ' ' LEU . 2.4 mt-10 -120.77 117.02 26.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.203 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -104.29 147.29 27.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.648 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.82 136.03 22.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.818 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 45' ' ' LYS . 6.9 tpp180 -51.71 -88.98 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.243 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' N ' ' HG3' ' A' ' 44' ' ' ARG . 25.8 mmtm -82.59 48.65 1.34 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.007 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -162.73 146.68 11.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.971 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -67.64 137.61 93.13 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.56 176.32 9.7 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.574 2.183 . . . . 0.0 112.546 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.528 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 58.9 t80 -131.39 103.47 6.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.202 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.3 mt -97.6 111.87 23.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.081 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 33.6 tttm -45.2 -42.64 9.44 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.745 0.307 . . . . 0.0 111.527 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.8 p -176.63 165.79 2.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.888 0.375 . . . . 0.0 111.154 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.14 -11.34 4.62 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.158 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.17 2.19 11.47 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 117.707 0.753 . . . . 0.0 112.098 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -133.15 157.16 46.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.074 0.464 . . . . 0.0 111.184 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -153.92 120.18 5.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.331 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.641 HG23 ' O ' ' A' ' 57' ' ' ILE . 7.9 tt -74.93 99.94 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.098 0.475 . . . . 0.0 111.282 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.563 HD22 ' OD2' ' A' ' 15' ' ' ASP . 0.7 OUTLIER -51.68 163.39 0.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.209 -179.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.88 -22.0 65.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.458 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -96.53 31.91 2.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.761 0.315 . . . . 0.0 111.096 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.66 35.65 68.18 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.901 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -112.06 157.19 21.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.836 0.35 . . . . 0.0 111.033 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.4 tp -92.95 123.25 36.07 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.782 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.524 ' HB2' HD13 ' A' ' 58' ' ' LEU . 2.1 ttpt -108.24 108.57 19.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.693 0.283 . . . . 0.0 110.919 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.859 HD12 ' CG2' ' A' ' 14' ' ' ILE . 3.2 mt -88.1 137.47 21.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.404 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.8 tttt -87.82 -45.98 9.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.974 0.416 . . . . 0.0 111.829 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -142.53 109.21 5.4 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.481 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.937 HD21 HG21 ' A' ' 14' ' ' ILE . 5.7 mt -57.37 152.5 14.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.178 0.514 . . . . 0.0 111.564 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.733 ' C ' HD11 ' A' ' 10' ' ' LEU . 7.5 p -154.11 161.35 41.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.136 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.583 ' N ' HD11 ' A' ' 10' ' ' LEU . 26.2 mmm180 -50.62 -56.18 12.98 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.247 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -54.85 -22.19 13.79 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.465 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.697 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -81.39 -15.09 56.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.307 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.8 p -83.13 132.19 35.1 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.72 0.295 . . . . 0.0 110.733 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.45 -131.34 3.25 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.344 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -128.81 130.48 47.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.722 0.761 . . . . 0.0 110.627 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.484 ' CE1' HD12 ' A' ' 95' ' ' LEU . 25.7 m-85 -105.08 148.51 26.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.219 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.662 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 13.6 m-20 -130.73 122.35 27.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.767 0.318 . . . . 0.0 111.374 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.93 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -105.75 129.04 59.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.232 179.267 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.6 97.8 6.34 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.655 178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.639 ' CG1' HD12 ' A' ' 27' ' ' ILE . 87.2 t -89.36 129.92 39.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.335 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.543 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 96.9 m-85 -123.87 154.01 40.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.403 0.62 . . . . 0.0 111.188 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.533 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -87.79 175.31 7.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.352 179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 2.1 p -62.13 -21.69 65.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.115 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -96.27 25.6 4.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.161 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.95 27.72 51.51 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.69 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.15 156.84 16.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.319 . . . . 0.0 110.866 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -77.38 110.26 11.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.783 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.533 HD11 ' HB3' ' A' ' 82' ' ' SER . 33.3 mm -91.46 -48.33 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.293 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.483 HD21 ' CG ' ' A' ' 91' ' ' LYS . 2.6 tt -154.57 149.85 27.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.277 0.56 . . . . 0.0 111.709 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -141.11 108.58 5.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.289 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.483 ' CG ' HD21 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -121.59 157.33 30.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.416 0.627 . . . . 0.0 112.598 -178.254 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.662 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -140.0 124.59 18.16 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.126 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.644 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -122.34 164.82 17.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.036 0.446 . . . . 0.0 111.674 -179.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -111.94 124.21 51.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.239 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.893 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -108.84 113.61 26.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.419 -179.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.487 ' HD3' ' CD2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -113.21 117.13 31.02 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.193 0.52 . . . . 0.0 110.447 178.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.918 HG21 ' HB3' ' A' ' 68' ' ' LEU . 1.2 mt -108.61 110.28 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.924 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.5 mt -64.66 127.72 32.72 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.077 0.465 . . . . 0.0 110.219 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.907 -179.739 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.859 0.361 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 t70 60.38 79.96 0.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.92 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.42 -31.25 13.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.925 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.88 163.88 30.61 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.484 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -140.51 151.73 45.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.199 0.523 . . . . 0.0 110.908 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.939 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER -143.22 151.06 17.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.724 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -120.27 130.16 54.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.56 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.735 ' C ' HG23 ' A' ' 97' ' ' ILE . . . -148.9 -179.02 24.46 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.904 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.527 ' N ' HG23 ' A' ' 97' ' ' ILE . . . -132.09 134.85 45.95 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.071 0.462 . . . . 0.0 111.226 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.649 HD11 ' N ' ' A' ' 70' ' ' ARG . 0.7 OUTLIER -52.84 136.22 34.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.031 179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.2 -9.6 72.15 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.702 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.527 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.44 168.35 9.3 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.601 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -71.95 -170.94 14.65 Favored Glycine 0 C--O 1.227 -0.325 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.424 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.893 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 162.03 136.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-O 120.815 0.34 . . . . 0.0 110.43 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.411 ' OD2' HD22 ' A' ' 58' ' ' LEU . 65.7 t0 -123.72 130.43 52.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.402 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.426 HD11 ' HG ' ' A' ' 95' ' ' LEU . 0.0 OUTLIER -84.27 135.73 34.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.692 179.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.479 ' O ' HD21 ' A' ' 93' ' ' LEU . 73.5 m-20 -116.39 122.02 43.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.275 0.559 . . . . 0.0 111.813 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.925 HD11 HG11 ' A' ' 78' ' ' VAL . 3.2 mt -81.46 119.6 76.02 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.245 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.65 130.87 37.19 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.364 2.043 . . . . 0.0 112.999 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 30.0 m120 42.78 65.07 1.0 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -141.43 149.3 40.83 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 120.772 0.32 . . . . 0.0 110.559 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -137.91 117.43 12.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.939 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.564 ' SD ' HG21 ' A' ' 30' ' ' VAL . 1.7 tpt -79.57 75.39 6.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.972 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.7 p -107.44 -173.16 2.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -59.99 -32.34 70.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -59.24 -27.04 65.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.98 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.535 HD12 ' CG1' ' A' ' 80' ' ' VAL . 19.2 mm -78.81 128.1 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.492 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.483 ' OD1' HG22 ' A' ' 83' ' ' THR . 0.4 OUTLIER -111.3 -44.32 3.57 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.14 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 73.3 tt0 -130.31 116.32 18.18 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.172 -0.611 . . . . 0.0 112.537 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.564 HG21 ' SD ' ' A' ' 23' ' ' MET . 2.8 t -112.42 111.24 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.743 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -108.18 130.31 55.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.178 0.513 . . . . 0.0 112.239 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -112.68 84.65 2.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.9 178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.35 154.16 19.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.316 0.579 . . . . 0.0 112.247 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.424 ' HD3' ' CZ ' ' A' ' 76' ' ' TYR . 10.3 ttp-105 -143.96 118.32 9.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.602 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.01 -117.64 10.9 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.829 -179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.1 m -115.99 43.02 2.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.743 0.306 . . . . 0.0 110.739 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.7 m -151.14 160.06 44.09 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.171 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.537 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 6.0 mt -103.73 145.66 29.76 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.402 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 55.7 t -117.5 -43.42 3.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.153 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -166.06 111.31 0.84 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.752 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -117.66 112.42 20.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.042 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.42 ' CG ' ' N ' ' A' ' 43' ' ' LYS . 21.1 t80 -101.4 158.84 15.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.85 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.42 ' N ' ' CG ' ' A' ' 42' ' ' PHE . 2.1 mppt? -149.71 172.83 14.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.819 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.405 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -93.96 103.05 15.15 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.759 0.79 . . . . 0.0 109.797 179.306 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 44' ' ' ARG . 0.5 OUTLIER 82.48 -47.32 0.17 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.695 -179.435 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.8 ttt -54.01 167.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.863 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.19 128.72 61.17 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.048 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.407 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 97.9 Cg_endo -81.52 -174.44 2.18 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.605 2.203 . . . . 0.0 112.607 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.537 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 71.1 t80 -137.49 105.46 5.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.352 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.1 mt -99.73 112.26 24.52 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.402 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 78.0 tttt -44.53 -45.87 9.55 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.725 0.298 . . . . 0.0 111.368 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.87 166.69 2.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.94 0.4 . . . . 0.0 111.112 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.77 -11.61 2.13 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.401 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.49 2.01 10.58 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 117.79 0.795 . . . . 0.0 112.296 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -135.46 157.16 47.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.084 0.468 . . . . 0.0 111.284 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -153.32 122.06 6.4 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.249 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 57' ' ' ILE . 6.4 tt -76.0 101.52 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.152 0.501 . . . . 0.0 111.213 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.666 HD13 ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -54.35 160.35 1.7 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.138 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.19 -21.97 66.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.404 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -96.13 32.81 1.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.052 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.71 34.37 56.25 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.778 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.26 155.3 22.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.866 0.365 . . . . 0.0 111.028 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 tp -92.95 122.71 35.59 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.821 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.666 ' HB2' HD13 ' A' ' 58' ' ' LEU . 4.4 tmtt? -108.04 110.06 21.66 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.71 0.29 . . . . 0.0 110.863 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.84 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.8 mt -89.18 138.79 18.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.408 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -86.69 -47.67 8.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.008 0.432 . . . . 0.0 111.91 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -142.73 110.73 5.96 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.335 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 14' ' ' ILE . 7.2 mt -55.65 150.77 11.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.308 0.575 . . . . 0.0 111.795 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.648 ' C ' HD11 ' A' ' 10' ' ' LEU . 6.8 p -153.36 161.42 42.35 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.813 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.649 ' N ' HD11 ' A' ' 10' ' ' LEU . 1.5 ptp180 -50.91 -54.84 20.64 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.429 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -57.43 -20.64 31.53 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.459 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.693 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -82.76 -15.53 51.4 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.389 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.8 t -82.78 130.69 35.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.582 0.23 . . . . 0.0 110.446 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.51 -166.25 29.63 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.172 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.7 126.4 36.77 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 122.522 0.329 . . . . 0.0 111.538 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.424 ' CZ ' ' HD3' ' A' ' 34' ' ' ARG . 18.9 m-85 -102.93 151.83 22.01 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -131.52 125.77 33.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.754 0.312 . . . . 0.0 111.492 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.925 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -110.1 130.8 62.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.211 179.155 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.419 HG23 ' OD1' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -118.02 98.46 6.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.512 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.535 ' CG1' HD12 ' A' ' 27' ' ' ILE . 93.5 t -91.46 125.73 44.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.748 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.459 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.5 m-85 -118.39 152.79 35.18 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.91 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.658 ' HA ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -90.67 172.32 8.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.567 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.483 HG22 ' OD1' ' A' ' 28' ' ' ASP . 16.9 p -60.04 -19.46 52.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.377 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -93.97 25.27 3.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.233 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 57.59 20.95 40.63 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.787 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.62 166.08 11.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.703 0.287 . . . . 0.0 110.696 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -90.89 120.19 31.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.731 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.658 HD11 ' HA ' ' A' ' 82' ' ' SER . 38.3 mt -90.71 -58.87 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.498 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.811 HD11 ' HE2' ' A' ' 91' ' ' LYS . 2.7 tt -147.83 133.68 19.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.117 0.484 . . . . 0.0 111.879 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.419 ' OD1' HG23 ' A' ' 79' ' ' THR . 0.1 OUTLIER -121.23 109.61 15.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.492 -0.776 . . . . 0.0 108.923 178.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.811 ' HE2' HD11 ' A' ' 89' ' ' LEU . 31.5 mmtm -121.5 162.66 20.13 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.01 121.95 14.52 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.047 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.642 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -113.76 164.71 13.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.03 0.443 . . . . 0.0 111.737 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -114.73 111.82 21.86 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.271 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.939 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -99.22 99.38 10.34 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.245 -179.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -100.73 120.47 40.14 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.004 0.431 . . . . 0.0 110.455 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.759 HG12 HD22 ' A' ' 68' ' ' LEU . 1.7 mt -128.42 129.13 68.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.794 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.7 mt -82.65 169.55 16.12 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.739 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.879 179.885 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.833 0.349 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 68.33 -68.57 0.17 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.014 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.5 m -65.56 144.75 56.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.821 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.3 -150.71 35.6 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.475 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 2.7 m -50.63 147.34 4.76 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.378 0.609 . . . . 0.0 111.33 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.812 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER -141.03 147.32 22.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.717 -179.535 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -115.89 127.91 55.38 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.525 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -145.75 -178.8 21.52 Favored Glycine 0 N--CA 1.459 0.171 0 C-N-CA 120.322 -0.942 . . . . 0.0 112.705 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.429 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.96 134.68 48.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.069 0.461 . . . . 0.0 111.287 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.712 HD11 ' C ' ' A' ' 69' ' ' THR . 1.0 OUTLIER -55.62 134.82 51.31 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.741 179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.66 -8.58 77.02 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.456 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.53 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -106.95 167.16 10.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.614 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.41 -173.85 14.06 Favored Glycine 0 C--O 1.226 -0.385 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.551 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.814 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 161.24 136.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 122.579 0.352 . . . . 0.0 110.367 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.546 ' OD2' HD22 ' A' ' 58' ' ' LEU . 7.4 t0 -124.85 123.78 40.67 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.955 0.407 . . . . 0.0 111.525 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.726 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -79.07 112.19 16.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.744 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -93.76 124.89 38.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.191 0.52 . . . . 0.0 111.884 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.937 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -81.64 120.04 76.94 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.252 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.01 131.12 37.63 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.278 1.985 . . . . 0.0 112.901 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 32.9 m120 43.12 65.16 1.01 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -142.14 149.37 39.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.758 0.313 . . . . 0.0 110.607 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -138.83 117.41 12.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.407 ' SD ' HG21 ' A' ' 30' ' ' VAL . 4.1 tpt -81.17 76.22 8.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 46.8 p -111.43 -173.03 2.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -57.8 -30.52 65.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.966 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -62.1 -28.12 69.4 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.924 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.641 HD12 ' CG1' ' A' ' 80' ' ' VAL . 33.6 mm -87.74 126.8 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.383 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.73 -41.92 3.71 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 61.3 tt0 -125.84 118.32 25.24 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.28 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 30.9 t -121.32 117.69 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.019 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.449 ' NH1' ' CE2' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -115.81 136.94 52.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.266 0.555 . . . . 0.0 112.223 -178.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.478 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 74.8 m95 -112.12 87.38 2.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.702 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -101.05 149.91 23.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.355 0.598 . . . . 0.0 112.283 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.7 ttp85 -142.13 117.59 10.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.462 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.81 -115.65 7.13 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.17 -1.014 . . . . 0.0 111.737 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 t -118.59 44.35 2.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.786 0.327 . . . . 0.0 110.683 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.3 m -151.94 160.39 43.51 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.328 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.607 HD22 ' OE1' ' A' ' 41' ' ' GLU . 5.5 mt -103.25 146.89 27.76 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.479 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 56.1 t -119.01 -43.52 2.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 120.959 0.409 . . . . 0.0 110.476 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -174.73 114.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.045 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.607 ' OE1' HD22 ' A' ' 38' ' ' LEU . 1.1 pt-20 -128.35 156.04 43.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.009 0.433 . . . . 0.0 110.947 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -124.39 144.11 50.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.871 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.3 mtmm -145.72 111.25 5.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.649 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.3 tpp85 -47.98 -59.32 3.45 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.734 0.778 . . . . 0.0 111.148 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -82.56 46.72 1.09 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.941 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.7 mtt 177.59 -171.86 0.1 Allowed 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.928 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -109.09 146.76 34.54 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.821 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.3 155.78 51.1 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.576 2.184 . . . . 0.0 112.585 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.521 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 33.8 t80 -115.86 101.85 9.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.34 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 50' ' ' LEU . 11.2 mt -91.29 116.22 28.66 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.479 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 12.1 tptm -38.88 -90.33 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.729 0.641 . . . . 0.0 112.729 -178.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 m -117.41 22.68 12.28 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.76 -0.03 52.77 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.491 -0.861 . . . . 0.0 113.089 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.32 5.33 27.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 117.53 0.665 . . . . 0.0 111.02 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -126.24 158.22 36.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.024 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -138.71 119.55 14.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.147 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.649 HG23 ' O ' ' A' ' 57' ' ' ILE . 7.4 tt -78.13 99.67 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.182 0.515 . . . . 0.0 111.064 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.546 HD22 ' OD2' ' A' ' 15' ' ' ASP . 0.5 OUTLIER -55.47 153.14 7.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.279 -179.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.32 -19.79 56.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.475 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -96.24 31.94 2.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.861 0.363 . . . . 0.0 111.043 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.37 36.35 57.64 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.847 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -112.97 157.88 20.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 0.0 111.023 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 12.0 tp -95.2 122.49 37.93 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.125 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.507 ' HB2' HD13 ' A' ' 58' ' ' LEU . 1.0 OUTLIER -110.26 104.71 13.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.715 0.293 . . . . 0.0 110.696 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.806 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -81.02 134.59 26.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.774 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -78.28 -49.06 14.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.09 0.471 . . . . 0.0 111.513 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.53 112.99 5.62 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.134 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.814 HD21 HG21 ' A' ' 14' ' ' ILE . 5.8 mt -52.73 148.37 7.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.261 0.553 . . . . 0.0 111.873 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.712 ' C ' HD11 ' A' ' 10' ' ' LEU . 7.1 p -152.13 163.1 40.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.78 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.579 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -50.81 -55.22 17.91 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.291 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -52.66 -22.95 5.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.614 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -82.99 -13.87 55.13 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.571 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.7 t -83.45 119.96 25.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.672 0.272 . . . . 0.0 110.582 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.46 -139.06 5.85 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.467 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.4 m -120.32 130.86 54.63 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 117.382 0.591 . . . . 0.0 110.648 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -106.43 151.27 25.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.386 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.652 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 4.0 m-20 -134.47 121.81 21.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.332 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.937 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -106.8 133.46 51.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.24 179.247 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.28 103.6 9.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.549 178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.641 ' CG1' HD12 ' A' ' 27' ' ' ILE . 91.1 t -93.81 129.28 44.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.689 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.564 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.8 m-85 -121.44 153.64 37.61 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.998 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.714 ' OG ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -87.99 176.45 7.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.336 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.0 p -64.63 -28.67 69.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.979 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -77.3 -4.53 45.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.421 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 82.62 27.33 43.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.536 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.6 165.68 11.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 110.783 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.98 134.13 38.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.568 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.714 HD11 ' OG ' ' A' ' 82' ' ' SER . 37.8 mm -111.52 -66.64 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.397 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.914 HD21 ' HG3' ' A' ' 91' ' ' LYS . 3.5 tt -141.09 128.76 21.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.1 0.476 . . . . 0.0 111.845 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.47 107.22 14.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.177 178.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.914 ' HG3' HD21 ' A' ' 89' ' ' LEU . 16.0 mmtt -118.1 158.57 24.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.389 0.614 . . . . 0.0 112.536 -178.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.652 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -140.63 125.79 18.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.152 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.646 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -125.32 161.53 26.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.047 0.451 . . . . 0.0 111.65 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 5' ' ' THR . 1.6 m-20 -110.32 116.85 32.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.228 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.812 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -104.8 103.76 13.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.308 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.46 115.26 28.88 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.051 0.453 . . . . 0.0 110.692 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.736 HG12 HD22 ' A' ' 68' ' ' LEU . 3.1 mt -106.4 111.79 36.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.557 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 11.8 mt -78.25 170.24 16.94 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.246 0.546 . . . . 0.0 110.734 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.9 179.965 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 20.4 tpt85 . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.813 0.34 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.42 -62.26 1.51 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 m -132.13 163.61 28.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.915 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.94 163.23 54.19 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.442 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.8 m -138.92 154.78 48.38 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.261 0.553 . . . . 0.0 110.975 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.943 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -147.34 150.03 15.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.642 -179.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -118.84 131.15 56.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.926 0.393 . . . . 0.0 110.883 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.29 -178.53 19.19 Favored Glycine 0 N--CA 1.459 0.21 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.508 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.444 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -126.48 133.25 51.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.048 0.452 . . . . 0.0 111.313 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.421 ' CD1' ' HA ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -55.6 131.06 45.39 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.874 179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.51 -6.42 83.22 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.452 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.524 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.05 167.66 9.84 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.596 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.4 -172.93 11.85 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.597 -179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.836 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.0 OUTLIER 163.31 136.02 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.773 0.32 . . . . 0.0 110.354 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.467 ' OD2' HD22 ' A' ' 58' ' ' LEU . 2.1 t70 -121.75 122.47 39.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.936 0.398 . . . . 0.0 111.476 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.741 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -77.96 108.82 11.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.773 179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -93.3 123.11 36.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.176 0.513 . . . . 0.0 111.967 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.978 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -79.37 119.47 77.12 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.262 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.54 131.21 36.94 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.393 2.062 . . . . 0.0 112.976 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 43.27 64.74 1.13 Allowed 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -140.21 149.07 42.46 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.834 0.35 . . . . 0.0 110.497 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -132.9 116.72 16.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.1 90.01 7.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.915 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.8 p -125.84 -173.04 2.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.937 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.27 -30.53 64.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.941 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.712 ' O ' HG23 ' A' ' 83' ' ' THR . 2.0 t70 -62.07 -25.59 67.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.992 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.484 HD12 ' CG1' ' A' ' 80' ' ' VAL . 33.8 mm -79.34 128.47 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.509 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.2 -38.82 7.52 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.234 -0.291 . . . . 0.0 111.325 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 12.7 mt-10 -142.6 153.75 43.78 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-O 121.581 0.705 . . . . 0.0 112.355 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.8 t -148.26 116.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.162 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -112.24 134.1 53.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.071 0.462 . . . . 0.0 112.05 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.46 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 73.3 m95 -112.33 85.07 2.08 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -102.47 148.17 25.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.3 0.571 . . . . 0.0 112.22 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.04 118.75 13.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.557 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.91 -116.37 8.17 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.773 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.9 m -117.66 43.88 2.28 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.769 0.319 . . . . 0.0 110.71 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 94.7 m -152.88 160.0 43.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.265 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.536 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.8 mt -102.79 147.19 27.17 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.798 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 50.0 t -118.47 -42.92 2.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.285 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -167.47 112.17 0.7 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.597 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -118.51 119.32 34.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.969 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.708 ' HB2' HD13 ' A' ' 57' ' ' ILE . 49.1 t80 -105.92 157.66 17.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.705 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -152.99 151.42 30.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -59.83 90.27 0.02 OUTLIER 'General case' 0 CA--C 1.512 -0.511 0 CA-C-O 121.968 0.89 . . . . 0.0 110.63 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 80.85 -45.56 0.24 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.838 -1.528 . . . . 0.0 111.258 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -45.06 142.77 1.76 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.823 0.344 . . . . 0.0 111.293 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.2 122.34 53.41 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.074 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.67 -172.78 1.61 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.597 2.198 . . . . 0.0 112.567 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.536 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 68.7 t80 -136.82 104.24 5.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.284 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.48 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.1 mt -98.01 110.78 23.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.02 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.462 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 28.8 tttm -45.29 -40.58 7.8 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.77 0.319 . . . . 0.0 111.533 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 p -178.21 164.61 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.868 0.366 . . . . 0.0 111.205 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.75 -11.73 4.42 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.166 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.83 1.6 12.21 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 117.593 0.697 . . . . 0.0 112.155 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -131.99 156.97 45.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.184 0.516 . . . . 0.0 111.262 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -151.82 117.24 5.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.196 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.708 HD13 ' HB2' ' A' ' 42' ' ' PHE . 9.2 tt -73.83 99.48 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.321 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.623 HD23 HD21 ' A' ' 60' ' ' ASN . 0.7 OUTLIER -51.12 166.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.163 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.9 -23.96 65.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.637 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.623 HD21 HD23 ' A' ' 58' ' ' LEU . 6.1 p30 -96.76 33.33 1.88 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.796 0.331 . . . . 0.0 111.16 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.75 33.9 69.12 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.621 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.08 165.79 10.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.868 0.366 . . . . 0.0 111.012 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 10.3 tp -107.0 119.71 40.1 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.518 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HB2' HD13 ' A' ' 58' ' ' LEU . 1.5 ttpt -105.75 111.25 23.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.309 . . . . 0.0 110.996 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.836 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.7 mt -90.93 138.22 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.449 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -84.16 -48.19 10.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.066 0.46 . . . . 0.0 111.896 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -144.11 111.35 5.88 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.312 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.045 HD22 HD12 ' A' ' 97' ' ' ILE . 4.9 mt -53.61 147.22 11.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.22 0.533 . . . . 0.0 111.736 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.421 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 5.3 p -147.59 160.88 42.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.852 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.74 -56.43 12.04 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.093 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -53.6 -22.7 9.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.428 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.688 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -80.54 -15.24 57.16 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.627 0.251 . . . . 0.0 111.308 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.415 ' CB ' HG12 ' A' ' 97' ' ' ILE . 2.4 t -81.58 120.79 25.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.591 0.234 . . . . 0.0 110.578 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.98 -144.43 9.88 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.373 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.9 m -115.65 130.62 56.93 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.056 0.428 . . . . 0.0 110.663 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -108.26 133.23 52.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.24 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.724 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 17.4 m-20 -114.98 124.37 51.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.458 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.978 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -107.02 133.52 51.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.192 179.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.36 96.37 5.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.695 178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.492 HG12 ' HB ' ' A' ' 88' ' ' ILE . 70.9 t -86.74 126.9 40.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.234 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.517 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 2.6 m-30 -112.8 151.33 30.48 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.346 0.593 . . . . 0.0 110.612 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.73 ' HA ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -93.42 178.99 5.53 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.199 179.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 26' ' ' ASP . 73.5 p -68.51 -23.51 64.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.044 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -75.91 -5.22 45.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.592 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.29 24.57 47.08 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.666 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.64 -170.59 1.7 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.757 0.313 . . . . 0.0 110.683 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -105.31 115.62 30.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.971 0.415 . . . . 0.0 110.811 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.73 HD11 ' HA ' ' A' ' 82' ' ' SER . 74.4 mt -78.89 -51.66 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.343 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.688 HD21 ' HG3' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -151.83 136.25 16.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.204 0.526 . . . . 0.0 111.9 -179.246 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -118.4 106.98 13.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.386 -0.824 . . . . 0.0 108.884 178.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.688 ' HG3' HD21 ' A' ' 89' ' ' LEU . 7.4 mmpt? -116.48 156.97 25.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.724 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.14 122.45 18.23 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.132 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -117.98 159.41 23.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.896 0.379 . . . . 0.0 111.538 -179.239 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -109.16 110.76 22.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.381 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.943 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -102.27 100.2 10.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.071 -179.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.527 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.5 OUTLIER -95.16 123.43 38.66 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.071 0.462 . . . . 0.0 110.89 179.582 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.045 HD12 HD22 ' A' ' 68' ' ' LEU . 2.9 mm -107.81 117.47 53.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.999 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.5 mt -74.98 123.38 25.03 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.422 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.946 -179.868 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.873 0.368 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -108.07 154.3 21.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.934 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 m 60.48 108.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.9 160.92 15.15 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.518 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.417 ' HA ' ' HB2' ' A' ' 94' ' ' ASP . 4.9 m -137.46 154.17 49.96 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.249 0.547 . . . . 0.0 110.969 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.975 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -146.62 153.33 12.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.855 -179.204 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -121.89 136.39 54.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.033 0.444 . . . . 0.0 111.255 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.485 ' C ' HG23 ' A' ' 97' ' ' ILE . . . -151.45 178.68 28.65 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.303 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.442 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -128.03 133.8 49.15 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.049 0.452 . . . . 0.0 111.221 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.644 HD11 ' C ' ' A' ' 69' ' ' THR . 1.2 tp -53.51 134.88 40.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.901 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.65 -10.94 71.81 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.632 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.524 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -106.66 168.0 9.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.598 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -72.02 -169.61 12.37 Favored Glycine 0 C--O 1.227 -0.315 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.491 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.834 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.0 OUTLIER 163.79 136.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 120.963 0.411 . . . . 0.0 110.632 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -117.97 130.1 56.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.043 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -91.5 102.99 15.66 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -88.68 123.5 33.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.174 0.511 . . . . 0.0 112.3 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.947 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -79.2 119.96 78.95 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.022 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.03 131.04 37.15 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.262 1.975 . . . . 0.0 112.903 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 43.38 65.09 1.04 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -142.03 150.9 41.91 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.79 0.328 . . . . 0.0 110.595 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -139.44 117.75 12.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -82.78 78.37 9.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.862 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.7 p -112.51 -173.02 2.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.885 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -57.9 -30.66 66.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.967 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -61.49 -27.74 68.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.971 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.611 HD12 ' CG1' ' A' ' 80' ' ' VAL . 31.4 mm -84.38 127.62 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.447 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.5 OUTLIER -111.63 -44.08 3.55 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.247 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 45.8 tp10 -123.69 121.27 35.07 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.187 -0.605 . . . . 0.0 112.117 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.82 114.25 42.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.904 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -112.85 132.38 55.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.133 0.492 . . . . 0.0 112.289 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.413 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 71.7 m95 -113.3 87.77 2.68 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -101.7 148.13 25.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.313 0.578 . . . . 0.0 112.478 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -139.26 116.46 11.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.522 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.07 -116.52 8.46 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.729 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.5 t -117.39 43.87 2.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.866 0.365 . . . . 0.0 110.651 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.0 m -152.27 160.38 43.36 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.224 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.533 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.8 mt -101.7 146.5 27.65 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.464 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 52.9 t -118.52 -43.02 2.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.97 0.414 . . . . 0.0 110.199 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -166.6 110.17 0.75 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.579 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.44 121.76 40.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.79 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -103.36 146.63 28.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.041 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -153.06 117.9 5.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.69 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.4 ttm-85 -55.68 -56.7 17.35 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-O 121.845 0.831 . . . . 0.0 111.298 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -82.19 46.35 1.02 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.191 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 176.19 -172.4 0.08 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.894 0.378 . . . . 0.0 111.015 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.6 mttm -104.64 142.36 24.48 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.657 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.1 155.18 47.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.462 2.108 . . . . 0.0 112.709 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 48.9 t80 -113.21 100.73 8.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.131 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 50' ' ' LEU . 9.7 mt -94.08 111.15 22.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.069 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 36.3 tttt -45.99 -36.73 5.84 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.702 0.287 . . . . 0.0 111.452 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.0 p -178.74 164.29 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 111.222 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.74 -10.2 6.08 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.142 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.63 2.72 11.16 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.651 0.726 . . . . 0.0 112.188 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -132.08 156.89 45.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.107 0.48 . . . . 0.0 111.239 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -151.5 116.33 5.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.367 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.646 HG23 ' O ' ' A' ' 57' ' ' ILE . 9.7 tt -73.98 99.22 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.105 0.479 . . . . 0.0 111.295 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.656 HD23 HD21 ' A' ' 60' ' ' ASN . 0.7 OUTLIER -49.19 165.75 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.154 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.46 -23.67 65.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.566 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.656 HD21 HD23 ' A' ' 58' ' ' LEU . 6.3 p30 -96.21 33.11 1.8 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.188 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.02 34.71 73.41 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.604 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -104.31 171.16 7.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.899 0.38 . . . . 0.0 110.874 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 11.6 tp -112.81 122.35 47.39 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.499 ' HB2' HD13 ' A' ' 58' ' ' LEU . 16.1 tttt -109.04 108.88 19.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.683 0.278 . . . . 0.0 110.947 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.834 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -87.2 141.0 14.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.413 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -85.76 -50.86 6.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.025 0.441 . . . . 0.0 112.1 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -141.65 110.84 6.31 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.5 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.69 HD21 HG21 ' A' ' 14' ' ' ILE . 5.4 mt -53.83 147.58 11.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.643 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.644 ' C ' HD11 ' A' ' 10' ' ' LEU . 6.1 p -152.7 161.3 42.74 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.786 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.528 ' N ' HD11 ' A' ' 10' ' ' LEU . 13.3 mmm-85 -50.48 -56.12 12.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.331 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -57.6 -20.28 31.53 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.629 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.596 ' OD1' HD13 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -84.31 -15.75 45.47 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.533 0.206 . . . . 0.0 111.425 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 t -82.7 133.36 35.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.603 0.24 . . . . 0.0 110.483 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.07 -166.97 30.02 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.134 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.06 126.63 35.52 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.896 0.379 . . . . 0.0 111.435 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -106.84 128.2 54.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.33 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -112.07 129.16 56.31 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.853 0.359 . . . . 0.0 111.657 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.947 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -112.08 130.59 65.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.98 179.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.65 98.9 6.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.8 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.611 ' CG1' HD12 ' A' ' 27' ' ' ILE . 82.0 t -92.02 128.71 43.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.462 -178.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.532 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 98.3 m-85 -124.02 153.45 41.3 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.291 0.567 . . . . 0.0 111.108 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.631 ' CA ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -88.93 174.81 7.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.408 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.1 p -61.07 -22.34 64.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.169 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.83 26.46 4.06 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.168 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 54.74 25.77 37.53 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.691 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.24 155.59 16.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.778 0.323 . . . . 0.0 110.889 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.53 116.35 18.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.649 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.631 HD11 ' CA ' ' A' ' 82' ' ' SER . 36.2 mt -93.95 -69.3 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.339 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.906 HD21 ' HG3' ' A' ' 91' ' ' LYS . 2.6 tt -142.34 126.78 17.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.152 0.501 . . . . 0.0 111.903 -179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -115.3 106.95 14.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.906 ' HG3' HD21 ' A' ' 89' ' ' LEU . 5.7 mmpt? -118.15 162.49 18.13 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.464 0.65 . . . . 0.0 112.702 -178.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.6 119.96 10.93 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.067 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -114.45 157.83 22.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.836 0.351 . . . . 0.0 111.407 -179.235 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.417 ' HB2' ' HA ' ' A' ' 5' ' ' THR . 1.0 OUTLIER -107.09 115.23 29.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.361 179.449 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.975 ' HA ' HG12 ' A' ' 6' ' ' VAL . 38.3 tp -101.11 98.14 8.6 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.958 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.802 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -101.1 123.37 45.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.031 0.443 . . . . 0.0 110.599 179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.823 HD11 ' HG ' ' A' ' 95' ' ' LEU . 1.9 mm -122.61 126.65 74.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.065 -178.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 98' ' ' LEU . 12.7 mt -82.99 168.92 16.53 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.564 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.882 179.916 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.905 0.383 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.27 28.55 2.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.048 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.03 158.07 14.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.705 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.56 -150.89 6.08 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.928 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 m -119.43 150.02 40.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.225 0.536 . . . . 0.0 110.964 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.93 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -128.62 147.33 33.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.094 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.2 m95 -119.98 130.45 54.76 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.562 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.43 -178.07 18.92 Favored Glycine 0 N--CA 1.459 0.196 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.502 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.426 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -130.12 133.99 47.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.07 0.462 . . . . 0.0 111.551 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.431 ' CD1' ' HA ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -54.0 131.84 41.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.798 179.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.36 -10.65 74.3 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.58 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.517 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -107.07 168.97 8.84 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.6 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -73.52 -168.94 16.14 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.576 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.913 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 161.7 137.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 C-N-CA 122.675 0.39 . . . . 0.0 110.062 179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -120.8 124.33 44.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.935 0.397 . . . . 0.0 111.812 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.718 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -82.02 105.98 13.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.482 178.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.408 ' O ' HD21 ' A' ' 93' ' ' LEU . 69.8 m-20 -90.83 123.07 34.09 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.287 0.565 . . . . 0.0 112.304 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.949 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -80.38 120.35 79.13 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.176 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.27 130.71 37.27 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.32 2.013 . . . . 0.0 112.938 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 42.8 65.05 1.0 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -141.96 149.04 39.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.787 0.327 . . . . 0.0 110.501 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -141.7 117.15 10.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.941 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.38 80.44 3.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.902 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -110.01 -175.65 2.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.18 -33.09 68.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.912 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.79 -26.8 66.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.586 HD12 ' CG1' ' A' ' 80' ' ' VAL . 22.6 mm -79.41 128.32 38.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.405 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.433 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 0.9 OUTLIER -111.36 -44.44 3.54 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -179.089 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 42.6 tt0 -130.43 116.88 18.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 120.181 -0.608 . . . . 0.0 112.572 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -112.48 113.0 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.794 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -111.56 132.48 54.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.12 0.485 . . . . 0.0 112.206 -178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.431 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 70.3 m95 -113.31 86.53 2.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.488 -0.778 . . . . 0.0 108.954 178.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -102.62 148.1 25.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.316 0.579 . . . . 0.0 112.295 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.52 117.59 11.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.51 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.96 -116.62 8.53 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.206 -0.997 . . . . 0.0 111.768 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.1 t -117.28 43.76 2.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.76 0.315 . . . . 0.0 110.672 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.0 m -152.33 159.95 43.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.238 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.539 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.8 mt -103.11 146.83 27.8 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.465 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 51.3 t -118.45 -43.1 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.164 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -166.64 111.57 0.78 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.551 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -118.56 114.77 23.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.567 ' HB2' HD13 ' A' ' 57' ' ' ILE . 25.4 t80 -100.8 157.97 16.31 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.859 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 46' ' ' MET . 61.0 mtpt -153.35 140.28 19.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.77 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.433 ' HG2' ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -55.76 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.772 0.796 . . . . 0.0 110.823 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 43.4 mmtt 81.66 -46.98 0.21 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.11 -1.405 . . . . 0.0 111.229 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.452 ' HB2' ' HB3' ' A' ' 43' ' ' LYS . 1.3 mpt? -51.46 142.99 12.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.835 0.35 . . . . 0.0 111.056 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.28 126.17 73.37 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.192 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 89.8 Cg_endo -84.26 -171.19 0.97 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.643 2.228 . . . . 0.0 112.547 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.539 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 73.3 t80 -137.11 104.36 5.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.338 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 50' ' ' LEU . 7.9 mt -98.57 111.18 23.63 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 12.8 tptm -44.38 -54.58 5.73 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.807 0.336 . . . . 0.0 111.484 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -164.0 165.07 22.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.146 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.16 -11.69 3.49 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.112 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.41 2.24 11.91 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 117.674 0.737 . . . . 0.0 112.163 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -131.99 156.48 46.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.124 0.488 . . . . 0.0 111.392 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -152.57 119.59 5.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.252 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.644 HG23 ' O ' ' A' ' 57' ' ' ILE . 8.1 tt -75.0 100.26 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.112 0.482 . . . . 0.0 111.325 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.596 HD23 HD21 ' A' ' 60' ' ' ASN . 0.7 OUTLIER -50.63 167.57 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.169 -179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.74 -24.54 65.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.651 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.596 HD21 HD23 ' A' ' 58' ' ' LEU . 6.1 p30 -96.57 33.12 1.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.736 0.303 . . . . 0.0 111.18 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.8 33.37 67.84 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.563 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.38 165.39 11.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 0.0 111.049 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 tp -105.14 121.46 43.86 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.47 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.445 ' HB2' HD13 ' A' ' 58' ' ' LEU . 2.1 tmtp? -107.91 110.18 21.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 111.13 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.851 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -90.38 138.24 19.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.063 179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -93.3 -41.64 9.76 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.2 106.93 5.36 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.582 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.913 HD21 HG21 ' A' ' 14' ' ' ILE . 7.8 mt -57.35 143.73 38.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.13 0.491 . . . . 0.0 111.461 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.431 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 5.1 p -144.36 159.53 42.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.037 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.32 -56.46 12.93 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.022 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -54.25 -21.83 10.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.429 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.623 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -79.39 -14.44 58.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.3 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.4 t -80.57 129.11 34.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.65 0.262 . . . . 0.0 110.475 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.01 -165.06 30.18 Favored Glycine 0 N--CA 1.439 -1.127 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.12 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -93.98 126.65 39.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.702 0.287 . . . . 0.0 111.349 -179.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -104.44 130.86 52.31 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.129 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -112.84 125.8 54.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.881 0.372 . . . . 0.0 111.603 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.949 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.26 130.04 62.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.12 179.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.12 98.44 6.63 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.597 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.586 ' CG1' HD12 ' A' ' 27' ' ' ILE . 91.9 t -91.71 123.34 43.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.583 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.446 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 99.0 m-85 -116.33 152.68 33.39 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.172 0.511 . . . . 0.0 111.135 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.638 ' CA ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -90.5 172.96 8.35 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.526 -179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.403 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 7.5 p -57.1 -22.63 41.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.234 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -96.02 26.42 4.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.147 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.87 25.52 30.53 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.718 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.4 156.65 16.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.82 0.343 . . . . 0.0 110.832 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -79.01 107.52 11.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.695 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.638 HD11 ' CA ' ' A' ' 82' ' ' SER . 38.6 mt -82.2 -70.71 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.347 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.799 HD21 ' HG3' ' A' ' 91' ' ' LYS . 1.5 tt -141.43 128.18 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.112 0.482 . . . . 0.0 111.892 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.85 106.57 14.33 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.799 ' HG3' HD21 ' A' ' 89' ' ' LEU . 5.2 mmtt -117.36 162.45 17.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.446 0.641 . . . . 0.0 112.631 -178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.87 120.88 10.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.162 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.642 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -116.78 161.12 19.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.81 0.338 . . . . 0.0 111.403 -179.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.81 112.22 24.37 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.201 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.93 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -102.26 101.84 12.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.279 -179.485 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -98.31 119.81 37.63 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.06 0.457 . . . . 0.0 110.67 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.77 HG21 ' HB3' ' A' ' 68' ' ' LEU . 3.8 mt -112.79 118.24 57.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.732 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 98' ' ' LEU . 8.8 mt -69.8 118.65 12.91 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.683 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.829 -179.809 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.835 0.35 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -88.59 -65.18 1.04 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.6 160.85 6.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.88 -149.61 39.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.499 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -46.33 147.96 1.02 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.325 0.583 . . . . 0.0 111.328 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.85 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -140.22 144.64 27.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.773 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -114.71 126.14 54.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.437 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.17 -179.62 22.49 Favored Glycine 0 N--CA 1.459 0.197 0 C-N-CA 120.214 -0.993 . . . . 0.0 112.76 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.436 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -130.26 134.85 47.53 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.05 0.452 . . . . 0.0 111.353 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.675 HD11 ' C ' ' A' ' 69' ' ' THR . 0.8 OUTLIER -53.07 136.3 35.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.006 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.33 -8.34 74.74 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.668 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.534 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.12 167.8 9.75 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.612 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -71.23 -173.86 17.23 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.565 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.819 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 162.19 136.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 122.493 0.317 . . . . 0.0 110.401 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -122.86 128.18 50.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.964 0.412 . . . . 0.0 111.489 -179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -85.14 106.6 16.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.858 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -89.22 124.45 34.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.152 0.501 . . . . 0.0 111.911 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.967 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -79.97 119.62 77.23 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.138 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.16 131.38 38.69 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.367 2.045 . . . . 0.0 112.945 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.5 m120 42.81 65.03 1.01 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.416 ' HB2' HD13 ' A' ' 89' ' ' LEU . 8.9 t80 -141.6 149.29 40.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.817 0.342 . . . . 0.0 110.56 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -143.87 116.43 8.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.02 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.0 ttt -80.68 77.69 7.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.15 -174.44 2.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.2 -30.73 62.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.08 -24.74 65.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.02 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.538 HD12 ' CG1' ' A' ' 80' ' ' VAL . 45.2 mm -85.52 126.54 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.457 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.415 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -111.59 -42.65 3.8 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 122.142 -0.349 . . . . 0.0 111.742 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.493 ' OE1' ' HB2' ' A' ' 81' ' ' TYR . 6.7 mp0 -117.57 158.75 24.05 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 119.944 -0.702 . . . . 0.0 112.001 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.6 t -154.28 108.7 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.884 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.457 ' NH1' ' CE2' ' A' ' 81' ' ' TYR . 0.6 OUTLIER -111.15 129.82 55.82 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -110.62 86.11 2.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.848 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -103.13 153.66 20.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.342 0.591 . . . . 0.0 112.303 -178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -145.48 116.24 7.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.503 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.08 -117.67 11.04 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.75 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.5 m -115.59 42.85 2.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.785 0.326 . . . . 0.0 110.659 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.4 m -150.59 160.62 43.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.145 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.722 HD21 ' OE2' ' A' ' 41' ' ' GLU . 5.7 mt -106.68 147.89 29.03 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.447 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 55.6 t -119.45 -44.16 2.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.255 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.34 112.55 1.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.43 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.722 ' OE2' HD21 ' A' ' 38' ' ' LEU . 2.2 mt-10 -119.48 114.62 22.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.081 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.788 ' HB2' HD13 ' A' ' 57' ' ' ILE . 26.0 t80 -107.5 144.25 34.72 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.888 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -143.98 134.89 25.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.413 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -47.96 -29.03 3.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.495 0.664 . . . . 0.0 111.536 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.24 39.1 0.57 Allowed 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.852 179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 41.25 -165.19 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.582 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 mttm 54.76 65.19 5.23 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.694 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -79.87 -170.41 1.0 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.564 2.176 . . . . 0.0 111.945 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.553 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 73.7 t80 -133.1 98.51 4.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.575 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 50' ' ' LEU . 10.7 mt -95.24 112.78 24.44 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.447 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 19.3 tttm -34.82 -89.43 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.1 t -118.76 23.45 11.45 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 73.24 0.18 51.25 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.973 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -85.32 6.29 26.92 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 117.534 0.667 . . . . 0.0 111.012 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -126.57 158.37 36.41 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.975 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -140.27 118.66 12.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.203 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.788 HD13 ' HB2' ' A' ' 42' ' ' PHE . 6.4 tt -76.09 101.79 2.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.214 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.555 HD13 ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -53.28 163.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.098 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.64 -21.79 64.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.72 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -97.88 33.31 2.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.779 0.323 . . . . 0.0 111.103 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.89 36.43 80.24 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.738 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.49 166.86 10.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 0.0 110.92 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 11.9 tp -107.71 121.41 44.65 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.893 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.555 ' HB2' HD13 ' A' ' 58' ' ' LEU . 4.3 tmtt? -109.15 103.87 12.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.735 0.302 . . . . 0.0 110.814 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.776 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.7 mt -79.91 134.54 27.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.533 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.2 tttm -79.47 -48.46 13.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.025 0.441 . . . . 0.0 111.675 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -147.31 113.29 5.79 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.243 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.819 HD21 HG21 ' A' ' 14' ' ' ILE . 5.7 mt -53.5 149.04 8.33 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 111.716 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.675 ' C ' HD11 ' A' ' 10' ' ' LEU . 6.1 p -151.94 160.45 43.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.03 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.656 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -51.28 -56.53 12.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.075 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -55.26 -20.82 12.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.346 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.657 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -81.33 -15.39 55.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.413 -179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.4 t -79.03 128.96 33.93 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.608 0.242 . . . . 0.0 110.576 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.46 -167.33 30.27 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.331 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.76 125.77 36.6 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.529 -0.336 . . . . 0.0 111.418 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -101.45 149.2 24.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.177 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -131.28 123.13 27.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.694 0.283 . . . . 0.0 111.567 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.967 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -108.65 128.81 64.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.036 179.159 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.13 97.9 6.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.64 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.538 ' CG1' HD12 ' A' ' 27' ' ' ILE . 82.0 t -86.25 137.97 19.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.139 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.493 ' HB2' ' OE1' ' A' ' 29' ' ' GLU . 84.2 m-85 -132.16 153.56 50.4 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 121.58 0.705 . . . . 0.0 111.602 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.585 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -87.64 -179.62 6.34 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.43 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.415 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 41.7 p -65.81 -35.5 80.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.942 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -77.91 -3.67 42.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.434 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.37 24.68 42.47 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.533 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.4 160.06 14.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.828 0.346 . . . . 0.0 110.699 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 106.71 11.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.682 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.585 HD11 ' HB3' ' A' ' 82' ' ' SER . 40.2 mm -87.35 -43.67 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.304 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.608 HD11 ' HE2' ' A' ' 91' ' ' LYS . 3.1 tt -157.69 149.97 22.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.218 0.533 . . . . 0.0 111.822 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.92 109.9 5.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.003 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.608 ' HE2' HD11 ' A' ' 89' ' ' LEU . 20.7 mmtm -121.63 162.24 21.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.482 0.658 . . . . 0.0 112.77 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.16 121.95 11.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.9 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.646 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -120.17 163.2 18.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 0.0 111.688 -179.189 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -111.13 114.27 27.4 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.369 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.85 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -100.94 103.71 14.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.396 -179.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.46 113.22 25.82 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.08 0.467 . . . . 0.0 110.551 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.691 HG21 ' HB3' ' A' ' 68' ' ' LEU . 3.7 mt -109.34 115.05 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.523 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.0 mt -78.97 169.96 17.41 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.24 0.543 . . . . 0.0 110.761 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.897 179.93 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 29.9 ttt-85 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.824 0.345 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -66.27 81.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.8 t -84.55 104.63 14.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.35 -150.36 19.37 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.591 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -47.71 139.62 7.14 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.496 0.665 . . . . 0.0 111.439 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.793 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -134.8 155.72 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.393 -179.652 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -122.77 128.49 50.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.826 0.346 . . . . 0.0 111.005 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.7 178.51 24.31 Favored Glycine 0 N--CA 1.459 0.233 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.454 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.411 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -125.34 135.11 52.11 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 120.941 0.4 . . . . 0.0 111.106 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.834 HD12 HG21 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -52.7 132.41 36.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.792 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.66 -12.45 69.45 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.83 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.512 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -104.74 169.78 8.26 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.219 0.509 . . . . 0.0 110.016 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.512 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -79.68 168.78 52.87 Favored Glycine 0 C--O 1.224 -0.515 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.25 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.869 ' CG2' HD12 ' A' ' 65' ' ' ILE . 2.2 tp -179.09 140.26 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.696 0.284 . . . . 0.0 110.765 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -124.08 131.52 53.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.031 0.443 . . . . 0.0 111.647 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.833 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -88.09 113.68 23.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.586 179.135 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -97.83 125.63 42.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.193 0.521 . . . . 0.0 111.931 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.947 HD11 HG11 ' A' ' 78' ' ' VAL . 3.2 mt -81.62 119.95 76.73 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.299 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.23 131.0 36.52 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.355 2.037 . . . . 0.0 112.865 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 27.6 m120 43.42 65.14 1.04 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -142.3 149.3 39.33 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.804 0.335 . . . . 0.0 110.531 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -138.65 117.46 12.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.931 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -80.87 82.41 6.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.78 -174.27 2.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.765 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -56.82 -30.94 64.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.954 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -60.98 -28.01 68.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.596 HD12 ' CG1' ' A' ' 80' ' ' VAL . 23.4 mm -81.57 127.75 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.444 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.55 -44.16 3.55 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 122.214 -0.304 . . . . 0.0 111.736 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 72.6 tt0 -127.43 116.23 20.13 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 120.217 -0.593 . . . . 0.0 112.31 -178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 t -113.2 114.28 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.974 178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.8 mtp180 -113.08 132.12 55.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.084 0.469 . . . . 0.0 112.192 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.402 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 70.2 m95 -113.18 83.26 1.8 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -99.17 150.9 21.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.299 0.571 . . . . 0.0 112.274 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.47 116.01 9.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.62 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.29 -117.36 10.29 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.76 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -115.25 42.77 2.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.837 0.351 . . . . 0.0 110.759 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 89.2 m -152.0 160.03 43.58 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.215 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.56 HD21 ' OE2' ' A' ' 41' ' ' GLU . 5.8 mt -104.09 146.94 28.01 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.452 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 52.0 t -117.89 -42.83 2.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.293 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -166.21 113.11 0.88 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.455 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.56 ' OE2' HD21 ' A' ' 38' ' ' LEU . 2.4 mt-10 -120.53 116.32 25.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.094 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.46 ' HB2' HD13 ' A' ' 57' ' ' ILE . 32.1 t80 -99.83 152.07 20.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.666 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -142.47 145.84 34.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.841 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -59.45 91.75 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 122.177 0.989 . . . . 0.0 110.555 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 81.37 -46.86 0.23 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 113.628 -1.624 . . . . 0.0 111.158 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -50.27 146.3 5.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.098 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -57.87 127.29 78.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.114 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.415 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 87.1 Cg_endo -83.23 -171.14 1.04 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.656 2.238 . . . . 0.0 112.467 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.531 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 69.4 t80 -135.03 104.64 6.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.343 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.1 mt -99.27 111.09 23.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.0 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 55.6 tttm -44.94 -42.46 8.16 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.579 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 93.0 p -176.66 164.96 2.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.966 0.412 . . . . 0.0 111.213 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.36 -12.37 4.36 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.732 -0.746 . . . . 0.0 113.118 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.44 1.06 12.69 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 117.75 0.775 . . . . 0.0 112.182 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -131.1 157.38 43.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.11 0.481 . . . . 0.0 111.214 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -153.95 125.24 7.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.513 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.665 HG23 ' O ' ' A' ' 57' ' ' ILE . 6.9 tt -84.04 101.53 8.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.164 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.657 HD23 HD21 ' A' ' 60' ' ' ASN . 1.2 mp -61.32 166.97 3.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.991 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.04 -45.58 80.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.205 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.657 HD21 HD23 ' A' ' 58' ' ' LEU . 3.5 p30 -56.32 -22.88 33.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.137 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.85 35.05 4.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.59 179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -116.03 154.48 29.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.878 0.371 . . . . 0.0 110.924 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 12.7 tp -83.46 122.94 29.19 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.463 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -104.46 109.79 21.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.701 0.286 . . . . 0.0 111.38 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.869 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.8 mt -93.29 127.34 45.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.939 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 ttpp -85.63 -36.31 20.41 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -147.16 110.23 4.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.812 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.078 HD22 HD12 ' A' ' 97' ' ' ILE . 4.9 mt -56.62 144.88 30.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.056 0.455 . . . . 0.0 111.469 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.677 ' C ' HD11 ' A' ' 10' ' ' LEU . 7.5 p -149.25 163.79 36.67 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.843 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.582 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -50.84 -55.52 16.55 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.223 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -52.9 -23.01 6.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.539 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.646 ' OD1' HD13 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -79.53 -14.01 59.15 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.472 -179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.436 ' CB ' HG12 ' A' ' 97' ' ' ILE . 2.6 t -81.15 124.74 29.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.685 0.279 . . . . 0.0 110.707 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.1 -166.87 29.47 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.296 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.94 130.34 38.55 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.56 0.344 . . . . 0.0 111.139 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -106.21 148.65 27.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.063 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 14.7 m-20 -132.42 127.2 34.85 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.834 0.35 . . . . 0.0 111.641 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.947 HG11 HD11 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -109.76 131.13 61.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.202 179.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.0 98.61 6.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.476 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.596 ' CG1' HD12 ' A' ' 27' ' ' ILE . 93.5 t -92.05 123.29 44.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.65 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.496 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 99.3 m-85 -117.17 152.11 35.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.271 0.558 . . . . 0.0 111.027 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.646 ' CA ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -89.96 173.64 8.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.532 -179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.8 p -57.38 -24.31 54.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.191 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -96.01 27.5 3.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.169 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 53.78 25.13 28.59 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.686 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.04 144.26 25.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.799 0.333 . . . . 0.0 110.818 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.78 107.04 3.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.643 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.646 HD11 ' CA ' ' A' ' 82' ' ' SER . 40.0 mt -80.97 -69.9 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.373 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.915 HD21 ' HG3' ' A' ' 91' ' ' LYS . 1.9 tt -141.68 129.76 22.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.192 0.52 . . . . 0.0 111.87 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.28 107.23 14.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.472 -0.786 . . . . 0.0 108.897 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.915 ' HG3' HD21 ' A' ' 89' ' ' LEU . 5.0 mmpt? -117.84 158.71 24.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.43 0.633 . . . . 0.0 112.676 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.655 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.19 122.33 18.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.146 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.653 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -120.63 162.98 18.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.984 0.421 . . . . 0.0 111.519 -179.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.92 136.85 48.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.335 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.833 HD12 HD21 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -131.78 100.8 5.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.273 -179.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 1.1 mmm180 -92.81 124.04 36.52 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.038 0.446 . . . . 0.0 110.945 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.078 HD12 HD22 ' A' ' 68' ' ' LEU . 4.4 mm -106.46 103.73 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.841 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.3 mt -67.66 120.15 13.57 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.598 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.892 -179.754 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.779 0.323 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -64.82 88.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.944 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.83 153.59 17.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.829 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.82 -150.49 41.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.514 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -48.21 146.71 2.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.21 0.529 . . . . 0.0 111.36 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.903 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -142.02 153.64 18.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.62 -179.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -121.38 131.33 54.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.926 0.393 . . . . 0.0 110.697 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.786 ' C ' HG23 ' A' ' 97' ' ' ILE . . . -149.69 -179.71 25.75 Favored Glycine 0 N--CA 1.459 0.226 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.812 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.562 ' N ' HG23 ' A' ' 97' ' ' ILE . . . -126.49 135.34 51.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.938 0.399 . . . . 0.0 110.735 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.732 HD11 ' C ' ' A' ' 69' ' ' THR . 1.2 tp -55.49 130.32 42.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.003 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.49 -6.96 77.97 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.656 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.534 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -106.28 169.18 8.66 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 117.122 0.461 . . . . 0.0 109.941 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.534 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -76.77 166.63 54.17 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.139 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.832 HG21 HD21 ' A' ' 68' ' ' LEU . 1.6 tp -177.56 138.34 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.793 0.33 . . . . 0.0 110.986 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.493 ' OD2' HD22 ' A' ' 58' ' ' LEU . 3.1 t70 -120.6 120.48 35.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.44 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.722 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -77.44 105.08 8.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.767 179.299 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.456 ' O ' HD21 ' A' ' 93' ' ' LEU . 54.0 m-20 -88.93 124.84 34.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.228 0.537 . . . . 0.0 112.152 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.924 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -81.8 119.96 76.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.118 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.93 131.8 39.02 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.221 1.947 . . . . 0.0 112.877 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 43.61 65.45 0.99 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -143.28 149.44 37.86 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.742 0.306 . . . . 0.0 110.549 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -141.08 117.14 10.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.958 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.82 79.91 6.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.31 -173.74 2.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.791 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.64 -30.46 61.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.0 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -62.56 -28.83 70.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.626 HD12 ' CG1' ' A' ' 80' ' ' VAL . 23.2 mm -86.05 127.16 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.476 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.408 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -112.82 -42.78 3.53 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.091 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.547 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 37.9 tt0 -127.67 118.22 23.44 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.155 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.81 118.52 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.21 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -117.43 135.83 53.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.271 0.558 . . . . 0.0 112.17 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.487 ' CH2' ' HB3' ' A' ' 16' ' ' LEU . 69.9 m95 -111.13 88.24 2.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.971 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -98.7 141.8 31.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.364 0.602 . . . . 0.0 112.267 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -132.12 114.92 15.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.396 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.26 -114.02 5.41 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.64 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.2 t -118.38 44.28 2.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.731 0.3 . . . . 0.0 110.652 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.1 m -154.95 159.56 40.49 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.906 0.384 . . . . 0.0 111.332 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.534 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 4.6 mt -99.18 148.17 24.37 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.804 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.481 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 48.4 t -119.32 -42.26 2.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.444 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -173.5 114.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.724 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -124.73 156.55 37.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.092 0.472 . . . . 0.0 110.907 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -129.44 144.33 51.2 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.753 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.64 114.29 5.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.644 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -51.78 -59.41 4.34 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.721 0.772 . . . . 0.0 111.097 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -82.76 46.89 1.13 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.849 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 177.98 -172.21 0.12 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.839 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -108.1 142.33 25.06 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.718 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.05 154.62 47.53 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.504 2.136 . . . . 0.0 112.479 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.534 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 43.6 t80 -112.7 103.09 11.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.158 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 50' ' ' LEU . 7.9 mt -93.53 113.36 25.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.2 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.481 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 31.0 tttt -47.94 -45.39 30.99 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.745 0.307 . . . . 0.0 111.365 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.1 p -175.27 165.13 3.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.91 0.386 . . . . 0.0 111.191 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.92 -12.43 3.73 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.698 -0.763 . . . . 0.0 113.214 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.02 -1.48 17.35 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.727 0.763 . . . . 0.0 112.063 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -131.38 157.03 44.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.063 0.458 . . . . 0.0 111.206 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -151.3 119.18 6.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.134 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' ' 57' ' ' ILE . 4.2 tt -74.5 103.89 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.115 0.483 . . . . 0.0 111.223 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.639 HD13 ' HB2' ' A' ' 64' ' ' LYS . 0.7 OUTLIER -51.77 173.07 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.313 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.5 -26.81 67.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.346 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -96.13 32.4 1.95 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.048 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.08 26.3 58.24 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.483 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.58 173.54 8.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.879 0.371 . . . . 0.0 111.04 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.468 HD11 HG12 ' A' ' 39' ' ' VAL . 8.5 tp -109.93 118.35 36.21 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.633 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.639 ' HB2' HD13 ' A' ' 58' ' ' LEU . 12.8 tttp -106.63 108.71 20.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.83 0.347 . . . . 0.0 110.957 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.831 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.4 mt -87.65 135.77 24.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.435 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 ttpp -82.62 -46.37 13.37 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.038 0.447 . . . . 0.0 111.831 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.72 112.04 5.78 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.132 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.875 HD22 HG12 ' A' ' 97' ' ' ILE . 6.1 mt -53.76 151.03 6.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.289 0.566 . . . . 0.0 111.865 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.732 ' C ' HD11 ' A' ' 10' ' ' LEU . 7.1 p -154.3 162.42 41.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.815 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.59 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.1 OUTLIER -50.78 -56.4 12.27 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.037 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -57.02 -20.86 26.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.327 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.632 ' OD1' HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -87.06 -14.89 40.18 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.426 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.3 t -90.96 129.62 36.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.649 0.261 . . . . 0.0 110.609 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 154.08 -130.66 2.98 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.588 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 m -123.11 128.73 50.5 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 117.814 0.807 . . . . 0.0 110.931 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -109.06 149.09 29.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.235 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 12.9 m-20 -131.26 125.57 33.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.849 0.356 . . . . 0.0 111.582 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.924 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.98 131.58 60.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.038 179.209 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.637 HG23 ' ND2' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -119.95 96.35 5.14 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.599 178.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.626 ' CG1' HD12 ' A' ' 27' ' ' ILE . 74.1 t -85.75 128.06 39.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.468 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.547 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 83.0 m-85 -117.61 151.56 36.93 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.062 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.614 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -88.73 174.26 8.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.494 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -61.76 -18.67 60.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.265 179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -94.08 23.45 4.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.207 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.65 21.71 50.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.668 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.42 176.49 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.736 0.303 . . . . 0.0 110.617 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.09 116.46 30.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.708 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.614 HD11 ' HB3' ' A' ' 82' ' ' SER . 31.9 mm -90.47 -46.93 14.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.362 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.631 HD11 ' HE3' ' A' ' 91' ' ' LYS . 1.6 tt -153.6 148.4 26.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.188 0.518 . . . . 0.0 111.796 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.637 ' ND2' HG23 ' A' ' 79' ' ' THR . 10.6 t-20 -136.79 108.58 7.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.197 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.631 ' HE3' HD11 ' A' ' 89' ' ' LEU . 46.3 mmtt -121.13 156.6 31.96 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.655 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.37 122.24 17.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.966 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.65 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -118.2 158.97 24.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.018 0.437 . . . . 0.0 111.728 -179.09 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -111.81 107.99 17.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.263 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.934 HD22 HD11 ' A' ' 97' ' ' ILE . 0.5 OUTLIER -94.29 98.46 10.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.095 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -98.02 126.05 43.26 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.995 0.426 . . . . 0.0 110.498 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.934 HD11 HD22 ' A' ' 95' ' ' LEU . 2.3 mp -134.34 133.58 55.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.91 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.52 169.02 14.89 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.712 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.96 179.857 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.867 0.365 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -106.5 -40.03 5.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.916 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 p -60.16 175.84 0.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.68 167.18 32.03 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.578 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.0 m -142.97 147.63 35.48 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 121.26 0.553 . . . . 0.0 110.939 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.891 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER -139.19 150.51 23.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.812 -179.472 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -120.89 128.87 53.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.669 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.24 -178.82 22.82 Favored Glycine 0 N--CA 1.46 0.254 0 C-N-CA 120.216 -0.993 . . . . 0.0 112.748 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.448 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -130.11 133.63 46.79 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.146 0.498 . . . . 0.0 111.597 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.41 ' CD1' ' HA ' ' A' ' 69' ' ' THR . 0.6 OUTLIER -52.08 131.7 32.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.179 179.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.94 -7.96 80.72 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.74 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.528 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.01 168.33 9.36 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.603 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.91 -174.24 16.93 Favored Glycine 0 C--O 1.228 -0.249 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.502 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.815 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 163.13 136.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.803 0.335 . . . . 0.0 110.386 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -126.25 125.22 42.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.919 0.39 . . . . 0.0 111.436 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.481 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -77.37 122.49 25.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.735 179.251 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -103.71 123.05 46.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.177 0.513 . . . . 0.0 111.963 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.938 HD11 HG11 ' A' ' 78' ' ' VAL . 3.3 mt -81.78 119.53 75.55 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.145 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.71 130.92 37.27 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.386 2.057 . . . . 0.0 112.98 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 42.79 65.13 0.99 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -141.72 149.13 40.12 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.79 0.329 . . . . 0.0 110.553 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -145.01 115.24 7.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.967 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.5 ttt -78.19 76.45 4.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.849 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.19 -173.74 2.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.822 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -56.86 -30.79 64.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.03 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -65.4 -26.74 68.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.009 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.602 HD12 ' CG1' ' A' ' 80' ' ' VAL . 43.6 mm -85.58 127.28 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.347 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.411 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -113.02 -42.05 3.62 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.182 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 6.6 tm-20 -128.26 138.78 52.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.881 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 85.2 t -145.27 124.37 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.295 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.446 ' NH1' ' CE2' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -118.84 139.16 52.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.136 0.493 . . . . 0.0 112.222 -179.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.48 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 69.2 m95 -111.49 83.28 1.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -96.54 151.59 19.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.408 0.623 . . . . 0.0 112.351 -178.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.445 ' HD2' ' CE1' ' A' ' 76' ' ' TYR . 6.0 ttp-105 -143.93 116.75 8.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.439 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.92 -114.82 6.09 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.18 -1.009 . . . . 0.0 111.671 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.2 m -118.47 44.25 2.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.754 0.311 . . . . 0.0 110.701 179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.9 m -153.29 160.37 42.71 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.287 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.657 HD13 ' OE1' ' A' ' 41' ' ' GLU . 5.5 mt -104.4 147.86 27.07 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.475 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 46.9 t -119.14 -42.06 2.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.581 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.48 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -174.2 116.09 0.21 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.022 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.657 ' OE1' HD13 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -124.36 159.47 30.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.009 0.433 . . . . 0.0 110.792 179.24 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -126.36 149.89 48.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.884 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -159.42 111.71 2.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.672 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.5 tpp180 -51.63 -59.62 4.08 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.737 0.78 . . . . 0.0 111.014 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 20.4 tttp -82.77 47.28 1.18 Allowed 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.837 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.09 -172.68 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 8.2 mtpt -108.59 156.69 38.32 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.772 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 47' ' ' LYS . 1.0 OUTLIER -82.36 161.27 17.4 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.919 2.413 . . . . 0.0 112.477 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.517 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 39.1 t80 -127.03 99.48 5.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.931 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 50' ' ' LEU . 11.6 mt -91.98 109.06 20.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.132 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 7.6 ttmt -47.6 -33.44 6.6 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.682 0.277 . . . . 0.0 111.468 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 87.6 p -174.01 163.53 4.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.925 0.393 . . . . 0.0 111.217 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.71 -6.97 19.08 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.587 -0.816 . . . . 0.0 113.008 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.52 5.56 10.55 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 117.626 0.713 . . . . 0.0 112.003 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -132.78 157.65 44.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.109 0.481 . . . . 0.0 111.434 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -148.59 118.15 6.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.003 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.644 HG23 ' O ' ' A' ' 57' ' ' ILE . 10.1 tt -77.56 98.45 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.086 0.47 . . . . 0.0 111.389 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -51.6 163.29 0.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.031 179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.17 -22.39 65.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.592 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -96.23 32.87 1.86 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.763 0.316 . . . . 0.0 111.234 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.53 36.55 71.2 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.738 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -108.84 158.04 18.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.94 0.4 . . . . 0.0 111.014 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.3 tp -99.39 121.8 41.62 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.586 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.43 108.21 18.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.793 0.33 . . . . 0.0 111.141 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.799 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.3 mt -86.95 138.91 18.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.41 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -85.07 -47.12 10.5 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.057 0.456 . . . . 0.0 111.855 -179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -143.6 111.43 6.06 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.233 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.815 HD21 HG21 ' A' ' 14' ' ' ILE . 5.3 mt -53.28 144.07 17.06 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.894 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.41 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 5.0 p -141.76 159.97 41.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.923 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.11 -56.23 15.81 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -55.72 -19.48 11.14 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.578 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.594 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -79.22 -14.3 59.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.568 0.223 . . . . 0.0 111.475 -179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 98.5 p -85.23 128.43 34.68 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.629 0.252 . . . . 0.0 110.753 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.32 -135.08 4.34 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.542 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.7 m -124.29 130.4 52.44 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 117.556 0.678 . . . . 0.0 110.714 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.445 ' CE1' ' HD2' ' A' ' 34' ' ' ARG . 16.3 m-85 -107.41 151.6 25.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.979 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.642 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 12.4 m-20 -133.59 124.66 27.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.314 . . . . 0.0 111.593 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.938 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.09 133.54 53.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.283 179.045 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.04 103.39 9.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.671 178.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.602 ' CG1' HD12 ' A' ' 27' ' ' ILE . 94.9 t -93.7 129.66 43.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.42 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 97.9 m-85 -121.71 154.93 36.24 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.151 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.557 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -89.98 178.3 6.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.588 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.411 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 27.0 p -64.26 -22.97 67.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.068 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.8 m-20 -95.74 23.48 6.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.098 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.52 25.87 61.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.524 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.5 152.29 18.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.839 0.352 . . . . 0.0 110.8 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -74.82 119.9 19.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.718 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.557 HD11 ' HB3' ' A' ' 82' ' ' SER . 32.8 mm -92.79 -67.83 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.381 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.919 HD21 ' HG3' ' A' ' 91' ' ' LYS . 1.0 OUTLIER -146.06 133.28 20.52 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.147 0.499 . . . . 0.0 111.85 -179.304 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.22 107.41 14.41 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.919 ' HG3' HD21 ' A' ' 89' ' ' LEU . 25.4 mmtt -117.55 156.61 27.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.428 0.633 . . . . 0.0 112.662 -178.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.642 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -137.98 122.69 18.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.084 179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.649 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -119.68 160.76 21.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.079 0.466 . . . . 0.0 111.607 -179.211 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -110.05 116.13 31.01 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.158 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.891 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -100.07 100.71 11.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.362 -179.441 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.5 OUTLIER -96.72 115.16 26.95 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.096 0.474 . . . . 0.0 110.353 179.277 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.696 HG12 HD22 ' A' ' 68' ' ' LEU . 3.8 mt -116.33 120.14 64.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.838 -178.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 9.3 mt -70.29 119.65 14.79 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.684 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.85 -179.813 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.873 0.368 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.41 -39.43 94.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.873 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 p -59.33 136.67 58.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.942 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.4 -149.28 41.87 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.561 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.5 m -45.99 137.03 6.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.408 0.623 . . . . 0.0 111.466 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.729 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.4 OUTLIER -130.02 146.63 33.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.484 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.474 ' CE2' ' HD3' ' A' ' 96' ' ' ARG . 82.9 m95 -112.05 127.52 55.92 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.609 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.18 -178.18 22.27 Favored Glycine 0 N--CA 1.459 0.217 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.887 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.445 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -125.14 133.34 52.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.048 0.451 . . . . 0.0 111.123 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.729 HD12 HG21 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -53.93 133.14 43.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.027 -179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.69 -6.35 83.72 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.757 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.542 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.42 167.31 10.13 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.994 0.397 . . . . 0.0 110.006 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.586 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.43 -175.69 18.44 Favored Glycine 0 C--O 1.228 -0.264 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.622 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.829 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.1 tp 167.33 136.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.897 0.38 . . . . 0.0 110.726 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.509 ' OD2' HD22 ' A' ' 58' ' ' LEU . 1.3 t70 -121.81 132.11 54.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.187 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.617 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -90.4 108.95 20.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.855 179.359 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -91.71 123.36 35.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.225 0.536 . . . . 0.0 112.209 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.945 HD11 HG11 ' A' ' 78' ' ' VAL . 3.4 mt -80.82 120.07 77.9 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.112 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.78 130.95 37.26 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.301 2.0 . . . . 0.0 112.975 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 42.67 64.96 1.01 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -140.87 149.55 42.1 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.593 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -146.29 116.35 7.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -78.67 81.64 4.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.947 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.35 -175.14 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -57.57 -32.81 67.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.897 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -63.74 -23.73 67.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.144 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.563 HD12 ' CG1' ' A' ' 80' ' ' VAL . 37.4 mm -81.11 127.84 39.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.414 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -105.96 -38.36 6.35 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 122.231 -0.293 . . . . 0.0 111.728 -179.319 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 17.8 mt-10 -141.09 152.64 44.93 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.662 0.744 . . . . 0.0 112.448 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -145.68 117.98 2.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.125 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 mtm180 -115.19 133.65 55.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.024 0.44 . . . . 0.0 112.155 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.414 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 68.6 m95 -110.73 83.65 1.79 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -98.65 146.29 26.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.298 0.57 . . . . 0.0 112.288 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -137.19 116.93 13.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.532 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.05 -115.9 7.58 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.734 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.8 m -117.3 43.73 2.26 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.833 0.349 . . . . 0.0 110.71 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 96.5 m -153.6 160.05 42.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.282 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.548 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.6 mt -102.2 147.08 27.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.464 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 48.2 t -118.4 -42.7 2.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.258 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -166.47 111.55 0.8 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.562 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -117.69 119.69 35.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.941 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.705 ' HB2' HD13 ' A' ' 57' ' ' ILE . 51.5 t80 -104.55 157.98 16.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.79 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.405 ' CG ' ' HB2' ' A' ' 46' ' ' MET . 10.4 ttmt -151.75 145.45 25.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.942 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.59 91.55 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 121.967 0.889 . . . . 0.0 110.705 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 81.66 -47.21 0.21 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.164 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.405 ' HB2' ' CG ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -48.92 144.51 4.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.083 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -57.2 127.29 76.16 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.273 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -84.49 -167.94 0.48 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.721 2.28 . . . . 0.0 112.493 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.548 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 75.6 t80 -139.18 104.02 4.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.319 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.2 mt -98.45 109.33 22.1 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 10.3 ttmt -44.57 -39.77 5.2 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.774 0.321 . . . . 0.0 111.529 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 71.4 p -177.83 163.98 1.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 111.122 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.28 -11.46 4.95 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.025 -179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.413 ' HA ' ' CD ' ' A' ' 66' ' ' LYS . . . -74.29 0.42 14.31 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 117.786 0.793 . . . . 0.0 112.233 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -130.79 156.87 44.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.161 0.505 . . . . 0.0 111.303 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -150.73 117.4 5.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.098 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.705 HD13 ' HB2' ' A' ' 42' ' ' PHE . 12.0 tt -75.72 97.29 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.45 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.609 HD23 HD21 ' A' ' 60' ' ' ASN . 0.8 OUTLIER -47.01 168.36 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.184 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.59 -24.57 65.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.592 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.609 HD21 HD23 ' A' ' 58' ' ' LEU . 5.8 p30 -96.83 33.63 1.84 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.737 0.303 . . . . 0.0 111.21 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.65 34.18 69.38 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.56 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.39 165.09 11.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 0.0 111.043 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.41 HD11 HG12 ' A' ' 39' ' ' VAL . 10.5 tp -106.13 120.56 42.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.499 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.26 111.2 23.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.725 0.298 . . . . 0.0 110.991 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.829 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.4 mt -90.92 135.88 25.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.369 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.443 ' HG3' ' N ' ' A' ' 67' ' ' ASN . 0.0 OUTLIER -80.7 -45.96 16.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.074 0.464 . . . . 0.0 111.991 -179.044 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.443 ' N ' ' HG3' ' A' ' 66' ' ' LYS . 0.4 OUTLIER -145.8 113.31 6.3 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.468 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.638 HD22 ' CG1' ' A' ' 97' ' ' ILE . 4.2 mt -53.85 145.57 15.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.513 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.44 ' HA ' HD11 ' A' ' 10' ' ' LEU . 4.7 p -145.67 158.75 43.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.004 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.59 -55.92 14.12 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.417 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.06 -22.81 11.69 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.411 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.617 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.4 OUTLIER -76.3 -14.58 60.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.248 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.445 ' CB ' HD12 ' A' ' 97' ' ' ILE . 2.8 t -79.39 119.92 23.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.706 0.288 . . . . 0.0 110.521 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.13 -147.27 12.55 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.144 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.5 m -116.62 130.78 56.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.102 0.451 . . . . 0.0 110.59 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -106.72 129.77 54.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.38 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.708 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 2.0 m-20 -112.85 123.9 51.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.569 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.945 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -105.99 133.92 49.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.031 178.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.426 HG23 ' ND2' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -120.37 96.93 5.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.877 178.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.563 ' CG1' HD12 ' A' ' 27' ' ' ILE . 82.8 t -87.29 127.76 40.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.1 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.489 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 2.5 m-30 -112.81 152.6 28.99 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.298 0.57 . . . . 0.0 111.02 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.857 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -92.72 176.7 6.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.366 179.646 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.427 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 2.1 p -67.4 -18.34 65.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.236 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -89.94 12.13 18.39 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.422 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.74 25.05 74.95 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.631 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.11 -169.4 1.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.644 0.259 . . . . 0.0 110.595 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.1 mtt-85 -119.76 99.73 6.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.938 0.399 . . . . 0.0 110.783 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.857 HD11 ' HB3' ' A' ' 82' ' ' SER . 38.5 mm -58.0 -61.31 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.423 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.639 HD21 ' CG ' ' A' ' 91' ' ' LYS . 0.3 OUTLIER -144.14 140.47 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.226 0.536 . . . . 0.0 112.019 -179.032 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.426 ' ND2' HG23 ' A' ' 79' ' ' THR . 17.0 t-20 -121.65 109.23 14.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.807 178.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.639 ' CG ' HD21 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -119.38 160.85 21.52 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -178.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.708 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -139.37 122.65 17.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.159 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.661 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -119.61 161.98 19.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.871 0.367 . . . . 0.0 111.233 -179.466 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.06 146.1 33.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.265 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.729 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.4 OUTLIER -136.4 119.1 16.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.213 -179.533 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.474 ' HD3' ' CE2' ' A' ' 7' ' ' TRP . 0.0 OUTLIER -119.87 124.6 46.46 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.318 0.58 . . . . 0.0 111.038 179.215 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.729 HG21 HD12 ' A' ' 10' ' ' LEU . 3.9 mp -103.44 103.9 15.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.784 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.79 125.63 25.42 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.319 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.966 -179.837 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.774 0.321 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 64.23 -79.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.93 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.1 p -86.37 99.09 11.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.874 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.89 161.47 54.44 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.53 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.439 HG23 ' HB2' ' A' ' 94' ' ' ASP . 96.4 m -136.41 118.88 15.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.883 0.373 . . . . 0.0 110.802 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.91 HG23 ' HA ' ' A' ' 95' ' ' LEU . 2.6 m -98.11 178.49 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.304 0 CA-C-O 121.848 0.832 . . . . 0.0 112.496 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.437 ' CE3' ' HB2' ' A' ' 96' ' ' ARG . 69.5 m95 -147.56 162.26 39.45 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.543 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -172.25 178.48 44.39 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.494 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -119.8 135.05 55.02 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-O 120.883 0.373 . . . . 0.0 110.827 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.686 HD11 ' C ' ' A' ' 69' ' ' THR . 1.2 tp -57.11 133.27 54.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.892 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.03 -2.84 87.15 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.593 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.576 ' NE2' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -106.56 168.33 9.24 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.576 ' O ' ' NE2' ' A' ' 12' ' ' HIS . . . -82.66 163.47 42.33 Favored Glycine 0 C--O 1.223 -0.556 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.098 -178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.832 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.5 tp -176.11 137.91 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.952 0.406 . . . . 0.0 111.183 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.46 ' OD2' HD22 ' A' ' 58' ' ' LEU . 2.6 t70 -116.99 119.74 36.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.079 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.433 ' CD1' HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -80.94 114.45 19.83 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.957 179.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -94.1 124.03 37.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.168 0.509 . . . . 0.0 111.925 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.925 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.4 mt -80.4 119.78 77.41 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.023 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.449 ' O ' HD11 ' A' ' 89' ' ' LEU . 32.1 Cg_exo -59.39 130.85 37.64 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.281 1.987 . . . . 0.0 112.931 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 42.7 65.17 0.98 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -141.96 151.14 42.27 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.869 0.366 . . . . 0.0 110.638 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -141.35 117.98 10.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.829 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.71 78.4 7.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.009 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.5 p -110.77 -172.88 2.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.25 -30.53 68.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -61.46 -27.28 68.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.016 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.603 HD12 ' CG1' ' A' ' 80' ' ' VAL . 21.0 mm -81.76 127.52 39.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.451 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.95 -43.64 3.56 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 60.1 tt0 -128.39 116.38 19.68 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.196 -0.601 . . . . 0.0 112.412 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.7 t -116.22 117.12 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.886 178.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -118.17 133.53 55.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.202 0.525 . . . . 0.0 112.384 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -109.63 84.52 1.94 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.767 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -95.06 149.94 20.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.382 0.61 . . . . 0.0 112.432 -178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 22.9 ttp180 -139.66 113.47 8.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.408 179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.47 -114.77 6.24 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.217 -0.992 . . . . 0.0 111.613 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 t -117.01 43.62 2.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.77 0.319 . . . . 0.0 110.629 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 66.4 m -153.74 160.08 42.17 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.332 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.557 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.5 mt -101.42 147.12 26.73 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.431 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 51.1 t -118.21 -43.25 2.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.189 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.4 112.45 0.83 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.294 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -119.28 120.08 35.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.195 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.771 ' HB2' HD13 ' A' ' 57' ' ' ILE . 14.0 t80 -97.48 152.41 19.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.471 179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.422 ' CG ' ' HB2' ' A' ' 46' ' ' MET . 1.0 OUTLIER -150.47 121.78 7.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.863 -179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.34 95.8 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.975 0.893 . . . . 0.0 111.377 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 81.51 -47.36 0.23 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 113.844 -1.525 . . . . 0.0 111.119 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.422 ' HB2' ' CG ' ' A' ' 43' ' ' LYS . 3.7 mtt -50.02 156.55 0.75 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.913 0.387 . . . . 0.0 111.097 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -68.42 114.3 20.88 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.482 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -69.18 -173.2 0.6 Allowed 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.516 2.144 . . . . 0.0 112.218 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.557 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 70.5 t80 -137.46 98.89 3.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.756 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 50' ' ' LEU . 9.5 mt -93.89 113.81 25.9 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 6.5 tptp -36.43 -90.06 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.7 m -118.56 21.45 12.57 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.08 -1.52 55.19 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.451 -0.881 . . . . 0.0 113.125 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -82.81 3.42 29.56 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 117.546 0.673 . . . . 0.0 111.008 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -124.31 158.05 33.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.782 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -140.95 120.53 13.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.202 179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.771 HD13 ' HB2' ' A' ' 42' ' ' PHE . 4.7 tt -76.99 103.33 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.12 0.486 . . . . 0.0 111.375 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.624 HD23 HD21 ' A' ' 60' ' ' ASN . 0.7 OUTLIER -54.5 166.58 0.42 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.102 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.3 -23.48 64.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.72 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.624 HD21 HD23 ' A' ' 58' ' ' LEU . 6.0 p30 -96.53 33.3 1.84 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.734 0.302 . . . . 0.0 111.214 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.97 34.01 64.9 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.632 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.3 173.87 6.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 0.0 111.034 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 tp -114.22 121.07 42.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.57 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.412 ' HB2' HD13 ' A' ' 58' ' ' LEU . 17.2 tttt -107.61 104.07 13.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.823 0.344 . . . . 0.0 111.051 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.832 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.6 mt -82.27 127.18 39.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.625 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -76.0 -45.65 33.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.065 0.459 . . . . 0.0 111.322 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.11 111.9 4.82 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.235 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.829 HD22 HG12 ' A' ' 97' ' ' ILE . 4.5 mt -56.21 152.01 11.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.12 0.486 . . . . 0.0 111.681 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.686 ' C ' HD11 ' A' ' 10' ' ' LEU . 8.7 p -153.17 163.35 40.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.123 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.635 ' N ' HD11 ' A' ' 10' ' ' LEU . 21.4 mmt85 -51.42 -54.76 23.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.476 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -58.56 -19.22 36.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.321 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.41 -15.8 34.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.37 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.479 ' CB ' HD12 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -82.7 130.83 35.19 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.823 0.344 . . . . 0.0 110.586 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.56 -130.83 3.26 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.325 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 1.3 m -125.82 126.65 44.85 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 117.753 0.776 . . . . 0.0 111.063 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.428 ' CD1' HD21 ' A' ' 16' ' ' LEU . 61.2 m-85 -97.03 149.93 21.37 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.21 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.648 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 11.5 m-20 -132.94 120.53 21.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.201 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.925 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -107.91 128.54 63.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.174 179.444 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.73 97.4 5.83 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.603 ' CG1' HD12 ' A' ' 27' ' ' ILE . 71.2 t -87.01 126.79 40.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.52 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.507 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 97.2 m-85 -118.71 151.56 37.76 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.236 0.541 . . . . 0.0 111.024 179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.629 ' CB ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -89.72 173.62 8.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.406 -179.893 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.3 p -59.95 -29.51 68.46 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.926 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -77.77 -4.07 44.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.491 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.86 27.2 51.3 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.531 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.17 165.16 11.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.846 0.355 . . . . 0.0 110.79 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.37 115.37 21.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.644 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.629 HD11 ' CB ' ' A' ' 82' ' ' SER . 34.9 mt -91.16 -67.71 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.322 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.724 HD21 ' CG ' ' A' ' 91' ' ' LYS . 4.5 tt -136.41 130.14 32.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.062 0.458 . . . . 0.0 111.71 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -120.71 108.68 14.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.333 178.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.724 ' CG ' HD21 ' A' ' 89' ' ' LEU . 0.3 OUTLIER -119.61 153.51 35.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.275 0.56 . . . . 0.0 112.337 -178.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.648 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.91 121.69 16.48 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.496 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.641 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -120.63 164.85 15.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.243 -179.587 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.439 ' HB2' HG23 ' A' ' 5' ' ' THR . 1.1 m-20 -124.24 107.24 10.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.66 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.91 ' HA ' HG23 ' A' ' 6' ' ' VAL . 7.2 tt -101.8 113.89 27.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.017 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.437 ' HB2' ' CE3' ' A' ' 7' ' ' TRP . 0.2 OUTLIER -96.77 111.93 23.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.874 0.369 . . . . 0.0 110.479 179.299 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.829 HG12 HD22 ' A' ' 68' ' ' LEU . 5.6 mt -95.33 109.14 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.873 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mt -67.76 125.32 25.87 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.416 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.879 -179.762 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 48.9 ptt85 . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.798 0.332 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -73.61 -44.69 56.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.923 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.55 120.5 39.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.44 166.67 21.98 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.556 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.6 m -147.11 147.68 30.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 110.972 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.881 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -138.72 145.17 28.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.648 -179.469 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -116.49 127.43 54.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.877 0.37 . . . . 0.0 110.737 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.55 177.42 29.48 Favored Glycine 0 C--N 1.329 0.161 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.662 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.408 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -122.18 135.6 54.8 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.913 0.387 . . . . 0.0 110.75 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.725 HD11 ' C ' ' A' ' 69' ' ' THR . 1.1 tp -54.46 130.01 38.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.714 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.85 -9.27 68.33 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.762 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.569 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -108.6 170.74 7.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 117.002 0.401 . . . . 0.0 109.927 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.569 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -79.87 175.2 55.05 Favored Glycine 0 C--O 1.224 -0.502 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.119 -178.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.856 ' CG2' HD12 ' A' ' 65' ' ' ILE . 2.0 tp 178.13 139.19 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.691 0.281 . . . . 0.0 110.906 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -116.08 126.21 53.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.94 0.4 . . . . 0.0 111.317 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -86.54 105.57 16.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.806 179.304 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -88.3 123.75 33.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.144 0.497 . . . . 0.0 112.194 -178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.923 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.3 mt -80.25 120.05 78.34 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.055 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.82 130.98 37.31 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.313 2.008 . . . . 0.0 112.859 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 43.09 65.22 1.0 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 113.045 0.758 . . . . 0.0 113.045 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -142.0 150.96 42.02 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.801 0.334 . . . . 0.0 110.617 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -140.61 117.68 11.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.98 84.08 7.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.956 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.0 p -119.66 -173.01 2.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -57.45 -30.03 64.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.955 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -63.14 -28.02 69.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.968 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.637 HD12 ' CG1' ' A' ' 80' ' ' VAL . 36.4 mm -87.38 127.02 41.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.44 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.405 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -112.76 -42.37 3.62 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.053 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 34.1 tt0 -124.99 118.74 26.91 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.146 -178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 42' ' ' PHE . 39.3 t -123.74 112.79 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.262 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -112.62 139.0 48.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.205 0.526 . . . . 0.0 112.071 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.461 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 71.7 m95 -112.39 82.99 1.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.865 178.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -94.69 142.92 26.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.337 0.589 . . . . 0.0 112.286 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.44 118.23 18.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.418 178.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.97 -113.73 5.01 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.654 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.5 p -119.55 44.82 2.28 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.738 0.304 . . . . 0.0 110.663 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.8 m -156.46 159.64 38.83 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.887 0.375 . . . . 0.0 111.315 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.52 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 4.8 mt -99.81 147.49 25.43 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.697 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 40.3 t -118.37 -41.14 2.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.481 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -172.97 117.54 0.31 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.679 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -122.53 156.94 33.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 110.617 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 30' ' ' VAL . 63.5 t80 -121.53 134.54 55.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.717 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -129.37 113.44 14.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.753 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 -44.7 95.73 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.527 0 CA-C-O 122.165 0.983 . . . . 0.0 111.114 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.4 mttt 81.44 -47.12 0.23 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 113.493 -1.685 . . . . 0.0 110.968 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.5 mtt -55.78 150.36 13.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.94 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.34 111.06 3.68 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.152 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -69.71 -166.53 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.466 2.11 . . . . 0.0 112.043 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.52 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 84.9 t80 -136.67 113.7 10.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.869 0.366 . . . . 0.0 111.481 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 50' ' ' LEU . 10.1 mt -108.69 112.64 25.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.98 179.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 24.3 tttm -44.67 -49.22 10.5 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.732 0.301 . . . . 0.0 111.381 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.52 168.69 2.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.085 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -52.82 -12.46 1.7 Allowed Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.817 -0.706 . . . . 0.0 113.445 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.74 0.3 13.44 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 117.847 0.824 . . . . 0.0 112.336 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -136.99 156.89 47.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.013 0.435 . . . . 0.0 111.269 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -150.8 120.46 6.99 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.232 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.627 HG23 ' O ' ' A' ' 57' ' ' ILE . 4.7 tt -75.59 103.9 3.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.047 0.451 . . . . 0.0 111.368 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.522 HD23 HD21 ' A' ' 60' ' ' ASN . 1.6 mp -54.15 169.03 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.069 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.33 -24.44 64.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.624 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.522 HD21 HD23 ' A' ' 58' ' ' LEU . 5.8 p30 -96.48 33.22 1.84 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.79 0.329 . . . . 0.0 111.157 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.04 31.0 64.43 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.723 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.47 174.03 6.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.886 0.374 . . . . 0.0 111.117 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 11.1 tp -113.7 121.11 43.12 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.53 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.481 ' HG3' HD11 ' A' ' 58' ' ' LEU . 3.1 tmtp? -106.87 106.32 16.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.755 0.312 . . . . 0.0 111.196 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.856 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.7 mt -86.4 135.41 25.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.067 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -90.75 -40.72 11.67 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -143.63 109.19 5.13 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.758 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.848 ' HB3' HG21 ' A' ' 97' ' ' ILE . 5.3 mt -58.54 145.89 37.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.129 0.49 . . . . 0.0 111.339 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.725 ' C ' HD11 ' A' ' 10' ' ' LEU . 4.5 p -148.78 158.48 44.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.238 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.681 ' N ' HD11 ' A' ' 10' ' ' LEU . 9.9 mmm-85 -50.5 -57.1 8.88 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.185 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -54.42 -22.29 12.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.094 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.559 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -81.4 -14.81 56.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.319 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.445 ' HB3' HD12 ' A' ' 97' ' ' ILE . 5.0 p -83.55 138.2 33.5 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.647 0.26 . . . . 0.0 110.845 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.07 -126.02 2.32 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.681 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.2 m -132.99 129.61 38.42 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.864 0.832 . . . . 0.0 110.921 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.53 ' CE1' HD12 ' A' ' 95' ' ' LEU . 23.6 m-85 -103.91 151.28 23.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.293 179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -132.63 122.42 24.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.371 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.923 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -108.0 127.85 63.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.056 179.288 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.98 97.09 6.03 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.637 ' CG1' HD12 ' A' ' 27' ' ' ILE . 80.7 t -88.16 130.25 38.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.304 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.555 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 96.8 m-85 -124.02 154.45 39.86 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.269 0.556 . . . . 0.0 111.184 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.534 ' CB ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -87.98 175.85 7.59 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.381 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.405 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 20.3 p -62.65 -22.03 66.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.165 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -96.0 24.97 5.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.191 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.63 26.83 53.82 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.581 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.69 157.84 15.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.816 0.341 . . . . 0.0 110.816 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.12 111.41 14.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.641 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.534 HD11 ' CB ' ' A' ' 82' ' ' SER . 34.4 mm -92.98 -49.72 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.33 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.518 HD21 ' CG ' ' A' ' 91' ' ' LYS . 2.6 tt -154.01 149.15 26.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.283 0.563 . . . . 0.0 111.773 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -140.62 108.32 5.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.173 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.518 ' CG ' HD21 ' A' ' 89' ' ' LEU . 7.4 mmpt? -120.52 159.2 25.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.83 121.71 14.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.039 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.647 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -120.91 161.89 20.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.892 0.377 . . . . 0.0 111.695 -179.256 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.59 125.81 53.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.199 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.881 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -106.31 101.51 10.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.233 -179.44 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.36 108.95 21.78 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.22 0.533 . . . . 0.0 110.412 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.848 HG21 ' HB3' ' A' ' 68' ' ' LEU . 3.6 mt -110.44 113.41 44.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.731 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mt -67.69 121.0 14.98 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.534 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.912 -179.872 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.812 0.339 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -131.31 -65.86 0.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.897 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.3 115.34 3.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.87 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 166.41 160.65 13.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.495 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.415 HG23 ' HB2' ' A' ' 94' ' ' ASP . 97.3 m -64.58 118.72 9.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 0.0 110.887 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.89 HG23 ' HA ' ' A' ' 95' ' ' LEU . 2.9 m -95.74 178.57 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 CA-C-O 121.78 0.8 . . . . 0.0 112.345 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.433 ' CE3' ' HB2' ' A' ' 96' ' ' ARG . 73.3 m95 -145.42 161.97 38.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.55 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.48 179.16 41.15 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.427 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.413 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -122.63 134.42 54.5 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.976 0.417 . . . . 0.0 111.25 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.686 HD11 ' N ' ' A' ' 70' ' ' ARG . 1.2 tp -58.0 134.09 56.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.692 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.0 -4.11 83.89 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.393 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.614 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.4 OUTLIER -108.99 167.94 9.73 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.614 ' O ' ' CE1' ' A' ' 12' ' ' HIS . . . -78.73 -173.4 43.02 Favored Glycine 0 C--O 1.224 -0.504 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.659 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.895 HG21 HD21 ' A' ' 68' ' ' LEU . 1.1 tp 164.18 136.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.756 0.312 . . . . 0.0 110.38 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -116.93 118.7 33.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.89 0.376 . . . . 0.0 111.391 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.475 HD21 ' CD1' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -81.23 102.93 10.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.849 179.299 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -85.97 124.73 32.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.192 0.52 . . . . 0.0 111.724 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.94 HD11 HG11 ' A' ' 78' ' ' VAL . 3.4 mt -78.42 119.93 79.16 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.154 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -58.26 130.15 36.33 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.37 2.047 . . . . 0.0 113.094 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 42.44 64.61 1.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.518 ' HB2' HD13 ' A' ' 89' ' ' LEU . 9.6 t80 -140.7 149.0 41.64 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.817 0.341 . . . . 0.0 110.585 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -139.42 117.16 11.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.961 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.35 81.14 7.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.868 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.54 -174.53 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.829 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -56.8 -30.78 64.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.961 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -64.02 -27.85 69.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.565 HD12 ' CG1' ' A' ' 80' ' ' VAL . 33.6 mm -83.67 127.88 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.429 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -111.73 -44.06 3.54 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 13.9 tp10 -125.91 134.58 51.53 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.317 -179.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -135.41 108.01 8.54 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.723 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -105.17 132.03 51.9 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 68.3 m95 -109.01 82.88 1.66 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -99.17 157.92 16.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.394 0.616 . . . . 0.0 112.467 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.2 ttp180 -149.3 113.8 5.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.509 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.46 -117.03 9.4 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.741 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 p -115.0 42.47 2.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.741 0.305 . . . . 0.0 110.705 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.0 m -150.66 160.4 43.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.237 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.541 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 6.2 mt -106.82 147.94 29.11 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.686 -0.486 . . . . 0.0 109.686 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.444 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 53.7 t -119.03 -43.76 2.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.235 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.39 113.26 1.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.527 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.528 ' OE2' HD21 ' A' ' 38' ' ' LEU . 2.2 mt-10 -118.51 113.58 21.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.051 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.561 ' HB2' HD13 ' A' ' 57' ' ' ILE . 16.5 t80 -103.82 120.99 42.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.882 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -120.07 132.68 55.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.466 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.9 tpp85 -47.72 -28.43 2.46 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.497 0.665 . . . . 0.0 111.684 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.8 tttm -82.73 41.9 0.75 Allowed 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.906 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 41.58 -164.8 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.501 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.4 mmtm 54.69 69.45 2.08 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.57 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -82.48 176.56 7.81 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.978 2.452 . . . . 0.0 111.939 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.541 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 69.8 t80 -125.34 99.87 6.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.337 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 50' ' ' LEU . 9.1 mt -96.24 105.66 17.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.931 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.444 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 39.8 tttm -43.92 -59.2 2.38 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.586 -179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 32.6 p -144.74 162.75 35.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.929 0.395 . . . . 0.0 111.193 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -63.08 -8.16 21.67 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.615 -0.803 . . . . 0.0 113.022 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.432 ' HA ' ' HD2' ' A' ' 66' ' ' LYS . . . -78.39 3.41 15.78 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 117.559 0.679 . . . . 0.0 111.952 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -125.5 157.36 37.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.273 0.559 . . . . 0.0 111.743 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -154.55 124.65 6.77 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.212 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 57' ' ' ILE . 3.0 tt -83.49 106.66 14.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.308 -179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.66 HD23 HD21 ' A' ' 60' ' ' ASN . 1.2 mp -65.7 172.79 3.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.904 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.3 -44.83 64.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.156 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.66 HD21 HD23 ' A' ' 58' ' ' LEU . 4.7 p30 -57.33 -25.13 58.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.06 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.69 33.42 3.84 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.547 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -113.39 154.61 26.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.841 0.353 . . . . 0.0 110.964 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 tp -84.39 122.05 28.4 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.459 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.406 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -102.99 111.33 23.61 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.831 0.348 . . . . 0.0 111.421 -179.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.865 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.8 mt -97.13 122.64 48.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.114 179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.432 ' HD2' ' HA ' ' A' ' 54' ' ' ALA . 1.6 ptpp? -89.27 -33.76 16.84 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.471 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -140.8 104.82 4.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.601 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.895 HD21 HG21 ' A' ' 14' ' ' ILE . 6.2 mt -63.01 154.43 30.68 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.13 0.49 . . . . 0.0 111.458 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.545 ' C ' HD11 ' A' ' 10' ' ' LEU . 5.1 p -152.35 157.04 40.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.209 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.686 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -50.11 -55.98 12.77 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.363 -179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -52.63 -24.6 8.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.132 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.01 -15.36 44.42 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.255 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.403 ' N ' HD12 ' A' ' 97' ' ' ILE . 14.4 p -77.86 126.2 30.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.415 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 154.21 -131.08 3.09 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.447 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 1.3 m -126.03 129.19 48.68 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 117.711 0.756 . . . . 0.0 111.143 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.475 ' CD1' HD21 ' A' ' 16' ' ' LEU . 63.9 m-85 -99.82 148.4 24.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.035 178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.651 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 12.8 m-20 -130.05 122.23 27.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.769 0.319 . . . . 0.0 111.356 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.94 HG11 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.57 130.55 62.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.274 179.34 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.94 96.72 5.29 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.818 178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.565 ' CG1' HD12 ' A' ' 27' ' ' ILE . 55.0 t -86.56 134.07 28.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.243 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.491 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 81.0 m-85 -127.39 156.69 41.65 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.347 0.594 . . . . 0.0 111.199 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.661 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -90.02 174.96 7.37 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.448 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.3 -24.94 66.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.15 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -95.9 27.1 3.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.198 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.7 23.61 37.32 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.719 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.61 156.32 18.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.731 0.3 . . . . 0.0 110.823 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.58 118.42 22.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.541 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.661 HD11 ' HB3' ' A' ' 82' ' ' SER . 45.9 mt -102.05 -67.1 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.425 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.569 HD21 ' CG ' ' A' ' 91' ' ' LYS . 5.1 tt -134.18 148.8 50.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.322 0.582 . . . . 0.0 111.875 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.69 109.21 5.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.061 179.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.569 ' CG ' HD21 ' A' ' 89' ' ' LEU . 58.4 mmtt -122.53 153.33 39.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.651 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -139.85 122.95 16.81 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.284 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.647 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -122.82 165.28 16.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.267 -179.522 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.415 ' HB2' HG23 ' A' ' 5' ' ' THR . 0.7 OUTLIER -125.22 106.32 9.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.73 179.709 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.89 ' HA ' HG23 ' A' ' 6' ' ' VAL . 7.1 tt -101.16 114.86 29.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.897 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -96.79 108.33 20.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.408 179.338 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.748 HG12 HD22 ' A' ' 68' ' ' LEU . 8.6 mt -90.88 108.94 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.776 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.91 120.38 13.5 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.571 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.872 -179.835 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.876 0.369 . . . . 0.0 111.269 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -158.75 169.24 24.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 m -60.47 -175.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.74 160.81 24.66 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.537 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 5.8 m -138.78 154.64 48.52 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.292 0.568 . . . . 0.0 111.067 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.743 HG11 HD12 ' A' ' 95' ' ' LEU . 0.3 OUTLIER -153.61 141.56 13.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.884 -178.604 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 65.4 m95 -115.73 139.35 50.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.81 0.338 . . . . 0.0 110.957 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.57 176.59 28.21 Favored Glycine 0 C--O 1.228 -0.221 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.972 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -117.61 135.12 54.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 117.172 0.486 . . . . 0.0 111.121 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.565 HD12 HG21 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -54.02 130.38 37.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.713 179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.11 -8.95 75.64 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.887 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.549 ' NE2' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER -106.57 170.97 7.62 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.549 ' O ' ' NE2' ' A' ' 12' ' ' HIS . . . -86.55 174.36 46.56 Favored Glycine 0 C--O 1.224 -0.477 0 C-N-CA 120.705 -0.759 . . . . 0.0 113.468 -178.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.815 ' CG2' HD12 ' A' ' 65' ' ' ILE . 3.3 tp 179.59 144.08 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.6 0.238 . . . . 0.0 110.632 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -120.69 129.94 53.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.951 0.405 . . . . 0.0 111.639 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -91.52 104.08 16.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.713 179.222 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -86.19 123.9 31.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.188 0.518 . . . . 0.0 111.911 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.934 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.4 mt -79.55 120.19 79.43 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.184 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.25 130.63 36.92 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.26 1.973 . . . . 0.0 113.0 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 43.08 64.78 1.1 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 179.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -141.67 150.5 41.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.784 0.326 . . . . 0.0 110.551 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -142.07 117.55 10.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.881 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -79.97 76.87 6.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.978 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.1 p -105.86 -172.51 2.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -59.08 -31.45 68.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.966 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.01 -26.94 68.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.99 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.552 HD12 ' CG1' ' A' ' 80' ' ' VAL . 22.1 mm -79.01 129.21 37.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.43 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.418 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.9 OUTLIER -112.68 -44.11 3.37 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.082 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 69.2 tt0 -132.45 116.39 16.73 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.001 -0.68 . . . . 0.0 112.655 -178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.31 114.69 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -112.17 130.73 55.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.172 0.51 . . . . 0.0 112.36 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -112.73 85.37 2.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.987 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -98.97 148.75 23.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.252 0.548 . . . . 0.0 112.229 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.0 114.69 9.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.609 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.45 -117.73 11.5 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.809 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.5 m -114.64 42.36 2.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.764 0.316 . . . . 0.0 110.665 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 95.7 m -151.95 160.18 43.57 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.235 -179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.542 HD21 ' OE2' ' A' ' 41' ' ' GLU . 5.5 mt -102.94 146.15 28.75 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.463 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 46.9 t -117.59 -42.47 2.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.941 0.401 . . . . 0.0 110.243 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 49' ' ' PHE . . . -165.83 112.17 0.89 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.492 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.542 ' OE2' HD21 ' A' ' 38' ' ' LEU . 2.2 mt-10 -120.36 112.67 19.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.066 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.43 ' HB2' HD13 ' A' ' 57' ' ' ILE . 22.4 t80 -102.34 158.88 15.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.761 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.412 ' N ' ' CD1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -147.93 174.4 11.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.927 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.427 ' HD3' ' HA ' ' A' ' 44' ' ' ARG . 2.7 tpp180 -99.58 105.7 17.61 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 121.82 0.819 . . . . 0.0 109.791 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 44' ' ' ARG . 2.3 tmtt? 82.77 -47.95 0.16 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.296 -1.32 . . . . 0.0 110.706 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -56.91 178.18 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.742 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.45 132.52 31.65 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.209 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.412 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 91.7 Cg_endo -84.29 -175.31 2.13 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.767 2.311 . . . . 0.0 112.52 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.536 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 78.7 t80 -138.83 106.17 5.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.415 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 50' ' ' LEU . 7.9 mt -100.95 110.66 22.73 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 36.2 tttt -44.84 -49.14 10.99 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.73 0.3 . . . . 0.0 111.607 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.1 p -169.84 164.98 9.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.956 0.408 . . . . 0.0 111.319 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.77 -12.1 4.78 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 120.711 -0.757 . . . . 0.0 113.138 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.28 0.93 12.69 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 117.782 0.791 . . . . 0.0 112.083 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -131.94 157.54 43.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.052 0.453 . . . . 0.0 111.09 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -154.09 127.21 8.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.512 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.661 HG23 ' O ' ' A' ' 57' ' ' ILE . 7.1 tt -86.02 101.26 10.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.178 0.513 . . . . 0.0 111.276 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.633 HD23 HD21 ' A' ' 60' ' ' ASN . 1.2 mp -58.68 171.16 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.957 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.7 -44.64 77.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.185 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.633 HD21 HD23 ' A' ' 58' ' ' LEU . 4.9 p30 -58.2 -25.1 61.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.07 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.75 34.17 3.88 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.568 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -112.96 154.73 25.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.789 0.328 . . . . 0.0 110.968 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 13.0 tp -82.72 123.13 29.01 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.632 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.413 ' HB2' HD13 ' A' ' 58' ' ' LEU . 1.4 tptt -106.38 110.09 22.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.906 0.384 . . . . 0.0 111.219 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.815 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.9 mt -92.21 121.2 42.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.148 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -81.14 -36.21 30.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.894 0.378 . . . . 0.0 111.798 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -144.25 107.52 4.56 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.706 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.605 HD22 ' CD1' ' A' ' 97' ' ' ILE . 4.4 mt -59.03 143.73 47.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.058 0.456 . . . . 0.0 111.337 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.448 ' HA ' ' CD1' ' A' ' 10' ' ' LEU . 9.2 p -143.33 165.09 28.45 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.856 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.7 mmt85 -50.5 -54.94 18.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.256 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -53.45 -23.87 11.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.41 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -73.5 -13.57 61.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.567 0.222 . . . . 0.0 111.427 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.418 ' HB3' ' CG1' ' A' ' 97' ' ' ILE . 5.0 p -82.78 116.05 21.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.68 0.276 . . . . 0.0 110.647 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.27 -144.93 10.3 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.21 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.3 m -120.38 131.02 54.64 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.145 0.472 . . . . 0.0 110.621 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -103.96 131.99 50.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.411 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.708 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 1.9 m-20 -114.39 123.4 49.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.286 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.934 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -106.11 129.06 59.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.275 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.47 97.66 6.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.552 ' CG1' HD12 ' A' ' 27' ' ' ILE . 77.7 t -88.0 123.23 40.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.436 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.445 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 93.4 m-85 -113.81 151.15 32.46 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.224 0.535 . . . . 0.0 111.053 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.61 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -90.79 172.87 8.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.545 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 16.9 p -60.81 -19.18 59.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.351 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.6 m-80 -94.39 24.67 4.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.218 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.82 23.29 44.4 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.6 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.94 176.11 5.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.783 0.325 . . . . 0.0 110.735 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.1 ttt180 -98.31 126.47 43.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.676 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.61 HD11 ' HB3' ' A' ' 82' ' ' SER . 51.4 mt -101.24 -61.42 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.416 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.749 HD21 ' CG ' ' A' ' 91' ' ' LYS . 5.0 tt -140.06 129.53 24.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.113 0.483 . . . . 0.0 111.855 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -120.54 108.54 14.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.17 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.749 ' CG ' HD21 ' A' ' 89' ' ' LEU . 26.2 mmtt -121.05 159.69 25.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.352 0.596 . . . . 0.0 112.439 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.708 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -139.83 121.75 15.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.45 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 93' ' ' LEU . 1.4 mp -119.49 165.39 14.45 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.865 0.364 . . . . 0.0 111.152 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 5' ' ' THR . 0.7 OUTLIER -123.47 134.31 53.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.639 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.743 HD12 HG11 ' A' ' 6' ' ' VAL . 8.5 tt -129.73 132.37 46.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.023 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -109.8 132.29 54.28 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.931 0.396 . . . . 0.0 111.062 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.605 ' CD1' HD22 ' A' ' 68' ' ' LEU . 7.0 mm -101.12 100.9 11.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.615 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.8 mt -74.86 122.81 23.95 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 120.971 0.415 . . . . 0.0 110.479 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.318 -0.848 . . . . 0.0 110.912 -179.829 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.731 0.3 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -107.48 -67.12 0.98 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.898 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.87 -166.81 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.821 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 73.65 -150.24 42.86 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.397 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 1.8 m -47.07 146.07 1.89 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.252 0.548 . . . . 0.0 111.267 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.815 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -142.01 148.86 20.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.706 -179.187 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -118.53 128.57 54.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.659 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -144.07 179.66 21.24 Favored Glycine 0 N--CA 1.46 0.296 0 C-N-CA 120.242 -0.98 . . . . 0.0 112.733 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.41 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -124.72 134.7 52.74 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.929 0.395 . . . . 0.0 111.116 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.683 HD11 ' N ' ' A' ' 70' ' ' ARG . 1.0 OUTLIER -52.81 134.57 36.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.158 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.73 -6.44 82.75 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.928 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -105.97 168.66 8.97 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 117.144 0.472 . . . . 0.0 109.988 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.529 ' O ' ' CD2' ' A' ' 12' ' ' HIS . . . -77.11 163.59 52.27 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.203 -178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.872 ' CG2' HD12 ' A' ' 65' ' ' ILE . 1.6 tp -176.97 138.96 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 O-C-N 122.635 -0.332 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -125.48 133.3 52.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.928 0.394 . . . . 0.0 111.352 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.836 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -87.24 122.4 30.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.563 179.156 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.458 ' O ' HD21 ' A' ' 93' ' ' LEU . 77.4 m-20 -103.59 124.49 48.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.134 0.492 . . . . 0.0 111.687 -179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.957 HD11 HG11 ' A' ' 78' ' ' VAL . 3.2 mt -80.51 119.46 76.37 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.349 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.26 131.33 38.19 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.357 2.038 . . . . 0.0 113.066 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.15 64.81 1.01 Allowed 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -139.69 149.32 43.54 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.809 0.337 . . . . 0.0 110.517 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -135.38 117.01 14.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.511 ' SD ' HG21 ' A' ' 30' ' ' VAL . 1.8 tpt -87.53 83.62 7.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 44.9 p -115.47 -173.13 2.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.849 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -58.61 -31.62 68.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.861 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.47 -24.91 67.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.945 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.492 HD12 ' CG1' ' A' ' 80' ' ' VAL . 34.6 mm -79.86 127.89 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.43 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.441 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 1.3 t0 -103.9 -38.37 7.04 Favored 'General case' 0 N--CA 1.455 -0.198 0 O-C-N 122.267 -0.27 . . . . 0.0 111.673 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 81' ' ' TYR . 8.8 mt-10 -141.96 151.81 42.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.722 0.772 . . . . 0.0 112.574 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.511 HG21 ' SD ' ' A' ' 23' ' ' MET . 45.5 t -145.29 106.87 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 114.438 -1.255 . . . . 0.0 109.955 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -101.53 126.05 48.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.079 0.466 . . . . 0.0 112.232 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -105.16 84.39 2.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.03 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -103.99 156.13 18.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.233 0.539 . . . . 0.0 112.211 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.58 117.73 7.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.734 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.99 -118.12 12.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.826 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.9 t -115.19 42.52 2.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.758 0.313 . . . . 0.0 110.721 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 90.9 m -149.93 159.94 43.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.136 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.533 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 6.3 mt -105.57 145.69 30.62 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.173 -0.467 . . . . 0.0 109.872 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.407 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 54.2 t -117.04 -43.6 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.086 0.47 . . . . 0.0 110.089 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.91 112.36 0.89 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.713 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -116.5 111.79 20.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.076 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -110.19 115.35 29.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.943 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 10.0 pttp -120.08 142.7 48.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.472 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 -50.76 -24.93 3.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.235 0.54 . . . . 0.0 111.878 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -81.41 37.88 0.47 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.225 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.4 ttm 40.05 -163.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.63 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.5 mttt 52.47 65.18 6.4 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.65 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -78.66 179.76 6.2 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.548 2.165 . . . . 0.0 112.055 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 64.4 t80 -129.87 98.71 4.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.433 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 50' ' ' LEU . 10.1 mt -95.82 108.68 21.05 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 38.8 tttt -42.19 -37.83 1.57 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.707 0.289 . . . . 0.0 111.7 -179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.52 165.4 1.36 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.902 0.382 . . . . 0.0 111.07 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.64 -10.49 4.52 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.338 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.65 2.01 10.88 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 117.748 0.774 . . . . 0.0 112.185 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -132.1 157.59 43.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.092 0.473 . . . . 0.0 111.262 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -155.94 123.87 5.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.421 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.648 HG23 ' O ' ' A' ' 57' ' ' ILE . 6.6 tt -81.25 101.73 6.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.224 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.676 HD23 HD21 ' A' ' 60' ' ' ASN . 0.8 OUTLIER -58.88 173.35 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.993 -179.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.78 -45.19 65.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.199 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.676 HD21 HD23 ' A' ' 58' ' ' LEU . 4.6 p30 -58.15 -21.88 48.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.123 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.67 35.06 4.18 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.611 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -116.1 155.17 28.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.841 0.353 . . . . 0.0 111.036 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 12.1 tp -81.77 122.46 27.7 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.671 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -104.83 110.26 22.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.752 0.311 . . . . 0.0 111.111 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.872 HD12 ' CG2' ' A' ' 14' ' ' ILE . 3.1 mt -91.38 134.35 30.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.339 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -82.73 -45.94 13.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.015 0.436 . . . . 0.0 111.692 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.77 112.31 5.6 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.249 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.066 HD22 HD12 ' A' ' 97' ' ' ILE . 4.4 mt -51.37 146.49 6.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.166 0.508 . . . . 0.0 111.974 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.581 ' C ' HD11 ' A' ' 10' ' ' LEU . 2.7 p -143.98 155.23 43.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.826 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.683 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.6 OUTLIER -50.11 -56.33 11.33 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.363 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -52.98 -23.8 8.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.162 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.553 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -77.32 -16.17 59.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.303 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.438 ' CB ' HG12 ' A' ' 97' ' ' ILE . 22.1 p -76.95 117.48 18.58 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.641 0.258 . . . . 0.0 110.711 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.54 -151.33 21.17 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.169 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.6 m -110.05 131.34 55.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.783 0.325 . . . . 0.0 110.512 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -105.21 151.72 23.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.266 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.661 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 12.1 m-20 -133.8 125.0 27.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.847 0.355 . . . . 0.0 111.434 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.957 HG11 HD11 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -107.47 134.23 49.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.256 179.195 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.39 95.03 4.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.649 178.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.493 HG12 ' HB ' ' A' ' 88' ' ' ILE . 64.8 t -85.31 130.97 35.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.015 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.538 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 2.7 m-30 -116.87 152.99 33.32 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.31 0.576 . . . . 0.0 110.764 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.507 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -92.48 179.24 5.58 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.884 179.393 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 0.8 OUTLIER -64.78 -23.61 67.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.088 179.619 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -84.69 -5.12 59.3 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.52 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.56 19.23 55.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.812 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.88 141.82 37.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.749 0.309 . . . . 0.0 110.861 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.39 111.04 2.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.95 0.405 . . . . 0.0 111.014 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.507 HD11 ' HB3' ' A' ' 82' ' ' SER . 26.1 mm -80.14 -40.29 20.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.159 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.913 HD21 ' HG3' ' A' ' 91' ' ' LYS . 4.4 tt -152.82 127.36 9.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.107 0.479 . . . . 0.0 111.885 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -117.35 108.12 15.2 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.913 ' HG3' HD21 ' A' ' 89' ' ' LEU . 15.5 mmtt -119.32 159.4 24.22 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.661 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.73 122.41 17.49 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.071 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.643 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -119.88 162.15 19.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.015 0.435 . . . . 0.0 111.57 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 5' ' ' THR . 29.0 m-20 -111.25 122.6 48.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.449 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.836 HD12 HD21 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -117.2 101.95 8.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.051 -179.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.545 ' C ' HD13 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -94.42 125.18 38.9 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.129 0.49 . . . . 0.0 110.929 179.721 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.066 HD12 HD22 ' A' ' 68' ' ' LEU . 2.8 mm -108.72 112.49 40.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.999 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 98' ' ' LEU . 10.1 mt -73.68 123.54 24.26 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.416 179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.1 mp0 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.883 -179.793 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.776 0.322 . . . . 0.0 111.148 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -72.49 149.38 44.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.882 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.5 p -78.78 -76.47 0.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.876 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.62 158.84 30.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.574 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.1 m -142.74 152.69 42.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.22 0.534 . . . . 0.0 110.92 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.955 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.8 OUTLIER -142.63 145.47 23.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.866 -179.308 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 79.2 m95 -115.13 130.09 56.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.802 0.334 . . . . 0.0 110.752 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -147.57 -179.62 23.74 Favored Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.781 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.434 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -129.79 134.43 47.57 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.972 0.415 . . . . 0.0 111.192 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.66 HD11 ' N ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -53.63 135.86 39.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.992 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.88 -8.77 74.64 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.73 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.527 ' CE1' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.61 167.37 10.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.594 ' O ' ' HB ' ' A' ' 14' ' ' ILE . . . -70.89 -171.75 11.34 Favored Glycine 0 C--O 1.226 -0.377 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.472 -179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.893 HG21 HD21 ' A' ' 68' ' ' LEU . 1.0 OUTLIER 163.04 136.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.94 0.4 . . . . 0.0 110.531 179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -119.33 134.02 55.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.067 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -92.18 105.27 17.53 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.173 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.42 ' O ' HD21 ' A' ' 93' ' ' LEU . 61.9 m-20 -88.45 122.09 31.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.183 0.516 . . . . 0.0 112.116 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.941 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.3 mt -80.58 119.46 76.34 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.229 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -60.68 131.76 39.4 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.316 2.011 . . . . 0.0 112.878 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 43.26 65.37 0.98 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -142.75 149.31 38.57 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-O 120.791 0.329 . . . . 0.0 110.625 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -142.75 116.95 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.948 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -79.07 78.82 5.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.909 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.2 p -107.37 -173.49 2.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.843 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.31 -34.87 71.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.923 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -59.76 -24.77 64.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.994 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.548 HD12 ' CG1' ' A' ' 80' ' ' VAL . 26.9 mm -78.61 129.08 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.448 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 0.4 OUTLIER -110.72 -45.11 3.54 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.024 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 63.6 tt0 -135.36 118.24 16.23 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 120.02 -0.672 . . . . 0.0 112.786 -178.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 t -110.08 115.08 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.922 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -112.82 132.87 55.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.297 0.57 . . . . 0.0 112.426 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.451 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 70.3 m95 -112.28 86.48 2.36 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.342 -0.844 . . . . 0.0 108.784 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -100.44 145.67 27.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.272 0.558 . . . . 0.0 112.386 -178.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.8 ttp85 -136.98 118.43 14.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.403 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.95 -114.7 5.98 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.685 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.4 m -119.3 44.69 2.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.763 0.316 . . . . 0.0 110.663 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.8 m -154.78 159.98 40.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.309 -179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.525 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 5.7 mt -101.47 146.76 27.2 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.482 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 41.8 t -117.05 -41.25 2.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.992 0.425 . . . . 0.0 110.494 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -170.42 113.62 0.45 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.676 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -117.72 149.36 40.87 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.046 0.45 . . . . 0.0 110.422 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.434 ' HA ' ' HB3' ' A' ' 48' ' ' PRO . 55.2 t80 -127.75 158.17 38.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.932 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 28' ' ' ASP . 0.6 OUTLIER -146.49 169.94 17.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.678 179.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.409 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -93.47 102.08 14.29 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.757 0.789 . . . . 0.0 109.543 179.263 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.409 ' CB ' ' O ' ' A' ' 44' ' ' ARG . 29.0 tttt 82.93 -47.42 0.15 Allowed 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.588 -178.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.2 ttt -55.92 169.83 0.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.757 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -86.51 134.24 38.41 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.173 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.434 ' HB3' ' HA ' ' A' ' 42' ' ' PHE . 93.4 Cg_endo -82.83 -176.07 2.72 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.694 2.263 . . . . 0.0 112.691 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.525 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 61.0 t80 -130.62 106.77 8.71 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.156 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.4 mt -99.49 113.89 26.53 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.197 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.482 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 22.6 tttt -46.91 -44.83 20.09 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.71 0.291 . . . . 0.0 111.431 -179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 p -176.54 165.78 2.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.122 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.02 -12.09 3.59 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.159 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.71 0.94 13.58 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 117.746 0.773 . . . . 0.0 112.133 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -132.93 156.81 46.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.102 0.477 . . . . 0.0 111.195 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -151.23 118.43 5.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.348 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.642 HG23 ' O ' ' A' ' 57' ' ' ILE . 8.8 tt -75.04 99.31 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.064 0.459 . . . . 0.0 111.319 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.633 HD23 HD21 ' A' ' 60' ' ' ASN . 0.7 OUTLIER -49.59 167.02 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.245 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.74 -23.92 65.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.555 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.633 HD21 HD23 ' A' ' 58' ' ' LEU . 5.9 p30 -96.59 33.18 1.87 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.836 0.351 . . . . 0.0 111.183 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.54 34.33 69.07 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.713 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.51 166.4 10.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.876 0.369 . . . . 0.0 111.007 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.428 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . 10.4 tp -107.24 120.72 42.91 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.515 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.421 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -107.38 110.64 22.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 110.875 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.801 HD12 ' CG2' ' A' ' 14' ' ' ILE . 2.8 mt -89.56 137.53 21.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.363 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -84.79 -47.11 10.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.974 0.416 . . . . 0.0 112.006 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -143.35 110.86 5.84 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.403 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 14' ' ' ILE . 6.7 mt -55.2 150.78 10.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.71 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.596 ' C ' HD11 ' A' ' 10' ' ' LEU . 5.4 p -152.14 158.6 43.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.924 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.66 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -50.53 -56.27 12.37 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.2 -179.684 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -55.03 -22.41 15.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.129 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.643 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.3 OUTLIER -80.16 -14.41 58.49 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.313 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.3 t -79.59 127.34 32.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.644 0.259 . . . . 0.0 110.581 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 153.56 -167.85 32.07 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.226 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.55 125.33 36.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.763 0.316 . . . . 0.0 111.487 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -103.32 130.7 50.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.29 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -113.29 126.07 54.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.857 0.36 . . . . 0.0 111.562 -179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.941 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.4 OUTLIER -108.01 126.14 64.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.027 179.178 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.88 97.91 6.85 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.548 ' CG1' HD12 ' A' ' 27' ' ' ILE . 69.0 t -90.41 124.24 42.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.441 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.404 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 85.1 m-85 -112.93 151.22 30.78 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.169 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.633 ' HB3' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -90.75 173.8 7.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.551 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.5 p -61.23 -18.46 58.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.385 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -93.01 22.98 4.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.325 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.57 19.52 48.57 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.656 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.55 -178.73 3.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.703 0.287 . . . . 0.0 110.616 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -101.08 126.3 47.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.778 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.633 HD11 ' HB3' ' A' ' 82' ' ' SER . 33.7 mm -98.95 -54.44 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.417 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.744 HD21 ' CG ' ' A' ' 91' ' ' LYS . 5.3 tt -144.98 126.12 14.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.105 0.479 . . . . 0.0 111.98 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -118.01 107.41 14.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.1 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.744 ' CG ' HD21 ' A' ' 89' ' ' LEU . 8.2 mmpt? -120.17 162.79 18.74 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.85 120.56 12.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.091 179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.639 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -115.11 156.47 25.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.87 0.367 . . . . 0.0 111.531 -179.139 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.02 121.45 43.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.244 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.955 ' HA ' HG12 ' A' ' 6' ' ' VAL . 9.7 tp -108.85 98.59 8.06 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.286 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -96.59 110.73 23.08 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.125 0.488 . . . . 0.0 110.322 179.18 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.749 HG21 ' HB3' ' A' ' 68' ' ' LEU . 4.6 mt -104.9 113.16 41.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.895 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 98' ' ' LEU . 8.8 mt -69.0 121.01 15.76 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.549 179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.939 -179.84 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.876 0.369 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.02 -39.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.837 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.4 t -58.04 125.32 22.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.923 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 90.23 -148.81 19.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.552 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -45.2 145.83 1.02 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.411 0.624 . . . . 0.0 111.454 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.899 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.6 OUTLIER -137.88 144.56 30.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.619 -179.261 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 80.6 m95 -112.68 129.56 56.36 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.799 0.333 . . . . 0.0 110.882 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -153.98 177.6 31.34 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.76 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -121.76 135.62 54.93 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.969 0.414 . . . . 0.0 110.848 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.801 HD11 ' C ' ' A' ' 69' ' ' THR . 1.7 tp -56.92 129.34 41.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.901 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.53 -4.69 76.68 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.502 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.559 ' NE2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.9 168.7 9.09 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.559 ' O ' ' NE2' ' A' ' 12' ' ' HIS . . . -77.74 160.67 49.02 Favored Glycine 0 C--O 1.224 -0.524 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.083 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.815 HG21 HD21 ' A' ' 68' ' ' LEU . 1.6 tp -176.14 138.06 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.834 0.349 . . . . 0.0 111.237 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -117.92 129.24 55.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.208 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -86.55 106.09 17.29 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.22 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.484 ' O ' HD21 ' A' ' 93' ' ' LEU . 67.5 m-20 -88.72 126.28 35.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.304 0.573 . . . . 0.0 112.008 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.913 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.3 mt -80.79 119.82 77.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.153 179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.33 131.26 37.66 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.318 2.012 . . . . 0.0 112.862 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 m120 43.27 65.37 0.99 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.469 ' HB2' HD13 ' A' ' 89' ' ' LEU . 9.3 t80 -142.7 151.3 41.2 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 110.55 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -141.94 114.97 8.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.29 83.27 5.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.935 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.14 -174.07 2.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.86 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -56.08 -30.02 61.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.953 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -63.67 -27.87 69.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.999 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.643 HD12 ' CG1' ' A' ' 80' ' ' VAL . 35.1 mm -87.39 127.04 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.399 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -113.03 -42.16 3.6 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -179.069 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 43.2 tt0 -124.63 118.38 26.38 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.174 -178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 41' ' ' GLU . 24.6 t -122.43 115.09 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.152 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -114.59 137.34 52.0 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.2 0.524 . . . . 0.0 112.261 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.446 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 71.9 m95 -112.19 85.58 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.86 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -97.28 142.39 29.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.287 0.565 . . . . 0.0 112.264 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.77 118.55 19.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.424 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.81 -114.22 5.45 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.095 -1.05 . . . . 0.0 111.687 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.7 m -119.68 44.94 2.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.732 0.301 . . . . 0.0 110.686 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.0 m -155.26 159.68 40.23 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.906 0.384 . . . . 0.0 111.357 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.535 ' HB3' ' CE2' ' A' ' 49' ' ' PHE . 4.5 mt -97.82 147.29 24.56 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.7 178.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 55.2 t -119.13 -43.09 2.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.341 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -172.45 114.39 0.3 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.725 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 1.1 pt-20 -125.05 156.61 37.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.078 0.466 . . . . 0.0 111.005 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -127.54 142.2 51.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.845 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.6 ' HE2' ' HE3' ' A' ' 46' ' ' MET . 1.5 ttpt -146.61 113.19 5.99 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.697 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -51.65 -59.31 4.43 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 121.795 0.807 . . . . 0.0 111.114 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -82.5 46.57 1.07 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.908 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.6 ' HE3' ' HE2' ' A' ' 43' ' ' LYS . 0.0 OUTLIER 176.85 -172.11 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.816 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.7 mmtt -107.55 141.04 22.16 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.755 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.61 155.17 59.45 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.445 2.097 . . . . 0.0 112.48 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.535 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 46.5 t80 -111.61 103.54 11.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.177 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 50' ' ' LEU . 8.3 mt -94.79 112.89 24.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.289 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 19.9 tttp -48.07 -46.63 33.82 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.695 0.283 . . . . 0.0 111.23 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -173.41 166.11 4.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.9 0.381 . . . . 0.0 111.196 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.38 -11.47 3.63 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.376 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.53 -0.09 14.09 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 117.834 0.817 . . . . 0.0 112.236 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -132.84 157.8 44.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.076 0.465 . . . . 0.0 111.073 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -152.07 124.45 8.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.43 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.649 HG23 ' O ' ' A' ' 57' ' ' ILE . 4.7 tt -84.61 103.9 12.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 111.176 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.668 HD23 HD21 ' A' ' 60' ' ' ASN . 1.4 mp -62.73 172.63 1.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.005 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.36 -45.15 63.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.147 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.668 HD21 HD23 ' A' ' 58' ' ' LEU . 4.5 p30 -57.43 -22.45 43.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.113 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 102.01 35.0 4.1 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.634 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -115.33 155.38 27.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 110.979 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.2 tp -85.48 122.72 30.02 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.798 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.1 OUTLIER -104.84 108.24 19.62 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.736 0.303 . . . . 0.0 111.073 179.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.794 HD12 ' CG2' ' A' ' 14' ' ' ILE . 4.0 mt -89.35 132.59 33.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.449 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -81.13 -46.06 15.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.953 0.406 . . . . 0.0 111.76 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -147.16 112.64 5.6 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.322 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.834 ' HB3' HG21 ' A' ' 97' ' ' ILE . 5.1 mt -54.16 149.62 9.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.166 0.508 . . . . 0.0 111.746 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.801 ' C ' HD11 ' A' ' 10' ' ' LEU . 5.2 p -151.32 158.26 43.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.153 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.612 ' N ' HD11 ' A' ' 10' ' ' LEU . 5.5 mmt180 -50.62 -56.82 10.07 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.173 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.37 -20.76 20.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.315 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.621 ' O ' HD23 ' A' ' 95' ' ' LEU . 0.4 OUTLIER -93.17 17.03 11.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.289 -179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.48 146.99 36.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.684 0.278 . . . . 0.0 110.756 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 135.32 -117.71 1.76 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.291 -0.957 . . . . 0.0 112.901 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -138.04 130.3 29.0 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 117.717 0.759 . . . . 0.0 110.848 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -103.98 151.92 22.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.359 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.668 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 11.6 m-20 -132.57 124.15 27.86 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.192 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.913 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -109.46 127.3 66.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.223 179.484 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.58 97.18 6.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.715 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.643 ' CG1' HD12 ' A' ' 27' ' ' ILE . 73.2 t -88.22 131.78 34.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.269 -179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.551 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 96.0 m-85 -125.35 154.67 41.47 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.313 0.577 . . . . 0.0 111.198 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.534 ' CB ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -87.77 175.71 7.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.414 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.41 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 2.1 p -62.82 -22.1 66.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.118 179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -96.21 24.87 5.3 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.114 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.92 27.35 56.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.645 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.45 157.14 16.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.331 . . . . 0.0 110.866 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.46 111.0 12.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.611 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.534 HD11 ' CB ' ' A' ' 82' ' ' SER . 35.2 mm -93.22 -51.55 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.403 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.469 HD13 ' HB2' ' A' ' 21' ' ' PHE . 2.5 tt -151.02 149.78 29.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.212 0.53 . . . . 0.0 111.697 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.7 108.35 5.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.176 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.466 ' CG ' HD21 ' A' ' 89' ' ' LEU . 4.1 mmpt? -122.06 156.19 34.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.378 0.608 . . . . 0.0 112.516 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.668 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -139.42 123.65 18.0 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.174 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.655 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -122.51 163.05 20.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 0.0 111.437 -179.344 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.23 133.05 53.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.482 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.899 ' HA ' HG12 ' A' ' 6' ' ' VAL . 8.1 tp -113.36 97.9 6.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.635 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -95.37 108.13 20.31 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.105 0.478 . . . . 0.0 109.98 178.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.834 HG21 ' HB3' ' A' ' 68' ' ' LEU . 1.6 mt -106.65 110.51 31.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.001 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.9 mt -66.68 126.68 29.73 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.289 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.927 -179.749 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.817 0.341 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -103.0 114.64 29.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.894 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -177.23 165.22 2.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.844 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 66.53 -149.29 51.3 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.499 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -45.84 140.72 3.41 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.267 0.556 . . . . 0.0 111.461 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.872 HG12 ' HA ' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -133.69 149.53 30.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.775 -179.521 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -118.16 127.16 53.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.59 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -149.69 177.7 27.68 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 120.326 -0.94 . . . . 0.0 112.826 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.4 ' O ' ' CD1' ' A' ' 68' ' ' LEU . . . -123.56 135.55 54.06 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.889 0.376 . . . . 0.0 110.969 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.675 HD11 ' C ' ' A' ' 69' ' ' THR . 0.9 OUTLIER -53.17 134.59 38.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.053 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.55 -5.31 84.96 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.852 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.548 ' NE2' ' O ' ' A' ' 13' ' ' GLY . 0.2 OUTLIER -107.34 168.68 9.06 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 117.126 0.463 . . . . 0.0 109.958 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.548 ' O ' ' NE2' ' A' ' 12' ' ' HIS . . . -78.57 162.09 48.85 Favored Glycine 0 C--O 1.224 -0.509 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.287 -178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.879 HG21 HD21 ' A' ' 68' ' ' LEU . 1.9 tp -176.54 138.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.764 0.316 . . . . 0.0 111.008 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.667 ' OD2' HD22 ' A' ' 58' ' ' LEU . 8.0 t0 -124.09 128.23 48.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.254 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.428 HD21 HD12 ' A' ' 95' ' ' LEU . 0.0 OUTLIER -81.93 125.09 30.33 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.157 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -104.09 124.23 48.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.275 0.559 . . . . 0.0 111.914 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.958 ' CD1' HG11 ' A' ' 78' ' ' VAL . 3.4 mt -82.1 119.94 76.18 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.417 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.97 131.15 37.88 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.37 2.047 . . . . 0.0 112.96 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 42.65 65.23 0.96 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -142.18 149.13 39.31 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.643 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -138.75 117.58 12.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.912 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.26 81.87 8.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.0 p -117.47 -173.01 2.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -57.13 -30.43 64.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.69 -24.52 64.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.012 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.557 HD12 ' CG1' ' A' ' 80' ' ' VAL . 37.1 mm -85.01 127.44 39.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.348 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -111.15 -43.86 3.67 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.172 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 81' ' ' TYR . 34.6 tt0 -127.77 118.29 23.47 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.295 -0.562 . . . . 0.0 112.125 -178.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.7 t -119.09 144.33 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.373 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -148.14 132.4 17.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.053 0.454 . . . . 0.0 112.076 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.46 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 54.5 m95 -108.07 89.41 2.99 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -98.36 146.57 25.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.395 0.617 . . . . 0.0 112.481 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.67 116.99 11.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.353 178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.1 -114.81 6.14 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.641 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.1 m -119.06 44.66 2.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.807 0.337 . . . . 0.0 110.654 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.5 m -154.27 160.74 41.93 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.294 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.593 HD13 ' OE1' ' A' ' 41' ' ' GLU . 4.1 mt -102.58 148.22 25.82 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.525 ' HA ' ' HB2' ' A' ' 51' ' ' LYS . 43.2 t -119.49 -41.31 2.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.746 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 32' ' ' TRP . . . -173.05 114.27 0.25 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.904 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.593 ' OE1' HD13 ' A' ' 38' ' ' LEU . 0.7 OUTLIER -128.07 154.71 45.39 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.183 0.516 . . . . 0.0 110.754 179.311 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -117.86 156.02 29.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.833 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -151.96 119.12 5.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.342 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.414 ' C ' ' H ' ' A' ' 46' ' ' MET . 0.0 OUTLIER -48.67 -25.6 1.86 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.329 0.585 . . . . 0.0 111.547 -179.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -77.47 28.73 0.15 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.124 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.414 ' H ' ' C ' ' A' ' 44' ' ' ARG . 1.4 ttt 52.26 169.9 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.201 0.524 . . . . 0.0 111.68 179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.1 mtpt 62.4 78.06 0.31 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.973 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -83.12 -166.92 0.41 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.614 2.209 . . . . 0.0 111.928 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.52 ' CE2' ' HB3' ' A' ' 38' ' ' LEU . 83.5 t80 -127.92 111.16 13.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.811 0.338 . . . . 0.0 111.416 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.494 HD23 ' HA ' ' A' ' 50' ' ' LEU . 9.2 mt -107.32 112.28 25.04 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.005 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 8.0 ttmt -46.71 -41.33 14.88 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.673 0.273 . . . . 0.0 111.464 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.2 p -177.03 164.38 2.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.946 0.403 . . . . 0.0 111.231 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.94 -11.95 4.91 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.734 -0.746 . . . . 0.0 113.106 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.86 1.05 13.59 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-N 117.688 0.744 . . . . 0.0 112.075 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -131.8 157.24 44.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.102 0.477 . . . . 0.0 111.161 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -151.41 119.69 6.36 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.216 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 57' ' ' ILE . 7.8 tt -76.79 99.52 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.216 0.531 . . . . 0.0 111.237 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.667 HD22 ' OD2' ' A' ' 15' ' ' ASP . 0.7 OUTLIER -53.1 163.08 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.275 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -66.58 -21.76 66.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.39 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.61 30.41 2.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.802 0.334 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.26 36.08 67.64 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.892 -0.671 . . . . 0.0 113.02 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -111.67 157.39 20.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.822 0.344 . . . . 0.0 110.963 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.404 HD11 HG12 ' A' ' 39' ' ' VAL . 10.7 tp -93.19 121.25 34.35 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.716 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.584 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -106.77 107.49 18.53 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.876 0.37 . . . . 0.0 110.948 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.839 HD12 ' CG2' ' A' ' 14' ' ' ILE . 3.4 mt -87.48 136.47 23.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.437 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 34.1 tttm -86.04 -45.91 10.99 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.952 0.406 . . . . 0.0 111.713 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.47 110.96 5.6 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.319 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.879 HD21 HG21 ' A' ' 14' ' ' ILE . 5.5 mt -53.78 152.39 5.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.169 0.509 . . . . 0.0 111.855 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.675 ' C ' HD11 ' A' ' 10' ' ' LEU . 6.0 p -152.92 159.36 42.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.194 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.673 ' N ' HD11 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -51.1 -56.94 10.15 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.078 -179.782 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -55.28 -20.94 12.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.735 ' OD2' HD13 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -81.38 -14.8 56.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.425 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.407 ' HB3' HD12 ' A' ' 97' ' ' ILE . 5.6 p -81.99 137.88 35.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.58 0.229 . . . . 0.0 110.863 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 146.63 -124.62 2.04 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.835 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.1 m -136.92 133.43 35.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 117.9 0.85 . . . . 0.0 110.595 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.541 ' CE1' HD12 ' A' ' 95' ' ' LEU . 29.3 m-85 -108.69 135.55 49.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.44 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.726 ' OD1' ' HB2' ' A' ' 92' ' ' ALA . 17.2 m-20 -115.44 121.93 44.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.162 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.958 HG11 ' CD1' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -104.58 130.94 54.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.304 179.401 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.97 104.23 10.69 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.557 ' CG1' HD12 ' A' ' 27' ' ' ILE . 89.7 t -95.91 125.44 48.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.7 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.553 ' HB2' ' HB3' ' A' ' 29' ' ' GLU . 77.9 m-85 -119.31 147.54 44.19 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.28 0.562 . . . . 0.0 111.058 179.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.551 ' OG ' HD11 ' A' ' 88' ' ' ILE . 0.0 OUTLIER -88.85 178.75 6.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.491 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.427 ' HA ' ' HB2' ' A' ' 28' ' ' ASP . 1.0 OUTLIER -64.06 -18.65 64.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.208 179.628 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -94.73 20.88 8.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.234 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 55.85 30.05 56.08 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.756 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.56 153.66 20.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.821 0.344 . . . . 0.0 110.901 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.21 106.04 6.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.707 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.551 HD11 ' OG ' ' A' ' 82' ' ' SER . 28.4 mm -78.23 -64.68 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.404 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.917 HD21 ' HG3' ' A' ' 91' ' ' LYS . 3.0 tt -145.1 133.26 21.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.155 0.502 . . . . 0.0 111.814 -179.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.2 108.33 14.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.168 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.917 ' HG3' HD21 ' A' ' 89' ' ' LEU . 7.9 mmpt? -121.2 158.08 28.83 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.726 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . . . -138.39 122.43 17.92 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.238 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.652 ' N ' HD12 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -118.45 160.77 21.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.963 0.411 . . . . 0.0 111.421 -179.39 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -106.79 131.82 53.46 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.383 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.872 ' HA ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -117.39 99.16 6.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.319 -179.456 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -94.84 111.92 23.67 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.188 0.518 . . . . 0.0 110.524 179.238 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.782 HG21 ' HB3' ' A' ' 68' ' ' LEU . 4.0 mt -110.67 114.18 46.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.753 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mt -68.08 119.49 12.77 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.652 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.938 -179.842 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_